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Abstract 
ABSTRACT 
 
Cyanobacteria are common inhabitants of freshwater lakes and 
reservoirs throughout the world. Under favourable conditions, certain 
cyanobacteria can dominate the phytoplankton within a waterbody and 
form nuisance blooms. Case reports and anecdotal references dating 
from 1949 describe a range of illnesses associated with recreational 
exposure to cyanobacteria: hay fever-like symptoms, pruritic skin rashes 
and gastro-intestinal symptoms (the latter probably related to ingestion of 
water) are most frequently reported. Some papers give convincing 
descriptions of allergic responses to cyanobacteria; others describe more 
serious acute illnesses, with symptoms such as severe headache, 
pneumonia, fever, myalgia, vertigo and blistering in the mouth. A U.S. 
coroner recently found that a teenage boy died as a result of accidentally 
ingesting a neurotoxic cyanotoxin from a golf course pond; this is the first 
recorded human fatality attributed to recreational exposure to 
cyanobacteria. One of the main public health concerns with exposure to 
freshwater cyanobacteria relates to the understanding that some blooms 
produce toxins that specifically affect the liver or the central nervous 
system. The route of exposure for these toxins is oral, from accidental or 
deliberate ingestion of recreational water, and possibly by inhalation. 
Cyanobacterial lipopolysaccharides (LPS) are also reported to be 
putative cutaneous, gastrointestinal, respiratory and pyrogenic toxins.  
 
The aims of this project were to enhance the understanding of public 
health issues relating to recreational exposure to cyanobacteria by 
conducting epidemiological and laboratory-based toxicology studies.  
 
A prospective cohort study of 1,331 recreational water users was 
conducted at various sites in southern Queensland, the Myall Lakes area 
of New South Wales, and central Florida. The study design sought to 
make improvements over previously published epidemiological studies, in 
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that an unexposed group was recruited from cyanobacteria-free waters, 
cyanobacterial toxins were measured in site water samples, and 
respondents were asked to rate the severity of reported symptoms. This 
study has shown an increased likelihood of symptom reporting amongst 
bathers exposed to high cyanobacterial cell density (measured by total 
cell surface area) compared to those exposed to low cyanobacteria-
affected waters. Mild respiratory symptoms appear to be the predominant 
symptom category.  
 
A clinical dermatology study to examine delayed-contact hypersensitivity 
reactions to cyanobacterial extracts was conducted. The study groups 
were 20 patients presenting for diagnostic skin patch testing at the Royal 
Brisbane Hospital’s dermatology outpatient clinic; a convenience sample 
of 20 individuals was recruited from outside the hospital as a control 
group. One patient developed unequivocal reactions to several 
cyanobacteria extracts, with no dose-response pattern seen, indicating 
that the reactions were allergic in nature.  
 
A mouse model of delayed-contact hypersensitivity, the mouse ear 
swelling test, has demonstrated that the purified toxin 
cylindrospermopsin, a highly water-soluble compound, is capable of 
producing cutaneous injury. Encrusting lesions were seen on abdominal 
skin during the induction phase of these experiments. Delayed-contact 
hypersensitivity reactions were also demonstrated with this toxin.  
 
LPS from two non-axenic cyanobacterial samples – Cylindrospermopsis 
raciborskii and Microcystis aeruginosa – were extracted and purified. 
Thermoregulation studies were performed using a mouse model of rectal 
temperature measurement. Separate groups of mice were injected with 
these LPS extracts at two dose levels. Thermoregulation studies were 
also conducted with purified cyanobacterial toxins: microcystin-LR and 
cylindrospermopsin and anatoxin-a; cyanobacterial LPS samples purified 
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by collaborators in Adelaide were also investigated for thermoregulation 
potential. These experiments have shown that the LPS extracts are 
weakly active when compared with responses to much lower doses of 
Escherichia coli LPS. Cylindrospermopsin also produces hypothermic 
responses in mice – comparable to pyrexia in larger mammals – although 
at a later stage than was seen with LPS extracts.  
 
Supplementing the experimental observations of the toxicology and 
immunotoxicology of cyanobacterial LPS are insights gained from beyond 
the cyanobacteria literature on the mechanisms of toxicity of different 
LPS structures. Cyanobacterial LPS was initially suggested to be toxic in 
the 1970s, at a time when lipid A, the active moiety of LPS, was thought 
to be identical across all Gram-negative bacteria. More recent work 
raises questions about the attribution of cutaneous and gastrointestinal 
illness to cyanobacterial LPS, with the understanding that some bacterial 
lipid A structures are LPS antagonists, LPS is not toxic by the oral route, 
and LPS is not reported as a toxin in the clinical dermatology literature. 
Gut-derived lipopolysaccharides, however, exert potent synergistic 
effects with a variety of xenobiotic hepatotoxins, and the well-known 
shock-like syndromes associated with severe cylindrospermopsin and 
microcystin poisoning deserve further scrutiny from the perspective of 
immunotoxicology. 
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CHAPTER 1: THESIS INTRODUCTION AND RATIONALE. 
CYANOBACTERIA AND HUMAN HEALTH, EPIDEMIOLOGY OF 
RECREATIONAL EXPOSURE – A REVIEW OF THE LITERATURE 
 
1.1. THESIS OVERVIEW AND RATIONALE 
 
This candidate’s brief was to investigate public health impacts of recreational 
exposure to freshwater cyanobacteria by conducting both an epidemiologic 
study and laboratory-based toxicology studies. Chapter 1 will introduce the 
topic of cyanobacteria in recreational waters with an overview of the main 
cyanotoxins. A comprehensive review of anecdotal and case reports of human 
illness attributed to recreational exposure to cyanobacteria will follow, with 
discussion of some important papers. Epidemiological studies of recreational 
exposure to cyanobacteria will be reviewed. A brief synopsis of the 
advantages and disadvantages of various common epidemiological study 
designs will follow; their actual and potential application to the study of 
recreational exposure to cyanobacteria will be raised. Discussion of some 
water-related risk factors that may be important differential diagnoses for 
cyanobacteria-related illness will conclude the chapter. 
 
Chapter 2 presents a review of cyanobacterial lipopolysaccharide (LPS). 
Cyanobacterial LPS is frequently cited in the cyanobacteria literature as a 
toxin responsible for a variety of heath effects in humans, from skin rashes to 
gastrointestinal, respiratory and allergic reactions. In order to place the 
biological activity of cyanobacterial LPS in the context of the much more 
widely studied lipopolysaccharides of Gram-negative bacteria, particularly 
Escherichia coli and Salmonella spp, some relevant aspects of the broader 
immunology, microbiology and structural biochemistry literature will be 
reviewed. 
 
An epidemiologic investigation of recreational exposure to freshwater 
cyanobacteria is presented in Chapter 3. A prospective cohort study was 
conducted in southern Queensland, the Myall Lakes area of New South Wales 
(both areas are located in eastern Australia), and central Florida, USA. This 
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study aimed to improve on previously published epidemiological studies of this 
topic: more subjects were recruited (n=1331); subjects were asked to 
categorise the severity of illnesses reported to have commenced within the 
follow-up period; cyanobacterial toxins were directly identified and quantified; 
reference subjects (i.e. controls) were recruited from individuals participating 
in water recreation at sites unaffected by cyanobacteria; and exposure was 
defined in terms of cyanobacterial cell biomass – cell surface area and cell 
biovolume – as well as the more traditional exposure measure of cell 
numbers. Weaknesses of this study and some inherent limitations of all 
epidemiological studies into recreational exposure to cyanobacteria will be 
extensively discussed in this chapter and in Appendix 2.  
 
Another study involving human volunteer subjects follows in Chapter 4. This 
investigation was a pilot study into cutaneous effects of aqueous extracts of 
toxic and non-toxic cyanobacteria. This clinical dermatology study utilised an 
internationally accepted and standardised technique for diagnosing irritant and 
delayed-contact hypersensitivity: the Finn chamber method of skin patch 
testing. This study utilised a case-control design: the study group comprised 
patients attending a tertiary referral hospital outpatient dermatology clinic for 
diagnostic skin patch testing, and the control group was a convenience 
sample of mostly undergraduate medical and postgraduate environmental 
toxicology students.  
 
Chapter 5 continues the cutaneous reactivity theme of the previous chapter, 
presenting a mouse model of delayed-contact hypersensitivity, the mouse ear 
swelling test. This model encompasses induction and challenge phases, with 
test material applied to the depilated abdominal skin of test mice, and vehicle 
applied to control mice abdomens for the induction period. Challenge involves 
the application of test material to a naïve skin site – one ear of each mouse – 
with control mice serving to confirm that non-irritant doses are being used. 
Discussion of the immunological nature of irritant and hypersensitivity 
reactions of the skin is presented in Chapter 5. This discussion develops a 
theme which appears throughout this thesis, that innate immune reactions 
may explain some mechanisms of toxicity of cyanobacterial hepatotoxins. This 
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concept of the immunotoxicology of cyanobacteria was not anticipated at the 
start of this thesis, but developed from the candidate’s reading of the 
mechanisms of toxicity of heterotrophic bacterial LPS for Chapter 2.  
 
Chapter 6 presents the final experimental work of this thesis, which 
investigated the thermoregulatory effects of cyanobacterial LPSs and some 
purified cyanobacterial exotoxins. This experiment was designed as an initial 
foray into the field of immunotoxicology, from the realisation that exogenous 
substances, including toxins, which affect changes in thermoregulation do so 
by indirect mechanisms. The study of pyrogens, regulated hyperthermia and 
hypothermia is essentially a study of innate immunity, because the 
mechanisms are directed by endogenous mediators, principally cytokines, 
these being principal component proteins of the innate immune system. A 
mouse model of thermoregulation was conducted, with core temperatures 
measured by digital rectal thermometry.  
 
Insights gained from the immunology literature and from the experimental 
work undertaken for this thesis led to the inclusion of Chapter 7. This chapter 
is a critical review of the cyanobacteria literature from an immunotoxicology 
perspective, specifically that of innate immune mechanisms. An alternative 
hypothesis to explain some of the laboratory findings of microcystin and 
cylindrospermopsin poisoning is presented in Chapter 7. Other workers have 
published studies of cyanobacterial toxicology where the measured end-points 
were innate immune proteins such as Tumour Necrosis Factor – alpha (TNF-
α) and Interleukin 1 beta (IL-1β). However, the topic of cyanobacterial 
toxicology has not been systematically approached using the knowledge base 
and research techniques of immunotoxicology. Chapter 7 will conclude with 
suggested approaches to test the hypothesis that the cyanobacterial 
hepatotoxins may cause illness and tissue injury through indirect 
mechanisms, mediated by endogenous agents. 
 
The thesis concludes with Chapter 8, which summarises the main findings, 
and the strengths and limitations of the work. 
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1.2. INTRODUCTION 
 
Cyanobacteria are a diverse group of prokaryotes that occupy a broad range 
of ecological niches by virtue of their age, having first appeared some 2.5 
billion years ago, and specialisation. All cyanobacteria are photoautotrophic 
organisms, yet many can grow heterotrophically, using light for energy and 
organic compounds as a carbon source (Adams, 1997). The cyanobacteria 
are a remarkably widespread and successful group, colonising freshwater, 
marine and terrestrial ecosystems, including extreme habitats such as 
Antarctic lakes, salt works and hot springs (Fogg et al, 1973 pp 273, 277, 
299).  
 
Cyanobacteria have come to the attention of public health workers because 
many freshwater and brackish species can produce a range of potent toxins. 
This observation was first reported over 120 years ago, when sheep, horses, 
dogs and pigs were seen to die within hours of drinking from a lake affected 
by a bloom of the brackish-water cyanobacterium Nodularia spumigena 
(Francis, 1878). Since then, many reports of livestock and wild animal deaths 
have appeared in the literature. Such reports have been collated by several 
authors (Schwimmer & Schwimmer, 1964; Schwimmer & Schwimmer, 1968; 
Codd & Beattie, 1991; Carmichael & Falconer, 1993; Ressom et al, 1994 
pp40-3). Some reports are dramatic in terms of the number of animals 
affected or the rapid progression of illness and death, with mass deaths of 
thousands of animals (Rose, 1953), and large animals succumbing within 
minutes (McLeod & Bondar, 1952; Codd et al, 1995).  Laboratory-based 
toxicological investigations have confirmed that freshwater and brackish 
cyanobacteria produce several categories of toxin that are (with one exception 
– the saxitoxins) unique to cyanobacteria. The topic of cyanobacterial toxins 
has been widely studied, and many excellent texts and reviews are available. 
Some examples that this author has found useful are: Carmichael (1981); 
Carmichael et al (1985); Falconer (1993); Ressom et al (1994); Codd et al 
(1995); Sivonen (1996); Chiswell et al (1997); Codd et al (1997); Dawson 
(1998);  Falconer (1998);  Hunter (1998); Chorus & Bartram (1999);  Codd et 
al (1999); Botana (2000); Chorus (2001). 
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1.3. Cyanotoxins 
 
Cyanobacterial toxins are usually classified either by chemical structure or by 
their effects on different organ systems; the latter approach will be used here 
to broadly classify toxins into three groups: hepatotoxins, neurotoxins and 
dermal toxins.  
 
 
1.3.1. Hepatotoxins  
 
Two classes of hepatotoxic compounds are produced by cyanobacteria: the 
cyclic peptide microcystins and nodularins, which are highly selective liver 
protein phosphatase inhibitors (Van Dolah, 2000), and cylindrospermopsin, a 
cyclic guanidine alkaloid toxin, initially found in Cylindrospermopsis raciborskii 
and also produced by Umezakia natans, Aphanizomenon ovalisporum, 
Anabaena bergii and Raphidiopsis curvata (Shaw et al, 1999; Sivonen & 
Jones, 1999; Griffiths & Saker, 2003).  
 
 
1.3.1.1. Microcystins and Nodularins 
 
More than 60 microcystin derivatives have been identified (WHO, 2003 p140); 
the most toxic congener being microcystin-LR. Microcystins are mainly 
produced by Microcystis aeruginosa, but are also seen in other Microcystis 
species, and other genera including Anabaena, Nostoc, Planktothrix and 
Aphanocapsa (Dawson, 1998; Domingos et al, 1999; WHO, 2003 p141). 
Nodularin is produced by some strains of the brackish water species 
Nodularia spumigena; only about five variants have been described (Takai & 
Harada, 2000; Saito et al, 2001). Microcystins and nodularins enter 
hepatocytes via the bile-acid transport system (Codd et al, 1999), and they 
are classified as hepatotoxins because of their specificity in targeting the liver 
in animals. Injury and subsequent death is due to disruption of the lobular and 
sinusoidal structure, and intrahepatic haemorrhage (Takai & Harada, 2000). 
Most microcystins have i.p. mouse LD s in the range of 45-70μg/kg for the 50
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most toxic forms (WHO, 2003 p140), and nodularin has an LD50 of 60μg/kg 
(Ressom et al, 1994 pp 31-32).  
 
 
1.3.1.2. Cylindrospermopsin 
 
Cylindrospermopsin is also classified as a hepatotoxin, because in pure form 
it mainly affects the liver (Chiswell et al, 1997; Sivonen & Jones, 1999). 
However, its structure and mechanism of toxicity are different to the 
microcystins. Cylindrospermopsin is a protein synthesis inhibitor (Terao et al, 
1994; Froscio et al, 2003); crude extracts of C. raciborskii damage the 
kidneys, spleen, thymus, stomach and heart when given to mice (Seawright et 
al, 1999; Sivonen & Jones, 1999). Significant variability in the severity of 
hepatic and renal damage caused by different batches of C. raciborskii with 
similar cylindrospermopsin content raises the possibility of other toxicological 
mechanisms associated with this cyanobacterium (Falconer et al, 1999b). 
Deoxycylindrospermopsin, an analogue of cylindrospermopsin, has been 
identified but it does not appear to contribute to the toxicity of C. raciborskii 
(Norris et al, 1999). 7-epicylindrospermopsin, a toxic minor metabolite, has 
been isolated from a culture of Aphanizomenon ovalisporum from Israel 
(Banker et al, 2000). C. raciborskii is receiving more research attention 
because of its potential adverse effects on drinking water supplies. Unlike 
some other cyanobacterial toxins which have low oral toxicity compared with 
intraperitoneal toxicity, cylindrospermopsin is bioavailable via the oral route 
(Chiswell et al, 1997; Falconer, 1999; Seawright et al, 1999). In 1979, 
cylindrospermopsin-producing C. raciborskii was believed to be the causative 
organism in the so-called Palm Island mystery disease, when 148 individuals, 
mostly children, presented with hepatomegaly, malaise, anorexia and 
vomiting. Eighty-two per cent of the children developed acidosis and 
hypokalemia, 39% developed profuse diarrhoea, in most cases with frank 
blood present (Byth, 1980; Hawkins et al, 1985; Griffiths & Saker, 2003). The 
mouse i.p. LD50 for cylindrospermopsin is reported as 2.1mg/kg at 24 hours, 
and 200µg/kg at 5-6 days (Ohtani et al, 1992). 
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1.3.2. Neurotoxins 
 
There are three groups of cyanobacterial neurotoxins, classified according to 
structure: anatoxin-a and homoanatoxin-a, which are alkaloids; anatoxin-a(S), 
a phosphate ester; and saxitoxins, also alkaloid compounds. 
 
 
1.3.2.1. Anatoxin-a and homoanatoxin-a 
 
The first alkaloid toxin to be isolated and characterised was anatoxin-a, 
produced by a toxic strain of Anabaena flos-aquae (Carmichael et al, 1985). 
Anatoxin-a has since been isolated from toxic strains of other Anabaena 
species, and from Oscillatoria, Aphanizomenon and Microcystis (Codd et al, 
1997; Sivonen & Jones, 1999). Anatoxin-a has an LD50 (i.p. mouse) of 200-
375µg/kg (Fitzgeorge et al, 1994; Ressom et al, 1994 p29). A related 
compound, homoanatoxin-a, has been isolated from a strain of Phormidium 
formosum (Skulberg et al, 1992). Anatoxin-a and homoanatoxin-a cause a 
potent neuromuscular blockade, which manifests as staggering, gasping and 
muscle fasciculation in affected animals; death results from paralysis of 
respiratory muscles (Skulberg et al, 1992; Ressom et al, 1994 p28; Codd et 
al, 1997).  
 
Anatoxin-a production by cyanobacteria appears to be largely a northern 
hemisphere phenomenon, at least as far as Anabaena circinalis is concerned. 
A. circinalis is a major bloom-forming cyanobacterium with a worldwide 
distribution, yet American and European isolates produce only anatoxin-a, 
while Australian isolates produce saxitoxins exclusively (Beltran & Neilan, 
2000). Anatoxin-a degradation products were reportedly found in a benthic 
cyanobacteria mat in New Zealand that apparently killed a dog some ten 
minutes after it licked the mat (Hamill, 2001). Bloom sampled are not routinely 
analysed for anatoxin-a in Australia, though perhaps a research project to 
systematically screen for this potent neurotoxin in Australian cyanobacteria 
might be warranted. 
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1.3.2.2. Anatoxin-a(S) 
 
A structurally unrelated toxin, anatoxin-a(S) has been found in some 
Anabaena species (Sivonen & Jones, 1999). Anatoxin-a(S) is an 
anticholinesterase; its intra-peritoneal LD50 in mice is 20µg/kg. 
 
 
1.3.2.3. Saxitoxins 
 
The other group of cyanobacterial alkaloid neurotoxins are the saxitoxins; 
these are sodium-channel blockers, inhibiting nerve axon conduction (Codd et 
al, 1997). Saxitoxins are also known as paralytic shellfish poisons because 
they were initially isolated from shellfish, which concentrated the toxin from 
marine dinoflagellates (Gorham & Carmichael, 1988). Nineteen different 
saxitoxins have been recognised from cyanobacteria, produced by Anabaena, 
Aphanizomenon, Lyngbya and Cylindrospermopsis spp (Carmichael et al, 
1997; Lagos et al, 1999; Sivonen & Jones, 1999; Sivonen, 2000). Mouse i.p. 
LD s are 10-30µg/kg (WHO, 2003 p140). 50
 
 
1.3.3. Dermal toxins 
 
The marine filamentous cyanobacterium Lyngbya majuscula has been known 
to cause severe primary contact irritation in swimmers for over four decades 
(Grauer, 1959; Grauer & Arnold, 1961). Signs and symptoms are a burning 
sensation, erythema, blistering and deep desquamation (Moore, 1984). The 
toxins responsible for these effects have been identified as two phenolic bis-
lactones, called aplysiatoxin and debromoaplysiatoxin (Moore et al, 1984). 
Lyngbyatoxin A, a modified cyclic dipeptide also found in L. majuscula, is 
another inflammatory agent which, although not implicated in so-called 
seaweed dermatitis, is reported to have caused severe oral and gastro-
intestinal inflammation after accidental ingestion (Moore, 1996). 
Debromoaplysiatoxin has also been isolated from other marine cyanobacteria 
such as Schizothrix and Oscillatoria (Moore et al, 1984). These potent 
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inflammatory toxins operate through mechanisms similar to those of phorbol 
esters; they are tumour promoters, activating protein kinase C (Moore, 1984).  
 
 
1.3.4. Other toxins  
 
Cyanobacterial lipopolysaccharides are extensively cited with reference to 
their presumed toxic properties, and will be reviewed in the following chapter 
of this thesis. Cyanobacteria are rich sources of bioactive compounds; 
structurally diverse metabolites with cytotoxic, tumour-promoting and enzyme-
inhibiting properties are known and presumably many more await discovery. 
Some of these metabolites are discussed by Bickel et al, (2001) and Forchert 
et al, (2001).  
 
 
1.4. Recreational exposure to cyanobacteria  
 
1.4.1. Anecdotal and case reports 
 
Cyanobacteria are common inhabitants of freshwater lakes and reservoirs 
throughout the world. Under favourable conditions, certain cyanobacteria can 
dominate the phytoplankton within a waterbody and form nuisance blooms. 
Case reports and anecdotal references dating from 1949 describe a range of 
illnesses associated with recreational exposure to cyanobacteria: hay fever-
like symptoms, pruritic skin rashes and gastro-intestinal symptoms are most 
frequently reported. Some papers give convincing descriptions of allergic 
responses to cyanobacteria (Heise, 1949; Cohen & Reif, 1953). Others 
describe more serious acute illnesses, with symptoms such as severe 
headache, pneumonia, fever, myalgia, vertigo and blistering in the mouth 
(Dillenberg & Dehnel, 1960; Carmichael et al, 1985; Turner et al, 1990; Codd 
& Beattie, 1991). The first and so far only description of a fatality related to 
recreational exposure to cyanotoxins appeared in news reports recently. A 
U.S. coroner concluded that a teenage boy died as a result of ingesting 
anatoxin-a-producing cyanobacteria from a golf course pond, although there 
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was an unusual sequence of events preceding the death (Behm, 2003; 
Campbell & Sargent, 2004). The principal public health concerns regarding 
recreational exposures relate to the potential, presumably a now-realised 
potential if the aforementioned fatality is indeed attributable to cyanotoxin 
poisoning, for exposure to hazardous levels of cyanotoxins in untreated 
waters. Routes of exposure are through direct contact with skin and mucous 
membranes, via inhalation, and by ingestion, either accidental or deliberate.  
 
Table 1.1 presents all anecdotal and case reports that this author is aware of 
in the medical and scientific literature referring to supposed cyanobacteria-
related illness in humans through recreational and occupational exposures.   
 
 
 
 
 
 TABLE 1.1. Reports of human morbidity and mortality attributed to recreational exposure to freshwater cyanobacteria.
Year Season Location Number 
affected 
Estimates of 
number 
unaffected 
Age Water 
activity 
Signs & 
Symptoms 
Dominant 
plankton 
Time of 
onset after 
exposure 
Symptom 
duration 
Diagnostic 
criteria 
Predisposing 
conditions 
Notes References 
 
Hayfever-like symptoms (conjunctivitis, rhinitis, sneezing) 
 
1934 Late 
summer 
Muskego Lake, 
Waukesha 
County, WI, USA 
Report of 
single 
subject, 
male 
N/S 57 Swimming Itching of eyes, 
nasal congestion 
“weedy lake” 3 hours <48 hours  History of 
frequent sinus 
infections 
 Heise, 1949 
 
 
1935 Late 
summer 
Muskego Lake, 
WI, USA 
Same 
subject 
N/S  Swimming Same 
symptoms, + 
mild asthma 
 As above As above    Heise, 1949 
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1936-
1946 
 
 
Late 
summer 
North Lake, 
Waukesha 
County, WI, USA 
Same 
subject 
N/S  Swimming Nasal discharge 
and congestion, 
conjunctivitis, 
mild asthma 
Oscillatoreaceae 
(sample taken in 
late summer, 
1944) 
N/S N/S Surface scum 
extracts gave 
immediate skin 
reactions. 
Cutaneous 
injection of 
0.03mL of 
1:1,000 dilution 
resulted in mild 
asthma within 20 
mins. Control 
subjects did not 
react to scum 
extracts  
 Subject swam in 
North Lake 
during summer 
months over the 
ten-year period, 
without incident 
until mid-August 
each year, when 
swimming was 
followed by 
symptom onset. 
Heise, 1949 
Desensitisation 
injections over 4 
years were 
successful 
Hayfever 
symptoms: 
during 
exposure; 
N/S  N/S  Billings, 
1981 
1979 Late 
summer 
Lake 
Wallenpaupack, 
PA, USA 
5 (family 
group) 
N/S N/S 
(parents 
+ son + 
daughter 
+ friend) 
Swimming “Severe” 
hayfever-like 
symptoms 
(sneezing, nasal 
discharge, eye 
irritation): 3/5 
N/S. Lake 
developed a 
distinct green 
colour several 
days prior to 
incident.  3 
weeks later: 
heavy bloom of 
Anabaena 
 
 
earache: 
several 
hours after 
exposure 
earache: 2/5 
1979 
 
 
Late 
summer 
Lake 
Wallenpaupack, 
PA, USA 
20-30 60-90 (those 
affected 
comprised 
approx 25% of 
aquatic event 
participants) 
N/S (high 
school 
students) 
Participating 
in school 
aquatic 
event 
Eye irritation, 
sore throat, 
earache, 
sneezing, nasal 
discharge, 
swollen lips 
N/S. see above During 
exposure or 
within 2-3 
hours 
Within 2-3 
days 
 
*Subsequent 
exposure 
reportedly 
caused re-
occurrence of 
symptoms  
 N/S Affected 
individuals were 
members of a 
high school 
summer aquatic 
program. The 
event was 
cancelled 
because of 
these illnesses 
Billings, 
1981 
N/S N/S N/S Single male N/S N/S 
(adult) 
Swimming Hayfever-like 
symptoms 
Bloom of 
Microcystis 
N/S N/S  N/S  Reif, 1981  
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 Year Season Location Number 
affected 
Estimates of 
number 
unaffected 
Age Water 
activity 
Signs & 
Symptoms 
Dominant 
plankton 
Time of 
onset after 
exposure 
Symptom 
duration 
Diagnostic 
criteria 
Predisposing 
conditions 
Notes References 
 
Cutaneous symptoms  
 
1949-
1952 
Summer Lake Carey, PA, 
USA  
Report of 
single 
subject, 
female 
Reported skin 
rash “never 
appeared in 
other bathers 
swimming in 
the same 
water” 
6 
(condition 
first seen 
at age 3 
years) 
Swimming Seasonal 
erythematous 
papulo-vesicular 
rash, 
occasionally 
progressing to 
oozing and 
crusting. Rash 
limited to face, 
neck, shoulders, 
upper chest and 
extremities; rash 
never seen on 
areas covered 
by swimsuit 
1-2 hours < 2 weeks (if 
no further 
contact with 
lake water) 
Skin patch 
testing: strong 
positives to 
Anabaena 
filtered from lake 
water, 
chloroform 
extract of same, 
and phycocyanin 
extract  
None (apart 
from reported 
condition) 
Rash never seen 
after swimming 
in artificial pools 
or ocean. Only 
seen after water 
exposure at 
Lake Carey, and 
once after 
bathing in a 
Canadian lake 
Cohen & 
Reif,  
Anabaena 
 1953 
 
Late 
1940s 
& mid 
1950s 
Late 
summer 
Lake Ringsjön, 
Scania, Sweden 
“several” 
members of 
a family 
N/S N/S 
(“young 
girl” + 
siblings) 
Swimming Pruritic skin 
rashes 
N/S N/S    Cronberg, 
1999 
Cronberg et 
al, 1999 
Gloeotrichia 
echinulata 
 35
1977 Summer Mingechaur 
Reservoir, 
Azerbaijan 
7 13 N/S Swimming Slightly raised, 
erythematous 
spots, 2-6mm 
diameter; seen 
on skin 
bordering and 
outside swimsuit 
Benthic Lyngbya 
kützingii; also 
“planktonic blue-
green algae 
colouring the 
water” 
2nd day after 
swimming 
10-12 days    Pashkevich, 
1979 
1985 N/S UK N/S N/S N/S Sail-
boarding 
Skin rashes N/S (“toxic 
blooms”) 
N/S N/S  N/S  NRA, 1990 
p43  
1989 N/S Japan (lake) 1 N/S N/S 
(adult) 
Collecting 
algal scum * 
Rashes N/S N/S  N/S  NRA, 1990 
p59 
M. aeruginosa 
containing 
microcystins 
 
1989 Late 
summer – 
early 
autumn 
Bewl Water, 
Kent, UK 
1 N/S N/S Fishing ‘blotchy’ skin on 
face and hands 
after handling 
water on three 
separate 
occasions 
Microcystis sp Within two 
hours 
Several days  N/S  NRA, 1990 
p100  
 
1989 N/S NRA South West 
Region, UK 
N/S (“some 
NRA staff”) 
N/S N/S 
(adults) 
Sampling 
water * 
Tingling 
sensations on 
hands 
“Potentially toxic 
cyanobacteria 
species” 
N/S N/S  N/S  NRA, 1990 
p102  
1989 Early-mid 
autumn 
Welton Water, 
Yorks, UK 
N/S N/S N/S N/S (“water 
users”) 
Rashes Anabaena sp N/S N/S  N/S  NRA, 1990 
p105  
1991 Late 
spring – 
early 
summer 
Darling-Barwon 
river system, 
NSW, Australia 
N/S N/S N/S 
(adults) 
Sampling 
water* 
Skin irritation Anabaena spp N/S N/S  N/S  NSW Blue-
Green Algae 
Task Force, 
1992 p32 
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Gastro-intestinal symptoms (nausea, vomiting, diarrhoea, abdominal pain) 
 
 36
1959 
 
 
Summer One of Katepwa 
Lakes, SK, 
Canada 
Report of 
single 
subject, 
male 
N/S N/S 
(adult) 
Swimming Headache, 
nausea, G-I 
upset 
N/S During night 
after 
swimming 
<48 hours.  Stool sample 
showed “many 
tiny greenish 
spheres which 
resembled in 
size and 
morphology the 
cells of 
Microcystis”. 
Stool specimen 
negative for 
Salmonella and 
Entamoeba 
N/S Subject sought 
medical advice 
for 
gastroenteritis, 
admitted to 
hospital, given 
oral 
chloramphenicol. 
Recovery within 
24 hours of 
admission 
Dillenberg & 
Dehnel, 
1960 
1959 Summer Long Lake, SK, 
Canada 
10 N/S N/S 
(children) 
Swimming Diarrhoea, 
vomiting 
N/S. Subjects 
swam in “algae-
covered lake 
water”. Dried 
Microcystis and 
Anabaena scum 
found later on 
shore 
N/S. 
Reported to 
local 
medical 
officer with 
illness on 
the day 
after 
exposure 
N/S Stool specimen 
from one child 
contained cells 
resembling 
Anabaena “in 
great numbers” 
 Local farmer 
reported that two 
cows died after 
drinking from the 
lake 12-16 hours 
previously, 
during an algal 
bloom. A third 
sick cow 
recovered after 
receiving 
penicillin 
injections 
Dillenberg & 
Dehnel, 
1960 
 
 
N/S N/S N/S (lake) Single 
subject, 
male  
N/S 4 Fell into 
lake, 
swallowed 
water # 
Abdominal pain, 
nausea, 
vomiting, 
diarrhoea, 
wooziness, 
headache, thirst 
N/S Day of 
exposure: 
G-I 
symptoms; 
N/S N/S  Dillenberg, 
1964 
Aphanizomenon 
found in stool 
and vomitus 
specimens 
 
 
next day: 
wooziness, 
headache, 
thirst 
1961 N/S N/S 4 N/S N/S 
(students) 
Swimming Headache, 
malaise, 
diarrhoea 
Heavy growth of 
Microcystis and 
Anabaena 
N/S N/S  N/S  Dillenberg, 
1964  
1989 Early 
autumn 
Rutland Water, 
Leics, UK 
N/S N/S 2 & 3 
year-olds 
Playing at 
edge of 
scum 
Vomiting & 
diarrhoea 
N/S N/S Microcystin-LR 
found to be 
principal 
cyanobacterial 
toxin present 
N/S 20 sheep and 15 
dogs died over 
approx 3 weeks 
in late summer – 
early spring after 
contact with 
bloom scum 
Codd & 
Beattie, 
1991 
M. aeruginosa 
 
 
1990 N/S Unnamed lake, 
Tiel, The 
Netherlands 
N/S N/S N/S Swimming “G-I complaints” N/S N/S Water quality 
parameters and   
food-borne 
pathogen testing 
negative 
N/S Mouse bioassay 
and HPLC-UV 
confirmed 
presence of 
anatoxin-a 
van Hoof, 
1994 
Anabaena flos-
aquae  
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Progression to fatal illness 
 
 37
 
2002 
 
 
Mid-
summer 
Golf course 
pond, 
Milwaukee, WI, 
USA 
5 0 17 yo 
male and 
4 friends 
“splashing 
and diving”. 
Two most 
severely 
affected 
boys had 
their heads 
under water 
for varying 
periods of 
time # 
17-year-old 
developed 
nausea, 
vomiting, 
progressed to 
“shock” and 
“seizure”, acute 
heart failure; 
death occurred 
approx. 48 hours 
after exposure. 
One teenager 
who also 
apparently 
ingested water 
developed 
severe diarrhoea 
and abdominal 
pain. The other 
three youths 
developed 
“minor 
symptoms” 
Presumably A. 
flos-aquae 
containing 
anatoxin-a, 
determined from 
blood and stool 
samples of the 
boy that died 
and the other 
severely affected 
youth 
N/S N/S Analysis of 
“tissue, blood 
and other fluid 
samples” from 
the two severely 
affected 
teenagers. 
Anatoxin-a found 
in unspecified 
sample/s. 
Autopsy showed 
“acute heart 
damage” but no 
evidence of 
meningitis or 
encephalitis.  
Analyses for 
pesticides, 
parasites and 
other pathogens 
negative 
N/S  The unusual 
feature of this 
case is the 
length of time – 
48 hours –  
between 
exposure and 
ingestion of 
contaminated 
water and 
subsequent 
death  
Behm, 2003 
 
Campbell & 
Sargent, 
2004 
 
 
Cold & flu-like symptoms (incl. fever, headache, myalgia, arthralgia, sore throat, respiratory and gastro-intestinal) 
 
Recovering 
when 
questioned on 
2
N/S. Lake had a 
visible bloom on 
day of exposure.   
Microcystis and 
Anabaena bloom 
35 days prior to 
exposure 
3 hours: 
abdominal 
pain, 
nausea, 
vomiting 
Dillenberg & 
Dehnel, 
1960 
1959 Summer Echo Lake, SK, 
Canada 
Report of 
single 
subject, 
male  
N/S N/S 
(adult) 
Intending to 
swim – fell 
into lake, 
swallowed 
an 
estimated 
half-pint of 
water # 
Abdominal 
cramps and 
pain, nausea, 
vomiting, painful 
diarrhoea, fever, 
severe 
headache, 
weakness, pain 
in limb muscles 
and joints. 
Stools and 
vomitus were 
slimy and green 
Stool specimen 
showed 
“innumerable 
spheres of 
Microcystis and 
2-3 well-
preserved 
curved chains of 
A. circinalis per 
high-power field” 
N/S During bloom 35 
days prior to 
exposure, an 
unknown 
number of dogs 
and geese died 
after swimming 
in the lake. 
Other dogs 
sickened after 
drinking lake 
water. Also fish 
kills 
 
 
nd day after 
exposure 
5 hours: 
diarrhoea; 
next 
morning: 
fever, 
headache, 
myalgia, 
weakness  
N/S N/S N/S (swimming 
hole) 
Single 
subject, 
male 
N/S 12 Swimming Fever, loss of 
consciousness 
for six hours, 
dyspnoea, 
pneumonia, 
myalgia, 
arthralgia 
Abundant M. 
aeruginosa 
N/S (onset 
reported as 
sudden, 
with 
subsequent 
myalgia and 
arthralgia) 
N/S Stool sample: 
Aeromonas 
(Gram –ve 
bacteria), 
Spirogyra and 
Mougeotia (both 
green algae) 
N/S  Dillenberg, 
1964  
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1979 Late 
summer 
Lake 
Wallenpaupack, 
PA, USA 
15 N/S N/S Swimming Vomiting, 
nausea, 
diarrhoea, eye 
irritation, sore 
throat, fever, 
earache 
N/S. See above.  Symptoms 
occurred “a 
short time 
after contact 
with lake 
water” 
G-I symptoms: 
24-48 hours 
 N/S Affected 
individuals all 
holidaying in 
rental cottages. 
Well water to 
cottages free of 
bacterial 
contamination 
Billings, 
1981  
 
 
1979 Late 
summer 
Arrowhead Lake, 
PA, USA 
Single 
female 
N/S N/S 
(“young 
girl”) 
Swimming # Chills, sore 
throat, fever, 
nausea, 
diarrhoea 
N/S “within 
several 
hours” 
Approx. 3 
days 
 N/S  Billings, 
1981  
  
1989 Early 
autumn 
Rudyard Lake, 
Staffs, UK 
2 N/S 16  Swimming 
and 
canoeing 
exercises, 
the latter 
involving 
360
Malaise, sore 
throat, circum-
oral blistering, 
left-sided 
pleuritic pain, dry 
cough, vomiting, 
central 
abdominal pain, 
diarrhoea, fever 
Day after 
exposure 
<2 weeks Microcystin-LR 
found to be 
principal 
cyanobacterial 
toxin present 
N/S Both were 
hospitalised, 
having 
developed left 
lower-lobe 
pneumonia 
Turner et al, 
1990 
M. aeruginosa 
 
 Lawton & 
Codd, 1991 
Codd et al, 
1999 
0 rolls * 
# 
Chorus et al, 
2000  
Carmichael, 
2001a p19 
1989 Early 
autumn 
Rudyard Lake, 
Staffs, UK 
8 N/S N/S 
(soldiers) 
As above * 
# 
Sore throat, 
headache, 
abdominal pain, 
dry cough, 
diarrhoea, 
vomiting, 
blistered mouth 
 N/S N/S See above N/S All subjects were 
soldiers who had 
partaken in 
canoeing 
exercises, 
subsequently 
admitted to 
barracks medical 
centre 
Turner et al, 
1990 
M. aeruginosa 
 
 Lawton & 
Codd, 1991 
Codd et al, 
1999 
Chorus et al, 
2000  
Carmichael, 
2001a p19 
1992 Mid-
spring 
Darling River, 
Wilcannia, NSW, 
Australia 
2 N/S N/S - 
teenagers 
Swimming Gastroenteritis 
and myalgia 
Anabaena sp N/S Symptoms 
resolved after 
48 hrs 
One subject 
required 
admission to 
hospital.  
N/S Some Wilcannia 
residents 
reported itchy 
skin rashes after 
showering, even 
after carbon 
filtration of the 
town water 
supply 
Williamson 
& Corbett, 
1993 
 
 
N/S N/S Unnamed 
reservoir, UK 
Single 
subject, 
male 
N/S 39 Windsurfing Fever, nausea, 
vomiting 
N/S, but 
microcystin 
isolated from 
reservoir; 
several sheep 
and dogs died 
N/S “shortly 
after 
windsurfing 
trip” 
N/S Liver function 
tests, liver 
biopsy 
No significant 
past history, 
no 
medications 
Mild hepatic 
dysfunction 
investigated six 
weeks after 
exposure 
Probert et 
al, 1995  
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Mixed symptoms 
 
Heise, 1949 Long-standing 
history of 
autumn hay-
fever and 
seasonal 
asthma 
Oscillatoreaceae 
extracts elicited 
positive (but 
unspecified) 
reactions in 
“many 
individuals who 
knew that 
swimming 
caused hay 
fever” at 
dilutions up to 
1:100,000  
1945 Late 
summer 
Lake Keesus, 
Waukesha 
County, WI, USA 
Report of 
single 
subject, 
female 
N/S 39 Swimming Gross eyelid 
oedema, nasal 
congestion, 
generalised 
urticarial rash  
N/S “while 
swimming” 
N/S Skin test with 
Oscillatoreaceae 
extract (0.03mL 
of 1:10,000 
dilution) resulted 
in immediate 
and severe local 
reaction treated 
by local injection 
of adrenaline 
 
 
1946 Late 
summer 
Lake Keesus, 
WI, USA 
Same 
subject 
N/S  Swimming As above N/S N/S N/S    Heise, 1949 
 
1973-4 Summer Belgrano Park 
pond, Santa Fe 
City, Argentina 
N/S N/S N/S Swimming 
and bathing 
G-I symptoms, 
dermatitis, otitis, 
conjunctivitis 
Mainly M. 
aeruginosa; 
bloom contained 
“up to 60,000 
colonies/mL” 
N/S N/S N/S N/S  Pizzolon et 
al, 1999  
 
 39
1979 
 
 
Late 
summer 
Arrowhead Lake, 
PA, USA 
Initial 
reports: 20-
30 children, 
several 
adults. 12 
children + I 
adult 
investigated 
N/S 4-12, + 
adult 
Swimming Headache: 8/13 
stomach 
cramps: 9/13 
nausea: 5/13 
vomiting: 7/13 
diarrhoea: 11/13 
fever: 5/13 
rash: 1/13 
sore or inflamed 
throat: 3/13 
N/S During 
exposure, to 
maximum 
12 hours 
after 
exposure. 
Most 
symptoms: 
<72 hours 
Stool samples of 
four children 
negative for 
Salmonella and 
Shigella. Throat 
swab of one 
child with sore 
throat negative 
for viral 
involvement 
N/S Routine weekly 
monitoring for 
faecal coliforms 
showed counts 
were ≤40/100mL 
prior to incident 
Billings, 
1981 
All symptoms: 
≤5 days 
Rash on 
arms & legs 
of adult ♀ 
developed 
“shortly 
after wading 
along lake 
edge” 
N/S  Carmichael 
et al, 1985 
1980 Mid-
summer 
Pocono 
Highlands Lake, 
PA, USA 
N/S 
“swimmers” 
N/S N/S Swimming Eye irritation, 
earache, sore 
throat 
Anabaena sp N/S N/S Water samples 
produced signs 
of poisoning in 
mice suggestive 
of hepatotoxin. 
LD
 
 
50 = 90 mg/kg  
(i.p. mouse) 
1980 Late 
summer 
Lake Lahonton, 
NV, USA 
N/S 
“several… 
N/S N/S Water 
skiing, 
swimming 
Erythema, eye 
irritation, 
dizziness, 
nausea, 
stomach 
cramps, 
diarrhoea 
N/S N/S LD
 
 affected ” 
 
Aphanizomenon 
flos-aquae 
50 = 500 
mg/kg body 
weight (i.p. 
mouse) 
N/S  Carmichael 
et al, 1985 
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1980 Mid-
summer 
Camp William 
Penn, PA, USA 
75-100 N/S N/S N/S 
(“campers 
affected 
from contact 
with water”) 
Conjunctivitis, 
sore-red throat, 
headaches, 
diarrhoea, 
nausea 
Anabaena sp N/S N/S  N/S  Carmichael 
et al, 1985  
 
 
 
 
1981 Mid-
summer 
Harveys Lake, 
PA, USA 
N/S (“many 
reports…”) 
N/S N/S N/S Skin irritation, 
nausea, 
dizziness, 
diarrhoea 
N/S N/S Mouse toxicity 
testing of water 
showed both 
neurotoxins and 
hepatotoxins 
present. LD
N/S Lake closed to 
public access 
until early spring 
Carmichael 
et al, 1985 
Anabaena flos-
aquae  
 
50 = 
125 mg/kg 
1989 Early 
autumn 
Rutland Water, 
Leics, UK, and 
other UK lakes 
N/S 
(“several”) 
N/S N/S Sail-
boarding # 
Skin rashes, 
nausea, 
vomiting, 
blistering inside 
mouth, severe 
thirst 
N/S N/S Microcystin-LR 
found to be 
principal 
cyanobacterial 
toxin present 
N/S 20 sheep and 15 
dogs died over 
approx 3 weeks 
in late summer – 
early spring after 
contact with 
bloom scum 
NRA, 1990 
p92 
M. aeruginosa 
 
 Codd & 
Beattie, 
1991 
Lawton & 
Codd, 1991 
1990 Spring Lake Cargelligo, 
NSW, Australia 
2 or 3 N/S N/S Swimming Two cases of 
conjunctivitis, 
one case of rash 
N/S N/S  N/S Lake closed as 
water supply for 
one month while 
bloom evident 
Christopher 
et al, 1991 
Anabaena 
circinalis  
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1991 
 
 
Summer-
Autumn 
Lakes 
Alexandrina and 
Albert, SA, 
Australia 
1 N/S N/S 
(adult) 
Crayfishing Skin and/or eye 
symptoms 
(pruritus, skin 
rash, sore red 
eyes) 
Nodularia sp N/S N/S Case identified 
retrospectively 
by either 
interview with 
local residents, 
local health 
workers or 
surveillance 
through local 
GPs 
N/S 7 other cases 
identified, all 
with skin and/or 
eye symptoms. 
Two of them 
also had asthma 
symptoms, one 
had hay fever 
symptoms, 
another a sore 
throat. Water 
contact was by 
showering or 
bathing 
Soong et al, 
1992 
1991 
 
 
Late 
spring – 
early 
summer 
Darling River, 
Wilcannia, NSW, 
Australia 
1 Sole report 
after 
surveillance 
requests to 
report 
confirmed or 
suspected 
cyanobacteria
-related illness 
during an 
extensive 
riverine bloom 
N/S 
(adult) 
Water skiing Skin rash, 
conjunctivitis, 
diarrhoea, 
respiratory 
difficulty 
Anabaena spp N/S N/S  N/S All schools along 
the river system 
were asked to 
report increases 
in illness-related 
absenteeism, 
especially for G-I 
symptoms. No 
such increase 
was reported 
NSW Blue-
Green Algae 
Task Force, 
1992 p32 
4
0
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Codd et al, 
1999 
 
1991-2 
 
 
Summer River Murray, 
SA, Australia 
11 N/S 1-64 “water 
sport…. 
particularly 
skiing”. One 
of these 
cases had 
skin contact 
through 
both water 
sport and 
residential 
water use 
Contact 
exposure (n=2): 
rash, itching, 
mouth blistering, 
eye irritation; 
oral ingestion 
(n=3): diarrhoea, 
vomiting, 
nausea, muscle 
weakness, sore 
throat, 
respiratory 
difficulty, 
headache; 
contact + oral 
exposure (n=6): 
mixture of above 
symptoms  
Predominantly 
A. circinalis 
N/S N/S Cases 
investigated 
following 
telephone or 
personal 
complaints to 
health 
authorities and 
water supply 
management 
N/S 15 further cases 
with exposure to 
River Murray 
water from 
reticulated water 
supply 
El Saadi & 
Cameron, 
1993 
1996 
 
N/S Hollingworth 
Lake, UK 
11 N/S N/S (sea 
cadets) 
Canoe 
capsizing 
trials * 
Facial rashes, 
asthmatic signs, 
dry sporadic 
cough, vomiting 
Planktothrix 
agardhii, 
containing three 
microcystins  
Day of, and 
after 
exposure 
N/S  N/S  
1997 
 
 
Autumn Lake 
Sammamish, 
WA, USA 
N/S 
(“several”) 
N/S “young 
children” 
Swimming G-I complaints, 
rashes 
M. aeruginosa, 
microcystins 
measured at 
approx. 500 µg/g 
dry weight 
N/S N/S N/S N/S A dog began 
“heaving and 
coughing”, died 
four hours after 
exposure to 
bloom  
Calvan, 
1997 
Johnston & 
Jacoby, 
2003 
 
 
 
 
 
 
# – cyanobacteria-affected water reportedly ingested (table column: “Water activity”) 
 
* – occupational exposure (table column: “Water activity”) 
 
N/S – not stated 
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1.4.2. Search criteria, rationale & discussion – Table 1.1. 
 
1.4.2.1. Rationale and criteria for constructing Table 1.1. 
 
Table 1.1 comprises all references that could be found in the medical and 
scientific literature, including conference proceedings, which describe specific 
incidents involving human illness and exposure to freshwater cyanobacteria in 
recreational or occupational settings. The following citation sources were not 
examined for this exercise: 
 
• Reports of cyanobacteria-associated illness from recreational exposures 
 to marine or estuarine waters 
• Publications written in languages other than English – with the exception 
 of the Russian paper by Pashkevich (1979), which we are grateful to have 
 translated by Dr Tatiana Komarova, who works in our laboratory. 
• Newspaper reports – with three exceptions: two reports that describe the 
 first human fatality to be attributed to recreational contact with 
 cyanobacteria (Behm, 2003; Campbell & Sargent, 2004). At the time this 
 thesis was submitted, these were apparently the only published 
 references to this tragedy, so were included here because of their 
 importance. The cyanobacteria research community awaits publication of 
 a comprehensive case report in the scientific or medical literature. 
 Another news article supplements a cursory description of 
 cyanobacteria-associated illnesses; both the news report and the 
 scientific publication appear to describe the same incident, with more 
 detail provided by the journalist (Calvan, 1997; Johnston & Jacoby, 
 2003).  There are undoubtedly many more publications in the news media 
 that report suspected cyanobacteria-related human and animal morbidity 
 and mortality: for example Duggan (2004) and Ruff (2004) reported on 
 cyanobacteria blooms in Nebraska lakes that were associated with two 
 dog deaths and more than 40 complaints of acute eye, upper respiratory, 
 gastrointestinal and skin symptoms.  
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Bibliographic database searches were not particularly helpful; a PubMed 
search conducted in May, 2004 using the terms “(cyanobacteria* OR blue 
green alga*) AND recreation*” generated 37 citations, only one of which was 
suitable for inclusion in Table 1.1.  
 
The references cited in Table 1.1 vary considerably with respect to their 
evidentiary value. Some reports are very brief, with little or no detail beyond 
location and the kind of illness reported (NRA, 1990; Christopher et al, 1991). 
One cites “concept paper” references that apparently did not progress beyond 
conceptualisation (van Hoof, 1994). On the other end of the scale are 
examples of thorough, considered case reports, describing relevant medical 
history and diagnostic investigations (Heise, 1949; Cohen & Reif, 1953). 
Dead-end reference trails aside, the intention here is not to cast aspersions on 
citations that are light on information. There may be very good reasons for the 
dearth of detail, not least of which is that non-specific, mild and self-limiting 
illnesses probably do not merit much discussion beyond the curiosity-driven 
association with exposure to cyanobacteria. However, some references to 
more serious illnesses leave a great deal unanswered, e.g. the 12 year-old 
boy who reportedly lapsed into unconsciousness for a six-hour period, and 
developed pneumonia, myalgia and arthralgia (Dillenberg, 1964).  
 
The layout of Table 1.1 shows columns that are essentially devoid of content: 
estimates of the number of individuals exposed to suspect waters that were 
unaffected when one or more individuals report potential cyanobacteria-
related illness, and indications as to the presence or absence of predisposing 
medical conditions. Again, the aim here is not to discredit comments about 
anecdotal reports that did not provide such information, but to suggest 
pointers to the sort of information that would be helpful in interpreting cases 
that present in similar circumstances in the future. There may be many 
reasons why such information did not appear in most of the reports cited in 
Table 1.1, given that, by definition, anecdotal and case reports are 
retrospective. The observation that repeated water contact in a particular lake 
preceded a skin eruption on a six year-old girl, while other bathers appeared 
unaffected, helped support a diagnosis of hypersensitivity in that case (Cohen 
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& Reif, 1953). Even one of the few reports of mass effects, with 20-30 children 
suffering conjunctival and upper respiratory symptoms during a school aquatic 
event, is tempered by the observation that that number, crude estimate that it 
is, represented about 25% of those exposed (Billings, 1981).  
 
There are significant challenges and obstacles to conducting rigorous 
epidemiological studies of recreational exposure to cyanobacteria. It is the 
opinion of this author that much useful information could be gleaned from a 
well-conducted case series, especially if investigations into suspicious cases 
are supplemented with clinical investigations such as specific IgE levels. 
Some of these topics are discussed further in Chapter 3, Section 3.5.9, and 
Appendix 2. 
 
 
1.4.2.2. Further discussion, Table 1.1. 
  
The column titled “time of onset after exposure” is instructive. While many 
gaps are evident, those reports that have indicated symptom onset time 
suggest that responses can be rapid, with some urticaria and hayfever-like 
symptoms commencing while subjects are still in the water (Heise, 1949; 
Billings, 1981). While a disparate range of signs and symptoms are listed in 
Table 1.1, there seem to be a good proportion of reports that describe a 
collective group of symptoms resembling immediate or Type-I hypersensitivity 
reactions. Immediate hypersensitivity reactions are commonly associated with 
atopy, which is the familial tendency to react to naturally occurring antigens, 
mostly proteins, through an IgE-mediated process. Atopy commonly manifests 
as a spectrum of diseases, e.g. seasonal rhinitis, conjunctivitis, asthma and 
urticaria. Different atopic illnesses often affect the same individual. A 
fundamental feature of Type-I hypersensitivity reactions is the rapid onset of 
symptoms – normally seconds to minutes – following exposure to antigens 
(IPCS, 1999 pp57, 88-93, 130, 224; Behrendt & Becker, 2001, Borish & 
Steinke, 2003; Lemanske & Busse, 2003; Prussin & Metcalfe, 2003).  
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Some serious though apparently self-limiting gastro-intestinal illnesses have 
been reported after contact with cyanobacteria in recreational waters, 
presumably through ingestion of affected water. Dillenberg & Dehnel (1960) 
describe how an adult male inadvertently swallowed lake water affected by a 
bloom of Microcystis sp and Anabaena circinalis. After some three hours he 
developed cramping abdominal pain and nausea, which progressed to painful 
diarrhoea followed by a fever of 38.90C, severe headache, lassitude, myalgia 
and arthralgia. Such illnesses are worrying, considering the two boys that 
were sickened – one of whom subsequently died – after exposure to 
cyanobacteria in a golf course pond suffered acute and severe gastro-
intestinal illnesses (Behm, 2003).  
 
Occupational exposures were included in this review, although some caution 
should be exercised when comparing occupational and recreational 
exposures. Waters that are obviously discoloured or visibly affected by 
cyanobacteria scums may be of interest to aquatic field workers who are keen 
and/or obliged to collect samples. The two incidents involving UK soldiers and 
sea cadets conducting canoe capsizing activities, presumably under orders 
from their supervising officers (“What these lads need is a taste of British 
steaming pondscum…”), occurred in waters that were reportedly subject to a 
“heavy bloom of Microcystis spp” (Chorus et al, 2000) and a “scum of 
Oscillatoria…” (Codd et al, 1999). Waters that are obviously suffering a loss of 
visual amenity may be shunned by many recreational users, although 
avoidance behaviour in such circumstances cannot be taken for granted (see 
Chapter 4, Section 4.4.10 for further discussion of this topic).  
 
The other reports that are of particular interest to this author and to the 
broader study of exposure to cyanobacteria are those grouped in Table 1.1 
under “cold & flu-like symptoms”. Several publications describe individuals 
presenting with a flu-like illness, with signs and symptoms including fever, 
headache, lassitude, arthralgia, myalgia, sore throat, cough, diarrhoea and 
vomiting. A proposed explanation for this constellation of symptoms is that of 
a coordinated, cytokine-mediated, innate immune response. Fever and 
malaise are events that are directed by endogenous mediators, and discussed 
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further in Chapter 6 of this thesis (Sections 6.1.1. and 6.4.3.1.1). This 
spectrum of signs and symptoms also mimics those reported in volunteer 
studies of intravenous Gram-negative bacterial lipopolysaccharide injection 
(Martich et al, 1993; Burrell, 1994; Brandtzaeg, 1996; Wright, 1999). 
Mammalian responses to LPS are mediated by inflammatory cytokines 
(further discussion in Chapter 2, Section 2.5 of this thesis). Flu-like reactions 
to immunostimulant drugs are sometimes referred to as “acute cytokine 
syndromes” (Descotes, 2004).  
 
 
1.4.3. Epidemiology of recreational exposure to cyanobacteria, including 
“Epidemiology for cyanobacteriologists” 
 
A critique and discussion of the published epidemiological studies on 
recreational exposure to cyanobacteria will be incorporated into a brief primer 
for cyanobacteriologists on the most commonly applied approaches to 
epidemiology. Study types that have not been applied to the topic of 
recreational exposure to cyanobacteria will be discussed and examples drawn 
from similar studies into coastal water quality and recreational exposure. The 
advantages and disadvantages of each kind of study will be briefly outlined. 
Each study type will be presented in increasing order of robustness, as there 
is a broadly agreed upon hierarchy of study types with respect to the ability of 
each to determine causation.  
 
Five epidemiological studies of recreational exposure to cyanobacteria have 
been published to date: three analytical cross-sectional studies from the U.K. 
using similar survey instruments (Philipp, 1992; Philipp & Bates, 1992; Philipp 
et al, 1992), a small case-control study from Australia (El Saadi et al, 1995), 
and a larger prospective cohort study, also from Australia (Pilotto et al, 1997).  
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1.4.3.1. Anecdotal and case reports 
 
Anecdotal and case reports represent the weakest evidence of causation, as 
there is no comparison with unexposed “control” subjects. However, their 
utility is clearly very important in alerting the medical and scientific community 
to unusual events and disease mechanisms, and for generating hypotheses. 
This community was first alerted to the toxic potential of cyanobacteria in 
1878, with a report to the journal Nature by George Francis, who observed the 
rapid death of large stock animals after drinking contaminated water (Francis, 
1878). Anecdotal reports of unusual illness or deaths in wild and pet animals 
after drinking green or “scummy” water still serve as useful sentinel events to 
warn local authorities and communities that there is a problem in their 
waterbody. The collation of reports of human morbidity and possible mortality 
in Table 1.1 has led this author to suspect that the so-called flu-like illnesses 
reported after recreational exposures are indications that some cyanobacterial 
products are signalling cytokine-mediated innate immune responses. The 
question as to whether more anecdotal reporting of these events in the 
medical literature is warranted remains open. Opinions regarding the value of 
case reporting vary, but most seem to agree that case reports should serve 
one of two broad functions: the progress of medical science (what is not yet 
known), and education and quality assurance (what is unrecognised by 
individual clinicians) (Vandenbroucke, 1999). Case reports are often designed 
to emphasise unusual findings, yet some editorials dispute the utility of such 
reports, largely on the basis that if presenting illnesses are so rare, most 
practitioners will never encounter them (Hoffman, 1999; Thornton, 2001).  
 
That cyanobacteria can produce potent and lethal toxins is not a novel 
observation, but it is probably not widely understood by primary healthcare 
providers. Exposures to aquatic cyanobacteria are common in recreational 
settings, and the dynamic nature of cyanobacterial bloom progression and 
toxin production demands vigilance by general practitioners and emergency 
physicians. Published case reports and case series would still be valuable 
educational tools, both for primary healthcare providers and the cyanobacteria 
research community. Reports of severe illness, mass outbreaks or post-acute 
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morbidity, with careful attention to exposure history, predisposing conditions, 
duration of signs and symptoms and supplemented by near-time water quality 
data would be most appropriate for publication.  
 
 
1.4.4. Cross-sectional studies 
 
The three studies by Philipp and co-workers are examples of analytical cross-
sectional studies (Philipp, 1992; Philipp & Bates, 1992; Philipp et al, 1992). In 
a cross-sectional study, exposure and outcome are determined at the same 
time. Figure 1.1 shows the design of a cross-sectional study. 
 
 
 
 
 Defined population
Not exposed; 
do not have 
disease 
Not exposed; 
have disease 
Exposed; do 
not have 
disease 
Exposed; 
have disease 
Collect information on exposure and disease
Figure 1.1. Cross-sectional study design. 
Adapted from Gordis, 2004 p173. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The three studies led by Dr Philipp used similar questionnaires (published in 
Philipp & Bates, 1992). They were distributed to recreational users of six 
inland waterbodies, five of which experienced cyanobacteria blooms during 
1990. The questionnaires elicited information on exposure to study waters and 
the presence of specific symptoms in a defined period prior to receiving the 
form. This period ranged from 14 days (Philipp & Bates, 1992) to four weeks 
(Philipp et al, 1992). One questionnaire asked about exposure to the study 
water on a weekend when a bloom occurred some 2½ weeks previously 
(Philipp, 1992). Recreational interest groups were used to target likely users 
of the waterbodies; questionnaires were mailed to members of sailing and 
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angling clubs. Site authorities distributed questionnaires at one study lake 
(Philipp et al, 1992). The results of these three studies were similar: mostly 
minor morbidity was reported, with similar disease patterns across sites.  
 
The theoretical advantages of this study type are that it is reasonably cost-
effective, and in this context – recreational exposure to cyanobacteria – it can 
be conducted opportunistically to take advantage of any sudden-onset 
cyanobacteria blooms. Disadvantages relate to the difficulty in establishing a 
temporal relationship between exposure and outcome (Gerstman, 1998 p146; 
Gordis, 2004 p174). The studies conducted by Philipp and his team (Philipp, 
1992; Philipp & Bates, 1992; Philipp et al, 1992) were examples of analytical 
cross-sectional studies, in that unexposed individuals served as controls for 
statistical comparison of illness prevalence. Cross-sectional studies can be 
conducted without a control group, in which case they are descriptive studies, 
often used to estimate the prevalence of disease.  
 
 
1.4.5. Case-control studies 
 
A case-control study of illness rates was conducted after an extensive 
Anabaena circinalis-dominant bloom along South Australia’s Murray River in 
the summer of 1991-1992 (El Saadi et al, 1995). A case-control study is a 
retrospective analysis that identifies cases of the disease of interest (case 
group), and suitable individuals without the disease (control group), then looks 
back in time to determine the exposure status of individuals in each group. 
Figure 1.2 shows the study design of a case-control study. 
 
Figure 1.2. Case-control study design. 
Adapted from Gordis, 2004 p160.
Exposed Not exposed Exposed Not exposed 
Disease 
(Cases) 
No disease 
(Controls) 
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El Saadi et al (1995) enlisted the cooperation of medical practitioners in eight 
towns along the Murray River. Patients presenting with G-I or dermatological 
complaints comprised the case group; the patient presenting after each case 
was identified served as the control group. Exposure was determined by 
identifying each subject’s principal source of water for drinking, domestic use 
(bathing, dishwashing) and recreation during the week prior to consultation. 
The various sources of domestic and drinking water were from rainwater tanks 
or springs, untreated river water or chlorinated river water. Recreational 
exposure was categorised as no contact, direct exposure to river water, or 
other exposure, e.g. farm dams or treated water in swimming pools. The study 
found a significantly increased risk of G-I symptoms for those drinking 
chlorinated river water, and an increased risk of G-I and cutaneous symptoms 
in those using untreated river water for domestic purposes. As far as 
recreational exposures were concerned, the study found a statistically non-
significant increase in the relative odds of developing G-I or skin symptoms 
amongst those exposed to river water, but that risk was lower than for those 
exposed to other sources of recreational water. The number of subjects was 
small for the recreational exposure component of the study, with only some 50 
subjects reporting any recreational exposure during the study period, which 
comprised 16% of the study group.  
 
The advantages of a case-control design for investigating recreational 
exposure to cyanobacteria are that studies can be conducted opportunistically 
in response to the development of cyanobacteria blooms, and the principal 
general advantage of case-control studies applies here, in that they are very 
useful for investigating infrequent outcomes. The study of El Saadi et al 
(1995) has another advantage over other epidemiological studies into 
recreational exposure to cyanobacteria in that medical practitioners 
ascertained outcome data, as opposed to self-reporting of symptoms. General 
disadvantages of the case-control design principally relate to the problem of 
recall bias, where individuals with the disease of interest tend to overestimate 
relevant past exposures compared to exposure estimates made by the control 
group (Gerstman, 1998 p151; Gordis, 2004 pp169-70). Recall bias may not be 
so much of a problem for investigating acute illnesses following recreational 
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exposure to cyanobacteria, where a fairly short time lag between exposure 
and symptom onset can be anticipated, especially if recreational exposure is 
determined by a yes/no response. The main problem with a case-control 
study in this context will be in actually identifying cases. A case-control design 
would not be suitable for investigating outcomes from exposure to a 
cyanobacteria bloom in a lake adjacent to a city, as most recreational users 
who do develop symptoms would presumably seek medical attention after 
they return home, i.e. from one of a large number of medical practitioners. El 
Saadi et al (1995) alluded to the difficulty of gaining the cooperation of 
medical practitioners, as they approached practices in 11 towns along the 
Murray River, yet those in three towns presumably refused to participate in 
their study. The diffuse spread of cases from point sources of exposure (a 
cyanobacteria-affected waterbody) across a large town or city would make a 
case-control study practically unworkable. A case-control study would also be 
unsuitable for recruiting subjects that did not seek medical attention for 
symptoms occurring after exposure. However, a well-designed case-control 
study would be valuable if geographical location is a primary consideration. 
This would require enlisting the cooperation of medical practitioners in small 
townships near to cyanobacteria-affected recreational waters that are 
sufficiently remote from larger urban centres to allow recruitment of local 
residents and tourists who will camp nearby.  
 
 
1.4.6. Cohort studies 
 
The study by Pilotto et al (1997) and the study reported in Chapter 3 of this 
thesis are examples of prospective cohort studies. A cohort study compares 
disease outcomes in exposed and unexposed populations; exposure is 
estimated before determining outcomes. Figure 1.3 shows the design of a 
cohort study. 
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Figure 1.3. Cohort design. The timeline on the left describes a prospective cohort study; 
the timeline on the right describes a retrospective cohort study.  
Adapted from Gordis, 2004 p152. 
Do not 
develop 
disease 
Exposed Not exposedPresent  Past
Present or 
future 
Future Develop 
disease 
Develop 
disease 
Do not 
develop 
disease
 
 
Pilotto et al (1997) recruited individuals at five recreational waterbodies in 
three Australian states. Cyanobacteria blooms were anticipated at these sites, 
based on occurrences in previous years. Individuals were approached and 
invited to participate in the study. Participants completed a face-to-face 
interview to determine health status and recreational water activities; two 
telephone follow-up interviews were conducted at two and seven days 
following the day of recruitment into the study. Individuals that did not have 
water contact on the recruitment day served as the control group. No 
significant differences in symptom occurrence were reported at the 2nd day 
follow-up, but the authors concluded there was a significant increase in 
symptoms at 7 days, after excluding subjects with symptoms or previous 
recent recreational water exposure. The cohort size from which these 
significant results were drawn was rather small, with 295 exposed subjects, 
and 43 unexposed controls. The significance of increased symptom reporting 
at 7 days but not 2 days following exposure is not clear to this author. Pilotto 
et al (1997) interpreted this as possibly due to delayed allergic responses, 
although this too is curious, as so-called “late phase” allergic and asthmatic 
responses tend to occur some 4-24 hours after allergen exposure, which 
would presumably be identified at a 2-day follow-up interview (IPCS, 1999 
pp59, 93; McConnell & Holgate, 2000). Further discussion of the strengths 
and weaknesses of the study by Pilotto et al (1997) can be found in Chapter 
3, Sections 3.5.1, 3.5.2, 3.5.5 and 3.5.7.4.1 of this thesis.  
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The study of Pilotto et al (1997) and the study reported in Chapter 3 of this 
thesis are both examples of a prospective cohort design, where study subjects 
have their exposure status determined, and are then followed forward in time 
to observe the development of disease. For these investigations into 
recreational exposure to cyanobacteria, exposure status was determined by 
collecting water samples on the day subjects were recruited into the study; 
cyanobacteria were identified and enumerated and the resultant cell counts or 
biomass estimates formed the basis of exposure at any given site on a 
particular day. One of the problems with this approach is that cyanobacterial 
blooms are dynamic and can change rapidly. Unless the presence of 
significant cyanobacterial biomass can be predicted with some degree of 
certainty, a prospective cohort design can result in wasted effort if the water 
samples reveal lower than anticipated levels of cyanobacteria. This problem 
undoubtedly occurred in some instances during the study reported in Chapter 
3. One possible approach to dealing with this would be to conduct a 
retrospective cohort study.  
 
Ferley et al (1989) conducted a retrospective cohort study to investigate the 
epidemiology of microbial pollution in riverine recreational waters. Water 
samples were collected and analysed twice-weekly from recreational beaches 
at eight summer camps in a French river basin. Study subjects were 
interviewed about recreational activities at the camp on days preceding the 
interview. Applying this design to the epidemiology of recreational exposure to 
cyanobacteria would require a site where a sufficient number of campers stay 
for long enough to be questioned retrospectively about their exposure. 
Subjects could then be enrolled into the exposed group of a retrospective 
cohort study if and when analysis of water samples showed that defined 
thresholds for cyanobacteria or cyanotoxins had been exceeded. All this 
would still require considerable organisation and expense; probably the best 
way to study this topic using a cohort design would be to concentrate 
recruitment at chronically cyanobacteria-affected waterbodies, as we were 
able to achieve at some sites in Florida (see Chapter 3).  
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Whether a cohort study is conducted prospectively or retrospectively, the 
basic study design is identical – exposed and unexposed groups are 
compared with respect to disease outcome (Gordis, 2004 p152). General 
advantages of a cohort design are the ability to determine disease onset (the 
exposure precedes the disease), and the study of exposures in natural 
settings (Gerstman, 1998 p148, 152). General disadvantages relate to 
confounding, which refers to differences in the distribution of risk factors other 
than the exposure of interest between exposed and unexposed groups. 
Cohort studies can be expensive and resource intensive (Gerstman, 1998 
p148, 152). 
 
 
1.4.7. Experimental epidemiology 
 
Randomised trials are considered the “gold standard” study in many clinical 
settings, including assessment of new pharmacological therapy. However, 
experimental studies are unusual tools in the field of environmental 
epidemiology, largely because of ethical problems, insofar as potentially 
harmful exposures cannot be randomly assigned (Gerstman, 1998 p155). 
However, there are exceptions. Fleisher et al (1993, 1996, 1998) and Kay et 
al (1994) describe randomised trials to investigate gastrointestinal and other 
illnesses in subjects exposed to coastal recreational waters with varying 
microbiological water quality. A randomised trial compares the development of 
disease in exposed and unexposed subjects, but unlike a cohort study, entry 
of study subjects to exposure groups is by random allocation. Figure 1.4 
shows the basic design of a randomised trial. 
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Figure 1.4. Randomised intervention design. 
Adapted from Gordis, 2004 p116.  
Do not 
develop 
disease
Exposed Not exposed 
Develop 
disease 
Develop 
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Do not 
develop 
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The recruitment and exposure methodology for these studies, reported in 
Fleisher et al (1993) and Kay et al (1994), involved recruiting study subjects 
from shopping centres, sporting clubs and other locations some three weeks 
prior to trials taking place. All subjects were given a medical examination and 
structured interview 2-3 days before the trial to determine any acute or 
predisposing illnesses. Subjects were then randomly allocated to either 
exposed or non-exposed groups. On the day of the trial, those in the exposed 
group were instructed to remain in the water for at least 10 minutes, and to 
immerse their heads three times. Observers were employed to monitor the 
activity and time each bather spent in the water. Those in the non-exposed 
group were restricted to a roped-off area on the beach, and observers were 
assigned to confirm that individuals in the non-exposed group did not enter 
the water. Follow-up procedures included medical examination, face-to-face 
interview and self-administered questionnaire. Frequent and extensive water 
sampling was conducted throughout each trial; microbial water quality 
parameters such as faecal coliforms and faecal streptococci were the 
exposure measures used in statistical modelling. Ethical concerns were 
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addressed by conducting the studies at beaches that met European 
mandatory directives for faecal indicator counts, although beaches used in 
one study failed guidance levels (Fleisher et al, 1993). Only subjects 18 years 
or older were studied.  
 
The most significant advantage of a randomised trial is that so-called 
confounding variables – extraneous factors that might influence the study 
outcome – are evenly distributed across exposed and unexposed groups, 
leaving any observed differences in outcome directly attributable to the study 
factor (Gerstman, 1998 p155). From the perspective of water-based 
recreational exposures, Kay et al (1994) correctly contrast the strengths of 
their design with the relative methodological weaknesses of cohort studies, 
pointing out that individuals who swim and those who do not will self-select 
into each exposure category, and may differ with respect to factors other than 
bathing water quality.  
 
Randomised trials also have their own inherent weaknesses: ethical concerns, 
as mentioned above; they are expensive and resource intensive; subjects 
may not always comply with their treatment or exposure allocation; and there 
is a degree of artificiality introduced, so observed outcomes of the study may 
not be generalisable to the broader population (Gerstman, 1998 p155).  
 
The advantages and limitations of a randomised trial to investigate the 
epidemiology of recreational exposure to cyanobacteria will now be briefly 
discussed. Fleisher et al (1993) and Kay et al (1994) highlight another 
important strength of their study, which is directly applicable to the topic of 
planktonic cyanobacteria in recreational waters. Their frequent water sampling 
regime allowed each exposed subject to be assigned an index of exposure. 
Significant temporal and spatial variation in indicator organism densities can 
be seen in marine recreational waters (Fleisher et al, 1998), which is exactly 
the same situation with planktonic freshwater cyanobacteria (Carmichael & 
Gorham, 1981). The advantages of such an approach for investigating 
recreational exposure to cyanobacteria would be that a positive result from a 
well-designed randomised trial would be powerful evidence of causation. 
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Ethical hurdles could possibly be overcome insofar as there are presently no 
mandatory directives for recreational exposure to cyanobacteria. Several 
European countries and others such as Australia and Canada have or are in 
the process of adopting exposure guidelines. The studies of Fleisher et al 
(1993, 1996, 1998) and Kay et al (1994) could be improved on insofar as their 
work was conducted “single-blind”, i.e. the follow-up interviewers and medical 
examiners were unaware of the exposure status of their study subjects, but 
study subjects were obviously aware of their exposure status. As discussed in 
Chapter 3 of this thesis (Section 3.5.2), there is a risk that the use of non-
bathers as a control group for water-based recreational activity might lead to 
under-reporting of relevant symptoms by the control group. A randomised trial 
to investigate recreational exposure to cyanobacteria could conceivably be 
conducted as a “double-blind” enterprise, by the use of reference waterbodies 
unaffected by cyanobacteria. Florida would be ideally suited to such work, as 
oligotrophic and eutrophic inland recreational waters can be found in close 
proximity to one another (discussed in Section 3.5.2).  
 
On the other side of the equation are several important factors that militate 
against conducting a randomised trial to study the health impacts of 
recreational exposure to cyanobacteria, at least in the near future: 
 
• Cost: compared to the limited epidemiological studies that have been 
 conducted already in this area, the resources, organisation and planning 
 required to conduct a randomised study with a similar level of rigour to 
 those conducted to examine faecal contamination of coastal waters would 
 be formidable. Hiring observers and medical examiners, analysing large 
 numbers of water samples for cyanobacteria and cyanotoxins, and 
 compensating subjects for their time and travel costs would not be a trivial 
 exercise. 
• Ethics: while a study could conceivably be conducted because of the 
 absence of mandatory directives, what kind of exposures should be 
 sought in order to model realistic, real-world activities in waters affected by 
 cyanobacteria – and more importantly, cyanotoxin-affected waters? With 
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 the presumption that the most hazardous exposure to cyanotoxins is via 
 the oral route, should study subjects be instructed to swallow lake 
 water? While inadvertent or deliberate consumption of cyanotoxin-affected 
 water undoubtedly occurs in natural recreational settings, it would clearly 
 be unethical to randomly assign such consumption. 
• Compliance: Investigators conducting a randomised trial should 
 anticipate a significant level of non-compliance from subjects allocated to 
 cyanobacteria exposure. If cyanobacteria-affected study waters are visibly 
 affected by green discolouration, surface scums or unusual odours, expect 
 a good number of volunteers to refuse to even dip their toes in it. 
 Significant non-compliance could be avoided by choosing study 
 waters that are not subject to the aesthetic impacts of cyanobacteria, but 
 such waters would presumably be only marginally affected compared to 
 waters affected by frank cyanobacteria blooms and simultaneously 
 frequented by recreational users.  
• Artificiality:  Organisational demands of having volunteers swimming in a 
 defined (and restricted) area of a lake, while being observed throughout, 
 and conducting an associated water sampling regime would necessitate 
 relatively short-term exposures, say 10-60 minutes. The ability to relate 
 cyanobacterial biomass or cyanotoxin indices to individual subjects would 
 see significant improvements in exposure measurement over all 
 epidemiological studies conducted to date in this field. However, this 
 would not model the diversity of exposures seen in natural settings, where 
 various recreational activities (e.g. swimming, skiing, sailing) occur over 
 different spatial and temporal dimensions (one beach vs whole lake; 
 minutes vs essentially all day). Cohort studies are ideal for observing 
 exposures in natural settings, but, as discussed in Chapter 3 of this thesis, 
 there is a loss of precision when it comes to measuring such diverse 
 exposures. Children make up a significant proportion of the population that 
 participates in recreational water exposure, but ethical concerns would 
 presumably preclude them from participating in a randomised trial.  
• Uncertainties: there is much that is still not known about 
 cyanobacteria-associated morbidity from recreational exposures. The 
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 toxicologic profiles of different cyanotoxins are variable, with different 
 organ systems targeted. Many complex questions remain that would make 
 the generalisability of outcomes from a randomised trial somewhat 
 unreliable at present. How would we measure cyanobacteria – by cell 
 count or biomass estimates? What kind of thresholds for different 
 cyanotoxins would be appropriate to study? Are senescent blooms more 
 hazardous because of increased cell lysis, cyanotoxin release and/or 
 increases in epiphytic heterotrophic bacteria? Are those with allergic 
 disease more at risk of developing some acute illnesses after contact with 
 cyanobacteria, and if so, how would that finding influence exposure 
 recommendations?  
 
 
1.4.8. Other epidemiological study designs 
 
The study types discussed above are the most commonly conducted 
approaches to answering epidemiological questions. The presentation of each 
design is highly simplified, as is intended only as a very basic introduction for 
cyanobacteriologists unfamiliar with the discipline. They are presented in 
ascending order of their reliability in determining causality: anecdotal and case 
reports < cross-sectional studies < case-control studies < cohort studies < 
randomised trials. The field of epidemiology is very much larger and more 
complex than that presented in this introduction, with many more potential 
approaches to tackling this problem. Some brief examples: 
 
• Ecologic studies: The study designs discussed in Sections 1.4.4 to 1.4.7 
 use observations made on individual subjects. An ecologic study uses 
 groups of people as the unit of observation, e.g. classes in schools, 
 factories, cities or countries (Rothman & Greenland, 1998). An ecologic 
 study was conducted by Pilotto et al (1999) to examine the relationship 
 between cyanobacterial contamination of drinking water supplies and 
 adverse perinatal outcomes. Exposure data was conducted at the level of 
 towns and cities (n=156) for which water-quality data pertaining to 
 cyanobacteria was available; outcome data was gathered from state 
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 government birth records for those towns. The authors noted the 
 assumptions that must be made about drinking water supplies (rainwater 
 and other alternatives, avoidance of off-flavoured water, water treatment 
 processes) in order to conduct such a study. The assumptions that would 
 be required about population-wide recreational or occupational exposures 
 to cyanobacteria would make an ecologic study of little value; tourists 
 often frequent recreational waters, and short-term health outcomes would 
 be practically impossible to track. 
• Case-crossover design: this study design was originally used to 
 investigate brief exposures that result in immediate, short-term effects and 
 acute outcomes that have a rapid and unambiguous onset. Only cases are 
 observed, i.e. subjects with outcomes of interest; relative risks are 
 calculated by comparing the frequency of exposure before the outcome 
 (case period) with respect to an earlier period (control period), so study 
 subjects serve as their own controls (Maclure, 1991; Wang et al, 2004).  
• Hybrid designs: Various composite designs are available; the most 
 important being the nested case-control study, which is a case-control 
 study conducted within a cohort study. Advantages of this design are in 
 cost and efficiency, when only the sub-set of the cohort that develop 
 disease and their matched control subjects would have exposure 
 information measured (Kleinbaum et al, 1982 pp70-88; Gordis, 2004 
 pp172-3).  
 
The above discussion hopefully highlights the choices available to 
epidemiologists to further investigate the topic of recreational exposure to 
cyanobacteria. All study designs have their own inherent strengths and 
weaknesses, some study designs would be inappropriate. The conclusions of 
Kleinbaum et al (1982 p92) apply here, in that the chosen design should be 
carefully tailored to the study objectives, the nature of the disease being 
studied, socio-political constraints, and the availability of time, money and 
personnel.  
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1.5. Water-related risk factors 
 
A formidable array of water-borne microbial pathogens is associated with 
recreational exposures in freshwater environments. This section will briefly 
discuss some of these risk factors that may confound epidemiological studies 
and complicate clinical diagnoses of cyanobacteria-related illness.  
 
 
1.5.1. Freshwater-related dermatoses 
 
• Avian cercariae: avian cercariae are schistosome larvae for which 
 humans are an accidental host. Released by aquatic snails – an 
 intermediate host – on bright, sunny days, the larvae enter exposed skin 
 but cannot proceed past the dermis or epidermis. The cercariae can cause 
 a prickling sensation as they penetrate the skin; pruritus and macules are 
 the initial signs and symptoms, sometimes a diffuse erythema and 
 urticaria can develop and last for several hours. In sensitised individuals, 
 an allergic reaction can occur, with intense itching and a papular rash 
 developing between 12 and 24 hours after exposure. (Hoeffler, 1977; 
 Gonzalez, 1989; Marquardt et al, 2000; Habif, 2004 p539). Fever, nausea 
 and vomiting can also accompany severely affected cases (Anon, 1988; 
 Gonzalez, 1989). Recent work has characterised the response to avian 
 cercariae using a mouse model. These are immediate (Type I) 
 hypersensitivity reactions, after which a late-phase reaction occurs in 
 response to cercariae in the skin. These reactions are clearly Th-2 
 phenomena, i.e. IL-4 and IL-13-associated (Kourilova et al, 2004). Thus 
 the clinical presentation of cercarial dermatitis – recent water exposure 
 (usually in a recreational setting) in warmer months, pruritus, erythema, 
 ±urticaria, gastro-intestinal symptoms and fever – can be difficult to 
 delineate from the picture of cyanobacterial dermatitis. The dermatoses 
 associated with cyanobacteria cannot be readily differentiated from 
 cercarial dermatitis by description of the signs and symptoms alone, with 
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 the possible exception of the prickling sensation, although this initial 
 reaction can go unnoticed (Gonzalez, 1989). 
 
• Gram-negative bacteria: Aeromonas hydrophila and Chromobacterium 
 violaceum are abundant in freshwater habitats. Both usually cause 
 infection through a pre-existing skin wound, though the clinical picture in 
 each case does not match any of any of the reports listed in Table 1.1. A. 
 hydrophila causes cellulitis and a purulent discharge; aspiration of water 
 can cause pneumonia and septicaemia. C. violaceum infections present 
 with various cutaneous signs that are secondary to systemic disease, 
 including sepsis (Auerbach, 1987). Vibrio vulnificus has reportedly caused 
 soft tissue infection after contact in brackish inland waters, though most 
 cases are associated with estuarine contact (Hunter, 1997 p114-5). 
 Pseudomonas aeruginosa is widely-distributed in natural and artificial 
 aquatic environments. Cutaneous infection presents as an erythematous 
 or urticarial rash some 18-24 hours after water contact and progresses to 
 a follicular dermatitis. Fever and pruritus are uncommon. Most reports of 
 pseudomonal dermatitis are related to spa pool or hot-tub exposures 
 (Sausker, 1987; Hunter, 1997 pp165-171). P. aeruginosa in recreational 
 waters is a common cause of otitis externa, presenting as a purulent 
 discharge (Hunter, 1997 p166). Diagnostic criteria include culturing the 
 organism from skin or ear swabs; the incubation period would also help to 
 distinguish P. aeruginosa infection from cyanobacteria-related 
 dermatoses. 
 
• Non-allergic urticaria: physical stimuli such as heat, cold and exercise 
 can induce itching and hives in susceptible individuals (Brooks et al, 
 2003; Habif, 2004 pp145-7). 
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1.5.2. Gastro-intestinal illness 
 
• Shigellosis: Shigella outbreaks are the most commonly reported cause of 
 disease associated with untreated inland recreational water in the USA, 
 with 16 events affecting almost 1,300 people between 1985 and 1994 
 (Hunter, 1997 p43). The incubation period is typically 2-3 days, with an 
 upper limit of about 7 days. Illness severity is strain-dependent, with most 
 S. sonnei infections being mild and self-limiting, and S. dysenteriae type 1 
 associated with severe diarrhoea which may progress to a life-threatening 
 illness (Hunter, 1997 p125). 
 
• E. coli: E. coli are markers of faecal pollution in recreational waters. 
 Disease outbreaks traced to enterohaemorrhagic E. coli 0157 have been 
 reported from recreational water exposures (Hunter, 1997 p148; Moe, 
 1997). 
 
• Norwalk-like viruses: Various transmission routes, including recreational 
 water outbreaks have been documented (Moe, 1997). 
 
 
1.5.3. Other microbial pathogens 
 
• Viruses: Pharyngo-conjunctival fever outbreaks associated with non-
 enteric adenoviruses in recreational waters have been reported (Moe, 
 1997). 
 
• Legionella: Legionella infections have been associated with recreational 
 water contact (Moe, 1997).  
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1.6. Possible under-diagnosis of cyanobacteria-related illness 
 
The examples given above highlight some of the differential diagnoses that 
need to be worked through when considering possible cases of 
cyanobacteria-related illness from recreational exposures. Competent history-
taking and diagnostic microbiology support will correctly diagnose many such 
cases. Competent history-taking and clinical diagnostic support also operated 
in several of the case reports listed in Table 1.1, with the early dermatological 
testing and microscopic examination of stool and vomitus samples lending 
strong support to the suspicion of cyanobacteria-related morbidity.  
 
Misdiagnosis of cyanobacteria-related disease may occur in both directions. In 
1978, nearly half the population of an industrial town in Finland were affected 
by a flu-like illness, with symptoms of fever, fatigue, cough, dyspnoea and 
myalgia. Symptoms occurred some 3-6 hours after taking a bath, shower or 
sauna and persisted for 8-16 hours. The outbreak lasted for some four 
months. This epidemic was investigated on several fronts, and provocation 
testing demonstrated an obvious link to the reticulated water supply. Tap 
water was cultured in a range of organic media for fungal and bacterial 
pathogens. No definitive pathogen was identified to explain the epidemic, yet 
in three published reports the authors describe how the shallow lake that was 
the town water source had taken on a distinct opaque blue-green appearance, 
had a musty smell, and the sand filtration system was covered by a mat of 
cyanobacteria. This change occurred in the same month (August, i.e. late 
summer) that the epidemic began. Analysis of crude lake water in the third 
month after the onset of the epidemic showed high coliform counts, 
Aspergillus fumigatus and unspecified blue-green algae. Investigations 
centred on identifying antibodies to mesophilic actinomycetes, which the 
authors (Ojanen et al, 1983) note were not pathogenic, whereas aquatic 
cyanobacteria were known at the time to be toxic. The health workers 
investigating the outbreak apparently did not consider the possibility of a 
cyanobacterial exotoxin breakthrough into the reticulated supply (Aro et al, 
1980; Muittari et al, 1980a; Muittari et al, 1980b; Muittari et al, 1982; Ojanen, 
1983). The epidemiological report of Aro et al (1980) came closest to 
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suggesting that cyanobacteria may have been involved, suggesting that 
“towards the end of summer….the microorganisms in the lake multiply rapidly 
and produce some toxic substance or allergen”, and reported that 
cyanobacterial endotoxin concentration in lake and tap water was high. This 
incident appears to have been retrospectively attributed to the presence of 
cyanobacterial endotoxins in the reticulated supply (Rapala et al, 2002). A 
similar outbreak occurred almost three years earlier in a Swedish town, 
though with a much smaller proportion of cases identified. Cyanobacteria 
were known to affect the town’s raw water supply, and the investigators did 
consider the possibility that cyanotoxins may have been responsible for the 
outbreak (Atterholm et al, 1977), though the analytical technique used by 
investigators at the time – gas chromatography – would have failed to detect 
the presence of cyanobacterial exotoxins in the post-treatment water supply. 
While no conclusions can be made about events that occurred over 25 years 
ago, from the descriptions of the outbreaks and the raw water supplies, most 
cyanobacterial toxicologists would rate cyanotoxin exposure with a high index 
of suspicion. 
 
A similar outbreak occurred more recently in Homa Bay, Kenya, in 1998. 
Apparently associated with a mass development of cyanobacteria in Lake 
Victoria, an epidemic of fever, malaise, dizziness and upper respiratory 
symptoms was related to hot water bathing. Symptoms lasted 12-24 hours, 
and returned when a shower or bath was taken again. This outbreak was 
reported in a conference abstract; the authors suggested cyanobacterial 
endotoxins were responsible, though it is not stated whether any investigation 
of cyanobacterial exotoxins was conducted (Annadotter et al, 2000).  
 
 
1.7. Concluding remarks 
 
The true incidence of acute cyanobacteria-associated illness from recreational 
exposure is unknown, as many outcomes are likely to be mild and self-
limiting, so medical attention is not sought. With a long-standing knowledge 
gap amongst primary healthcare providers, non-specific signs and symptoms 
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caused by cyanobacterial products are likely to be under-diagnosed (Ressom 
et al, 1994 p69). Codd (2000) stated:  
 
 “Evidence linking human illnesses with cyanobacterial cells and toxins 
 is open to criticism because of shortfalls in early detailed case 
 definitions, because diagnoses were made by exclusion, and because 
 identification and quantification of cyanobacterial toxins in health 
 incidents have, until recently, been lacking.” 
 
The collation of anecdotal and case reports of illness associated with 
recreational exposure to cyanobacteria in Table 1.1 will hopefully highlight 
some of the knowledge gaps. Particular attention should be given to 
determining the onset and duration of individual symptoms in future case 
reporting, as well as detailing the presence or absence of any predisposing 
medical conditions.  
 
A review of the epidemiological studies conducted to date on this topic was 
also combined with discussion of some common study designs used to 
investigate similar kinds of exposures to other microbial pathogens. The 
benefits and shortcomings of each of these study designs if and when applied 
to the study of recreational exposure to cyanobacteria were discussed. This 
was intended to be an introductory overview of environmental epidemiology 
for non-epidemiologists, and interested readers should refer to standard 
epidemiology texts for more detail.  
 
The most important advances in understanding the health impacts of 
cyanobacteria have come from the discipline of toxicology. The major toxins 
have been extensively studied and characterised, and while there is still much 
to be discovered in the field of cyanobacterial toxicology, significant advances 
in the future will be made at the interface of toxicology and epidemiology. 
Molecular epidemiology techniques using yet-to-be discovered biomarkers of 
exposure, susceptibility and outcome will refine knowledge of the risks 
associated with various acute and chronic exposures to cyanotoxins. The 
collaborative skills that epidemiologists and toxicologists can bring to this 
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endeavour were visualised with a mildly jaundiced eye by Paddle (1990), 
whose chapter on epidemiology for toxicologists is an excellent general 
primer: 
 
 “The total evidence about the risk to humans…will consist of the 
 toxicologist’s precise, experimental data about the wrong species at the 
 wrong exposure, and the epidemiologist’s imprecise, observational 
 data about the right species at the right exposure.” 
 
In conclusion, anecdotal and case reports of variable reliability have 
suggested a range of symptoms are associated with exposure to 
cyanobacteria in recreational or occupational settings. Some reports of 
cutaneous reactions are strongly suggestive of allergic reactions, and 
symptoms such as rhinitis, conjunctivitis, asthma and urticaria also hint at 
immediate hypersensitivity responses. Flu-like illnesses involving a 
constellation of symptoms including fever, malaise, myalgia, arthralgia, severe 
headache, cough and sore throat are, in this author’s opinion, explained by a 
cascade action of pro-inflammatory cytokines. If correct, this implies that some 
cyanobacterial products possess ligands that initiate innate immune 
responses, and such responses may need to be considered in terms of their 
potential to direct pathological changes in the liver and other organ systems. 
 
The epidemiology of recreational exposure to cyanobacteria is incomplete at 
present. All common epidemiological approaches have their own inherent 
advantages and disadvantages; identification of biomarkers for exposure, 
susceptibility and outcome in the future should lead to a significantly improved 
perception of the risks of bathing in cyanobacteria-affected waters.  
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CHAPTER 2: CYANOBACTERIAL LIPOPOLYSACCHARIDES; TOXICITY 
OF GRAM-NEGATIVE HETEROTROPHIC LPS – A REVIEW OF THE 
LITERATURE 
 
 
2.1. Introduction 
 
Cyanobacterial LPS is attributed with a range of pathological effects in 
humans, from gastro-intestinal illness, cutaneous signs and symptoms, 
allergy, respiratory disease, headache and fever. This chapter will review the 
studies of cyanobacterial LPS, and will attempt to place the knowledge of 
these products within the broader understanding of LPS from Gram-negative 
heterotrophic bacteria. The chapter will present an overview of the 
mechanisms of toxicity of Gram-negative bacterial LPS, discussing the history 
of its discovery and the present perception of its pathogenicity.  
 
 
2.2. Cyanobacterial LPS and symptoms in humans 
 
Table 2.1 lists some of the signs and symptoms reportedly associated with 
exposure to cyanobacterial LPS, and references that imply particular 
symptoms or symptom groups are explained by contact with cyanobacterial 
LPS.   
 
 
 
 
 
 
 
     Table 2.1. Signs and symptoms attributed to cyanobacterial lipopolysaccharides. 
GASTRO-
INTESTINAL DERMAL EYE ALLERGIC RESPIRATORY HAYFEVER HEADACHE DIZZINESS CRAMPS 
BLISTERING 
OF MUCOUS 
MEMBRANES 
FEVER REFERENCES 
3           
Keleti et al, 1979; Sykora et al, 
1980; Gerba & Goyal, 1981; 
Keleti & Sykora, 1982; Gorham 
& Carmichael, 1988; Beasley 
et al, 1989; Tyagi et al, 1999  
3 3          
NRA, 1990 p16; Drikas, 1994; 
Yoo et al, 1995; Codd et al, 
1997; Pitois et al, 2000  
3 3 3 3        
QLD Water Quality Task 
Force, 1992 p15; Burch, 1993; 
Steffensen et al, 1999; Leder 
et al, 2002; CRC for Water 
Quality & Treatment, ?year 
 3          Johnstone, 1995; Marshall et al, 2001; Shaw et al, 2001;  
 3  3        Pilotto et al, 2004 
   
3 
“ALLERGIC 
AND TOXIC 
RESPONSES” 
       Falconer, 1994a Kuiper-Goodman et al, 1999 
3 3  
3 
“RESPIRATORY 
ALLERGY”  
       
Ressom et al, 1994 p33; 
Environmental Health Unit, 
Queensland Health, 2001 
3 3 3         Falconer, 2001 
3 3     3 3    Codd & Poon, 1988 
3      3 3 3   Codd et al, 1989a 
 
3 
“CYTOTOXIC” 
SKIN 
IRRITATION 
         Chorus, 1993 
Chapter 2: Cyanobacterial LPS; review of the toxicity of Gram
-negative heterotrophic LPS 
3 3 3   3    3  NSW DLWC, 2000a 
          3  
Hindman et al, 1975; Chorus, 
2001; Fitzgerald, 2001 
3   3       3 Rapala et al, 2002 
    3   3   3 Annadotter et al, 2000 
   
3 
 “LPS of 
contaminating 
bacteria 
implicated” 
       Torokne et al, 2001 
NSW MRACC, 2002  3   3  3 3 3 3 3 
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Table 2.1 does not present an exhaustive list of citations implicating 
cyanobacterial LPS with human illness. Many such references are found in 
review articles, and the table does not include citations which discuss 
cyanobacterial LPS in the context of cyanobacterial toxins without linking them 
to specific illnesses – e.g. “Cyanobacterial toxins are of three main types: 
lipopolysaccharide endotoxins, hepatotoxins, and neurotoxins.” (Moe, 1997); 
“Potential irritant; affects any exposed tissue” (Sivonen & Jones, 1999); 
“[lipopolysaccharides] are responsible for the irritant nature of cyanobacterial 
material” (Hitzfeld et al, 2000); and “…toxicants such as…lipopolysaccharide 
endotoxins…affect any exposed tissue…” (Mwaura et al, 2004).  
  
 Several authors note that the health implications of cyanobacterial LPS are 
poorly understood and the topic requires more research (Burch, 1993; 
Carmichael & Falconer, 1993; Codd et al, 1995, 1999; Bartram et al, 1999; 
Kuiper-Goodman et al, 1999; Steffensen et al, 1999; Codd, 2000; Carmichael, 
2001a; Chorus & Fastner, 2001). Only one reference was found in the 
cyanobacteria literature that raises doubts about illness caused by 
cyanobacterial LPS: Carmichael (1981) suggests that the relationship 
between ingested LPS and illness in an immunologically competent population 
is debatable, there being little evidence that people with a normal LPS-
containing gut flora would be affected by LPS from water supplies.  
 
The relationship between cyanobacterial LPS and illness is discussed in terms 
ranging from cautious: “…may be responsible…” (Codd & Poon, 1988), 
“possibly [due to] lipopolysaccharides” (Chorus & Fastner, 2001), to definitive: 
“dermatotoxic lipopolysaccharides” (NSW DLWC, 2000a; Shaw et al, 2001). 
Cyanobacterial LPS has also been implicated as the cause of an outbreak of 
pyrogenic reactions in a haemodialysis clinic in 1974 (Hindman et al, 1975).  
 
The references in the literature to the association between cyanobacterial LPS 
and this rather diverse range of symptoms are not based on any research 
evidence specific to cyanobacterial LPS. As will be discussed later in this 
review (Section 2.9), the few toxicological investigations that have been 
carried out to date are mostly limited to the end-points of lethality and the local 
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Shwartzman reaction, which produces a dermonecrotic lesion in rabbits by 
sequential subcutaneous and intravenous injections. Rather, symptomatology 
attributed to contact with cyanobacterial LPS appears to be something of a 
default diagnosis for illnesses that are not otherwise explained by the current 
knowledge of cyanobacterial exotoxins, most of which are somewhat specific 
to their target organ system.  
 
The most likely explanation for the ready attribution of these illnesses to 
cyanobacterial LPS lies in the realisation that LPS from Gram-negative 
heterotrophic bacteria are implicated in significant morbidity – and mortality – 
so cyanobacteria, which are widely but somewhat inaccurately accepted as 
Gram-negative bacteria (see Section 2.3) may equally be responsible for 
illness because they contain LPS.  Codd (2000) suggests as much, noting that 
as LPS of other bacteria are associated with G-I and inflammatory illness, so 
too cyanobacterial LPS may be in the frame with respect to water-related 
illness.  
 
There is a danger that what was initially speculation about cyanobacterial LPS 
may evolve into orthodoxy without basis in research findings. This review will 
attempt to examine more closely the mechanisms by which LPS from Gram-
negative heterotrophic bacteria is associated with morbidity, and compare and 
contrast cyanobacterial LPS and heterotrophic bacterial LPS.  
 
 
2.3. Cyanobacteria: Gram-negative or Gram-positive? 
 
Most references to cyanobacteria describe these organisms as Gram-negative 
prokaryotes (Stanier & Cohen-Bazire, 1977; Codd & Poon, 1988; Holt et al, 
1994; Hunter, 1997 p97). Weckesser et al (1979) state that the presence of 
LPS is evidence for the Gram-negative cell wall architecture of cyanobacteria. 
However, Weckesser et al, (1974) reported that a strain of Anabaena variabilis 
they investigated was Gram-positive, “like other blue-green algae…” Drews 
(1973) also classifies cyanobacteria as Gram-positive. Golecki (1988) 
reviewed electron microscopy studies of the cell wall architecture of various 
 71
Chapter 2: Cyanobacterial LPS; review of the toxicity of Gram-negative heterotrophic LPS 
bacteria, and suggested that cyanobacteria have characteristics of both Gram-
negative and Gram-positive organisms. They contain an outer membrane and 
LPS, which are defining characteristics of Gram-negative bacteria (Lugtenberg 
& Van Alphen, 1983; Hobot, 2002), and a thick, highly cross-linked 
peptidoglycan layer similar to Gram-positive organisms. Jürgens & Weckesser 
(1985) and Golecki (1988) suggest that the chemical and structural 
organisation of the cell wall may place cyanobacteria in a separate 
phylogenetic category to both Gram-negative and Gram-positive bacteria, with 
cyanobacteria developing independently of Gram-negative and Gram-positive 
bacteria from a common ancestor. However, according to Margulis & 
Schwartz (1998 p78), electron microscopy shows that cyanobacteria have 
Gram-negative cell walls.  
 
 
2.4. Terminology: “endotoxin” in the cyanobacteria literature 
 
While most references to endotoxin in the cyanobacteria literature (e.g. those 
in Table 2.1) are clearly referring to lipopolysaccharides, i.e. cell wall structural 
components, this is not always the case. McBarron & May (1966), Murthy & 
Capindale (1970), Heaney (1971), Rabin & Darbre (1975), and Elleman et al 
(1978) were describing the toxic properties of microcystins, but referred to the 
toxins as “endotoxins”. Kay (1991) refers to aphantoxin (now known as 
saxitoxins) from Aphanizomenon flos-aquae as an “alkaloid endotoxin”. 
Gentile & Maloney (1969) also labelled what were presumably saxitoxins as 
an endotoxin. Even as recently as 2000, cyanobacterial hepatotoxins and 
neurotoxins were being described as endotoxins (Frank et al, 2000). This 
misunderstanding of the nomenclature is also seen in biotoxin research fields 
outside of cyanobacteria: Ellis (1985) described brevetoxins as endotoxins. 
Immunologists clearly understand endotoxins to refer only to 
lipopolysaccharides of Gram-negative bacteria. The reader’s attention is 
drawn to this distinction, as throughout this chapter, and indeed in the entire 
thesis, “endotoxin” and “LPS/lipopolysaccharide” are used more or less 
interchangeably, whereas other cyanobacterial toxins such as microcystins, 
cylindrospermopsin, saxitoxins and anatoxin-a, when discussed in aggregate 
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are referred to as “exotoxins”. The history of the term “endotoxin” and its 
current use are discussed in the following section.  
 
 
2.5. Gram-negative bacterial LPS: introduction and its discovery 
 
LPS from many bacterial species will initiate acute inflammatory responses in 
mammals that are typical of the host reaction to tissue injury or infection 
(Martich et al, 1993). LPS can induce a large and diverse range of effects, 
ranging from pyrexia to Gram-negative septic shock, which manifests as a 
complex and dramatic syndrome involving fever, leucopoenia, hypotension, 
cardiopulmonary dysfunction, disseminated intravascular coagulation and 
multi-system failure (Schletter et al, 1995; Henderson et al, 1998 p172).  
 
The history of the understanding of LPS starts in the late nineteenth century, 
when Richard Pfeiffer used heat-inactivated lysates of Vibrio cholerae to 
provoke pathophysiological effects in guinea pigs (Schletter et al, 1995). 
Pfeiffer named the heat-stable and cell-associated toxic substance 
“endotoxin”, to distinguish it from the heat-labile and proteinaceous exotoxins, 
which were known to be secreted by replicating bacteria (Morrison and 
Raziuddin, 1982; Schletter et al, 1995; Rietschel et al, 1996; Henderson et al, 
1998 p139). Initial analyses of endotoxin revealed that it contained 
polysaccharide and lipid, and was thus named lipopolysaccharide. The terms 
“endotoxin” and “lipopolysaccharide” are widely used by workers in a variety of 
biomedical fields as synonyms to describe the same molecule (many 
references, e.g. Lynn & Golenbock, 1992; Elsbach & Weiss, 1993; Seydel et 
al, 1993; Olson et al, 1995; Schletter et al, 1995; Holst et al, 1996; Matsuura 
et al, 1996; Rietschel et al, 1996) including the field of cyanobacteria  
research: “lipopolysaccharide endotoxins” (Codd et al, 1989b; Environmental 
Health Unit, Queensland Health, 2001; Shaw et al, 2001). However, some 
authors have suggested that lipopolysaccharide should refer to the purified 
molecule, whereas endotoxin more appropriately describes macromolecular 
complexes of LPS, protein, phospholipid and nucleic acids (Morrison and 
Raziuddin, 1982; Burrell, 1994; Henderson et al, 1998 p137).  
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The study of LPS, which was largely concerned with investigating fever, 
progressed in the late 1940s with the discovery of endogenous pyrogens 
(Henderson et al, 1998 pp168-71). Since then, the field of cytokine biology 
has made enormous strides. It is now understood that the pathological effects 
of LPS are indirect, i.e. LPS acts by initiating a cascade of host-mediated 
responses: initially monocytes and macrophages are stimulated, and then 
neutrophils and platelets congregate in microcapillaries, causing vascular 
injury. Inflammatory cells release a range of endogenous mediators, including 
arachidonic acid metabolites, platelet-activating factor, cytokines such as 
interleukin-1 (IL-1), IL-6 and tumour necrosis factor-alpha (TNF-α), nitric oxide, 
toxic O2 metabolites, vasoactive amines, proteases and products of the 
complement and coagulation cascades. There are many reviews in the 
literature on cytokines and LPS - some recent examples are: Hewett & Roth, 
1993; Martich et al, 1993; Olson et al, 1995; Schletter et al, 1995; Holst et al, 
1996; Rietschel et al, 1996; Henderson et al, 1998; Heumann et al, 2002. 
Cytokine-mediated responses are extremely complex: cytokines are 
pleiotropic, i.e. a single type of cytokine affects several different types of cell. 
Cytokines have autocrine effects, i.e. they can stimulate the cells that secrete 
them to produce more cytokines, and paracrine effects – stimulating other 
cells to produce different cytokines (Hamblin, 1992). Signs and symptoms in 
human volunteers after administration of endotoxin are: fever, rigors, and 
influenza-like symptoms of fatigue, headache, nausea, myalgia, arthralgia, 
drowsiness, mild amnesia and diarrhoea (Martich et al, 1993; Burrell, 1994; 
Brandtzaeg, 1996; Wright, 1999). 
 
From the discovery that LPS-associated pathology results from the stimulation 
of host cell responses came the realisation that LPS binds to specific 
receptors in order to elicit the release of cytokines and other inflammatory 
mediators (Heumann et al, 2002). Several membrane-bound and soluble 
proteins have been shown to bind LPS; the most important appear to be CD14 
and LPS-binding protein (LBP) (Lynn & Golenbock, 1992; Olson et al, 1995; 
Schletter et al, 1995; Rietschel et al, 1996; Tobias et al, 1999; Heumann et al, 
2002). The Toll-like receptor (TLR) family are a recently discovered group of 
transmembrane receptors that are fundamental in signalling innate immune 
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responses to conserved microbial structures, and they are also involved in the 
recognition of some endogenous ligands. TLR4 is instrumental in signalling 
LPS from many Gram-negative bacteria, and TLR2 is involved in the 
recognition of some unusual lipopolysaccharides. There is a considerable and 
rapidly expanding body of literature on the TLR family; one of the most 
comprehensive reviews is by Takeda et al (2003).  
 
Knowledge of the role of specific receptors in mammalian hosts has led to the 
demonstration that LPS itself is non-toxic: CD14-deficient cell lines such as 
Chinese hamster ovary are unresponsive to LPS at high doses, and cell lines 
that show poor LPS activation can be converted to show high activation when 
transfected with the CD14 gene (Schnaitmann, 2002). LPS-unresponsive 
mouse strains and cytokine knockout strains also serve to reinforce the 
concept that LPS is not directly toxic, and the pathophysiology associated with 
Gram-negative LPS results from host-mediated factors (Morrison, 1983; 
Tracey et al, 1986; Galanos & Freudenberg, 1993; Müller-Loennies et al, 
1998; Qureshi et al, 1999; Tobias et al, 1999; Sing et al, 2000).  
 
 
2.6. LPS structure – similarities and differences across Gram-negative 
bacteria 
 
Lipopolysaccharides from different Gram-negative species apparently share 
common features in their basic architecture. A structure consisting of four 
covalently linked segments – a surface carbohydrate polymer (O-specific 
chain), a core oligosaccharide featuring an outer and inner region, and an 
acylated glycolipid (termed lipid A) – is seen in such ecologically diverse 
bacteria as Salmonella, Pseudomonas, Vibrio and Rhizobium (Rietschel et al, 
1992). The O-specific chain shows the most diversity, and is the basis for 
serological specificity (Schletter et al, 1995), while lipid A, which anchors the 
LPS molecule in the Gram-negative outer membrane, is the most conserved 
biochemical structure across different bacterial species (Morrison, 1983). 
There is unequivocal acceptance that the lipid A moiety is the biologically 
active component of LPS (Ulevitch & Tobias, 1999). This was confirmed by 
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the observations that lipopolysaccharides from polysaccharide-deficient 
mutant strains were equally as bioactive as parent LPS (Lüderitz et al, 1973; 
Morrison, 1983), and chemically synthesised Escherichia coli lipid A exhibits 
identical activity to natural E. coli lipid A (Galanos et al, 1985).  
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FIGURE 2.1. Schematic of the basic LPS structure. The O-specific polysaccharide is 
the unit that is most exposed to the external environment and so manifests the 
greatest structural diversity; lipid A is the most conserved structure. 
 
 
 
 
2.7. Are all LPSs equal in terms of their host-mediated responses? 
 
Although the basic structure of lipid A is seen in phylogenetically diverse 
Gram-negative bacteria, variations in the nature and location of acyl groups or 
alterations in the hydrophilic backbone can result in partial or total loss of 
biological activity (Erwin et al, 1991; Schletter et al, 1995; Rietschel et al, 
1996; Wiese et al, 1999). An example is seen in the case of some purple non-
sulfur bacteria, which could be considered to be somewhat more 
representative of cyanobacteria when it comes to drawing comparisons on the 
biological activity of LPS. Purple non-sulfur bacteria, being photosynthetic, are 
Gram-negative bacteria that occupy ecological niches, and therefore growth 
and reproductive strategies that much more closely resemble cyanobacteria 
than the heterotrophic, gut-dwelling E. coli and Salmonella. Lipid A from 
Rhodobacter sphaeroides and Rhodobacter capsulatus is not only inactive, 
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but is an antagonist of Enterobacteriaceae LPS-induced cell activation (Lynn 
& Golenbock, 1992; Takayama & Qureshi, 1992; Schletter et al, 1995; 
Henderson et al, 1998 pp157, 297-8). R. sphaeroides and R. capsulatus lipid 
A differs from that of Escherichia coli in several respects, all relating to the 
acylation pattern; the lack of endotoxic activity in R. sphaeroides and R. 
capsulatus appears to be attributable to the presence of five rather than six 
fatty acid groups, and the shorter chain lengths (C10 in R. sphaeroides and R. 
capsulatus compared with C14 in E. coli) in two ester-linked fatty acids 
(Takayama & Qureshi, 1992). Lipid A from R. sphaeroides and R. capsulatus 
is of pharmacological interest because of their LPS-antagonist properties; 
these lipid A structures and some synthetic derivatives have been shown to be 
potent LPS antagonists in vitro and to protect against LPS-induced morbidity 
and mortality in animal models (Rietschel et al, 1992; Henderson et al, 1998 
p298; Jagielo et al, 1998). Competitive inhibition of biologically active LPS by 
LPS antagonists further illuminates the requirement for host cell receptor sites 
in mediating the responses to LPS (Lynn & Golenbock, 1992).  Other purple 
non-sulfur bacteria, e.g. Rhodopseudomonas viridis and Rhodopseudomonas 
palustris are also reported to lack endotoxic activity (Weckesser et al, 1979; 
Takayama & Qureshi, 1992), but the lipid A from another purple non-sulfur 
bacterium, Rubrivivax gelatinosus, is reportedly associated with high lethality 
in mice – at similar doses that cause lethality in Salmonella – and high 
pyrogenicity in rabbits (Weckesser et al, 1979; Takayama & Qureshi, 1992). 
The high endotoxicity of R. gelatinosus is apparently due to the presence of 
six fatty acid groups in the lipid A structure (Masoud et al, 1990; Takayama & 
Qureshi, 1992).  
 
Bacteroides spp, which are common gut and periodontal commensals, have 
low endotoxic activity (Takada & Kotani, 1992). Bacteroides fragilis LPS 
inhibits E. coli LPS-induced endothelial adhesiveness for polymorphonuclear 
leucocytes, although B. fragilis LPS is reported to be directly toxic to 
endothelial cell cultures at high concentrations (Lynn & Golenbock, 1992). B. 
fragilis also has five fatty acyl groups in the lipid A moiety, and other structural 
differences to Salmonella and E. coli LPS, such as a monophosphorylated 
disaccharide backbone and longer fatty acyl chains (Weintraub et al, 1989).  
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FIGURE 2.2. Primary lipid A structures: E. coli has a bis-phosphorylated diglucosamine backbone with six 
amide and ester linked fatty acyl chains. The non-endotoxic (and LPS-antagonist) R. sphaeroides lipid A has 
an identical disaccharide backbone but has five acyl residues, shorter ester-linked primary acyl chains and 
an unsaturated acyl group. B. fragilis, which expresses low endotoxic potential, has a mono-phosphorylated 
backbone and five acyl chains with longer chain lengths than those seen in E. coli. Lipid A from 
Chromobacterium violaceum, like R. sphaeroides, is an LPS antagonist. 
Figures adapted from: Weintraub et al (1989), Rietschel et al (1992) and Takayama & Qureshi (1992). 
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Some pathogenic bacteria have LPS which reflects the highly specific niches 
they inhabit: enteric Gram-negative bacteria have long, hydrophilic and neutral 
O-specific polysaccharide chains which protects the organism from 
solubilisation by bile acids and intestinal enzymes, whereas organisms that 
colonise the mucous membranes of the respiratory and genital tracts have 
outer membrane surfaces that are hydrophobic and can be solubilized by bile 
(Griffiss et al, 1988; Preston et al, 1996). Gram-negative bacteria such as 
Neisseria, Haemophilus and Bordetella have developed unique surface 
glycolipids lacking O-antigens, which some workers call lipooligosaccharides 
(Griffiss et al, 1988; Preston et al, 1996).  
 
The presence of one or more secondary acyl chains appears to be essential 
for lipid A to stimulate some endotoxic reactions (Erwin et al, 1991; Takada & 
Kotani, 1992). One of the final stages of Enterobacteriaceae lipid A 
biosynthesis is the formation of acyloxyacyl groups, so-called secondary fatty 
acids (Raetz, 1992). A leucocyte enzyme, acyloxyacyl hydrolase, selectively 
removes these secondary fatty acyl groups, without releasing the 3-hydroxy 
acyl chains that substitute the lipid A disaccharide backbone (Munford & Hall, 
1986; Erwin et al, 1991). Deacylated LPS from E. coli, Salmonella 
typhimurium, Haemophilus influenzae and Neisseria meningitidis were shown 
to have reduced activities in a series of tests relating to endotoxic potential, in 
some cases by greater than two orders of magnitude, and deacylated 
Neisseria LPS demonstrated some antagonistic activity towards Neisseria and 
Salmonella LPS (Munford & Hall, 1986; Riedo et al, 1990; Erwin et al, 1991). 
 
The lipid A analog, compound 406, which lacks the two secondary fatty acids 
of E. coli lipid A, is unable to induce cytokines in human cells (Schletter et al, 
1995; Rietschel et al, 1996; Müller-Loennies et al, 1998). Rietschel et al 
(1996) propose that endotoxic capacity resides in the spatial conformation of 
lipid A, in that biologically inactive lipid A (e.g. R. capsulatus) conforms to 
lamellar structures, whereas endotoxic lipid A adopts exclusively cubic or 
hexagonal structures.  
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Netea et al (2002) suggest that the historical assumption that LPS from 
different Gram-negative bacteria possess similar biological effects is incorrect, 
and that differences between LPS across species are the rule rather than the 
exception. The authors discuss structure-function relationships between LPS 
and the Toll-like receptors (TLRs), which are integral in LPS-mediated 
signalling, suggesting that differences in the three-dimensional conformation 
of LPS molecules translate into differences in TLR signalling of 
proinflammatory cytokines. In their reviews of the supramolecular structure 
and phase transition states of LPS and lipid A, Seydel and Brandenburg 
(1992) and Seydel et al (1993) suggest that endotoxic activity is related to the 
three-dimensional conformation of LPS and the multimeric aggregates they 
form. The conformation of LPS or lipid A within such aggregates is not 
constant, but a reversible phase transition occurs, which is temperature-
dependent and related to the length and degree of saturation of the acyl 
chains and other physiological conditions.  
 
More recent work by Seydel and collaborators has led to the realisation that 
the biological activity of specific lipid A structures can be determined by an 
understanding of their supramolecular structure, which is a function of the 
monomeric conformation, which in turn is largely determined by the primary 
molecular structure (Wiese et al, 1999; Schromm et al, 2000; Seydel et al, 
2000a). The presence of sufficient negative charges on the disaccharide 
backbone – mainly, but not necessarily, two phosphate groups – has an 
important influence on lipid A molecular conformation and the binding capacity 
to serum proteins such as LBP (Schromm et al, 1998; Wiese et al, 1999). A 
high negative charge density is reported to be an essential requirement for 
agonistic and antagonistic properties; complete or partial substitution of 
negative charges can result in the loss of all biological activity (Wiese et al, 
1999; Seydel et al, 2001). Seydel’s team now suggest that a general principle 
can be applied regarding the molecular conformation of lipid A structures and 
their biological activity: lipid A structures that adopt conical/concave shapes 
have hexagonal or cubic supramolecular aggregate structures and express 
high endotoxic potential, whereas lipid A structures that adopt cylindrical 
conformations have lamellar aggregates and are either inactive or LPS 
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antagonists (Schromm et al, 2000). Thus lipid A of the photosynthetic 
bacterium R. gelatinosus, which has high endotoxic activity (Weckesser et al, 
1979; Takayama & Qureshi, 1992), was seen to adopt hexagonal aggregate 
structures, whereas the lipid A complexes of other non-endotoxic 
photosynthetic bacteria adopt cylindrical shapes and lamellar aggregate 
structures (Brandenburg et al, 1993; Schromm et al, 2000; Seydel et al, 
2000a). Lipid A from Chromobacterium violaceum forms a cylindrical 
geometry and is reportedly three orders of magnitude less active than E. coli 
lipid A (Seydel et al, 2000b). Ulmer et al (1992) also found that a synthetic 
lipid A structure based on C. violaceum lipid A had markedly lower cytokine-
inducing capacity than an E. coli-based synthetic lipid A. These findings are in 
contrast to some other reports, which describe C. violaceum lipid A as having 
a high agonist activity (Rietschel et al, 1996; Müller-Loennies et al, 1998). Of 
interest is the observation that the primary lipid A structures of C. violaceum 
and R. gelatinosus are very similar (bisphosphorylated diglucosamine 
backbone, six symmetrically distributed acyl chains differing only in the length 
of the two acyloxyacyl groups: C=12 in C. violaceum and C=10 for R. 
gelatinosus) (Takayama & Qureshi, 1992). Yet C. violaceum lipid A is an LPS 
antagonist, whereas R. gelatinosus lipid A expresses high agonist activity. 
Seydel et al (2000b) suggest that the chemical structures of these two lipid A 
complexes may need to be re-examined. Lipid A of Campylobacter jejuni, 
which has low endotoxic potential, shows a very slight tendency to adopt a 
conical/concave shape, whereas the lipid A of E. coli clearly adopts a 
conical/concave form (Moran, 1995; Schromm et al, 2000).  
 
As a result of these studies, the ability of a lipid A monomer to adopt a conical 
shape (the so-called endotoxic conformation) has been described as a 
prerequisite for endotoxicity (Seydel et al, 2000a). Seydel et al (2000b) 
suggest that when lipid A molecules are intercalated into target cell 
membranes, only lipid A which forms a conical shape – where the cross-
sectional area of the hydrophilic backbone is smaller than the cross section of 
the hydrophobic acyl groups – can exert a mechanical stress on signalling 
proteins. LPS with a lipid A moiety which assumes a cylindrical shape – cross-
sectional areas of the hydrophobic and hydrophilic components being roughly 
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equal – will occupy the binding site but be unable to activate signalling 
proteins, thus acting as an LPS antagonist (Seydel et al, 2000b; Seydel et al, 
2001). The number and distribution of acyl chains has been shown to affect 
the tilt angle of the disaccharide backbone with respect to the target cell 
membrane; the orientation of the backbone sugars appears to correlate with 
the endotoxic potential of the LPS. The lipid A molecular shape and the tilt 
angle of the backbone sugars are reported to be the complete determinants of 
endotoxic activity (Seydel et al, 2000b; Seydel et al, 2001).  
 
The discussion above has contrasted the endotoxic potential of lipid A 
structures from the most widely studied forms, those of the 
Enterobacteriaceae, with some unusual lipid A complexes from photosynthetic 
bacteria and synthetic lipid A analogs. The reason that cyanobacterial LPS 
has not been discussed here is simply that the required research has not been 
done as yet. No cyanobacterial lipid A structures have been published, 
therefore no inferences can be deduced as to their likely endotoxic potential, 
or lack of it. But with the knowledge that endotoxic potential can vary in the 
most fundamental way across Gram-negative bacteria, from agonistic to 
weakly active to inactive to antagonistic, it should be incumbent on the 
cyanobacteria research community to cease attributing biological activity and 
clinical symptoms to cyanobacterial LPS without research evidence. 
Cyanobacteria may not be typical Gram-negative organisms because of their 
unusual cell wall architecture (Section 2.3), and cyanobacteria will have 
experienced very different selection pressures to gut-dwelling Gram-negative 
bacteria, which may be reflected in different lipid A structures.  
 
 
2.8. LPS and infection 
 
Much research into LPS and lipid A has understandably concentrated on the 
severe, life-threatening host responses to circulating LPS that constitute 
Gram-negative septicaemia and septic shock. Many experimental models 
have utilised either in vitro studies of isolated cell lines or animal and human 
studies where LPS is exposed to the circulation by parenteral injection.  
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The matter of the degree to which cyanobacterial LPS/lipid A can stimulate 
mammalian cytokine networks under experimental conditions, which remains 
largely unanswered, is only one aspect in the understanding of cyanobacterial 
LPS and the gastro-intestinal, respiratory and dermal illnesses which have 
been attributed to contact with it. The other side of the story that needs to be 
considered is the mechanism by which cyanobacterial LPS might (and might 
not) stimulate endotoxic responses by the various natural exposure routes: 
ingestion, inhalation and contact. The following discussion will briefly review 
the association between acute gastrointestinal illness and Gram-negative 
bacterial LPS. Cutaneous responses to LPS will be briefly discussed.  
 
 
2.8.1. Terminology: infection, pathogen 
 
Infectious diseases caused by bacteria are characterised by several discrete 
steps: bacterial adhesion to the host, colonisation within or on the host, and 
evasion of host defences (Lugtenberg & Van Alphen, 1983; Henderson et al, 
1998 p37). The only references in the literature that describe cyanobacteria as 
invasive, infectious organisms were from two authors:  
 
• Rank (1985, 1987a, 1987b) put forward the hypothesis that a chronic, low-
 virulence infestation by cyanobacteria growing heterotrophically may 
 explain the aetiology of arteriosclerosis in humans and homeothermic 
 animals. The author bases his theory on ecological data, examining the 
 geographical, demographic and historical distribution of the disease. 
 Routes of infection are posited to be ingestion of unfermented milk, public 
 water supplies drawn from surface waters as distinct from groundwater 
 (Rank, 1987a, 1987b), and earth-contaminated food and other objects 
 (Rank, 1985). The author also critiques the three theories of the 
 pathogenesis of arteriosclerosis that were current at the time (response-to-
 injury, lipid hypothesis, and monoclonal hypothesis) and suggests 
 laboratory studies to replicate and study the disease. Such studies do not 
 subsequently appear in the literature, and no further reference to the 
 cyanobacterial infection hypothesis can be found.  
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• Ahluwalia et al (1997) and Ahluwalia (1999, 2001) posited the theory that 
 Microcystis aeruginosa is the causative organism of the mostly tropical, 
 water-exposure-related invasive disease rhinosporidiosis. However, this 
 theory has been disputed; convincing and probably conclusive evidence 
 appears to place the eukaryotic protist Rhinospiridium seeberi as the 
 causative organism [see Author’s reply to Ahluwalia (2001)]. 
 
Most public health workers would presumably place cyanobacteria-related 
illnesses in the context of environmental exposures, as distinct from familiar 
diseases due to communicable infectious bacteria, which in many cases 
feature transmissible illnesses, secondary to the original reservoir of infection. 
Cyanobacteria-related illness is viewed as intoxication, rather than infection, 
usually on the basis of a sudden onset of symptoms occurring soon after 
exposure (i.e. without an incubation period), and lack of secondary cases 
(Annadotter et al, 2001). Giesecke (2002 p12) defines infectious disease as 
“all diseases caused by micro-organisms”, with sub-definitions of 
communicable and transmissible disease (communicable disease: capable of 
being transmitted from an infected individual to another person, directly or 
indirectly; transmissible disease: able to be transmitted from one individual to 
another by ‘unnatural’ routes). Whether cyanobacteriologists would embrace 
that definition of infectious disease is moot, but most would agree that 
cyanobacteria-related diseases are neither communicable nor transmissible. 
Exotoxin-producing cyanobacteria certainly fit the dictionary definition of 
pathogenic (i.e. disease-causing) organisms; the reader’s attention is drawn to 
the distinction between infectious (implying colonisation and evasion of host 
defences) Gram-negative bacteria and non-infectious cyanobacteria in the 
following discussions on LPS and G-I and dermal illnesses. 
 
 
2.8.2. Mechanisms of vomiting and its relationship to LPS activity 
 
Nausea and vomiting are normal physiological responses to the ingestion of 
toxic substances; they are essential defences because they are the end result 
of the actions of sensorimotor systems that operate to identify and rapidly 
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expel hazardous substances from the upper G-I tract (Andrews & Hawthorn, 
1988; Grélot & Miller, 1994; Wood, 1999). The two main sensory systems that 
direct the emetic response are local, associated with the gut mucosa (pre-
absorptive response), and central, specifically the chemoreceptive trigger 
zone of the area postrema, located in the dorsal surface of the medulla 
oblongata (post-absorptive response) (Borison, 1989; Lang, 1999; Miller, 
1999). Stimulation of chemoreceptors in the stomach, jejunum and ileum by 
irritant chemicals such as hypertonic saline, copper sulfate or mustard, or by 
bacterial enterotoxins, leads to the activation of vagal sensory afferent nerves 
to the brain. Vagal efferent processing through the enteric nervous system 
stimulates enteric motor neurons to effect emesis (Andrews & Hawthorn, 
1988; Lang, 1999; Miller, 1999; Wood, 1999). Emetic chemoreceptors are also 
found in the vascular system; activation of these chemoreceptors will also 
initiate nausea and vomiting (Andrews & Hawthorn, 1988). Endogenous 
mediators of emesis such as dopamine, acetylcholine and enkephalin are 
reported (Andrews & Hawthorn, 1988). Prostaglandins have well-known 
emetic actions (Barnes, 1984).  
 
Circulating E. coli LPS is a potent emetic stimulant. In a series of experiments 
using piglets, Girod et al (2000) showed that parenteral administration of LPS 
provoked vomiting (as well as fever, rigors, purpura, diarrhoea and 
drowsiness). The authors suggested that LPS stimulates vomiting by means 
of cytokine-induced prostaglandins and other endogenous mediators acting 
both centrally and on vagal afferents. Other animal studies have demonstrated 
the emetic action of LPS (Sugiyama et al, 1966).  
 
The area postrema is reported to be the primary sensory area involved in 
nausea as well as vomiting, although nausea is accompanied by autonomic 
excitation, whereas vomiting is a somatic process independent of the 
autonomic nervous system (Barnes, 1984; Borison, 1989). Presumably LPS-
stimulated endogenous mediators are associated with symptoms of nausea, 
which is reported in several studies and reviews of intravenous exposure to 
LPS in human volunteers (Martich et al, 1993; Burrell, 1994; Brandtzaeg, 
1996; Wright, 1999).  
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To investigate vomiting associated with exposure to cyanobacteria, the 
appropriate research efforts should determine whether cyanobacterial LPS is 
capable of stimulating gut chemoreceptors, or if cyanobacterial LPS can gain 
access to the circulation and stimulate nausea and vomiting centrally. Another 
point of interest should be directed towards the cyanobacterial exotoxins, as to 
their capacity to stimulate either gut mucosal chemoreceptors, vascular emetic 
chemoreceptors, or whether they induce vomiting through the activity of 
endogenous mediators. Bacterial exotoxins such as staphylococcal 
enterotoxins (SEs) are known to stimulate emesis via gut chemoreceptors 
(Sugiyama & Hayama, 1965; Grélot & Miller, 1994; Wood, 1999). Worthy of 
note is that experimental induction of LPS-related emesis is achieved by 
intravenous or intraperitoneal routes (Sheth & Borison, 1960; Gilbert, 1962; 
Martin & Marcus, 1964; Sugiyama & Hayama, 1965; Sugiyama et al, 1966; 
Girod et al, 2000), whereas SEs readily elicit vomiting when administered 
intragastrically (Sugiyama et al, 1962; Sugiyama & Hayama, 1965). Also of 
interest with respect to cyanobacteria-related G-I illness are some similarities 
of clinical symptoms in the case of staphylococcal food poisoning: enteritis 
due to ingestion of SEs is characterised by rapid onset (1-4 hours) of vomiting 
± nausea and diarrhoea, abdominal cramping and dizziness (Sugiyama & 
Hayama, 1965; Jett et al, 2002). Staphylococcal food poisoning is an 
intoxication, not an infectious process (Jett et al, 2002). 
 
 
2.8.3. Diarrhoea and LPS 
 
One inference that can be drawn from the references that posit cyanobacterial 
LPS as the cause of G-I illnesses (see Table 2.1) is that these symptoms are 
not necessarily related to exposure to any of the known cyanobacterial 
exotoxins, the assumption being that exposure to – and presumably illness 
caused by – cyanobacterial LPS can occur with or without concurrent 
exposure to exotoxins (i.e. from non-toxic strains or species, or non-
production of exotoxins at the time of exposure). However, several questions 
need to be answered if LPS is the sole presumptive “G-I-toxin”. A hypothesis 
is needed for the mechanism of cyanobacterial LPS, in the absence of other 
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virulence factors, to initiate diarrhoea by the oral exposure route. Another 
explanation for cyanobacterial LPS-related diarrhoea is that the alteration in 
gut membrane permeability may be related to a cytokine cascade generated 
by circulating cyanobacterial LPS, but again, a hypothesis is needed to 
explain the exposure route for the LPS to overcome innate immune intestinal 
defences in order to gain access to the circulation.  
 
Some observations on the behaviour of Gram-negative bacterial LPS in the 
gut serve to cast doubt on the suspicions that cyanobacterial LPS alone is 
responsible for initiating acute gastro-intestinal illness in humans by the oral 
route: 
 
• Commensal gut flora: The human intestinal tract houses an enormous 
 population of bacteria, many of which are Gram-negative. The number of 
 microbes in the gut lumen exceeds the number of eukaryotic cells in the 
 human body by an order of magnitude (Henderson et al, 1998 p16; 
 Guarner & Malagelada, 2003), an observation that may lead some to 
 unkindly suggest that the principal reason for human existence is to serve 
 as bags for the housing and transport of bacteria. Nanthakumar et al 
 (2000) note that mature enterocytes are 100 to 1,000 times less sensitive 
 to LPS than neutrophils and hepatocytes, which is not surprising since 
 they are exposed to Gram-negative bacteria and their endotoxins since 
 birth when the gut is colonised.  
 
• Non-virulent strains: Most Gram-negative organisms are non-
 pathogenic. Pathogenicity involves a complex interaction between host-
 related and specific microbial virulence factors – the latter including pili, 
 fimbriae and heat shock proteins (Turner et al, 2001; Nataro, 2002). 
 Infectious, i.e. colonising, microbes are the most common cause of 
 diarrhoea worldwide; pathogenic strains commonly cause disease by the 
 action of enterotoxins (Farthing, 2000). That virulence factors other than 
 lipid A structures of LPS are responsible for gastro-intestinal disease is 
 seen in the protective effects of attenuated or mutant Gram-negative 
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 bacteria when used as live oral vaccines against pathogenic strains 
 (Ahmed et al, 1990; Kollaritsch et al, 2000; Turner et al, 2001; Salerno-
 Goncalves et al, 2003). Some E. coli strains are used as probiotics for the 
 treatment of gastrointestinal disease and infection prophylaxis in neonates 
 (Altenhoefer et al, 2004). 
 
• Anecdotal reports of consumption of non-hazardous cyanobacteria: 
 Heaney (1971) reports observations of cattle seen drinking from two Irish 
 lakes affected by thick scums of Anabaena flos-aquae and 
 Aphanizomenon flos-aquae without ill effect. This author can add a similar 
 observation: during recruitment for an epidemiology study (Chapter 3 of 
 this thesis) at Lake Coolmunda in southern Queensland, a frank 
 Microcystis aeruginosa bloom was in attendance. A group of six or seven 
 dogs were seen playing vigorously in the water, and three dogs were 
 observed drinking from it. The owners of the animals were questioned the 
 following day; all denied observing any adverse effects. The consumption 
 of Spirulina and other cyanobacteria provides further evidence that 
 cyanobacterial LPS cannot all be harmful. Cyanobacteria as food, 
 medicine and livestock feed will be discussed later in this chapter (Section 
 2.10).  
 
Oketani et al (2001) state that orally administered LPS is not harmful to 
animals, which is in stark contrast to LPS administered parenterally. Evidence 
for harmful effects of orally administered LPS is difficult to gather from the 
literature because of the overwhelming number of publications describing 
experimental use of LPS as an in vitro and in vivo immune stimulant. This 
candidate has been able to find two reports of in vivo LPS activity by the oral 
route: Yang et al (1998) showed that oral administration of E. coli LPS 
enhanced the progression of hepatoma in rats treated with thioacetamide. 
Yoshino et al (1999), using a mouse model of autoimmune disease, 
demonstrated that orally-dosed LPS exacerbated collagen-induced arthritis. 
These models of liver disease and autoimmunity are not applicable to the 
concept of acute G-I symptoms caused by cyanobacterial LPS in presumably 
healthy people in recreational settings and through cyanobacterial 
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contamination of drinking water supplies. However, they do serve to highlight 
the importance of gut mucosal immunity. LPS and other microbial products 
are constantly sampled by gut-associated lymphoid tissues, which contain the 
largest assemblage of immunocompetent cells in the body (Guarner & 
Malagelada, 2003). Translocation of small amounts of LPS from the gut lumen 
across the epithelium and into the portal circulation is an important immune-
stimulating process, with Kupffer cells in the liver playing an important role in 
clearance of LPS from the circulation (Guarner & Malagelada, 2003). LPS and 
other bacterial products from the normal gut flora can be a source of infection 
and sepsis when the integrity of the gut mucosa is disrupted. This occurs in a 
variety of disease states, including hypovolaemic shock, burn injury, trauma, 
acute liver failure, pancreatitis, cirrhosis and inflammatory bowel disease 
(Guarner & Malagelada, 2003).  
 
Roth et al (1997) suggest that endogenous (i.e. gut-derived) LPS is a potent 
synergist of the toxicity of a range of structurally and functionally unrelated 
hepatotoxic xenobiotic agents. The authors put the proposition that 
hepatotoxicity associated with some chemicals is indirectly caused by primary 
damage to the intestinal tract, which allows increased translocation of 
bacterial LPS into the portal circulation. The liver is then exposed to harmful 
levels of LPS, and the ensuing liver injury resembles that caused by large 
doses of LPS: changes in sinusoidal and parenchymal cells, neutrophil and 
platelet accumulation in sinusoids, then multifocal hepatocellular degeneration 
and necrosis. Yee et al (2000) showed that co-administration of individually 
non-toxic doses of LPS and the alkaloid phytotoxin monocrotaline produced 
significant liver injury, characterised by midzonal and centrilobular apoptotic 
and necrotic changes, coagulation and congestion, and loss of sinusoidal 
architecture. Ganey & Roth (2001) propose that the activation and increased 
expression of various soluble mediators, signalling molecules and cellular 
processes are crucial events in the augmentation of xenobiotic toxicity by 
bacterial LPS, and that the mechanisms of toxicity are complex and variable. 
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2.8.4. LPS and cutaneous reactions 
 
As with LPS and oral exposure, searching bibliographic databases for 
evidence of LPS/endotoxin as the primary cause of acute clinical dermatoses 
is a difficult task, again because of the many citations of in vitro immunology 
work using LPS to investigate various dermal cell processes. As a starting 
point, dermatology textbooks were perused, yet only one of a dozen or so 
standard texts made any reference to either LPS or endotoxin: Rietschel & 
Fowler (2001 p549-50) describe a single case report of a hospital worker who 
suffered dyshidrosis (a vesicular or vesicopustular eruption on the palms of 
the hands), which was linked to endotoxin in latex gloves. Various dermatoses 
are clearly associated with either superficial or systemic infection by many 
Gram-negative organisms, most notably Pseudomonas aeruginosa (Arnold et 
al, 1990 pp289-305). However, it is unreasonable to compare mechanisms of 
cutaneous disease from colonising Gram-negative bacteria to those due to 
cyanobacteria solely on the basis that both organisms contain LPS.   
 
 
2.9. Cyanobacterial lipopolysaccharides 
 
Literature searches using PubMed and Web of Science with the search terms 
(cyanobacteria* OR blue green alga*) AND (LPS OR endotoxin) revealed 17 
publications that describe the extraction ± purification of cyanobacterial 
lipopolysaccharides. The Westphal hot phenol/water method was used in 15 
of these studies (described in Chapter 6 of this thesis, Sections 6.2.1.1 and 
6.2.1.1.1). Jürgens et al (1989) used a sucrose density centrifugation and 
Triton X-100 extraction, and Papageorgiou et al (2004) compared the 
phenol/water method with novel extraction methods. Raziuddin et al (1983) 
used chloroform and acetic acid extraction to isolate lipid A from their LPS 
preparation. Table 2.2 lists the studies in which cyanobacterial 
lipopolysaccharides were tested for lethality in mice. All doses were reported 
in the original papers in terms of dose per mouse; these doses have been 
converted to mg/kg body weight for comparison purposes in Table 2.2. An 
assumed weight of 20g was applied to mice for the studies in which the 
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authors did not report the weight of their animals.  Note that the study of 
Scholtissek et al (1991) used galactosamine-sensitised mice, so their LPS 
doses are not directly comparable to those given in the other studies; a similar 
situation applies with the study of Katz et al (1977), where adrenalectomised 
mice were used. Adrenalectomy sensitises mice by three orders of magnitude 
to the lethal effects of LPS (Utili et al, 1977). 
 
Table 2.2. Cyanobacterial lipopolysaccharides and lethality. 
           Cyanobacterium   Lethality           Reference  
 
Anacystis nidulans   non-toxic at 10mg/kg**   Weise et al, 1970  
 
A. nidulans KM   2.5mg/kg† (= approx. 800x greater than  Katz et al, 1977 
    Salmonella minnesota LPS) 
 
Phormidium spp (x3)  all non-toxic at mean dose of 333mg/kg  Mikheyskaya et al, 1977 
 
Schizothrix calcicola  non-toxic at 200mg/kg   Keleti et al, 1979 
 
Anabaena flos-aquae UTEX 1444 non-toxic at 250mg/kg 
 130mg/kg    Keleti & Sykora, 1982 Anabaena cylindrica UTEX 1611 LD50
Oscillatoria brevis   LD  190mg/kg 50
   
 approx 45mg/kg** Microcystis aeruginosa 006  LD50
 60mg/kg**    Raziuddin et al, 1983    lipid A LD50
 40mg/kg** M. aeruginosa NRC-1  LD50
   lipid A LD  approx 45mg/kg** 50
 
 425mg/kg**    Tornabene et al, 1985 Spirulina platensis Lb 1475/4a  LD100
 
Microcystis sp PCC 7806  1 of 3 mice* died at 50μg/kg**   Scholtissek et al, 1991 
 
* galactosamine-sensitised (=TNF-α hypersensitised) 
† adrenalectomised mice 
** assumed weight of mice: 20g 
 
 
In addition to lethality, various other toxicity endpoints were examined in some 
of the studies listed in Table 2.2 and others. Buttke & Ingram (1975), Keleti et 
al (1979) and Keleti & Sykora (1982) investigated the local Shwartzman 
reaction, which is a dermonecrotic lesion elicited in rabbits by subcutaneous 
preparative and intravenous provocation injections. Keleti & Sykora (1982) 
also used a rabbit isolated ileal loop assay, which did not show any positive 
findings from the three cyanobacterial LPS isolates injected. Weise et al 
(1970) tested A. nidulans LPS for pyrogenicity in rabbits, reporting a tenfold 
lower response than that seen from E. coli LPS.  Schmidt et al (1980a) also 
tested the LPS from two Synechococcus strains for pyrogenicity, with 
maximum increases in rabbit body temperature of 1.50C after injection of up to 
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1mg/kg. The authors report that these doses are some three orders of 
magnitude higher than those required of Salmonella LPS to achieve the same 
effect. Best et al (2002) investigated the potential of isolated cyanobacterial 
lipopolysaccharides to reduce the activity of glutathione S-transferases in 
Zebra fish embryos. Most authors concluded that the cyanobacterial 
lipopolysaccharides they examined were weakly toxic when compared to the 
activity of positive control heterotrophic bacterial LPS. The exception was the 
work of Best et al (2002), who report that cyanobacterial LPSs reduced 
microsomal and soluble glutathione S-transferases in vivo to a greater extent 
than LPS from E. coli or Salmonella typhimurium. Lipopolysaccharides 
extracted and purified by IS and also by Papageorgiou et al (2004) were 
investigated by IS for their potential to affect thermoregulation in a mouse 
model, reported in Chapter 6 of this thesis. Studies were also conducted to 
determine the ability of these LPSs to affect endogenous nitrate and 
interleukin-6 production. These latter studies are not presented in this thesis 
due to limitations of time and text, and we will submit the findings of those 
investigations for separate publications.  
 
In addition to the studies cited above, nine reports describe the isolation and 
purification of cyanobacterial lipopolysaccharides for various biomedical, 
biochemical or structural studies, but no toxicological endpoints were 
investigated (Schnayer & Jenifer, 1974; Weckesser et al, 1974; Samimi & 
Drews, 1978; Jones & Yopp, 1979; Schmidt et al, 1980b; Jürgens et al, 1989; 
Martin et al, 1989; Schneider & Jürgens, 1991; Xu et al, 1997). The topic of 
cyanobacterial LPS was reviewed by Weckesser et al (1979), and Mayer & 
Weckesser (1984). These reviews are especially valuable in that they contrast 
the work done on other photosynthetic prokaryotes, especially the purple non-
sulfur bacteria, some of which have been shown to have lipid A structures that 
are LPS antagonists (also discussed above: section 2.7). No cyanobacterial 
lipid A structures have been described to date.  
 
In addition to work done on isolated and purified LPS, some reports discuss 
the activity of cyanobacterial LPS by use of the Limulus amoebocyte (LAL) 
assay. This is a highly sensitive test, though there are trade-offs in terms of 
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specificity, with other bacterial products such as peptidoglycan and glucan 
capable of registering positive responses (Roslansky & Novitsky, 1991; 
Henderson et al, 1998 p140). The assay may not always be a reliable 
predictor of cellular and in vivo responses (Tanamoto, 1995). The study of 
Rapala et al (2002) had some significant findings pertaining to the topic of 
presumed toxicity of cyanobacterial lipopolysaccharides. The authors used the 
LAL assay to test 26 axenic strains from five cyanobacterial genera; all 
responses were at least five orders of magnitude lower than reactions to E. 
coli LPS, and several were below the assay’s detection limits. This suggests 
that the lipid A structures of these lipopolysaccharides have some significant 
and fundamental structural differences to endotoxic lipid A, as the LAL assay 
does not react to some unusual or modified lipid A structures (Takada & 
Kotani, 1992).  
 
 
2.10. Spirulina platensis: the importance of exposure route 
 
S. platensis has a long history of use as a foodstuff, dietary supplement and 
livestock feed additive. The use of this cyanobacterium was comprehensively 
reviewed by Ciferri (1983), who concluded that extensive nutritional and 
toxicological testing has shown it to be a safe and valuable protein source. 
The use of Spirulina was briefly reviewed along with that of other edible 
microalgae by Kay (1991), who cited Ciferri (1983) in stating that some 
“negative effects” of Spirulina feeding were seen in multigenerational studies 
and mutagenicity tests. However, this appears to be a misinterpretation on the 
part of Kay (1991), as Ciferri (1983) described “negative results” from these 
studies. The original publications cited by Ciferri (1983) were unobtainable. 
More recent studies seem to support the suggestion that consumption of 
Spirulina is not harmful, and enhances various immune functions (Belay et al, 
1993; Hayashi et al, 1994; Qureshi et al, 1996; Al-Batshan et al, 2001).  
 
A single case report is the exception to the rest of the literature. Iwasa et al 
(2002) describe a 52-year-old male taking antihypertensive, hypolipidaemic 
and hypoglycaemic pharmacotherapy who developed abnormal hepatic 
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enzyme levels two weeks after taking Spirulina, presumably on a regular 
basis. Liver function tests showed a significant deterioration over the following 
three weeks, after which he was hospitalised. Although a physical examination 
was unremarkable, a liver biopsy revealed some degenerative changes. 
Serological studies for a range of viruses were negative. His medications and 
Spirulina were withdrawn, after which his hepatic function rapidly returned to 
normal. Hepatotoxicity in this case was attributed to consumption of Spirulina, 
on the basis of temporal relationships between liver function abnormality and 
recovery with consumption and withdrawal of Spirulina, although possible 
interaction effects with the medications would have been worth considering. 
This may have been the case with simvastatin, the cholesterol-lowering agent 
this individual was taking. Simvastatin causes increased proinflammatory 
cytokine production, and it can potentiate inflammatory responses induced by 
bacterial products (Matsumoto et al, 2004).  
 
The long-standing and widespread consumption of Spirulina spp illuminates 
the importance of considering the route of exposure in toxicology studies, and 
the dangers in this case of presumptive inference of disease from the findings 
of parenterally administered lipopolysaccharides. Tornabene et al (1985) 
reported a lethal dose of Spirulina platensis LPS in the range of 400mg/kg (i.p. 
mouse), although those findings are not supported by the work of this author 
(see Chapter 6, Sections 6.4.2.4 and 6.4.2.6). However, Falconer (1999) 
reported that cell lysates of Spirulina were highly toxic to mice when 
administered by intraperitoneal injection.  
 
Other cyanobacteria are consumed as foods, medicines and dietary 
supplements. Wild-harvested Aphanizomenon flos-aquae was over a decade 
ago reportedly “consumed by thousands of people without incident” (Kay, 
1991), although the lake that produces the commercially available product 
(Lake Klamath, Oregon) is sometimes subject to contaminating growth of 
Microcystis spp, and some A. flos-aquae end-product batches contaminated 
with microcystins have since been found (Schaeffer et al, 1999; Gilroy et al, 
2000). Nostoc commune, a terrestrial species, has a long history of use in 
China and Scandinavia as food and medicine (Brüll et al, 2000). The 
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widespread use of these products serves as a reminder that some 
cyanobacteria, and therefore their lipopolysaccharides, are not harmful by the 
oral route.  
 
 
2.11. LPS by inhalation 
 
In this author’s opinion, the sole natural exposure route that might explain 
aquatic cyanobacterial LPS-related illness is via inhalation of aerosolised cells 
or fragments. Extrapolating from the understanding of Gram-negative bacterial 
LPS on the respiratory system (as have most if not all of the authors cited in 
Table 2.1 for the presumed involvement of cyanobacterial LPS on various 
disease states), there is a significant and increasing body of literature on the 
association between endotoxin and pulmonary disease, including asthma, 
chronic obstructive airway disease and emphysema. Intact bacteria and cell 
wall fragments are readily aerosolised; bioaerosols of Gram-negative bacteria 
are widespread contaminants of soils, water and living organisms (Olenchock, 
1997; Stetzenbach, 1997). Exposure to airborne endotoxin has been 
associated with a range of occupational respiratory diseases, in industries 
where high concentrations of organic dusts are liberated, e.g. various 
agricultural settings, cotton milling, brewing, waste processing (Olenchock, 
1997; Michel, 2000). Endotoxin is also found in high concentrations in air 
pollution and household dust (Schwartz, 2001). Endotoxin in some aquatic 
environments can be aerosolised to disease-related concentrations: Rose et 
al (1998) investigated outbreaks of granulomatous pneumonitis affecting 
lifeguards at an indoor swimming pool, with some affected chronically. Gram-
negative bacteria, principally Pseudomonas spp, colonised water spray 
systems in the facility, and increased endotoxin in bio-aerosols was linked to 
the illnesses.  
 
Michel (2000) reviewed experimental inhalation studies of LPS: 4-12 hour 
periods of dyspnoea, chest tightness, myalgia, shivering, fatigue and malaise 
with or without fever were reported in a minority of normal subjects. Impaired 
pulmonary function in the form of bronchoconstriction, changes in non-specific 
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bronchial hyperresponsiveness and reduced alveolar-capillary diffusion were 
demonstrated. Asthmatic subjects responded with significant 
bronchoconstriction lasting five or more hours at doses of 20 µg, whereas 
normal subjects required doses of 80 µg or more to produce moderate 
bronchoconstriction (Michel, 2000). Of interest is the observation that LPS-
induced lung changes are associated with neutrophil activation, whereas 
purified allergen extracts induce bronchial eosinophilia in asthmatic subjects 
(Hunt et al, 1994; Michel, 2000). Normal subjects exhibit a broad range of 
responses to inhaled LPS: 9% of subjects developed airway obstruction after 
low-dose inhalation, and 15% showed a negligible airway response to high 
doses of LPS (Kline et al, 1999; Schwartz, 2001). Polymorphisms in genes 
coding for Toll-like receptors, especially Toll-like receptor-4, appear to be 
important determinants of variability in human responses to inhaled 
endotoxins. Arbour et al (2000) showed that a TLR4 sequence mutation is 
associated with an endotoxin hyporesponsive phenotype in humans.  
 
Schwartz (2001) describes asthma as a complex, heterogeneous disease with 
multiple clinical sub-types, polygenic inheritance, and influenced by many 
different environmental exposures. Endotoxin is one such exposure, which 
causes a biologically unique form of asthma (Schwartz, 2001). However, 
exposure to endotoxin early in life may confer beneficial effects: growing up on 
a farm and exposure to livestock is reportedly associated with a significant 
reduction in atopy, and there is an inverse correlation between house-dust 
endotoxin concentration and allergen sensitisation (Herz et al, 2000; Riedler et 
al, 2000; Riedler et al, 2001). This so-called “hygiene hypothesis” for allergic 
diseases describes the concept that allergy results from an imbalance in the 
T-helper cell (Th) subset. According to this theory, exposure to bacterial and 
viral pathogens in the prenatal and early childhood periods prevents the 
induction of allergen-associated Th2 cells by establishing a Th1-biased 
immunity (Herz et al, 2000; Reed & Milton, 2001). However, the hygiene 
hypothesis is complex and controversial, with contradictory observations and 
refinements to the theory appearing in the literature. Interested readers are 
directed to two excellent reviews and updates by Reed & Milton (2001), and 
Yazdanbakhsh et al (2002).  
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LPS and allergens initiate inflammatory processes in the airways through 
different pathways and cytokine cascades: LPS is recognised by innate 
immune cells, principally alveolar macrophages, which generate pro-
inflammatory cytokines such as IL-1, TNF-α and IL-8; the latter cytokine 
recruits and activates neutrophils. LPS also generates IL-12, which inhibits 
IgE responses. Allergens generate IL-4, IL-13 and IL-5, the latter cytokine 
being an activator of eosinophils (Reed & Milton, 2001).  
 
In the context of environmental exposures, endotoxins and allergens often 
occur together; synergistic effects are important considerations in that airway 
responses to combinations of LPS and allergen are reportedly greater than to 
either substance alone in atopic asthmatics (Eldridge & Peden, 2000; Reed & 
Milton, 2001). 
 
The impact of cyanobacteria on respiratory symptoms in atopic individuals is 
worthy of investigation, and may involve protein allergens and cyanobacterial 
endotoxin from both toxic and non-toxic blooms. However, the relative burden 
of cyanobacterial endotoxin to respiratory morbidity will depend on the 
capacity of the LPS of any given cyanobacterial species to act as an LPS 
agonist, or as an LPS antagonist, or be biologically inactive; such properties 
are as yet largely undetermined.  
 
An equally important research effort should be directed towards the capacity 
of inhaled cyanobacterial exotoxins to generate immunologically non-specific 
responses (i.e. in unsensitised individuals) in the bronchial tree. Microcystin-
LR appears to be able to efficiently gain access to the circulation by both 
intranasal and intratracheal routes (Fitzgeorge et al, 1994; Ito et al, 2001), but 
Gram-negative bacterial endotoxin delivered by inhalation does not cross into 
the pulmonary vasculature to enter the circulation, and at least one endotoxin-
stimulated cytokine – TNF-α – is compartmentalised in the airways (Nelson et 
al, 1989; Ghofrani et al, 1996; Reed & Milton, 2001). What is open to question 
is whether the serious cases of pneumonia reported after recreational 
exposure to cyanobacteria (see Chapter 1, Table 1.1) may be explained by 
the induction of an inflammatory response by inhaled cyanobacterial exotoxin, 
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progressing to recruitment and activation of neutrophils and confined to the 
pulmonary alveolar compartment. The possibility is also open as to whether 
less dramatic reports of respiratory illness may also be explained by a similar, 
albeit self-limiting process, in healthy, non-atopic individuals. Of course, this 
speculation does not exclude the likelihood of different, overlapping 
mechanisms of disease that may explain these phenomena – protein 
allergens in some cyanobacteria may provoke symptoms in atopic individuals, 
such symptoms possibly being exacerbated by the presence of cyanobacterial 
and/or epiphytic bacterial endotoxins.  
 
Cyanobacterial exotoxins may have the capacity to generate respiratory 
illness in non-atopic individuals, with endotoxins from cyanobacteria or 
commensal organisms possibly augmenting the symptoms. The potential for 
cyanobacterial and/or contaminant endotoxin alone to produce symptoms by 
inhalation exposure remains open, given the observation that LPS can 
produce measurable airway function changes in animal models and in some 
healthy individuals (Kline et al, 1999; Poynter et al, 2003; Okamoto et al, 
2004; Spond et al, 2004). Yet it remains unclear whether such experimentally-
induced changes in the airway function of healthy volunteers correlate with 
symptoms of respiratory dysfunction.  
 
 
2.12. Concluding remarks 
 
Lipid A, the endotoxic moiety of lipopolysaccharides, was in previous decades 
thought to remain constant across different Gram-negative bacteria (Seydel et 
al, 2000a). This is now understood to be incorrect; many non-enteric bacteria 
are seen to vary in their lipid A structures. Because the biological activity of 
lipid A is determined by its structure, the toxic potential of non-enteric bacteria 
can vary. Gram-negative organisms occupying different ecological niches will 
not have the same requirements for growth, and their outer membranes can 
be expected to vary in order to meet different environmental conditions 
(Lugtenberg & Van Alphen, 1983). Endotoxic potential cannot be assumed to 
be lacking in the lipopolysaccharides of non-enteric bacteria, however, as 
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seen in the high LPS agonist activity of lipid A from the non-pathogenic purple 
non-sulfur bacterium Rubrivivax gelatinosus, discussed in Section 2.5. A 
similar example is given by another group of non-pathogenic bacteria, 
Rhizobium spp, the LPS from some of which are comparable to that of 
enterobacterial LPS in lethal toxicity and cytokine-inducing activity (Urbanik-
Sypniewska et al, 1989; Urbanik-Sypniewska et al, 2000). Determining the 
lipid A structures of various nuisance cyanobacteria would be an interesting 
exercise in itself, but regardless of the findings, proponents of the 
“cyanobacterial LPS is toxic” cause need to define plausible exposure routes 
to allow LPSs to signal host receptors and initiate a pathogenic cytokine 
cascade.  
 
From the discussion in this chapter, this author will put the hypothesis that oral 
consumption of non-toxic cyanobacteria, i.e. absolutely or essentially free of 
any of the known cyanobacterial exotoxins, will not result in either vomiting or 
diarrhoea. This hypothesis would be falsified by experiments that show 
isolated cyanobacterial LPS or non-toxic crude extracts can cause 
gastrointestinal signs and/or pathology in a suitable model. The impression of 
this author is that reports of G-I symptoms in humans exposed to 
cyanobacterial products are indications of innate defences being signalled by 
exotoxins that have breached the intestinal barrier. Once this occurs, and gut 
permeability is sufficiently disrupted, LPS may well synergise the pathology of 
cyanotoxins, especially the hepatotoxins. From what little is known to date 
about the toxic potential of cyanobacterial LPS, i.e. that they are weakly toxic 
compared to those of the Enterobacteriaceae, gut-derived LPS would seem to 
be the more likely candidate for augmenting the pathology of cyanotoxins.  
 
In vivo studies of oral exposure to cyanotoxins would be well served by use of 
a vomiting-capable model, i.e. non-rodent experiments. 
 
There does not appear to be good evidence that cyanobacterial 
lipopolysaccharides are likely to initiate cutaneous reactions in healthy people 
exposed in recreational or occupational settings. Cutaneous reactions to 
cyanobacteria are discussed in detail in Chapters 4 and 5 of this thesis; 
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Chapter 5 discusses the discovery by this author and collaborators that the 
alkaloid toxin cylindrospermopsin is dermally active, causing both primary 
reactions and delayed-contact hypersensitivity.  
 
Exposure to bio-aerosols containing cyanobacterial endotoxins may be worthy 
of investigation, but this author is not convinced that cyanobacteria-related 
acute respiratory illness in non-atopic, non-allergic individuals is not equally or 
more likely to be explained by inhalation of cyanobacterial exotoxins. If some 
of the exotoxins turn out to possess ligands that stimulate innate immune 
responses (discussed further in Chapter 7), then the large pool of resident 
alveolar macrophages would be prime candidates for involvement in 
respiratory defences. The outbreaks of bath-water fever in Scandinavia and 
Africa (discussed in Chapter 1, Section 1.5.3) were, in this author’s opinion, 
suspicious of involvement by cyanobacterial exotoxin breakthrough into 
reticulated supplies. Similar outbreaks in future should be vigorously 
investigated for cyanotoxins if there is a suggestion of significant 
cyanobacterial contamination of source water.  
 
In conclusion, lipopolysaccharides of the Enterobacteriaceae are potent 
immunomodulatory and immunotoxic bacterial products that stimulate a wide 
variety of responses in mammals, not least of these being a desire to wax 
lyrical on the topic. Thus: 
 
 “Endotoxins possess an intrinsic fascination that is nothing less than 
 fabulous. They seem to have been endowed by Nature with virtues and 
 vices in the exact and glamorous proportions needed to render them 
 irresistible to any investigator who comes to know them” (Bennett, 
 1964).  
   
And: 
 
 “The dual role of LPS as effector and target makes it a fascinating 
 molecule which…still hides many miracles. It intrigues at the same time 
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 clinical, biological, chemical, and biophysical researchers…” (Wiese et 
 al, 1999). 
 
Facetiousness aside, these workers are pointing out that there is much to 
learn about the lipopolysaccharides of the most widely studied Gram-negative 
bacteria, these being the Enterobacteriaceae. The understanding of 
cyanobacterial LPS is utterly miniscule by comparison, and it does not reflect 
well on the cyanobacteria research community to blithely attribute such a 
disparate range of symptoms in humans to contact with these materials 
without any substantial research evidence. Weckesser, Drews and Mayer 
wrote in 1979 that: 
 
 “…the picture obtained with the Enterobacteriaceae cannot be 
 assigned to other Gram-negative bacteria without detailed 
 investigations. Considering the broad spectrum in morphological and 
 physiological diversity of the many taxonomic groups of both 
 photosynthetic bacteria and cyanobacteria, there is a wide open field 
 for studies on the composition of their cell wall.” (Weckesser et al, 
 1979). 
 
Ressom et al (1994 p33) stated that: 
 
 “Given the enormous heterogeneity in LPS from Gram-negative 
 bacteria there is every reason to suspect that the same will apply to 
 cyanobacterial LPS and, due to their taxonomic distance apart, 
 cyanobacterial LPS are likely to be different from those found in Gram-
 negative bacteria.” 
 
This author agrees with these statements.  
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CHAPTER 3:  EPIDEMIOLOGY OF RECREATIONAL EXPOSURE TO 
FRESHWATER CYANOBACTERIA – A PROSPECTIVE COHORT STUDY 
CONDUCTED IN SOUTH-EAST QUEENSLAND, THE MYALL LAKES 
AREA OF NSW AND CENTRAL FLORIDA 
 
 
3.1. INTRODUCTION 
 
Reports of illness following recreational exposure to cyanobacteria in the 
medical and scientific literature are sparse; significant under-reporting, 
especially of minor, self-limiting illnesses may explain this. However, a 
knowledge gap about cyanobacteria probably exists amongst many primary 
health care providers. 
 
Epidemiological studies are also few in number. Five have been published to 
date: three analytical cross-sectional studies from the UK using identical 
survey instruments (Philipp, 1992; Philipp et al, 1992; Philipp & Bates, 1992), 
a small case-control analysis from Australia (El Saadi et al, 1995), and a 
larger prospective cohort study, also from Australia (Pilotto et al, 1997). The 
UK studies and the smaller Australian study did not find any significant hazard 
from exposure to cyanobacterial blooms in recreational waters, but the study 
by Pilotto et al (1997) reported an increase in illness amongst those exposed 
to fairly low levels of cyanobacteria (>5,000 cells per mL) compared to 
unexposed individuals. 
 
The World Health Organization and the Agriculture and Resource 
Management Council of Australia and New Zealand have both published 
guideline levels for recreational exposure to cyanobacteria (Johnstone, 1995; 
WHO, 2003), yet there is concern that the current management practice in 
some countries (such as Australia) of warning all users or closing access to 
waterbodies is overly proscriptive. Such practices can result in unease 
amongst regular users of recreational waters that are affected by 
cyanobacteria, and can impact on communities surrounding these waters, 
which are important social and economic resources.  
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There is general agreement that further epidemiological studies are required 
to advance the awareness of acute cyanobacteria-related morbidity, so that 
advice and guidelines for recreational exposure can be revised and refined. 
 
  
3.2. AIMS 
 
Because of the small number of published epidemiology studies and the 
somewhat sporadic and incomplete compendium of case reports of human 
morbidity associated with recreational exposure to cyanobacteria, we sought 
to improve on the understanding of this topic by conducting a prospective 
cohort study. A better appreciation of this problem is important because of the 
competing demands of various interested parties. On the one hand are 
government public health agencies that are apprised of the potential for 
serious harm from exposure to potent cyanobacterial toxins in untreated 
waters. On the other are individuals, recreational water sporting groups and 
the communities adjacent to recreational waters for which recreational 
activities generate relaxation, enthusiastic commitments of time and energy 
and a significant economic resource.  
 
The principal aims in conducting this study were to improve the understanding 
of the problem, and to provide further data and recommendations to allow 
revision and refinement of recreational water exposure guidelines relating to 
planktonic cyanobacteria.  
 
 
3.2.1. SPECIFIC AIMS 
 
1. To measure cyanobacteria levels in designated water recreation sites by 
 three methods: cell counts (cells/mL), biovolume (mm3/L) and surface area 
 (mm2/mL). 
2. To identify cyanotoxins in designated water recreation sites by routine 
 analytical methods. 
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3. To estimate the period of exposure to recreational waters by self-
 administered questionnaire and validation at follow-up phone interview in 
 subjects exposed to waters with and without cyanobacteria. 
4. To measure the incidence of reported symptoms by telephone follow-up 
 interview in subjects exposed to waters with and without cyanobacteria. 
 
H1: There will be a significantly different incidence of reported 
 symptoms among exposed compared to unexposed recreational 
 water users. 
H2:  Among exposed recreational water users, there will be a 
 significantly different incidence of reported symptoms among 
 those who report greater recreational water exposure time. 
 
 
3.3. MATERIALS AND METHODS 
 
A prospective cohort design was employed; study subjects were enrolled at 
recreational water sites and asked to complete a self-administered 
questionnaire at the site before leaving for the day. They were also asked to 
submit to a telephone follow-up interview to be conducted as soon as 
practicable after three days from the day of enrolment. Water samples were 
collected for total phytoplankton identification and enumeration, cyanobacterial 
exotoxin quantification, and faecal coliform determination – the latter sampled 
only on days when a recruitment visit at a study site was followed by a routine 
working day, i.e. not on Saturdays, nor Sundays if the following Monday was a 
public holiday. Subjects were recruited over a three-year period at water 
recreation sites in southern Queensland, the Myall Lakes area of New South 
Wales, and central Florida. The various procedures are discussed in detail 
below. 
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3.3.1. Questionnaire design 
 
Survey instruments were designed de novo. Ms Lynne Martin, who at the time 
was Ethics Officer of the School of Research and Postgraduate studies, 
University of Queensland, provided recommendations about questionnaire 
design to enable de-identification after data entry. Dr Gerard Neville from the 
Queensland Health Environmental Health Unit gave valuable input into the 
questionnaire design. The questionnaire used in a similar study to this one 
(Pilotto et al, 1997) was not published and was not made available to us. 
 
The questionnaire, follow-up interview form and information letter are provided 
as Appendix 1. This appendix lists these documents in their final format, as 
used during study recruitment in Florida in 2002. The documents were 
designed to be de-identified for storage, i.e. name, phone number and 
signatures were on a separate page to the demographic and health 
information; the page with identifiers was separated from the remaining 
questionnaire after the follow-up interview was completed.  The questionnaire 
underwent several modifications throughout the course of the study, with the 
main aim of attempting to maximise the response rate. The principal 
modifications were: 
 
• The initial requirement for adult subjects to give written consent to 
 participate in the study was dropped. The Ethical Review Committee 
 agreed with a request that requirement for a signature represented an 
 unnecessary level of complexity and intrusion. As this project was an 
 observational study of outcomes relating to voluntary behaviour – 
 recreational activities – consent was deemed to be implicit on return of a 
 completed questionnaire. Written consent for volunteers under the age of 
 18 years was maintained.  
• A tick-box question about after-tax income was dropped after several 
 unsolicited written comments on returned questionnaires – both blank and 
 completed – and a refusal to participate in the follow-up interview indicated 
 a level of disquiet that was deemed likely to impact adversely on the 
 105
Chapter 3: Recreational exposure to cyanobacteria – an international prospective cohort study 
 questionnaire return rate. The potential recruit, who had completed and 
 returned the self-administered questionnaire, immediately objected to the 
 income question when contacted for the follow-up interview, declined to 
 listen to the reasoning behind asking the income question (a measure of 
 socio-economic status to be adjusted for in statistical analysis) and 
 terminated the conversation.  
• The initial questionnaire design attempted to define estimates of the time 
 subjects spent in the water by asking about the number of times during the 
 recruitment day that each subject went in the water, and entry and exit 
 times for each period of water-related activity. This series of branched 
 questions was later regarded as rather complex, and as they took up a 
 whole page of the questionnaire, they were replaced by a single question 
 asking respondents a tick-box estimate of the time spent engaging in 
 water-related activities on the day. In an attempt to validate this question, 
 it was also inserted into the follow-up interview, i.e. the same question was 
 asked twice – initially in the self-administered questionnaire, and again at 
 follow-up.  
• A request for obtaining consent to speak to primary medical practitioners if 
 consulted by subjects within the follow-up period was dropped from the 
 follow-up interview for recruitment in Florida. The consent process was 
 considered to be too time-consuming and bureaucratic for the likely gains. 
 The experience in Australia was that medical consultation rates within the 
 follow-up period were very low, and the interviews with medical 
 practitioners not particularly enlightening with respect to identifying 
 possible cyanobacteria-related morbidity.  
 
All health-related questions in the questionnaire were derived from the 
anecdotal and case reports in the literature on recreational exposure to 
freshwater cyanobacteria (see Chapter 1, Table 1.1).  Exceptions are 
questions 10 and 11 in the follow-up interview, which were designed to help 
identify avian cercariae or other aquatic and terrestrial invertebrate-related 
dermatoses. 
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3.3.2. Study population  
 
The study population of interest comprised adults and children engaging in 
recreational activities in enclosed waters – i.e. not marine waters – inhabited 
to varying degrees by planktonic cyanobacteria. The aim was to recruit as 
many individuals as possible into the study during each recruitment day. While 
not every individual who arrived at each site could be questioned to determine 
eligibility status and willingness to participate, failure to include all potential 
recruits occurred through essentially random, non-systematic means due to 
the exigencies of single-investigator recruitment. These demands relate to 
gaps in recruitment for toilet breaks, water sampling and avoiding disruption to 
the flow of vehicles into the site by waving through vehicles whenever more 
than three were awaiting entry.  
 
 
3.3.3. Location of study 
 
The study was initially designed to investigate recreational waters managed 
by South East Queensland Water, the principal source of funding for this work, 
these being lakes Somerset and Wivenhoe, situated some 80km north-west of 
Brisbane. The study commenced as planned, but as it progressed, it became 
apparent for several reasons – principally relating to a lack of diversity in the 
cyanobacteria profiles, and diminishing returns through encountering regular 
visitors to these sites – that the study should be expanded. Fortuitous 
opportunities arose to conduct the study in the Myall Lakes region of NSW, 
and central Florida. Further discussion of the reasons for broadening the 
geographic scope of this work appears in Appendix 2.  
 
Table 3.1 lists the study sites, their location by region, a brief description of the 
site, entry and exit routes – which determined the method of recruitment, 
discussed in the following section – and any features peculiar to the site that 
distinguish them from other sites. Sites are also flagged according to their 
status as cyanobacteria-affected or cyanobacteria-free (i.e. reference) sites. 
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Some sites that were identified as potential study sites on the basis of 
cyanobacteria monitoring programs were found to have low cyanobacteria 
measures, and were thus classified as reference sites. Two sites served as 
both study and reference sites due to variability in cyanobacterial densities 
over several recruitment visits.  
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SITE 
REGION DESCRIPTION 
POWERED 
WATERCRAFT 
ENTRY/ 
EXIT 
ROADS 
PECULIAR 
FEATURES 
(S)TUDY OR 
(R)EFERENCE SITE 
      Planned Actual 
Logan Inlet – 
Lake 
Wivenhoe 
South-east 
Queensland 
Large water-
supply storage  No Single 
 
S S+R 
Kirkleagh – 
Lake 
Somerset 
South-east 
Queensland 
Large water-
supply storage  Yes Single 
 
S R 
The Spit – 
Lake 
Somerset 
South-east 
Queensland 
Large water-
supply storage  Yes Single 
 
S S+R 
Brown Lake – 
Nth 
Stradbroke 
Island 
South-east 
Queensland Small dune lake No Single 
Acidic 
perched lake 
(pH 4.6 – 
4.7) 
R R 
Atkinson Dam South-east Queensland 
Small irrigation 
storage Yes Single  S S 
Natural Arch South-east Queensland 
Upper 
catchment 
stream 
No Single 
Water 
temperature 
lowest of all 
sites 
R R 
College's 
Crossing 
South-east 
Queensland 
Shallow river – 
release water 
from Wivenhoe 
Dam 
No Single 
Warning sign 
re bull whaler 
sharks. 
Baptism 
recruits  
R R 
Currumbin 
Rock Pool 
South-east 
Queensland 
Lower 
catchment 
stream 
No Single 
Dairy farms 
in catchment 
– faecal 
coliform 
counts often 
high 
R R 
Bombah 
Broadwater 
Myall Lakes 
NSW 
Large saline 
enclosed lake Yes Multiple 
 S R 
Myall Lake Myall Lakes NSW 
Large brackish 
water lake No Multiple 
 S S 
Smith's Lake Myall Lakes NSW 
Small saline 
enclosed lake Yes Single 
 R R 
Lake 
Coolmunda  
South/ central 
Queensland 
Small irrigation 
storage Yes Multiple 
 S S 
Hickory Point 
– Little Lake 
Harris 
Central Florida 
Part of a chain 
of connected 
inland lakes 
Yes Single 
 
S S 
Manatee 
Springs 
North/ central 
Florida 
Freshwater 
spring bulkhead No Single 
 R R 
Fanning 
Springs 
North/ central 
Florida 
Freshwater 
spring bulkhead No Single 
 R R 
Lake 
Seminole 
West/ central 
Florida 
Artificial lake in 
densely 
developed area 
Yes Single 
 
S S 
Doctors Lake North-east Florida 
Brackish water 
inlet of St Johns 
River 
Yes Single/ multiple 
 
S S 
Lake Cannon Central Florida Small urban lake Yes 
Single/ 
multiple 
 S S 
Lake Shipp Central Florida Small urban lake Yes Single 
 
Table 3.1. Recreational waters visited for recruitment of study subjects. 
S S 
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Written permission (gatekeeper approval) from management authorities to 
recruit members of the public into this study was sought and secured for all 
sites listed in Table 3.1. Gatekeeper approval was secured for other locations 
in Queensland and NSW that were not visited, usually because of low 
cyanobacteria counts in these sites through the period of recruitment. One 
local authority in NSW was keen to assist in this study, having had significant 
negative press and ensuing public disquiet regarding cyanobacteria in a 
recreational lake in the past. Again, this site was not visited due to the failure 
of that lake’s cyanobacteria to bloom during the study period. By way of 
contrast, several cyanobacteria-affected sites in Florida could not be visited 
because gatekeeper approvals were denied. Six management authorities in 
Florida – mostly county or city agencies – refused permission to conduct this 
study at their recreational waters. Further discussion of these political 
problems appears in Appendix 2. Two sites in Florida, for which gatekeeper 
approval was secured, were visited when cyanobacteria blooms were obvious, 
but study enrolment was abandoned because of low numbers of visitors 
engaging in water contact activities (although boating and jetty fishing were 
popular activities). No individuals were recruited from the public boat ramp at 
Mt Dora in two hours, so recruitment was shifted to another previously visited 
site. No potential recruits presented at Crescent Lake in 5½ hours, after which 
rain set in and your author returned, disappointed but not dispirited, to base 
camp. 
 
 
3.3.4. Sampling method – study subjects 
 
As discussed in Section 2 above, recruitment aims were to capture as many 
individuals as possible on each recruitment day. The number of entry and exit 
routes at each site essentially dictated recruitment methods. For sites with a 
single access road, a recruitment post (table, chair, sunshade) was 
established adjacent to the road, and vehicles were halted on approach with a 
“lollipop-stick” STOP sign. Vehicle occupants were offered a brief introduction 
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(name, university affiliation) and questioned about their study entry criteria. 
Those that were eligible to participate were then invited to do so, with a brief 
description of study requirements: “we’d like you to fill in this questionnaire 
today, which will take about 5 minutes; mostly YES/NO answers, and also we 
need to speak to you on the phone after three days to ask some more health-
related questions, which will take five to ten minutes”. An adult vehicle 
occupant was asked to nominate how many questionnaires the group would 
accept, these were then handed over, along with pencils, and the process 
repeated until about 1600-1700 each day, unless rain or storms set in. To 
ease the process of questionnaire return, a dedicated return box was secured 
on the exit side of the road, so it could be accessed from vehicles’ passenger-
side window. 
                   
                
               Image 3.1. Questionnaire return box.                           
 
In order to minimise disruption to the sites, vehicles waiting for site access 
behind a vehicle whose occupants were being instructed about study 
requirements were waved through if more than three vehicles were queuing.  
 
Waving through waiting vehicles thus represented a loss of potential study 
recruits, but no non-random effects on the sampling frame are apparent due to 
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this process. With practice, the process of halting a vehicle, establishing 
eligibility criteria, and delivering instructions on questionnaire completion and 
return could be completed in about 60 seconds.  
 
For sites with multiple entry and exit routes, a different method of recruitment 
was required. Myall Lake, Bombah Broadwater and Lake Coolmunda were 
ringed with campsites that could be approached by a number of roads. 
Establishing the recruitment post to stop vehicles at any one of these roads 
would have resulted in significant losses of potential recruits entering the lakes 
by alternate routes. For these three lakes the recruitment method involved two 
walking circuits of campsites around the lake – once in the morning, to 
distribute questionnaires, and again, by loose arrangement with those 
accepting questionnaires, in the late afternoon to collect completed forms. 
Children under the apparent age of sixteen years were not approached 
directly to determine study eligibility, and tents or caravans that were not 
obviously occupied at the time were not approached.  
 
Two sites listed in Table 3.1 (Doctors Lake and Lake Cannon) had more than 
one entry road, but as the primary recreational activities on these lakes 
involved powered watercraft, recruitment was conducted by the first method – 
halting approaching vehicles – at entry roads for public boat ramps. Further 
discussion of recruitment matters pertaining to diffuse water access points 
appears in Appendix 2. 
 
With both recruitment methods, children were welcome to participate in the 
study; the parent or guardian was asked to either complete or supervise 
completion of the questionnaire, and to nominate who should be interviewed 
for the follow-up call, as instructed in the questionnaire and information sheet 
(Appendix 1). Older teenagers who were at study sites without an 
accompanying adult were asked to complete accepted questionnaires on the 
day, but take them home for parental consent before returning them by mail.  
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A postage-paid envelope accompanied all distributed questionnaires as a 
back-up process to improve the return rate, although those accepting a 
questionnaire were encouraged in the verbal introduction to complete and 
return questionnaires on the day. These envelopes were most successful for 
the three lakes with multiple access roads, presumably because the afternoon 
questionnaire collection walk missed a significant number of people who had 
either temporarily or permanently vacated their campsite at that time.  
  
 
3.3.5. Timeframe 
 
Recruitment was conducted over a three-year period, commencing in 
November 1999 in south-east Queensland, and concluding in Florida in 
August 2002. Recruitment was conducted on 54 separate days, mostly on 
weekends and holiday periods in order to maximise recruitment efficiency by 
concentrating on peak-use periods of recreational activity. Recruitment was 
undertaken mainly during warmer months, when the highest levels of both 
recreational water demand and cyanobacteria were anticipated. Planned 
recruitment days did not proceed if steady rain was forecast or evident, at 
least in Queensland. Repercussions of inclement weather on the recruitment 
effort when the study was operating away from the investigator’s home base 
are discussed in Appendix 2.  
 
3.3.6. Entry criteria 
 
Entry criteria into the study were twofold: 
• Engaging or planning to partake in water-contact activities in the study 
 water body on the day of recruitment  
• Able to be contacted by phone for follow-up. 
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We sought to exclude those who were engaging in minimal or no water-
contact activities such as fishing from a boat, shore or jetty. To rapidly 
differentiate water-contact from minimal-contact activities, the introductory 
verbal approach to individuals was “Is anybody in the vehicle planning to go in 
the water and get wet here today?” This approach was especially helpful in 
separating those who were planning boating activities, including fishing, with 
every intention of staying as dry as possible, from others who were engaging 
in various watercraft endeavours where immersion or significant spray contact 
could be expected. This approach would, of course, fail to sample the former 
who encountered accidental immersion, or simply changed their minds and 
jumped in the water to cool off.  
 
 
3.3.7. Follow-up interview  
 
Respondents were asked to nominate a preference for the time and day of the 
follow-up interview; this was conducted after the third day following 
recruitment. The interviewers (mostly IS, with about 30 interviews conducted 
by Prof. Lora Fleming in Florida) requested to speak to study subjects within 
each household individually, i.e. we discouraged proxy interviewees. 
Exceptions were made in the case of children, where a parent or guardian 
was asked to decide whether or not their child would participate in the follow-
up directly. We encouraged parents of children under the age of about 10 
years to undertake the interview on their child’s behalf, except on occasions 
when a parent indicated that their child was both willing and capable of 
answering the questions directly.   
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3.3.8. Ethical approval  
 
The University of Queensland’s Behavioural and Social Sciences Ethical 
Review Committee (BSSERC) gave ethical clearance for the survey 
instruments (questionnaire, follow-up interview, consent and recruitment 
procedures) in November 1999, clearance number 
B/168/SocPrevMed/99/PhD. Amendments to the study protocol and survey 
instruments were approved by the BSSERC. Approval to conduct the work in 
Florida was granted by the University of Miami Human Subjects Committee, 
under protocol number 02/031A. 
 
 
3.3.9. Water sampling regime 
 
Water samples were collected for analysis of the following parameters: total 
phytoplankton identification and enumeration; cyanotoxins; faecal coliforms; 
chlorophyll A (Florida only). Water temperature was measured, initially with a 
glass bulb alcohol thermometer, and, when in-situ instrumentation became 
available after the commencement of this work, with a multi-parameter device 
that also recorded pH and conductivity. Water sampling and analysis 
procedures are detailed below. 
 
 
3.3.9.1. Total phytoplankton identification and enumeration  
 
Water samples were collected by a modified grab sample method. Unused 1L 
(Queensland) or 150mL (NSW and Florida) polypropylene sample bottles 
were used to collect water at a depth of approximately 70cm (mid-thigh height 
of IS). Samples were collected at a lesser depth at 50 paces from the 
shoreline at one of the Bombah Broadwater sampling sites, which is very 
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shallow at the main campsite, and from a wooden jetty at Lake Seminole, 
where the adjacent boat ramp was slippery underfoot and deemed unsafe to 
collect samples. At all sites, the relevant modification to the grab sample 
technique involved moving the sample bottle up and down in a vertical plane 
to sample water through the entire column. The importance of this 
modification was to avoid spurious cyanobacteria estimates through sampling 
only surface water. Cyanobacteria surface scums, although only seen at 
Doctors Lake in this study, can be widely distributed in the horizontal plane at 
the water surface, but are negligibly distributed vertically. Sampling only from 
the surface during such bloom events would tend to overestimate recreational 
exposures, as the surface area of skin exposed to sub-surface water far 
exceeds the area exposed to the water surface when swimming or wading. 
   
In an attempt to address temporal and spatial heterogeneity of cyanobacteria 
profiles within each waterbody, samples were collected from between one and 
four locations, depending on the size of the site. Samples were collected at 
two times: on arrival in the morning, and prior to departure in the afternoon. All 
samples were kept on ice, in darkness, and equal volumes were then pooled 
prior to leaving the site to form a composite sample. Composite samples were 
immediately fixed with Lugol’s iodine, and then stored at 40C until examined.  
 
Total phytoplankton analyses were conducted at three separate laboratories 
due to contractual obligations of the various agencies that funded this work.  
 
These laboratories were: 
• Queensland Health Scientific Services, Brisbane (NATA accredited) –  all 
 Queensland samples. 
• Australian Water Technologies, West Ryde – all Myall Lakes area 
samples. 
• CyanoLab, Palatka, Florida – all Florida samples. 
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Cell identification and enumeration at these three centres are conducted by 
broadly similar methods, using a calibrated counting chamber with phase-
contrast microscopy.  
 
Cell biovolume was determined by defining cyanobacteria cells as spherical or 
cylindrical, then measuring cell diameter (all cells) and length (idealised 
cylindrical cells). An appropriate number of cells were measured, and then 
averaged to give dimensions for each cyanobacterial taxon in each water 
sample. Data for each cyanobacterial taxon were summed in the database 
(see section 3.3.10 below) and total cyanobacterial cells/mL, biovolume and 
surface area were used as the measures of exposure for each recruitment day 
in subsequent statistical analyses.  
 
A spreadsheet algorithm was constructed by IS to convert cyanobacteria cell 
counts (cells/mL) into biovolume (mm3 2/L) and surface area (mm /mL). Cell 
dimensions produced biovolumes using the formulas v = 4 3πr/3  (idealised 
spherical cells) or v = πr2l (idealised cylindrical cells). Surface areas were 
calculated using the formulas S.A. = 4πr2 (idealised spherical cells) or S.A. = 
2(πr2) + (2πr)l (idealised cylindrical cells). Terms in the equations are: v = cell 
volume; r = cell radius; l = cell length; S.A. = cell surface area. 
 
An additional method of estimating phytoplankton standing crop became 
available after the commencement of this project. The laboratory purchased a 
Phyto-PAM Phytoplankton Analyzer (Heinz Walz GmbH), an integrated device 
for determining active chlorophyll content in natural waters by fluorescence. 
Chlorophyll data were recorded from December 2000 for the remainder of the 
study at Australian sites. This device was not available for the final stage of 
the study in Florida, so Phyto-PAM readings were supplemented by analysis 
of chlorophyll-a by routine acetone extraction and spectrophotometry at 
Columbia Analytical Services, Jacksonville (USEPA Standard Method 
10200H).  
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An overview of techniques for phytoplankton identification, enumeration and 
standing crop estimation (volumetry and chlorophyll-a) is found in Hötzel & 
Croome (1999), and Lawton et al (1999). Validation of counting techniques is 
discussed in Laslett et al (1997), and Laslett & Correll (2001). 
 
 
3.3.9.2. Cyanotoxins  
 
1L modified grab samples were collected in unused sample bottles and placed 
on ice, then stored at 40C until the accompanying phytoplankton identification 
and enumeration report was available. Samples that contained potentially 
toxic cyanobacteria were then analysed for specific cyanotoxins. Analysed 
toxins and their associated taxa were: 
 
• Microcystins : Microcystis spp, Anabaena spp, Planktothrix spp, 
• Saxitoxins (Australia only): Anabaena circinalis 
• Cylindrospermopsin: Cylindrospermopsis raciborskii, Aphanizomenon 
 ovalisporum 
• Anatoxin-a: (Florida only): Anabaena spp, C. raciborskii 
 
Australian samples were analysed at Queensland Health Scientific Services 
laboratories. Saxitoxins were analysed by HPLC with fluorescence detection 
using a Shimadzu LC10A system based on the methods of Lawrence et al 
(1995); microcystins were measured by the same HPLC system with 
photodiode array detection using the methods of Lawton et al (1994). 
Cylindrospermopsin was quantified by HPLC-MS/MS with a Perkin Elmer 
series 200 HPLC coupled to a PE SCIEX API 300 mass spectrometer 
(Eaglesham et al, 1999). 
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In Florida, toxins were analysed at CyanoLab. Cylindrospermopsin and 
anatoxin-a were determined by a HPLC-MS/MS method on a ThermoFinnigan 
LCQ Advantage system. Microcystins were determined by an ELISA method 
with a commercially available kit from Abraxis LLC (product # 520011).  
 
 
3.3.9.3. Faecal coliforms  
 
In an attempt to address the potential confounding effects of heterotrophic 
microbial contaminants on gastro-intestinal illness, samples were collected for 
faecal coliform analysis on recruitment days that immediately preceded a 
routine working day. Sub-surface samples were collected in 250mL sterile 
containers shortly before departing each site; containers were immediately 
placed on ice, and then stored at 40C until analysed. All samples were 
analysed within 24 hours following collection. Samples were analysed at the 
following laboratories: 
 
• Queensland Health Scientific Services, Brisbane, QLD (NATA accredited): 
method # AS 4276.7 (Australian Standard method for thermotolerant 
coliforms and Escherichia coli – membrane filtration method). 
• Centre for Integrated Environmental Protection, Griffith University, 
Brisbane, QLD: method # APHA 9222D (American Public Health 
Association – membrane filtration method).  
• Forster Environmental Laboratory, Forster, NSW (NATA accredited): 
method # APHA 9222D (American Public Health Association – membrane 
filtration method).  
• Columbia Analytical Services, Jacksonville, Florida (NELAC accredited): 
method # SM 9222D (USEPA Standard Method – membrane filtration 
method).  
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3.3.9.4. In-situ parameters 
 
In December 2000, NRCET purchased an integrated conductivity + pH + 
temperature meter (Model WP-81, TPS P/L, Brisbane). These parameters 
were subsequently recorded at all Australian study sites. In Florida, these 
measurements were recorded with a DataSonde MP 6600 (YSI Inc).  
 
On the understanding that conductivity in the inland surface recreational 
waters studied for this project does not shift dramatically enough to warrant 
freshwater sites being reclassified as brackish, study sites visited for 
recruitment of study subjects prior to collection of conductivity data were 
considered to be freshwater sites for the purpose of statistical analyses. Water 
quality data for Lakes Somerset, Wivenhoe and Atkinson were requested from 
the relevant management authorities for the year 2000; conductivity readings 
taken by these agencies show that these lakes were indeed well within the 
range for classification as fresh water. Brown Lake, which was visited in 
January 2000, was also assumed to be freshwater at the time, as monitoring 
of this lake over previous years has shown this lake to have very low 
conductivities (Mosisch and Arthington, 2001). The other two sites visited 
before conductivity data were collected for this study – College’s Crossing and 
Natural Arch – were assumed to be freshwaters on the basis of conductivity 
data collected since December 2000, and because of the hydrologic features 
of these two sites – College’s Crossing being downstream of Lake Wivenhoe, 
and natural Arch being an upper catchment stream. Study waters were 
classified as fresh, brackish or saline using conductivity parameters and 
guidelines published by the Queensland Departments of Environment & 
Heritage and Natural Resources (1999 p21). 
 
Unlike conductivity, where significant short-term changes in these study 
waters are unlikely, faecal coliforms and chlorophyll-a can fluctuate on a daily 
or weekly basis. Therefore analyses of symptom reporting using coliforms or 
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chlorophyll data as exposure variables were conducted only on the sub-sets of 
the cohort for which these readings were available for the day of recruitment.  
 
 
3.3.10. Database design and data manipulation 
 
A relational database – Microsoft Access 2000 – was constructed by IS to 
facilitate data entry and retrieval. Data were manipulated in this database by 
constructing queries, which were then exported to other programs (SPSS, 
Stata and Excel) for statistical analysis and graphing. All data were converted 
to categorical variables – cyanobacteria exposure variables of low, 
intermediate and high based on guidelines of the Queensland Department of 
Natural Resources and Mines (2004); other exposures, e.g. faecal coliforms 
as positive or negative according to regulatory guidelines – in this case the 
Australian and New Zealand guidelines for fresh and marine water quality 
(ANZECC & ARMCANZ, 2000). Age was categorised into five age groups 
(see Table 3.3). Smoking status was categorised into three groups: active, 
passive and non-smokers. Passive smokers were defined as either: 
 
• Non-smokers who lived in a dwelling where at least one other household 
 member smokes inside the house 
• Children under the age of 12 years who lived in a dwelling where at least 
 one other household member smokes inside the house (the question “Are 
 you a smoker or a non-smoker?” was only put to subjects aged 12 years 
 or over at the follow-up interview). 
 
The dependent variable for all statistical tests was symptom reporting; 
symptoms were pooled into an “any symptom” category, and because of the 
disparate nature of symptoms associated with cyanobacteria exposure, 
reported symptoms were allocated into five categories – ear, eye, gastro-
intestinal (G-I), respiratory and cutaneous. The single sign/symptom of fever 
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was also investigated as a separate category. Table 3.2 shows specific 
symptoms investigated in the follow-up interview, and their allocation into 
symptom groups for statistical analysis. 
 
Table 3.2. Symptom groups used for statistical analyses. Terminology is 
that used by the interviewer during the follow-up interview. 
Symptom 
group 
Symptoms 
  
Sore ear/s; discharge from ear/s Ear 
Sore eye/s; eye redness; discharge from eye/s; itchy eye/s Eye 
Vomiting; diarrhoea; abdominal pain; nausea G-I 
Difficulty breathing; dry cough; productive cough; runny 
nose; unusual sneezing; sore throat; wheezy breathing 
Respiratory 
Skin rash; redness of the skin not related to sunburn; 
unusual itchiness 
Skin 
Fever Fever 
Blisters on the skin not related to sunburn; blisters on the 
lips; swollen lips; blisters in the mouth 
Other 
Any of the above 
 
Any 
 
Only symptoms that were reported as commencing within the follow-up period 
were included for analysis, i.e. subjects were excluded from the specific 
analysis if they reported a symptom had started before recruitment into the 
study.  
 
A “muscle aches” question, designed to elicit reports of myalgia associated 
with a flu-like illness, was not included in this analysis as most respondents 
qualified this answer to the effect that their muscle pain was associated with 
strenuous exercise involving powered watercraft. Similarly “headache” data 
were collected but not analysed for in this study.  
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3.3.11. Statistical modelling 
 
The overall approach taken in this project was to conduct an initial series of 
univariate tests, as a screening process to identify potentially confounding 
variables, which would then be examined further in multivariate analyses. A 
significance level of α=0.05 was used for all statistical comparisons.  
Measures of independence were conducted by Chi-square tests of 
heterogeneity; Fishers exact test (2 x 2 crosstabulations) or the Fisher-
Freeman-Halton test (r x c crosstabs) were used when expected frequencies 
in >20% of cells were less than 5 (Freeman & Halton, 1951; Pallant, 2001 
pp257-8; Garson, 2003). 
 
Symptoms were categorised on the basis of severity; respondents were asked 
to rate any symptoms that occurred in the follow-up period as mild, moderate 
or severe. Early inspection of the data after enrolment in the study was 
completed revealed that the number of symptoms reported as “severe” was 
very low, so this category was combined with “moderate”, to form a single 
“moderate or severe” category, which was used for all subsequent analyses.  
 
Crosstabulations that suggested statistically significant relationships between 
outcomes, i.e. symptom reporting, and explanatory variables – e.g. age, sex, 
exposure to cyanobacteria – were those held over for inclusion in multivariate 
logistic regression analyses.  
 
Logistic regression models were constructed with cyanobacterial cell surface 
area as the principal explanatory variable. Other variable interactions that 
were revealed to be significant by univariate crosstabulations (i.e. when the 
null hypothesis that the explanatory and outcome variables are independent 
was rejected at the 5% level) were added to the regression models. These 
variables were age, sex, region (QLD/NSW/Florida), smoking status, prior 
history of asthma, hay fever or skin disease (eczema or dermatitis) and 
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conductivity of study waters. An interaction term combining time exposed to 
water and cyanobacterial cell surface area was also included. Region was 
included as a design variable in all crude regression and multivariate logistic 
regression models (see below, this section).  
 
The approach taken with the logistic regression analyses was to build a 
parsimonious model using backwards stepwise regression with the pooled 
“any symptom” category as the outcome variable. This model was then used 
as the template for subsequent modelling with the outcome variables of ear, 
eye, G-I, respiratory, skin symptoms and fever. A final model examining the 
“any symptom” outcome variable was run with the exclusion of subjects who 
reported exposure at the study waterbody over the five-day period prior to 
recruitment, as per the work of Pilotto et al (1997).  
 
The preliminary “any symptom” model revealed that the variables “sex”, 
“conductivity”, “passive smokers” and the “time*cyanobacteria” interaction 
term made insignificant contributions to the regression and were therefore 
dropped from the model. The variable “region” was included as a design 
variable in all crude and multivariate models, as there were significant 
differences between symptom reporting across the three regions (see 
discussion, section 3.5.7.1). All models included a clustering term to adjust 
standard errors for clustering of subjects within household groups. 
 
Multicollinearity between two categorical variables was deemed to exist if 
there was a strong relationship between the variables (i.e. Pearson’s Chi-
square statistic >100 or if the presence of both variables in a statistical model 
affected estimate stability or model convergence (Hosmer & Lemeshow, 2000 
pp140-1). 
 
Univariate crosstabulations were conducted using SPSS v11.5 (SPSS Inc, 
2002); some 2 x 2 and 2 x r crosstabs were run on Statcalc – Epi Info v6.O4d 
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(CDC, 2003). Logistic regression analyses were performed using Stata/SE 
v8.0 (StataCorp, 2003). 
 
 
3.3.12. Measures of agreement 
 
3.3.12.1. Exposure time  
In order to address the problem of validating the time that respondents 
reportedly spent in the water on the recruitment day, question 13 of the 
questionnaire was asked again at the end of the follow up interview (Q59, 
Appendix 1). Both answers were crosstabulated giving Cohen’s kappa 
coefficient. This repeat question was not included in the follow-up interview 
until November 2000; the number of subjects so analysed was 975.  
 
 
3.3.12.2. Measures of cyanobacteria exposure  
 
The three exposure levels (low, intermediate and high) for each of the three 
measures of exposure to cyanobacteria – cells/mL, and the derived values for 
surface area and biovolume – were crosstabulated. Cohen’s kappa statistic 
was used to compare agreement of exposure levels between the three 
exposure measures. Water samples in which no cyanobacteria were identified 
(n = 5) were not included in these kappa tests (n = 49 samples analysed).  
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3.4. RESULTS 
3.4.1. Recruitment 
Figure 3.1 shows the number of individuals who met the study’s entry criteria, the number recruited into the  
study, and the various categories that account for the difference between these two numbers.  
Chapter 3: Recreational exposure to cyanobacteria – an international prospective cohort study 
MET STUDY 
ENTRY 
CRITERIA  
n=3595
ACCEPTED 
QUESTIONNAIRE 
n=3193 (89%) 
REFUSED TO 
PARTICIPATE 
n=402 (11%) 
REFUSED 
FOLLOW-UP 
INTERVIEW  
n=2 (5%) 
DID NOT PROVIDE 
PHONE NUMBER 
n=20 (50%) 
DID NOT RETURN 
QUESTIONNAIRE 
n=1822 (57%)
RETURNED 
QUESTIONNAIRE 
n=1371 (43%) 
UNABLE TO 
CONTACT FOR 
FOLLOW-UP 
INTERVIEW  
n=12 (30%) 
FOLLOW-UP 
INTERVIEW 
CONDUCTED 
AND 
RECRUITED 
INTO STUDY 
n=1331 (97%)
FOLLOW-UP 
INTERVIEW 
NOT 
CONDUCTED 
n=40 (3%) 
DENIED 
KNOWLEDGE OF 
QUESTIONNAIRE  
n=4 (10%)
DEFACED 
QUESTIONNAIRE  
n=2 (5%) 
Figure 3.1. Flowchart showing recruitment and entry into the study. 
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A small proportion of individuals (n = 29) met the first entry criterion – planning 
water-contact activities – but failed the second, in that they were either 
unwilling or unable to be contacted by telephone for various reasons. A 
smaller proportion still (n = 19) could not have their entry criteria ascertained 
because of English language difficulties.  
 
The 1,331 subjects with follow-up data therefore represent 41.7% of those 
who agreed to participate in the study by accepting a questionnaire. Of the 
four individuals that denied knowledge of the study, three suggested that their 
names and contact numbers may have appeared on the questionnaire as a 
practical joke perpetrated by their friends; the fourth apparently had a 
questionnaire completed without his knowledge by his grandson. This 
individual did not wish to participate in the study.  
 
 
3.4.2. Demographic features 
 
Some demographic features of the cohort, along with smoking status, are 
listed in Table 3.3. Passive smokers were defined as those non-smokers, and 
children aged less than 12 years of age, who live in households where 
another member of that household smokes inside the dwelling.  
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Table 3.4 shows the number of subjects analysed by symptom group after 
excluding subjects that reported pre-existing symptoms. The numbers of 
subjects are also shown for those sub-sets of the cohort for which complete 
water quality data were not available (faecal coliforms and chlorophyll), and 
those remaining after excluding subjects that reported recent and subsequent 
exposures at study waterbodies. 
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  n (%) 
    
 1-12 312 (23.4) 
 13-24 346 (26.0) 
AGE 25-39 375 (28.2) 
 40-54 256 (19.2) 
 55-72 42 (3.2) 
    
SEX Female 635 (47.7) 
 Male 696 (52.3) 
    
 Florida 216 (16.2) 
REGION NSW 300 (22.5) 
 QLD 815 (61.2) 
    
SMOKING Smoker 247 (18.6) 
STATUS Passive smoker 131 (9.8) 
 Non-smoker 953 (71.6) 
Table 3.3. Demographic features and smoking status   
of the entire cohort. 
   
 
  Any Ear Eye G-I Resp. Cutaneous Fever 
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Entire cohort 1331 1331 1331 1331 1331 1331 1331 
 
 
 
 
 
 
885 
993 
846 
1326 
TABLE 3.4. Number of study subjects remaining after exclusion for pre-existing symptom/s, and prior or 
subsequent exposure at study site. Subjects recruited on days for which coliform or chlorophyll data were not 
collected are also excluded from these analyses.  
 
 
 
 
 
858 
966 
824 
 
1289 
 
 
 
 
 
 
      
Exclusion of subjects with pre-existing 
symptom/s 
1137 1297 1300 1303 1149 
      
Number with data on faecal coliforms – excluding 
subjects with prior symptom/s 
507   576 
      
768 Number with data on chlorophyll – excluding 
subjects with prior symptom/s 
766 867 867 869 
      
849 Exclusion of subjects with prior site exposure – 
within five days prior to recruitment – and prior 
symptom/s 
846 970 974 976 
   
723 
   
Exclusion of subjects with prior (5 days) or 
subsequent (3 days) site exposure + prior 
symptom/s 
723 824 830 831 
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3.4.3. Univariate analyses 
 
Tables 3.5 to 3.8 show the results of Chi-square tests for independence, with 
the row variables treated as explanatory or independent variables, while the 
column variables – symptom reporting rates – are the outcome or dependent 
variables. All crosstabulations were conducted only on subjects that reported 
symptom occurrence within the follow-up period, i.e. those reporting any 
symptom that commenced at any time within two weeks prior to recruitment 
were excluded from analyses of that particular symptom group. Analyses 
shown in Tables 3.5 to 3.8 are with all symptom reporting as a single variable, 
i.e. without considering differential rating of symptoms as mild, moderate or 
severe.  Table 3.12 shows the ratio of mild to moderate + severe symptoms 
reported by subjects classified by cyanobacterial cell surface area exposures. 
Percentages are for the proportion of subjects within the row category 
reporting symptom presence, e.g. in Table 3.5, 22 subjects in the 25-39 year 
age group reported eye symptoms. This is 6% of those in the 25-39 year age 
group, i.e. 94% (n=345) of 25-39 year-olds did not report eye symptoms within 
the follow-up period. 
 
 
 
 
 
 
 
 
 
  
       Table 3.5. Contingency table tests comparing proportion of symptom reporting against demographic factors and smoking status. 
 
      Any    Ear   Eye  G-I    Respiratory   Cutaneous Fever 
  n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
          
1-12 78 (28.5) 7 (2.3) 21 (6.9) 23 (7.5) 35 (12.5) 17 (5.6) 7 (2.3) 
13-24 112 (38.5) 17 (5.2) 25 (7.5) 26 (7.8) 55 (18.9) 19 (5.7) 4 (1.2) 
25-39 89 (28.3) 14 (3.8) 22 (6.0) 14 (3.8) 47 (15.1) 15 (4.1) 2 (0.5) 
40-54 49 (21.9) 6 (2.4) 9 (3.6) 11 (4.4) 26 (11.2) 5 (2.0) 2 (0.8) 
55-72 7 (21.3) 0 (0) 1 (2.5) 1 (2.4) 4 (11.5) 2 (5.1) 0 (0) 
 
 
 
AGE  
p  <0.001   0.15  0.26     0.077         0.098         0.20  0.34* 
               
Female 147 (27.1) 23 (3.8) 32 (5.1) 37 (6.0) 68 (12.5) 33 (5.6) 8 (1.3) 
Male 188 (31.7) 21 (3.1) 46 (6.8) 38 (5.6) 99 (16.4) 25 (3.7) 7 (1.0) 
 
SEX 
p     0.084   0.53   0.23  0.75         0.060         0.17         0.66 
               
Florida 45 (23.7) 5 (2.3) 17 (8.0) 10 (4.6) 21 (10.8) 4 (1.9) 1 (0.5) 
NSW 64 (25.0) 9 (3.1) 16 (5.5) 12 (4.1) 23 (8.7) 17 (6.0) 2 (0.7) 
QLD 226 (32.7) 30 (3.8) 45 (5.6) 53 (6.6) 123 (17.8) 37 (4.7) 12 (1.5) 
 
REGION 
p    0.011   0.55   0.41   0.20       <0.001         0.085         0.43* 
               
Non-smoker 215 (26.4)       100 (11.9)     
Passive smoker 30 (26.8)       18 (16.3)     
Smoker 90 (42.4)       49 (24.3)     
 
SMOKING 
STATUS 
p        <0.001             <0.001     
 
 
        p: χ2 (* = Fisher-Freeman-Halton exact test) 
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TABLE 3.6. Contingency table tests showing symptom reporting against cyanobacteria and other water-related factors. 
 
    Any    Ear     Eye   G-I     Respiratory    Cutaneous Fever 
  n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
          
Cyanobacteria  <2.4  241 (29.8) 33 (3.6) 59 (6.3) 57 (6.1) 116 (14.4) 43 (4.7) 10 (1.1) 
cell surface area 2.4 - 12.0  46 (25.6) 4 (2.0) 10 (4.9) 10 (4.8) 24 (12.4) 8 (3.9) 3 (1.4) 
(mm2/mL) >12.0  48 (32.7) 7 (4.2) 9 (5.5) 8 (4.8) 27 (18.1) 7 (4.2) 2 (1.2) 
 p 0.35    0.43     0.69    0.64   0.33   0.87  0.77* 
                
Cyanobacteria  <2.5  252 (30.0) 33 (3.4) 64 (6.6) 58 (6.0) 121 (14.4) 47 (4.9) 10 (1.0) 
cell biovolume  2.5 - 12.5  43 (24.6) 5 (2.5) 5 (2.5) 9 (4.4) 24 (12.8) 6 (3.0) 3 (1.5) 
(mm3/L) >12.5  40 (32.8) 6 (4.4) 9 (6.7) 8 (5.9) 22 (17.9) 5 (3.7) 2 (1.5) 
 p  0.25    0.64      0.077    0.65   0.45   0.43  0.62* 
                
Cyanobacteria <2x104 152 (29.2) 24 (4.1) 40 (6.7) 32 (5.4) 71 (14.0) 26 (4.5) 5 (0.8) 
cell counts 2x104 - 1x105 69 (32.7) 9 (3.6) 15 (6.0) 21 (8.4) 36 (16.5) 10 (4.1) 3 (1.2) 
(cells/mL) >1x105 114 (28.2) 11 (2.4) 23 (5.1) 22 (4.7) 60 (14.2) 22 (4.8) 7 (1.5) 
 p         0.49         0.33           0.52          0.12           0.65         0.90         0.59 
          
 <10  150 (30.3) 23 (4.1) 43 (7.6) 31 (5.5) 67 (13.8) 28 (5.1) 4 (0.7) 
Chlorophyll  10 - 50  47 (24.8) 6 (2.8) 5 (2.3) 10 (4.5) 25 (12.5) 7 (3.3) 4 (1.8) 
(μg/L) >50  27 (33.0) 5 (5.6) 5 (5.6) 6 (6.7) 14 (17.1) 4 (4.4) 1 (1.1) 
 p         0.26    0.48      0.021    0.72   0.59   0.57  0.26* 
               
Faecal  <150  102 (31.3)     19 (5.1)       
coliforms >150  57 (31.4)     8 (3.8)       
(CFUs/100mL) p 0.96        0.50       
 
p: χ2 (* = Fisher-Freeman-Halton exact test) 
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Table 3.7. Contingency table tests showing symptom reporting against further water-related factors. 
 
     Any    Ear    Eye  G-I   Respiratory  Cutaneous Fever 
  n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
           
Time spent in water <1 hour 166 (29.9) 23 (3.5) 33 (5.1) 40 (6.1) 89 (15.9) 26 (4.1) 7 (1.1) 
  >1 hour 169 (29.0) 21 (3.2) 45 (6.9) 35 (5.4) 78 (13.2) 32 (4.9) 8 (1.2) 
  p           0.75          0.75           0.17          0.54         0.19        0.45         0.80 
          
 <1 hour, <2.4 mm2/mL 132 (29.7) 20 (3.8) 25 (4.8) 34 (6.5) 66 (14.9) 22 (4.3) 6 (1.1) 
Water exposure time >1 hour, <2.4 mm2/mL 109 (29.8) 13 (3.2) 34 (8.4) 23 (5.7) 50 (13.8) 21 (5.2) 4 (1.0) 
+ cyanobacteria cell <1 hour, >2.4 mm2/mL 34 (30.6) 3 (2.4) 8 (6.5) 6 (4.8) 23 (20.2) 4 (3.2) 1 (0.8) 
surface area >1 hour, >2.4 mm2/mL 60 (27.8) 8 (3.3) 11 (4.5) 12 (4.8) 28 (12.3) 11 (4.5) 4 (1.6) 
 p           0.94          0.87           0.087          0.77         0.25        0.80         0.89* 
          
 <800 (fresh water) 268 (31.0)  62 (6.3)   39 (4.0)   
Conductivity (μS/cm) 2,500 - 8,000 (brackish) 18 (17.3)  2 (1.7)   3 (2.5)   
  >8,000 (saline) 49 (29.2)  14 (7.3)   16 (8.8)   
 p           0.015            0.099          0.008   
After exclusion of           
subjects reporting  <2.4 mm2/mL 200 (31.4) 28 (3.8) 45 (6.1) 52 (7.1) 99 (15.6) 31 (4.3) 8 (1.1) 
water recreation at  2.4 -12.0 mm2/mL 33 (30.8) 2 (1.7) 9 (7.4) 6 (4.9) 17 (15.3) 8 (6.7) 2 (1.6) 
study site during  >12.0 mm2/mL 32 (31.1) 3 (2.5) 3 (2.6) 6 (5.0) 19 (18.1) 6 (5.0) 2 (1.7) 
previous five days p           0.99          0.46*           0.23          0.51         0.80        0.49         0.69* 
After exclusion of          
subjects reporting  <2.4 mm2/mL 174 (32.2) 23 (3.7) 39 (6.3) 45 (7.2) 91 (17.0) 26 (4.2) 7 (1.1) 
prior (5 days) or  2.4 -12.0 mm2/mL 30 (31.6) 2 (1.9) 7 (6.4) 5 (4.6) 17 (17.3) 7 (6.6) 2 (1.8) 
subsequent (3 days) >12.0 mm2/mL 25 (28.4) 3 (3.0) 3 (3.0) 4 (4.0) 14 (15.6) 5 (5.0) 2 (2.0) 
exposures  p           0.78          0.73*           0.59          0.33         0.94         0.50*         0.45* 
 
p: χ2 (* = Fisher-Freeman-Halton exact test) 
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           TABLE 3.8. Contingency table tests showing symptom reporting against prior chronic illness. 
 
    Any    Ear     Eye   G-I   Respiratory   Cutaneous Fever 
  n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
          
Asthma No  270 (27.0) 40 (3.6) 62 (5.5) 62 (5.5) 134 (13.2) 43 (3.8) 13 (1.1) 
 Yes  65 (47.8) 4 (2.2) 16 (9.0) 13 (7.2) 33 (25.2) 15 (8.8) 2 (1.1) 
 p       <0.001         0.35           0.071        0.36         <0.001         0.004        1.0* 
                
Hay fever No  253 (26.3) 29 (2.7) 58 (5.4) 61 (5.7) 126 (12.9) 42 (4.0) 15 (1.4) 
  Yes  82 (46.6) 15 (6.5) 20 (8.9) 14 (6.0) 41 (24.0) 16 (7.1) 0 (0) 
 p       <0.001         0.004          0.042        0.84         <0.001         0.039        0.088* 
                
Skin (eczema  No 296 (28.2) 37 (3.1) 70 (5.9) 65 (5.5) 149 (14.1) 52 (4.4) 15 (1.2) 
or dermatitis) Yes 39 (44.3) 7 (6.2) 8 (7.0) 10 (8.5) 18 (19.4) 6 (6.0) 0 (0) 
 p        0.001         0.098*           0.63        0.17           0.17         0.45*        0.39* 
          
(1.0) 
(0) 
Urticaria No  260 (28.7) 35 (3.4) 60 (5.8) 51 (4.9) 127 (13.9) 44 (4.3) 11
(10.0) 0
       1.0* 
2(35.7) 
        0.22* 
5(5.0) 
          0.037* 
(10.5) 1
       1.0* 
2(5.0) 
          0.31* 
1 Yes  7 (43.8) 
        0.51*        0.26*  p  
2 (* = Fisher’s exact test)      p: χ
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Table 3.9 shows the cyanotoxin levels that were measured in study waters. 
No saxitoxins were found in any water samples. The table also shows the 
number of study subjects that were recruited on days when each cyanotoxin 
was present in water samples. Anatoxin-a was only analysed for in water 
samples collected from Florida study waters, as anatoxin-a is essentially a 
northern hemisphere cyanotoxin (see Chapter 1, section 1.3.2.1).  
Table 3.9.  Cyanotoxins measured in study waters. 
Cyanotoxin  Number of sites  Number of subjects exposed Levels detected 
   (& days) detected 
 
Microcystins          2 (2)         28   1µg/L & 12µg/L 
 
Cylindrospermopsin         4 (7)         124   1µg/L & 2µg/L 
 
Anatoxin-a          1 (1)         18   1µg/L 
 
 
 
Table 3.10 shows 3x2 contingency table tests for reported symptom presence (all 
symptoms pooled, i.e. “any symptom”) amongst subjects exposed and not 
exposed to cyanotoxins. Crosstabs: Three symptom groups (none, mild, 
[moderate + severe] x two cyanotoxin groups (present, absent in study water 
samples). Subjects reporting symptom presence prior to recruitment into the study 
were excluded from the analysis. Florida subjects only were examined in 
anatoxin-a cross-tabulations; cylindrospermopsin and microcystins crosstabs 
included the entire cohort.                               
Table 3.10. Contingency table tests showing reported 
symptom severity against cyanotoxin presence or absence in 
study waters. 
  Any Symptom 
  Mild Moderate 
+ Severe 
  n (%) n (%) 
Detected 27 (25.2) 13 (12.1)  
Not detected 182 (17.7) 113 (11.0) Cylindrospermopsin
p 0.12 
  
Detected 7 (26.9) 5 (19.2) 
Not detected 202 (18.2) 121 (10.9) Microcystins
p 0.13* 
  
Detected 6 (35.3) 2 (11.8) 
Not detected 27 (15.6) 10 (5.8) Anatoxin-a
p 0.043* 
   
2                           p: χ  (* = Fisher-Freeman-Halton exact test) 
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Table 3.11 shows symptoms occurring after recreational exposure to anatoxin-a 
(Lake Seminole, 4th August, 2002), as reported by eight study subjects. Self-
reported symptom severity rating and the day each symptom commenced are 
also shown (exposure day = day 1).  
 
 
Table 3.11. Symptoms reported by subjects exposed to water 
containing anatoxin-a (1µg/L). 
Subject Symptom Symptom 
severity 
Day symptom 
commenced 
   
1 eye redness moderate exposure day 
2 productive cough moderate 2nd day 
 nasal discharge moderate 3rd day 
 abdominal pain moderate 2nd day 
 unusual sneezing moderate 3rd day 
3 unusual sneezing mild 3rd day 
4 productive cough mild 3rd day 
 unusual sneezing mild 3rd day 
 sore throat mild 3rd day 
5 nasal discharge mild exposure day 
 headache mild 2nd day 
6 itchy eyes mild exposure day 
7 nasal discharge mild 2nd day 
 sore throat mild 2nd day 
8 diarrhoea mild 3rd day 
 nausea mild 3rd day 
 3.4.4. Symptom severity reporting 
 
Table 3.12 shows 3x3 crosstabs for the proportions of subjects reporting mild or moderate/severe symptoms by level of 
cyanobacteria exposure. Exposure variable: three levels of cyanobacteria exposure. Outcome variable: no symptoms (not 
shown), mild symptoms, moderate + severe symptoms (p = Chi-square or Fisher-Freeman-Halton exact test). From the “ratio” 
row we see that for all symptom groups, symptoms rated by subjects as mild were reported more frequently than moderate or 
severe symptoms. The highest proportion of “moderate + severe” symptoms occurred with gastro-intestinal illness; the highest 
proportion of “mild” symptoms was reported in the respiratory symptom group. 
 
Table 3.12. Symptom severity reporting by level of cyanobacteria exposure. 
 
  Any Ear Eye G-I Respiratory Cutaneous 
  Mild 
n (%) 
M + S  
n (%) 
Mild 
n (%) 
M + S  
n (%) 
Mild  
n (%) 
M + S  
n (%) 
Mild 
n (%) 
M + S  
n (%) 
Mild 
n (%) 
M + S  
n (%) 
Mild  
n (%) 
M + S  
n (%) 
              
<2.4 147 (18.1) 94 (11.6) 21 (2.3) 12 (1.3) 41 (4.4) 18 (1.9) 30 (3.2) 27 (2.9) 87 (10.8) 29 (3.6) 23 (2.5) 20 (2.2) 
             
2.4 – 12.0 28 (15.6) 18 (10.0) 3 (1.5) 1 (0.5) 5 (2.4) 5 (2.4) 5 (2.4) 5 (2.4) 19 (9.8) 5 (2.6) 6 (2.9) 2 (1.0) 
             
>12.0 34 (23.1) 14 (9.5) 4 (2.4) 3 (1.8) 6 (3.7) 3 (1.8) 5 (3.0) 3 (1.8) 22 (14.8) 5 (3.4) 6 (3.6) 1 (0.6) 
 
 
Cyanobacteria 
cell surface area 
(mm2/mL) 
      
 p 0.42 0.75*  0.75* 0.89   0.57 0.52* 
              
Ratio –  mild : (moderate + severe) 
symptoms 1.7 1.8 2.0 1.1   3.3 1.5 
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M + S = single categorical variable: mild + severe symptoms 
* = Fisher-Freeman-Halton exact test 
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3.4.5. Multivariate logistic regression models 
 
A series of logistic regression models were run to adjust for the impact on 
symptom reporting of potentially confounding variables identified through the 
univariate tests (tables 3.5 to 3.8). Cyanobacterial cell surface area was 
chosen as the principal exposure variable of interest (see following 
discussion, sections 3.5.4 and 3.5.7.4.2). The crude models adjust for region, 
and multivariate models also adjust for age, smoking and prior history of 
asthma, hay fever and eczema. Clustering of subjects within household 
groups is modelled in the multivariate analyses. Table 3.13 presents odds 
ratios (O.R.) and 95% confidence intervals for crude and multivariate models 
examining eight different outcome variables: any symptom, ear, eye, G-I, 
respiratory, cutaneous symptoms, fever, and any symptom after excluding 
subjects exposed to study waters within five days prior to recruitment. There 
was no evidence of multicollinearity between any of the variables investigated. 
Two significant findings were revealed: increased reporting of respiratory 
symptoms and from the pooled “any symptom” category was more frequent 
amongst subjects exposed to high cyanobacterial cell surface areas. A similar 
non-significant trend was seen for symptom reporting in ear, skin and fever 
categories. No relationship between exposure to intermediate levels of 
cyanobacteria and symptom reporting was apparent.   
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Table 3.13. Binary logistic regression analyses. Outcome variable: reports of symptom 
occurrence in the follow-up period. Main explanatory variable: total cyanobacterial cell 
surface area. Design variable included in all crude and multivariate models: region (QLD, 
NSW, Florida). Standard errors adjusted for clustering within households. 
 
Exposure                               Symptoms 
Cyanobacterial  None  Present  Crude models  Multivariate 
cell surface area n (%)  n (%)  O.R. (95% CI)  O.R. (95% CI) 
Any symptom 
 Low   569 (70.2) 241 (29.8) 1   1 
 Intermediate 134 (74.4)   46 (25.6) 0.82 (0.55, 1.23) 0.84 (0.56, 1.26) 
 High  99 (67.3)   48 (32.7) 1.63 (0.99, 2.66) 1.68 (1.00, 2.83) 
Ear symptoms 
 Low  895 (96.4)   33 (3.6)  1   1 
 Intermediate 199 (98.0)     4 (2.0)  0.62 (0.18, 1.48) 0.51 (0.18, 1.46) 
 High  159 (95.8)     7 (4.2) 1.92 (0.57, 6.50) 1.99 (0.56, 7.09) 
Eye symptoms 
 Low  872 (93.7)   59 (6.3) 1   1 
 Intermediate 196 (95.1)   10 (4.9) 0.82 (0.37, 1.82) 0.83 (0.36, 1.87) 
 High  154 (94.5)     9 (5.5) 0.61 (0.24, 1.56) 0.64 (0.25, 1.66) 
G-I symptoms 
 Low  871 (93.9)   57 (6.1) 1   1 
 Intermediate 199 (95.2)   10 (4.8) 0.85 (0.43, 1.68) 0.87 (0.42, 1.78) 
 High  158 (95.2)     8 (4.8) 0.86 (0.34, 2.15) 0.88 (0.35, 2.19) 
Respiratory symptoms 
 Low  691 (85.6) 116 (14.4) 1   1 
 Intermediate 169 (87.6)   24 (12.4) 0.96 (0.57, 1.59) 0.93 (0.56, 1.56) 
 High  122 (81.9)   27 (18.1) 1.97 (1.06, 3.69) 2.08 (1.09, 3.98) 
Cutaneous symptoms 
 Low  875 (95.3)   43 (4.7) 1   1 
 Intermediate 197 (96.1)     8 (3.9) 0.67 (0.28, 1.65) 0.70 (0.28, 1.75) 
 High  159 (95.8)     7 (4.2) 1.91 (0.85, 4.28) 1.94 (0.86, 4.35) 
Fever 
 Low  938 (98.9)   10 (1.1) 1   1 
 Intermediate 208 (98.6)     3 (1.4) 1.51 (0.41, 5.59) 1.76 (0.46, 6.74) 
 High  165 (98.8)     2 (1.2) 2.01 (0.46, 8.69) 1.84 (0.42, 8.14) 
Any symptom – after exclusion of subjects with recent (5 days prior to recruitment) exposure 
 Low  436 (68.6)  200 (31.4) 1   1 
 Intermediate   74 (69.2)    33 (30.8) 0.92 (0.58, 1.45) 0.93 (0.59, 1.48) 
 High    71 (68.9)    32 (31.1) 1.50 (0.79, 2.86) 1.62 (0.83, 3.16) 
Exposure: Low = <2.4mm2/mL; Intermediate = 2.4 – 12.0mm2/mL; High = >12.0mm2/mL 
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3.4.6. Measures of agreement  
 
3.4.6.1. Exposure time validation  
 
Of the 975 subjects that answered the identical “time spent in the water?” 
questions in both the questionnaire and the follow-up interview, 66.2% 
reported the same answer on both occasions. The kappa statistic was 0.57 
(95% CI 0.53, 0.61), McNemar test, p<0.001 
 
 
3.4.6.2. Measures of cyanobacteria exposure  
 
Table 3.14 shows Cohen’s kappa coefficients for crosstabulations of the three 
cyanobacteria exposure measures. The agreement column shows the 
proportion of exposure levels – low, intermediate and high – that matched 
both exposure levels.  
 
Table 3.14. Agreement between three measures of exposure to cyanobacteria. 
Exposures determined from n=49 study site water samples. 
Cyanobacteria exposure 
measures  
Kappa (95% CI) % agreement McNemar’s test (p) 
    
0.30 (0.14, 0.46) 53.1 <0.001 Cells/mL x surface area 
0.24 (0.09, 0.38) 46.9 <0.001 Cells/mL x biovolume 
0.83 (0.70, 0.97) 89.8 0.063 Surface area x biovolume 
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Table 3.15 gives the crosstabulation for water sample measurements of 
cyanobacterial cells/mL and the derived values of cell surface area. 
Agreement between each of the exposure levels is represented on the upper 
left to lower right diagonal.  
 
Table 3.15. Measure of agreement crosstabulation – surface area vs cells/mL measures 
of cyanobacteria in study water samples. 
 
 
 
Figure 3.2 shows the allocation of study subjects into low, intermediate or high 
cyanobacteria exposure levels, depending on the measure of exposure. 
 
 
 
 
 
 
 
 
 
  Cyanobacteria surface area 
 
Total 
  Low 
(<2.4mm2/mL)
Intermediate 
(2.4–12 mm2/mL) 
High 
(>12mm2/mL) 
 
 
Low 
(<20,000) 
10  0  0  10  
Cyanobacteria 
cells/mL 
 
Total 
 
Intermediate 
(20,000 - 100,000)
11  0  0  11  
 
High 
(>100,000) 
 
3  
 
24  
9  
 
9  
16  
 
16  
28  
 
49  
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Distribution of cohort according to cyanobacteria exposure measure
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         Figure 3.2. Allocation of study subjects into low, intermediate or high cyanobacteria exposure levels. 
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3.5. DISCUSSION 
 
The principal findings of this work are that individuals exposed to recreational 
waters from which total cyanobacterial cell surface areas exceeded 
12mm2/mL were more likely to report symptoms after exposure than those 
exposed to waters where cyanobacterial surface areas were less than 
2.4mm2/mL. Reporting of respiratory symptoms was similarly associated with 
exposure to high levels of cyanobacteria. Mild respiratory symptoms appeared 
to be the most influential contribution to overall symptom reporting.  
 
Traditional methods of enumerating cyanobacteria fail to encompass biomass 
estimates; such failure will lead to exaggerated estimates of exposure to 
cyanobacteria in recreational waters where picoplankton predominate.  
 
This study aimed to improve on some study design weaknesses of previously 
published work in this field; in this regard we were by and large successful, 
though this work suffered from an inferior questionnaire return rate and self-
reported estimates of water exposure time were poorer than we hoped for. 
 
Some of the difficulties and challenges presented by this work have been 
outlined in a report to the NIEHS submitted after the completion of this work in 
Florida (Appendix 2). Apart from the general difficulties in determining 
exposure to cyanobacteria – problems that apply to previously published work 
on recreational exposure to cyanobacteria as well as this study – some factors 
pertinent to this study will be discussed here. 
 
General recommendations for revising guidelines for recreational exposure to 
cyanobacteria are included in the following discussion, and suggestions are 
made for some future research efforts. 
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3.5.1. Response rate; sampling bias; possible unreliability of powered 
watercraft users 
  
The response rate of 42%, i.e. the proportion of those individuals that were 
enrolled in the study from those that met study criteria and accepted a 
questionnaire, compares unfavourably with the work of Pilotto et al (1997) who 
reported an impressive 93% recruitment of subjects that initially agreed to 
participate. The proportion of individuals meeting entry criteria who initially 
refused to participate in each study was similar: 10.5% in the Pilotto study; 
11.2% for this project. However, the principal reason for the difference 
between these two studies is that Pilotto et al conducted face-to-face 
interviews, collecting phone numbers at that time. We chose to collect data 
with a self-administered questionnaire, as we were concerned during the 
study design stage that we would not be able to reliably determine the length 
of time study subjects were exposed to recreational water by conducting face-
to-face interviews. Pilotto et al presumably ascertained water exposure times 
during their first follow-up interview. Other advantages of a self-administered 
questionnaire are that interviewer bias is avoided, and there is more time for 
considered replies. However, the main disadvantage of self-administered 
questionnaires over face-to-face interviews is that the response rate is usually 
lower (Quine, 1993)  
 
Another comparison of response rates in this field of study is provided by the 
three cross-sectional studies of Philipp (1992), Philipp & Bates (1992) and 
Philipp et al (1992). These studies, using mailed questionnaires, showed 
variable responses: 69%, 68%, 42% and 32% response rates are reported.  
We used an incentive (entry into a raffle for consumer electronic goods and 
lake camping and boating permits) in an attempt to improve the response 
rates. Inducements are increasingly being used in epidemiological studies; 
while our budget did not run to our favoured option of providing a cinema 
ticket with each questionnaire, we felt that entry into a prize draw would be an 
appropriate compromise. Other workers have shown improvements in 
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response rate by use of an inexpensive prize draw (Woodward et al, 1985; 
Leigh Brown et al, 1997).  
 
A low response rate is concerning because of the potential for sampling bias, 
which refers to the limited degree to which results from an unrepresentative 
sample can be generalised to the population from which the sample is drawn 
(Spry et al, 1989). We have no information about the 1,822 individuals who 
accepted a questionnaire but failed to return it. It is probably somewhat 
inevitable that the target population for this work is difficult to sample, dealing 
as we were with healthy individuals participating in leisure activities. Some 
clearly resented the intrusion of being asked to complete questionnaires on 
their day at the lake, and it is certainly possible that a significant proportion 
may have accepted a questionnaire on the assumption that this would satisfy 
the interviewer to the extent that he would then move on and speak to 
someone else. To what extent this affected the results of this work is 
unknown, though we have no reason to suspect that non-responders would be 
more likely than responders to both swim in cyanobacteria-affected waters 
and experience symptoms.  
 
In support of the comments in Appendix 2 about the perceived attitudes of 
powered watercraft users are references in the literature that suggest this 
group may have good reason to be concerned about restrictions on their 
activities, and therefore might be rather less reliable subjects for community 
environmental health research. Jet-ski users in particular are subject to 
restrictions because of the water and noise pollution generated by their 
activities. Personal watercraft are prohibited on all of Sydney Harbour (NSW 
Waterways Authority, 2003), powered watercraft were banned from Brown 
Lake on Stradbroke Island largely because of polycyclic aromatic hydrocarbon 
accumulation in lake sediments, although degradation of littoral and riparian 
vegetation and destabilisation of beach areas was also attributed to 
powerboat launching (Mosisch & Arthington, 2001). Calls have been made for 
water skiing and powerboating to be banned on sections of the Murray River 
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(Lobban, 1992), and the impacts of power boating on recreational waters are 
seen to degrade the amenity value for more sedate land and water-based 
activities (Mosisch & Arthington, 1998). Several individuals approached for 
recruitment at Lake Somerset expressed suspicion about the reasons for 
conducting the work, suggesting that management authorities were seeking 
reasons to close access to the lake.  
 
The politically-charged atmosphere at some of these lakes was brought into 
focus on Easter Friday, 2001, when recruitment was planned at The Spit, 
Lake Somerset. On that day, a supporter of the Somerset Dam Progress 
Association was also stopping vehicles entering the site, seeking petitioners to 
protest the “proposed closure” of Somerset Park, a nearby campsite. It was 
obvious to IS that the Association supporter was hostile (verbally) towards our 
recruitment of study subjects, and was sharing his concerns about the motives 
for conducting this study with vehicle occupants. In order to prevent any 
further hostility developing, study recruitment was shifted to nearby Kirkleagh 
(also on Lake Somerset) for that day.  
 
Perceptions of conflicting interests over recreational access to waterbodies 
are potential sources of a form of information bias referred to in epidemiology 
as “prevarication bias”. Or, more bluntly, lying. This occurs when subjects 
have an ulterior motive for responding to questions, and may downplay or 
exaggerate exposures and outcomes (Friis & Sellers, 1999 p289). To what 
degree prevarication bias occurred or influenced this study is unknown. 
Presumably those concerned about access to recreational water would under-
report symptoms, whereas those concerned about poor water quality 
parameters at study sites might reason that they may assist in drawing 
attention to or achieving remediation of polluted waters by falsely reporting 
adverse health outcomes.  
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3.5.2. Recruitment of control/low exposure subjects; site differences 
 
One of the presumed improvements of this work over previously published 
studies on recreational exposure to cyanobacteria rests on the decision to 
recruit a control group at waters that were known or suspected to be 
substantially free of cyanobacteria. We were concerned that the control 
subjects (i.e. non-bathers) in the studies of Pilotto et al (1997) and Philipp 
(1992), Philipp & Bates (1992) and Philipp et al (1992) might tend to under-
report relevant illnesses, given the propensity of some people to give the kind 
of answers that they think health researchers are seeking (Goldsmith, 1986). 
There is a risk that some individuals who are non-bathers, when presented 
with questions that are obviously concerned with water-related activities, might 
tend to downplay symptoms that they correctly assume are unrelated to water 
contact and then incorrectly assume to be of no interest to researchers. 
 
The ideal control waterbodies would be cyanobacteria-free lakes adjacent to 
cyanobacteria-affected lakes, with the same kinds of recreational activities 
occurring on both, and an equal opportunity to access both types of lake for 
recruitment of study subjects. This situation was not seen in any of the three 
regions – Queensland, NSW or Florida – but for different reasons. In 
Queensland, no such geographical proximity was found, so recruitment of 
reference subjects was conducted at sites that differed from cyanobacteria-
affected waters. Table 3.1 lists some of the unusual features and differences 
between reference and study sites. Brown Lake is a highly acidic lake, 
although it is not clear that this would have any significant impact on illness 
reporting. Basu et al (1982) found no evidence to suggest that exposure to 
lake water with a pH of 4.6 is harmful to healthy eyes. Currumbin Rock Pool 
can be adversely affected by high faecal coliforms, and presumably other 
microbial pathogens, although no significant impact of faecal coliforms on 
reporting of gastro-intestinal symptoms was seen in this work. Colleges 
Crossing was interesting in that it was the only site at which a warning sign 
about the presence of Bull Whaler sharks was erected. Bull Whalers are 
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aggressive sharks that move into fresh waters and will attack humans 
(Queensland Dep’t of Primary Industries and Fisheries, 2004). The fact that 
many individuals – including IS – enjoyed a refreshing dip at this site may 
have something to say about the propensity of many Australians to ignore 
warning signs about various hazards in recreational waters, discussed in the 
context of cyanobacteria warnings in Appendix 2. Curiously, this site was also 
the only one at which baptism was reported as a recreational activity by study 
subjects (n=2). It is not clear if there is any causal relationship between the 
presence of killer sharks and Pentecostalists at Colleges Crossing, and if so, 
what temporal direction that relationship might take.  
 
In the Myall Lakes area, the only cyanobacteria-free enclosed water we could 
identify before recruitment commenced was Smith’s Lake, which is a saline 
waterbody. We originally aimed to restrict this study to freshwater 
waterbodies, as we did not wish to entertain more potentially confounding 
variables such as the impact of salt water on cutaneous and ocular symptoms. 
However, the opportunity arose to conduct this work at the brackish and saline 
waters of the Myall Lakes, which had suffered an extensive bloom of 
Microcystis aeruginosa and Anabaena circinalis in the recent past (NSW 
DLWC, 2000b). In the event, we were fortunate to find only typical freshwater 
cyanobacteria at all the brackish and saline waters visited in NSW and Florida; 
typical estuarine and saline nuisance (and potentially toxic) cyanobacteria 
such as Nodularia were not found. We were also able to gather conductivity 
data at study waters, so we were able to examine salinity in our logistic 
regression models. The Myall Lakes arm of this study highlighted another 
problem in planning and conducting a prospective study to investigate 
recreational exposure to cyanobacteria (see following discussion, Section 
3.5.5). We identified Smith’s Lake as the only suitable reference site during 
the planning stage, with Bombah Broadwater and Myall Lake being 
anticipated study lakes. Bombah Broadwater had a thick scum of M. 
aeruginosa and A. circinalis in Easter 2000, but cyanobacteria levels during 
the recruitment period in the following summer were so low that the site had to 
be classified as a reference waterbody for this work.  
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The problem of variable features in reference and study sites was also seen in 
Florida, though for different reasons. The unusual karst terrane and 
associated hydrogeology in much of Florida results in oligotrophic and 
eutrophic recreational waters in close proximity to one another (US Geological 
Survey, 2002; Cervone, 2003). However, we were unable to recruit at some 
oligotrophic sinkhole lakes (i.e. low nutrient levels with consequently low 
cyanobacteria) where powerboats are permitted because of political concerns 
and private access (discussed in Appendix 2). We were able to recruit 
reference subjects at two of the many large spring bulkheads in Florida, 
though the type of recreational activity differed between cyanobacteria-
affected sites – where powered watercraft are permitted – and the recreational 
springs, where swimming and snorkelling are the primary activities. 
 
Given these differences in recreational activities and other features, we still 
consider that the approach taken – to actively recruit reference subjects in 
cyanobacteria-free waters – is superior to the alternative method of recruiting 
non-bathers at recreational water sites. We also considered recruiting 
reference subjects at study lakes during colder months when cyanobacteria 
populations can be expected to decline significantly. Three visits to Lake 
Somerset in late autumn and winter of 2000 successfully achieved the lowest 
cyanobacterial surface area measures at this site, but this strategy 
represented something of a wasted effort in that visitor numbers during the 
winter were too low for efficient recruitment of study subjects. The decision to 
define cyanobacterial surface areas as the most appropriate measure of 
exposure (see following discussion, Section 3.5.4) somewhat dissipated the 
problem of variability between reference and study waters, as two lakes 
(Wivenhoe and Somerset) functioned as both study and reference sites 
because of low cyanobacterial surface area counts at other times through the 
recruitment period.  
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3.5.3. Avian cercariae 
 
Cercarial dermatitis is a significant potential confounding variable for 
cyanobacteria-associated skin symptoms (see Chapter 1, Section 1.5.1). 
Question 10 of the follow-up interview (re “prickling sensation” – appendix 1) 
elicited only ten positive responses, and of these, only one subject also 
reported a pruritic rash during the follow-up period. This rash appeared on the 
inner thighs and underneath the swimming costume, which does not fit the 
picture of cercarial dermatitis, that being reportedly confined to exposed skin 
(Habif, 2004 p539). Outbreaks of cercarial dermatitis have been reported in 
the literature, with numerous individuals affected simultaneously (Hoeffler, 
1977; Anon, 1988; Marquardt et al, 2000 pp269-71); no indications of a similar 
outbreak were seen at any recruitment sites during the course of this study. 
South East Queensland Water, the management authority for Lake Wivenhoe, 
received reports of “several” water contact-associated skin rashes over one 
weekend in the summer of 2000. On a sunny day the following week, four 
workers (Drs O’Donohue and Mosisch of SEQ Water, Dr Glen Shaw and IS of 
NRCET) spent some hours collecting approximately 40 aquatic snails and 
bivalves from several sites at Lake Wivenhoe. Ms Lindsay Hunt of QHSS, 
Coopers Plains, examined these under a dissecting microscope. Only one 
suspicious larval form was seen and photographed, however, Dr Tom Cribb of 
the Department of Microbiology and Parasitology Department, University of 
Queensland, informed us that the larva was probably not that of a 
schistosome. None of the four workers reported any cutaneous signs or 
symptoms after this aquatic mollusc hunt.  
 
 
3.5.4. Measuring exposure to cyanobacteria 
 
When designing this study, we aimed to measure and report exposure to 
cyanobacteria by the usual method at the time, which is in cells per mL of lake 
water; this is the method used by Pilotto et al (1997) in their prospective 
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cohort study. However, when this study began to generate data, it became 
apparent that the cyanobacteria profile at study lakes was dominated 
numerically by picoplankton such as Aphanocapsa spp and Merismopedia 
spp. Cyanobacteria are heterogeneous in size, with picoplankton typically 1μm 
or less in diameter, whereas other common nuisance cyanobacteria have 
much larger cells, e.g. Anabaena circinalis, which typically have a diameter of 
6-8.5μm (Baker, 1991 p23). Therefore measuring only cyanobacterial cell 
counts will overestimate cyanobacterial biomass if picoplankton are dominant. 
We then decided to measure cyanobacterial biovolumes, and use these data 
as a measure of exposure. Later in the course of this work, and after 
stimulating discussions with Dr Ingrid Chorus at the Xth Harmful Algal Blooms 
Conference in Florida, we decided to derive cell surface area measurements 
as well. Dr Chorus’ suggestion was that because picoplankton have a higher 
surface area to volume ratio, exposures measured in biovolumes would tend 
to underestimate exposure to small cells. The yardstick used to derive cell 
biovolume and surface areas was taken from the Queensland Department of 
Natural Resources and Mines (2004) guidelines for recreational exposure to 
cyanobacteria. The relevant table is reproduced in Appendix 3. 
 
The index cyanobacterium for the above guidelines is a spherical cell of 6.2μm 
diameter, which is typical for Microcystis aeruginosa or Anabaena circinalis. 
So 20,000 cells/mL equates to biovolumes of 2.5mm3/L and surface area of 
2.4mm2 3/mL, and 100,000 cells/mL equals biovolumes of 12.5mm /L, and 
surface areas of 12.0mm2/mL. The decision to recommend cell surface area 
rather than biovolume as the most appropriate measure of exposure to 
cyanobacteria rests finally on the observation that in 48 of the 49 water 
samples collected at study sites in which cyanobacteria were present, total 
cyanobacterial surface area values (in mm2/mL) exceeded the values for total 
biovolume (in mm3/L). If spherical cells larger than 6.2μm are dominant in a 
water sample, biovolume measurements would exceed surface area 
measures. That the opposite occurred shows that cells smaller than 6.2μm 
were the most represented in a number of different recreational waterbodies in 
this work.  
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This is not to say that picoplankton are less important than larger 
cyanobacteria, as picoplankton such as Aphanocapsa are capable of 
producing cyanotoxins (Domingos et al, 1999) 
 
There are a number of limitations and assumptions in the derivation of 
biovolume and surface area data from cyanobacteria cell counts. Firstly there 
is the matter of defining all cells as either spherical or cylindrical in shape. This 
method fails to take account of ellipsoid cells such as Aphanothece spp. To 
account for ellipsoid cells would require additional cell measurements by the 
microscopist. For the purposes of this work, ellipsoid cells were idealised to 
cylindrical cells, which would tend to overestimate both biovolume and surface 
area exposures to ellipsoid cells. On the other hand, ellipsoid cells were minor 
components in the cyanobacteria profiles seen in water samples for this work, 
so errors in this regard probably did not significantly influence the results. And 
idealising cells as either spherical or cylindrical (with the additional 
measurements to account for ellipsoid cells) would probably account for most 
of the diversity in cyanobacterial cell morphology, in contrast to, for example, 
diatoms, which present considerably greater diversity in cell morphology. The 
paper by Hillebrand et al (1999) is instructive for microscopists interested in 
the topic of microalgal biomass estimates. These authors define several 
cyanobacterial genera as having prolate spheroid geometry, including genera 
such as Aphanothece which microscopists contracted for cyanobacterial 
identification and enumeration for this project categorised as having an 
ellipsoid shape. Differentiating between prolate spheroid and ellipsoid 
geometry involves a somewhat fine distinction, resting on the cross sectional 
shape (circular in the case of a prolate spheroid; elliptical for ellipsoid cells). 
The point being that only two measurements – length and diameter – are 
required to calculate the volume or surface area of a prolate spheroid cell 
(Hillebrand et al, 1999).  
 
Secondly, these techniques fail to accommodate exposure to flocculated cells. 
Mass concentrations of aquatic cyanobacteria can form macroscopic 
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aggregates in response to environmental factors such as an increase in pH or 
cations (Richmond & Becker, 1986). Flocculated cells disperse in a sample 
bottle, so that the cell counts and derived surface area and biovolume 
measures represent the sum of cells within macroaggregates. What is not 
clear, however, is the behaviour of flocculated cells when in contact with the 
skin of exposed individuals. If flocs are able to remain fully or partially intact 
during contact with the skin, then there will presumably be a significant 
number of cells that do not represent exposure in the field, so measures of 
cyanobacteria taken from a sample bottle will overestimate exposure if there is 
significant flocculation. This effect may also apply on the microscopic level, as 
mucilage-forming genera, e.g. Microcystis and Aphanocapsa form colonies 
within a gelatinous matrix. 
 
This matter flags what is probably the most significant source of uncertainty in 
this work, that of determining exposure to cyanobacteria. While estimating the 
number, volume and surface area of cyanobacterial cells within each sample 
bottle probably represents a reasonable effort in this project, such effort may 
fall into the realm of redundant precision when we come to apply these data to 
all individuals exposed to lake water on the day that sample was collected. 
Cyanobacteria surface scums are well known to move with the wind and the 
mosaic nature of cyanobacterial densities over distances as short as 10m has 
been described (Carmichael & Gorham, 1981). There may be considerable 
vertical and horizontal heterogeneity in cyanobacterial biomass within a 
waterbody, and this variability may be both spatial and temporal. A 
prospective cohort study such as this, while having the advantage of 
observing the normal scope and behaviour of recreational exposures, cannot 
reliably determine exposure of a group of people who will behave very 
differently – some bathing near the shore, others skiing around the whole lake. 
On the positive side, most of the high cyanobacteria sites visited for 
recruitment in this work had phytoplankton distributions that would have been 
high regardless of the variability in cell densities. These waters were coloured 
green throughout the visible water column; an example is seen in the case of 
Lake Coolmunda, which experienced an obvious Microcystis bloom during 
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Easter 2001. On arrival at the site, it was clear that a strong wind had moved 
the bulk of the cyanobacteria biomass over to the leeward aspect of the lake, 
with the windward side much less green-coloured. This presented a dilemma 
for recruiting study subjects, with the possibility of significantly different 
exposures depending on the area of the lake chosen for recreation. The 
approach taken was to draw a virtual cut-off line at the part of the lake where 
the green appearance started to fade and two water samples were taken on 
that day – one from the leeward side and one from the windward side. 
Subjects recruited on either side of this crude cut-off line were allocated the 
respective exposure from the results of each water sample. This method 
would fail to account for the movement across the whole lake of subjects 
towed by powered watercraft, and the potential existed for significant 
exposure misclassification. We were fortunate in that total cyanobacterial 
surface area measurements from these samples, while different as expected 
(14mm2 2/mL in the windward sample, 42mm /mL from the leeward sample), 
were both above the 12mm2/mL category designated for high exposures. The 
following day’s recruitment at Lake Coolmunda did not require a similar 
approach, as the wind had dropped and the bloom appeared to have 
redistributed itself evenly across the whole lake. No other instances of visible 
horizontal mass movement of cyanobacteria were seen at study lakes; Florida 
sites, which had cyanobacterial densities larger than Australian sites, were 
therefore likely to have yielded high exposures despite any mosaic variability 
within the waterbody.  
 
The only way to improve the estimates of exposure to cyanobacteria for an 
epidemiological study at present will be to conduct a randomised trial, using 
observers to monitor the time and place of each participant’s exposure, and 
collect water samples accordingly. This kind of study would, however, present 
a different set of problems and disadvantages (see Chapter 1, Section 1.4.7). 
The cost of conducting a properly designed randomised trial would be 
prohibitive and probably more productively spent on toxicological 
investigations.  
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3.5.5. Cyanotoxins in study waters; disadvantages with prospective 
studies 
 
The decision to measure cyanotoxins in study waters directly by HPLC-based 
methods was considered to be a design improvement over previous studies of 
recreational exposure to cyanobacteria (see Chapter 1), where cyanotoxins 
were either not considered or indirect and unquantified measures of 
cyanotoxin presence were used. However, the cyanotoxin levels we found in 
study waters were universally at low levels, and infrequently seen at study 
waters. Microcystins were only found on two occasions, at 1μg/L and 12μg/L; 
cylindrospermopsin was measured on seven occasions, but the levels were 
low at 1μg/L and 2μg/L. Saxitoxins were not seen in this study, and anatoxin-a 
was only measured at one Florida site on a single recruitment day, at 1μg/L. 
Table 3.10 showed an increase in symptom reporting amongst subjects who 
were recruited on the day when anatoxin-a was measured in the water, when 
compared to the remaining Florida subjects. An examination of the symptom 
reporting of the eight subjects declaring symptom onset after water exposure 
on the day that anatoxin-a was measured in the site water sample shows a 
disparate range of mild or moderate severity illnesses (see Table 3.11). Given 
this disparity, and the small number of subjects reporting any symptoms (n=8 
recruited from anatoxin-present water), it is difficult to interpret this statistically 
significant increase in symptom reporting compared with the remaining Florida 
subjects.  
 
Higher proportions of study subjects exposed to microcystins or 
cylindrospermopsin in study waters also reported symptom occurrence 
compared with subjects exposed to waters where these cyanotoxins were not 
measured (Table 3.10). However, as with anatoxin-a, the relatively small 
number of exposed individuals, predominance of mild symptoms and low 
concentrations of these toxins in recreational study waters are factors that 
caution against over-interpreting the public health significance of these 
findings.  
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The infrequent presence and low concentrations of cyanotoxins in study 
waters highlights one of the disadvantages in conducting a prospective cohort 
study, that cyanobacteria and especially cyanotoxin levels are often dynamic 
and therefore unpredictable. The unpredictability of cyanobacteria counts, and 
especially cyanobacterial biomass densities can also be seen in the skewed 
allocation of study subjects into exposure categories (see Figure 3.2). This 
work represents something of a mirror image to the work of Pilotto et al 
(1997), whose statistically significant results were based on an unbalanced 
proportion of exposed (n=295) to unexposed (n=43) subjects. This study 
ended up with many more low exposure subjects than those exposed to 
intermediate or high cyanobacteria, at least by the cell surface area measure 
recommended as a result of this work.  
 
Conducting retrospective epidemiological studies would to a large extent 
overcome the problem of determining significant exposures to cyanobacteria, 
but then a new set of problems come into play, such as recall bias and 
difficulties in identifying and locating suitable study subjects. The comparative 
advantages and disadvantages of common study designs were discussed in 
Chapter 1, Section 1.4.3.1, and some of the matters relating to predictability 
and unpredictability of cyanobacteria densities, and the relevant planning for 
this study are outlined in Appendix 2.  
 
 
3.5.6. Analyses done on sub-sets of the cohort 
 
3.5.6.1. Faecal coliforms and chlorophyll-a 
 
One of the design challenges with this project relates to the matter of 
recruiting study subjects on weekends and public holidays. Recruitment was 
geared towards weekends, as these are peak use times on recreational 
waters. However, holding times for analysis of faecal coliforms in Australia are 
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a maximum of 24 hours after collection, as were chlorophyll-a samples in 
Florida. Therefore, to have these analyses done for each study day would 
require calling in a microbiologist (for faecals) and lab technician (chlorophylls) 
for weekend work, involving costs that were prohibitive for this work. Therefore 
these analyses excluded those recruited on Fridays or Saturdays. No 
dependent relationship between gastro-intestinal or “any” symptom reporting 
and faecal coliforms counts greater than 150CFUs/100mL was seen (Table 
3.6) in this sub-set.  
 
The decision to measure chlorophyll-a in Florida only was taken on the basis 
that the PAM device, which we started using to collect chlorophyll data from 
December 2000, was not available for use in Florida. We thought that 
chlorophyll data from routine acetone extraction might be a useful supplement. 
In hindsight, combined data from these two separate methodologies were 
probably less reliable than the data acquired by the routine methods to identify 
and count cyanobacteria, for the following reasons: 
• PAM readings were opportunistic measures of cyanobacterial and total 
 chlorophyll, gathered because the device became available after the 
 commencement of this work. However, this is a research tool, and much 
 work remains to validate the performance of the instrument.  
• We did not appreciate the requirement for 24-hour maximum holding times 
 in Florida for chlorophyll samples before starting this work there, resulting 
 in significant data gaps. 
• Combining data gathered by different techniques is inherently risky. 
 
Again, with hindsight, better decision-making would have led us to either 
investigating the requirements for holding times more rigorously, with the 
possible incorporation of chlorophyll-a by acetone extraction from the 
beginning of the study, or alternatively abandoning this alternate measure of 
standing crop and spending the Florida chlorophyll dollars elsewhere.  
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3.5.6.2. Subjects with a prior history of urticaria 
 
This question was added to the questionnaire from May 2000, after further 
reading on the topic of immediate hypersensitivity reactions. In the event, only 
21 (2%) of 1076 subjects reported a prior history of urticaria, so this analysis 
did not proceed beyond univariate crosstabs tests (Table 3.8). 
 
 
3.5.6.3. Subjects reporting prior and prior or subsequent site exposure 
 
These sub-sets were analysed in response to the work of Pilotto et al (1997), 
who suggested that exposure to cyanobacteria could be confounded by either 
the presence of symptoms or exposure to recreational water in the five days 
prior to recruitment. The approach taken in this study differed in that all 
analyses reported in this chapter were done after excluding those subjects 
that reported previously existing symptoms. Further univariate tests were done 
after excluding those that reported prior exposure to the study lake, and 
further excluding those that reported exposures during the follow-up period. 
No significant findings were seen (Table 3.7).  
 
 
3.5.7. Statistical modelling 
 
3.5.7.1. Univariate tests 
 
Preliminary univariate tests (χ2 and exact tests) did not reveal any significant 
relationships between symptom reporting and cyanobacterial surface area 
exposures (Table 3.6). These preliminary results have been published in the 
Proceedings of the Xth Harmful Algal Blooms Conference (Stewart et al, 
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2004). However, other explanatory variables identified through this “statistical 
screen”, e.g. age, proved to be important co-variates in subsequent 
multivariate analyses. From Table 3.5, we see that the highest proportion of 
symptom reporting across all symptom groups except ”fever” was in the 13-24 
year age group. One observation from Tables 3.5 to 3.8 is that “respiratory” 
symptoms show more significant relationships with explanatory variables than 
is the case for any of the other individual symptom groups, although this may 
be completely or partly explained by the fact that more individual symptoms 
fell into the respiratory symptom category than was the case for any other 
symptom group (see Table 3.2).  
 
The variable “region” was included as a design variable in all subsequent 
crude regression and multivariate regression models, as there were significant 
differences between symptom reporting across the three regions (Florida odds 
ratio: 0.49, p 0.002; NSW 0.74, p 0.08 when compared to Queensland). 
 
A higher proportion of subjects enrolled in Queensland reported symptoms in 
the “respiratory” and “any” symptom categories (see Table 3.5). 
 
 
3.5.7.2. Logistic regression 
 
Results of the logistic regression models show that subjects exposed to high 
levels of cyanobacteria, as measured by total cyanobacteria cell surface area, 
were significantly more likely to report any symptoms than those exposed to 
low levels of cyanobacteria, after adjusting for region, age, smoking and a 
prior history of asthma, hay fever or eczema (odds ratio 1.68, p 0.05, 95% 
confidence interval 1.00-2.83; Table 3.13). In the individual symptom 
categories, respiratory symptoms were also significantly more likely to be 
reported by subjects exposed to high cyanobacterial surface areas compared 
to those exposed to low surface areas (O.R. 2.08; p 0.03, 95% CI 1.09-3.98). 
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The measured effect size was similar but non-significant for reporting of ear 
and cutaneous symptoms, fever and all symptoms after exclusion of subjects 
with prior site exposure, which suggests that the sample sizes were too small 
to show significant differences between symptom rates at different levels of 
exposure within these categories. No relationship can be detected between 
symptom reporting and exposure to intermediate levels of cyanobacteria (total 
surface area 2.4-12.0 mm2/mL).  
 
From both the crosstabulations and multivariate analyses, the symptom 
category that appears to be weighting the pooled “any symptom” category the 
most is that of respiratory symptoms, which itself shows a statistically 
significant increase in symptom reporting at high cyanobacterial exposures. 
However, from Table 3.12 we see that respiratory symptom reporting is 
skewed towards “mild” symptom rating. Therefore, the conclusion that 
symptom reporting is higher in individuals exposed to high cyanobacteria 
levels compared to those exposed to low cyanobacteria levels must be 
tempered by the observation that mild respiratory symptoms appear to be the 
dominant influence on overall symptom reporting. 
 
While cohort studies often estimate the risk of disease by use of relative risk 
(i.e. the ratio of the risk of disease in exposed subjects to the risk in 
unexposed subjects), this work reports in odds ratios (O.R.) – the ratio of the 
odds of disease development in exposed subjects to the odds of disease 
development in unexposed subjects. Either measure is appropriate in a cohort 
study (Gordis, 2004 pp179-83), and O.R. in this work allows direct comparison 
with the study by Pilotto et al (1997). O.R. is a valid measure of association 
but cannot be interpreted as a relative risk if the outcome is common. 
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3.5.7.3. Sample size, dose-response relationships 
 
Logistic regression analyses presented in Table 3.13 show that the cohort size 
was large enough to detect increased odds of symptom reporting in the “any 
symptom” and respiratory symptom categories amongst subjects exposed to 
high compared to low cyanobacteria exposure. Although non-significant, 
similar effect sizes in the increased symptom reporting by those exposed to 
high cyanobacteria levels was also seen in ear symptom, skin symptom and 
fever groups, as well as for symptom reporting after exclusion of subjects with 
recent prior exposure to study waters. This suggests that the sample sizes 
were too small to show significant differences between symptom rates at 
different levels of exposure within these categories, i.e. a series of Type II 
errors may have occurred. It seems plausible to suggest that larger sample 
sizes may have allowed us to confidently detect increased acute illness 
reporting from these symptom sub-groups. However, as this study essentially 
found only minor morbidity, the cost and effort required to conduct larger 
studies than this one would appear to outweigh the benefits. 
Recommendations for future epidemiological investigations into recreational 
exposure to cyanobacteria are discussed in Section 5.3.8. 
 
Dose-response relationships were not seen; with the exception of a non-
significant O.R. for febrile illness there was no increased reporting of 
symptoms at intermediate exposure but an increase at high exposure. One 
explanation for this may be a threshold effect, i.e. a minimum level of 
exposure is needed in order to see an effect.  
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3.5.7.4. Kappa scores 
 
3.5.7.4.1. Validation of time exposed to the water 
 
This measurement was done in an attempt to validate the “water exposure 
time” question in the questionnaire. Dr Adrian Sleigh, at the time in the 
Department of Social and Preventive Medicine, School of Medicine, University 
of Queensland, suggested in a meeting after the commencement of this 
project that we should examine this matter. The suggestion was to observe a 
sample of study subjects to see to what degree the time they actually spent in 
the water was reflected in the answers they gave to that question in the 
questionnaire. This was considered impractical for several reasons, and would 
have required major changes to the study design and budget in terms of the 
identification of subjects, hiring of observers and the attendant ethical 
challenges in monitoring scantily clad subjects – presumably through 
binoculars – for potentially lengthy periods of time. However, the importance 
of the validation matter was noted. Our compromise solution was to ask the 
exposure time question again during the follow-up interview. The kappa score 
of 0.57 for the crosstabulations of questionnaire and follow-up answers to this 
question represents moderate agreement (Landis & Koch, 1977), with 66% of 
subjects giving identical answers at both instances. A small proportion of 
subjects qualified their response to this question during the follow-up 
interview; these responses revealed a weakness in the study design. Some 
subjects were expressly aware that the answer they gave to the “time spent in 
the water” at follow-up differed to the answer they marked in the 
questionnaire. They stated that they filled in the questionnaire before they had 
completed their day’s water-related activity, thus spending more time in the 
water than they had originally estimated. The possibility that study subjects 
might give unreliable estimates of water exposure time if they filled in the 
questionnaire before completing their recreational activity was anticipated at 
the study design stage. Attention was drawn to this matter in the verbal 
instructions given to individuals who accepted a questionnaire; potential study 
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recruits were asked to complete most of the questionnaire at any time during 
the day, but to answer Question 13 shortly before exiting the site. This 
problem of reliably determining exposure time is probably inherent in this kind 
of observational study; Pilotto et al (1997), who conducted their prospective 
cohort study using face-to-face interviews presumably were able to determine 
exposure time only during the follow-up interview. While cohort studies are 
ideal for observing natural behaviours and exposures, the only way to 
significantly improve on the reliability of measuring water exposure time would 
be to conduct a randomised experimental design. Such a study would involve 
observers monitoring exposures for a fixed, presumably short, time period, 
and therefore would introduce a degree of artificiality into the process, along 
with the other significant ethical and cost constraints, as discussed in Chapter 
1, Section 1.4.7. 
 
We were not able to determine any statistically significant relationship 
between symptom reporting and exposure time, either by considering only 
exposure time, or the interaction term between exposure time and 
cyanobacteria (see Table 3.7, also section 3.3.11.). However, this matter may 
need to be considered further in future studies. When considering the kind of 
activities that may be associated with higher and more prolonged exposure to 
cyanobacteria and cyanotoxins, two extremes may serve to illustrate this 
topic. With advance apologies for stereotyping age-related behaviours, we 
may see in a significantly cyanobacteria-affected waterbody, a 65-year old 
engaging in a 10-minute, leisurely swim, breaststroke-style (i.e. keeping his 
head above the water at all times), in a calm, sheltered inlet. In the same lake, 
we may see a 15-year old ski enthusiast spending around six hours being 
towed over a mosaic cyanobacteria profile, with significant aerosolised 
exposure generated by the boat and significant full-body immersion, at speed, 
which presumably also may force water into contact with her nasal, oral and 
ocular mucous membranes. It would be logical therefore to assume that the 
exposure to cyanobacteria, and water-soluble cyanotoxins, might be 
significantly greater in the teenager. Within these two idealised extremes of 
recreational activity, ostensibly similar activities may also result in markedly 
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different exposures to cyanobacteria. Personal watercraft, a.k.a. jet skis, are 
niche marketed to retirement-age demographics (more so on US than 
Australian television in 2002), as well as the more familiar demographic of 
cashed-up young professionals. So jet-ski users could be seen in Florida 
engaging in a spectrum of behaviours, from aggressive, high-speed, spray 
generating loops, through to remarkably sedate, straight-line motoring by 
riders who appeared to be able to stay dry throughout. These matters highlight 
further the difficulty in getting a reliable understanding and measure of 
exposure in this field of environmental epidemiology. 
 
One study subject recruited in Florida, at Lake Seminole, made an intriguing 
comment that suggests prolonged, vigorous activity may be implicated in 
higher cyanobacterial exposures. After completing the follow-up interview, this 
subject remarked that he and his wife had noticed that their two children were 
“getting sick after spending all day tow-tubing in the lake” on “more than one 
occasion”. Quizzed about the nature of these illnesses, he described a flu-like 
condition affecting both children, with fever, malaise and myalgia that resolved 
spontaneously over about 24 hours following exposure to the lake. Lake 
Seminole is a chronically cyanobacteria-affected waterbody, with toxin-
producing species present. While such anecdotal reports must be treated with 
the usual caution in the absence of further confirmatory evidence, they hint 
towards exposure time and activity as being worthy of consideration by 
primary health care providers when presented with acute non-specific illness 
following recreational activities in suspect waterbodies.   
 
 
3.5.7.4.2. Cyanobacteria exposure measures 
 
Tables 3.11 and 3.12 show the generally poor agreement between the 
traditional method of estimating cyanobacterial density by counting the 
number of cells in a given volume of water, and alternative methods 
(biovolume or surface area) that encompass biomass estimates. Table 3.15 
 164
Chapter 3: Recreational exposure to cyanobacteria – an international prospective cohort study 
shows that 25% of samples that represented high exposure expressed in 
cells/mL, using the guideline alert level of 100,000 cells/mL (Queensland 
Department of Natural Resources and Mines, 2004), were reclassified as 
intermediate (n=9) or low (n=3) exposures when cell surface area 
measurements were used. All 11 samples representing intermediate exposure 
(20,000-100,000 cells/mL) were reclassified as low exposures by the same 
method. Figure 3.2 shows how study subjects were allocated to exposure 
categories within the cohort according to the three cyanobacterial cell 
measuring techniques.  
 
McNemar’s test is the 2x2 approximation of Bowker’s test of symmetry for 
parallel measures from matched cases (Bowker, 1948). The low probabilities 
for the cells/mL counts against biomass estimates of surface area and 
biovolume (Table 3.14) demonstrate asymmetric distributions. 
 
Some recreational water management authorities in Australia, e.g. 
Queensland Department of Natural Resources and Mines, have moved from 
reporting cyanobacterial cell counts to a biomass estimate using biovolume. 
The NSW Department of Infrastructure, Planning and Natural Resources uses 
a combination of biovolume and cells/mL. Other authorities are still using cell 
counts to direct management decisions and cyanobacteria hazard alert 
reporting. Table 3.14 shows that both biovolume and surface area 
measurements show strong agreement in allocating water samples into three 
exposure categories. However, as discussed in Section 3.5.4., surface area 
measurements may be a better measure of exposure to picoplankton than 
biovolume measures. A recommendation from this work is that a biomass 
exposure measure, either cell biovolume or surface area, would be an 
improved measure of exposure to cyanobacteria than cells/mL. The cell 
dimensions that need to be made by the microscopist are identical for both 
surface area and biovolume, and the extra time needed to measure cell 
dimensions may be offset by gains in estimating the biomass of filamentous 
cyanobacteria. In this case, individual cells within trichomes would not need to 
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be counted, as the dimensions of a representative number of trichomes would 
suffice. Determining the cell divisions within trichomes of many, though not all 
filamentous cyanobacteria such as Cylindrospermopsis raciborskii requires 
skill and experience. While microscopists with specific expertise in 
cyanobacteria are and will likely remain important assets, it may well be 
possible for them to determine cyanobacterial biomass without generating 
significant extra labour costs. However, this is not simple and straightforward, 
and some matters may conspire against minimising extra labour costs: 
 
• There may be significantly greater variation between trichome lengths of a 
 particular filamentous cyanobacterium in some samples than the variability 
 in cell dimensions. Informed decisions would need to be made as to the 
 relative benefit of measuring a representative proportion of trichomes 
 against that of counting individual cells and deriving biomass estimates 
 from cell dimensions (as done in this study). 
• Some trichomes will be difficult to measure because of their conformation; 
 the presence of many sigmoid or coiled trichomes may again make it more 
 efficient to count and measure individual cells. 
 
 
3.5.8. Guidelines for recreational exposure to cyanobacteria 
 
Guidelines for monitoring and management of cyanobacteria in recreational 
waters have been published by a number of different authorities. The NSW 
Blue-Green Algae Task Force recommended an alert level of 15,000 cells/mL 
of potentially toxic blue-green algae (NSW Blue-Green Algae Task Force, 
1992 p99). World Health Organization guidelines discuss a three-tier 
approach (low, moderate and high probability of adverse health effects), using 
guidance levels of 20,000 cells/mL and 100,000 cells/mL, or corresponding 
estimates of chlorophyll-a (WHO, 2003 pp149-54). It is a daunting task to 
devise simple management strategies to deal with a problem as complex and 
unpredictable as that of cyanobacteria and associated health risks in 
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recreational waters. Common-sense measures such as advising against 
contact with dried or surface scums have been recommended (Yoo et al, 
1995; WHO, 2003 pp151-4); such advisories remain prudent today and for the 
foreseeable future.  
 
This work was a study of exposures to non-toxic and potentially toxic 
cyanobacteria in recreational waters, but with essentially little or no exposure 
to known cyanotoxins. Recommendations arising from this work cannot be 
applied to situations where cyanobacterial exotoxins are found to be in 
possibly hazardous concentrations. Guidelines and management interventions 
that treat high levels of cyanobacterial species and genera that are known 
toxin producers as potentially hazardous on that basis alone may 
overestimate the public health risks. A more rigorous assessment of the risks 
will come with regularly updated knowledge of the actual cyanotoxin content in 
recreational waters. At present, this knowledge is only obtained from testing of 
water samples in specialist cyanotoxin laboratories, which is expensive and 
with a lag period measured in days. Research strategies directed at an 
inexpensive in-situ test for cyanotoxins would be appropriate; a suggested 
approach is discussed below in section 3.5.9.  
 
Management strategies that address the potential, not actual, presence of 
hazardous levels of cyanotoxins run the risk of propagating “warning fatigue”, 
where frequent or permanent advisories are ignored by a significant proportion 
of the public. This topic is discussed further in Appendix 2, and the complex 
matters of risk communication, public information and education are 
thoroughly canvassed from the cyanobacteria management perspective by 
Yoo et al (1995). 
 
Arising from this study are recommendations for revising exposure guidelines, 
discussed in the following section (3.5.9). 
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3.5.9. Recommendations 
 
The public health concerns about recreational exposure to cyanobacteria are 
well understood by cyanobacteriologists, who are aware of the potential for 
harm from exposure to toxic blooms. Recreational water managers are also 
following this matter with interest, with duty of care concerns uppermost in 
their thoughts. The main problem with conducting further epidemiology at 
present lies with the uncertainties in determining exposure to cyanobacteria, 
and the attendant risk of misclassification. It is the opinion of this author that 
the epidemiology of recreational exposure to known cyanotoxins, rather than 
the epidemiology of recreational exposure to cyanobacteria per se would be 
the most appropriate use of resources. This would probably take the form of 
case-control studies in areas where cases could be identified (i.e. suitably 
distant from major cities). A retrospective cohort study may be appropriate if 
analytical turn-around times are sufficiently rapid to allow for the interview of 
campers at cyanotoxin-affected sites. School-based surveillance would also 
be appropriate in regions or towns – not cities – affected by future toxic 
blooms. Despite the somewhat lowly status of case reporting in the 
epidemiologic hierarchy, there may be helpful information to be gained from a 
more thorough questioning of suspect cases, especially with respect to 
reporting any history of allergy or atopy.  
 
The concept of preepidemiology may be worth considering, and may yield 
some insight into the risks associated with recreational exposures to 
cyanobacteria. These assessments may take the form of “disease-cluster” 
analyses (Wartenberg, 1999). A premise of this thesis is that the morbidity and 
mortality of some cyanobacterial intoxications can be largely understood in 
terms of innate – i.e. non-clonal – immune responses. This also applies to the 
flu-like, self-limiting illnesses reported in the case and anecdotal literature. 
These non-specific signs and symptoms, characteristic of innate immune 
responses, can be explored and understood in terms of genetic 
polymorphisms, looking at relative deficiencies in pro or anti-inflammatory 
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cytokines and signalling molecules. The problem of determining exposure to 
cyanobacteria may be better dealt with in the future when biomarkers of 
exposure, susceptibility and effect are recognised. Research into cytokine 
polymorphisms might yield insights into the variability of human responses to 
some cyanotoxins. Cytokine polymorphisms could serve as biomarkers of 
susceptibility, defined as “an indicator of an inherent or acquired limitation of 
an individual’s ability to respond to the challenge of exposure to an 
environmental hazard” (Committee on Environmental Justice, 1999 p31). 
Stress-inducible proteins such as the cytochrome P450 enzymes, while good 
indicators of exposure to a variety of environmental toxicants, are poor 
biomarkers of outcome. Some of the heat shock proteins hold more promise 
as biological indicators of effect (Ryan & Hightower, 1999). 
 
Perhaps an integrated and co-ordinated approach may yield insights into 
primary mechanisms of cyanobacteria-related human toxicity. After all, 
recreational and occupational contact with cyanobacterial toxins can impose 
much higher acute exposures than are likely to be seen with treated drinking 
water exposures. That severe human intoxications are infrequent events also 
seems to be the case. Salient questions relate to the genetic differences 
between those who can be reasonably be suspected of having suffered 
severe reactions to cyanotoxins, those who suffer mild, self-limiting reactions, 
and those who are essentially asymptomatic. To get a better understanding of 
this could perhaps centre on establishing regional, multi-regional or maybe 
even international hubs to harness the following expertise: 
 
• Primary health care practitioners who would be aware of the signs and 
 symptoms associated with recreational exposure to cyanobacteria, and 
 would be more likely to enquire about a history of recent exposures to 
 nearby cyanotoxin-affected waters. They would also collect serum and 
 other tissue samples for future genetic analysis.  
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• Lake monitoring programs to report the presence of cyanobacteria blooms 
 in local waterways and manage the collection and transport of samples for 
 cyanotoxin analysis 
• Expert immunotoxicology and immunogenetics collaboration 
• Expert cyanotoxin analysis laboratories 
• Co-ordination of reporting  between various intra and inter-hub disciplines 
 
Because of the sporadic and essentially unpredictable presence of 
cyanotoxins in specific recreational waters, these hubs may spend 
considerable periods of time in abeyance, but with appropriate co-ordinating 
oversight and lines of reporting, they could be brought to life as opportunities 
present. As noted previously, the index waterbodies for these hubs would be 
those situated in regional areas, perhaps with significant tourist influx, but far 
enough away from major cities to allow for affected cases to be more likely to 
present for medical consultation within a defined network of providers who are 
involved in the hub.  
 
Preepidemiologic case reporting can be a very valuable guide to refining 
future epidemiologic designs (Wartenberg, 1999). Molecular epidemiology 
studies into cyanobacterial toxin exposure, both high-dose acute exposures 
and low-dose chronic exposures from drinking water contamination, may be 
better directed towards appropriate outcome measures by a comprehensive, 
prospectively planned case series of acute exposures.  
 
A major premise arising from this work is that public health research priorities 
should be directed more towards the epidemiology of recreational exposure to 
cyanotoxins, where the potential exists for serious morbidity and mortality. 
Indeed, this potential has apparently been realised with the recently reported 
death of a teenager in the United States (Behm, 2003; Campbell & Sargent, 
2004). Recreational water managers who might anticipate an added cost 
burden for routine monitoring of cyanotoxins may view this recommendation 
with dismay. Some authorities have well-established and appropriate 
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algorithms to trigger cyanotoxin monitoring. But to allow more authorities to 
participate in screening their resources for cyanotoxins, an appropriate 
avenue for research will be the development of cheap, reliable in-situ methods 
for detection of common cyanotoxins. A quantitative or at least semi-
quantitative reagent dipstick method, similar to the multi-parameter test sticks 
used in hospitals for routine urine analysis, would be a great resource for 
recreational water authorities. An intermediate step in this direction is seen in 
the gene-based work of Fergusson and Saint (2003), who describe a rapid 
and cost-effective assay to determine the presence of cylindrospermopsin-
producing cyanobacteria. While a negative result from a water sample would 
be reassuring, a positive result would yield no information about the presence 
of this particular toxin. Antibody-based methods may be a rewarding research 
venture for a dipstick test for cyanotoxins. 
 
This study has shown increased reporting of symptoms amongst those 
exposed to recreational waters where total cyanobacterial cell surface areas 
exceeded 12mm2/mL, with mild respiratory symptoms predominating. No 
relationship between symptom reporting and lower levels of cyanobacteria 
was seen. Therefore the following general recommendations to refine 
guidelines for recreational exposure are suggested, and may be specifically 
adapted to account for local conditions and budgets: 
 
1. Guidelines should state that all cyanobacteria blooms should be 
 approached with caution, and surface scums or dried bloom material are 
 potentially hazardous. 
2. Routine monitoring of recreational waters for cyanobacteria should 
incorporate biomass estimates. A single alert level of 12mm2/mL cell 
surface area, or 12.5mm3/L cell biovolume, or 50µg/L chlorophyll-a (if 
cyanobacteria are dominant) should guide further management decisions. 
3. Appropriate algorithm keys to guide monitoring of specific cyanotoxins 
 should operate. 
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4. Advisories should warn against ingesting cyanobacteria-affected water, 
 and discuss specific groups and behaviours for which ingestion of water 
 may be more likely, e.g. toddlers, alcohol or drug-affected individuals, and 
 group play involving forced immersion. 
5. Directions to comprehensive, regularly updated information about the 
 public health risks of cyanobacteria should accompany advisories. Such 
 information should discuss, in jargon-free language, gaps in expert 
 knowledge of the subject, and describe potential risks vs known 
 outcomes. 
 
 
3.5.10. SUMMARY AND CONCLUSIONS 
 
This prospective cohort study of 1,331 individuals has shown that subjects 
exposed to high levels of cyanobacteria in recreational waters, as measured 
by total cell surface area, were more likely to report symptoms following such 
exposure than subjects exposed to low levels of cyanobacteria. This finding 
was revealed by logistic regression analysis after adjusting for region, age, 
smoking and reported prior history of asthma, hay fever and eczema. 
Respiratory symptoms were most evident, and the reported severity of 
symptoms across all groups was low.  
 
Presumed strengths of this work compared with previously published 
epidemiological studies of recreational exposure to cyanobacteria are: 
 
• A prospective cohort design, with a larger overall cohort size. 
• Direct measurement and quantification of cyanotoxins in study waters, 
 rather than indirect estimates of cyanotoxin activity. 
• Recruitment of unexposed subjects engaging in water-based recreational 
 activities. 
• Reporting of the degree of severity of symptoms. 
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Because this and other studies of recreational exposure to cyanobacteria  
were essentially investigations involving outcomes of relatively low morbidity, 
recommended research priorities in this field should be directed towards the 
epidemiology of cyanotoxins in recreational waters. There is still much to be 
learned from eliciting a comprehensive history of exposure and outcome from 
suspicious cases presenting for medical attention, and subsequent publication 
of cases or case series. Opportunistic collection and storage of serum for 
future molecular epidemiology studies may also be apposite tasks. 
 
In the absence of suitable biomarkers of exposure at present, it may be 
appropriate to consider biomass estimates of cyanobacteria in recreational 
waters. This can be accomplished with a simple spreadsheet or database 
algorithm. Extra labour costs would need to be assessed; some costs may be 
offset if traded against measurement of individual cells within trichomes in 
some instances.  
 
Research and development aimed at a simple, real-time, cost-effective in-situ 
test for common cyanotoxins in water would be appropriate. The market for 
such a test would conceivably extend beyond recreational water management 
authorities to encompass drinking-water suppliers and haemodialysis clinics. 
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CHAPTER 4: HUMAN VOLUNTEER DIAGNOSTIC STUDY OF 
CUTANEOUS EFFECTS OF CYANOBACTERIA 
 
4.1. INTRODUCTION, HYPOTHESES AND RESEARCH STRATEGY 
 
4.1.1. Introduction 
 
Case and anecdotal reports of cyanobacteria-associated skin reactions are 
listed in Chapter 1, Table 1.1. While there are relatively few references in the 
scientific and medical literature since these reports began in 1949, under-
diagnosis of cyanobacteria-associated illness was suggested by Schwimmer 
& Schwimmer in 1968, a suspicion that possibly remains true today. Most 
reports of cyanobacteria-associated skin eruptions describe recreational or 
occasional occupational exposure; however there are anecdotal reports of 
skin rashes related to water treatment failures and subsequent presence of 
cyanobacterial products in reticulated supplies. In these instances, skin rashes 
were reported after showering or bathing (Williamson & Corbett, 1993; 
Falconer, 1998). “Several” people experienced acute dermatitis, as well as 
gastrointestinal symptoms, after drinking water from a riverine source affected 
by a cyanobacteria bloom in Portugal (Oliveira, 1991). 
 
Skin patch testing of cyanobacteria extracts was first reported in the USA in 
1953 to investigate a water contact-related seasonal dermatitis in a girl aged 
six years. Various extracts of an Anabaena sp dominant bloom sample were 
investigated, and identical patches were tested on the skin of 25 healthy 
subjects. Strong positive reactions were observed on the child, and none of 
the control subjects reacted to any Anabaena extracts. Over half the controls 
had mild to moderate reactions to hydroxylamine, which the authors describe 
as a decomposition product of cyanobacteria; the test subject reacted strongly 
to the hydroxylamine solution (Cohen & Reif, 1953).  
 
Pilotto et al (2004) conducted a Finn chamber study of six toxic and non-toxic 
laboratory isolates of various cyanobacteria. Three cyanobacteria isolates 
were tested on 64 volunteers and the other three isolates were tested on 50 
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volunteers. Each isolate was examined at six concentrations, with cells/mL 
being the cell density measurement. Whole and lysed cells were tested on 
each subject; patches were removed and read at 24 hours by a dermatologist. 
A five-level clinical grading scheme was used, from “0” (no reaction), then “+” 
(minimal or very weak erythema) through to “++++” (severe diffuse erythema 
with oedema). However, a “relatively small number of high-level gradings” was 
seen, so statistical analyses were conducted with all positive reactions 
collapsed into a single “positive” variable. Two negative control patches were 
used: an empty chamber, and a patch containing cyanobacterial culture 
medium. A series of logistic regression analyses were conducted to compare 
the rates of skin reactions under test patches compared to negative control 
sites, and to determine whether any dose-response relationships were 
evident. The authors report that 20-24% of subjects reacted to cyanobacterial 
test patches, though 23% of subjects responded to negative control patches. 
After excluding subjects who responded to negative control sites, 11-15% of 
subjects responded to cyanobacteria. No dose-response relationships were 
seen. Further discussion of the work of Pilotto et al (2004) follows in Section 
4.4.9.  
 
Intracutaneous testing of cyanobacteria to investigate cases of respiratory 
allergy has a long history, with convincing and sometimes dramatic 
immediate-type reactions seen on the skin of susceptible individuals, and 
negative responses from (presumably) healthy individuals (Heise, 1949; 
Heise, 1951).  
 
Dermatological testing of toxic cyanobacteria using animal models is limited to 
two previously published works (van Hoof et al, 1994; Torokne et al, 2001), 
which are difficult to interpret (see Chapter 5, Section 5.4.4.1), and the mouse 
model of delayed-contact hypersensitivity presented in chapter 5 of this thesis. 
Inferring human risks from the findings of animal models is limited by varying 
degrees of artificiality, including use of a vehicle, disruption of barrier function, 
and the use of adjuvants (discussed in Chapter 5, Section 5.4.2). Some 
differences are seen at the molecular level, e.g. the anti-inflammatory cytokine 
IL-10 appears to be regulated differently in humans and mice (Gröne, 2002). 
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However, animal models of cutaneous toxicity are important and useful 
sentinel predictors of dermal irritancy and hypersensitivity; indeed, long-
established animal models are required regulatory tests for the assessment of 
chemical irritancy and delayed-contact hypersensitivity (DCH) (Botham et al, 
1991).  
 
In order to complement the mouse models of irritancy and DCH conducted by 
IS, we sought to conduct diagnostic studies of the effect of cyanobacterial 
extracts in human volunteers. Preliminary work using a mouse model of 
irritancy was conducted, with negative results, prior to establishing 
collaborative links to conduct this human volunteer study (see Chapter 5, 
Section 5.4.1.1. for discussion of mouse irritancy work).  
 
 
4.1.2. Hypotheses 
 
Cutaneous reactions to cyanobacteria are infrequently reported in the 
literature, and there are some convincing descriptions of hypersensitivity 
reactions (Heise, 1949; Cohen & Reif, 1953). We therefore sought to narrow 
the search for positive cutaneous reactions to cyanobacteria by recruiting 
subjects with a history of inflammatory skin reactions. The working hypothesis 
was that application of cyanobacterial extracts to the skin would result in a 
higher rate of cutaneous reactions in individuals with a known or suspected 
history of cutaneous sensitivity sufficient to warrant specialist dermatological 
investigation, as compared to a convenience sample of non-patients. 
 
 
4.1.3. Aims and Research Strategy 
 
A research team was established to conduct a diagnostic study of irritant and 
delayed-contact hypersensitivity reactions using a closed skin-patch method. 
The team comprised Dr Ivan Robertson, Director, Department of Dermatology, 
Royal Brisbane Hospital; Dr Glen Shaw, NRCET; Prof. Philip Schluter, 
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formerly at the School of Population Health, University of Queensland; and IS 
as principal investigator and study coordinator. 
 
Skin patch testing is a routine diagnostic procedure in dermatology clinics 
worldwide, and is described and discussed in guidelines and dermatology 
textbooks (e.g. Marzulli & Maibach, 1996 pp478-83; Wilkinson & Shaw, 1998 
pp802-12; ECETOC, 2000 p38; Rietschel & Fowler, 2001 pp9-26; Hunter et 
al, 2002 pp35-6; Habif, 2004 pp98-103). The purpose of these studies was to 
assess the propensity for a range of cyanobacterial extracts to induce 
cutaneous irritant and hypersensitivity reactions in human volunteers. We 
wished to determine whether threshold doses that induce reactions in non-
patients, if indeed such reactions occur in this group, are lower in individuals 
with an active history of cutaneous symptoms. Irritant and hypersensitivity 
reactions would be determined both qualitatively and quantitatively, and the 
cyanobacteria would be characterised in terms of species (or genera if 
speciation were not possible), doses to be applied to the skin, and the 
presence or absence of known toxins.  
 
We sought to conduct a pilot study to determine the frequency of cutaneous 
reactions to cyanobacteria extracts in a group of hospital outpatients 
presenting for routine diagnostic skin-patch testing when compared to a group 
of non-patients. We aimed to match participants in the two groups by age and 
sex. A study of 20 hospital outpatients and 20 healthy volunteers was 
planned. 
 
 
4.2. MATERIALS AND METHODS 
 
4.2.1. Finn chambers 
 
The skin patch testing procedure uses a series of shallow aluminium 
chambers, 8mm internal diameter, 0.5mm depth, into which test materials are 
placed, either impregnated onto discs of filter paper or mixed in petrolatum 
(Pirilä, 1975). The aluminium chambers, called Finn chambers, are purchased 
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in strips with double rows of five chambers fixed to an adhesive tape. Test 
material is placed in each chamber, and the Finn chamber strips are placed 
on the skin, with extra adhesive tape reinforcement. 
 
              
Image 4.1. Finn chamber test strips. Ruler shows millimetre scale.  
 
4.2.2. Study participants 
 
A consecutive series of adults aged 18 to 65 years presenting for diagnostic 
skin patch testing at the Royal Brisbane Hospital’s dermatology outpatient 
clinic was invited to participate in the study.  
 
A convenience sample of volunteers was recruited for the control group. 
Advertisements were placed on noticeboards at three Brisbane locations: 
 
1. Queensland Health Scientific Services and National Research Centre for 
 Environmental Toxicology complex  
2. Herston Medical School, University of Queensland 
3. Herston public health building, University of Queensland 
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Permission to place these notices was sought and granted by administrative 
authorities at each facility. A total of 20 volunteers were recruited from these 
sites, and by word of mouth.  
 
All study participants were offered an information sheet and consent form. 
Study subjects were also asked to complete a simple questionnaire. The 
questionnaire requested basic demographic details (age, sex), history of 
allergic illness (asthma, hay fever, eczema, urticaria), relevant medications 
and a description of any freshwater-related dermatoses. These documents 
(information sheet / consent form; questionnaire) are provided in Appendix 4.  
 
Study subjects visited the outpatient department initially on a Monday, the 
clinic nurse prepared the skin of each subject’s back with acetone, and 
patches were applied to the skin. Outpatient subjects had a series of patches 
with test materials pertaining to the suspected diagnosis of their presenting 
dermatological complaint (e.g. Standard European Series containing common 
allergens – nickel sulfate, epoxy resin etc). An additional series of Finn 
chambers with cyanobacterial extracts was applied to the skin below the 
diagnostic patches. Non-outpatient volunteers had only cyanobacterial extract 
patches applied. The patches remained on the skin for approximately 48 
hours; patients were instructed to keep their back dry, i.e. bathe but not 
shower, and to refrain from sport or vigorous activity that might lead to frank 
perspiration, with resultant separation of Finn chamber strips from the skin. 
 
The patches were then removed at the clinic on the following Wednesday. The 
clinic nurse marked the position of each Finn chamber on the skin with a 
permanent marker pen; after allowing adhesive tape-related erythema to 
subside, patch test sites were read by a dermatologist. In order to maintain the 
integrity of patch site pen marks, subjects were instructed not to rub patch site 
skin; they returned to the clinic the next Friday (approximately 96 hours after 
patch application), when a dermatologist again examined patch sites.  
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The following images show the relevant stages of the patch-testing procedure. 
 
           
Image 4.2. Patch test strips applied to a volunteer’s skin.                Image 4.3. Volunteer’s skin after removal of Finn chambers,  
                                                                                                                demonstrating the markings used to identify each patch site. 
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4.2.3. Examination of patch sites: grading, irritant vs hypersensitivity 
reactions 
 
Readings of each patch site were scored for each subject at 48 hours and 96 
hours after application. Scores were allocated according to the following key: 
 
 
Table 4.1. Patch testing interpretation key. 
 
+/– Uncertain reaction: faint macular erythema only 
 
+ Weak (nonvesicular) positive reaction; erythema, infiltration, possibly papules 
 
++ Strong (vesicular) positive reaction; erythema, infiltration, papules, vesicles 
 
+++ Extreme positive reaction; bullous reaction 
 
– Negative reaction 
 
IR Irritant reaction of different types 
  
Adapted from Rietschel & Fowler (2001) p24 (interpretation key of the International 
Contact Dermatitis Research Group). 
 
 
 
Irritant reactions are viewed as false-positive reactions in skin-patch testing for 
sensitising materials (Rietschel & Fowler, 2001 p24). An irritant reaction is 
generally uniform, with a clear border; an allergic response is typically non-
uniform, with an irregular border that may be seen beyond the patch site 
(ECETOC, 2000 p38). 
 
 
4.2.4. Cyanobacterial extracts 
 
4.2.4.1. Species, strains, bloom samples 
 
Eight cyanobacterial extracts and one eukaryotic algal extract were tested, 
each at three concentrations. Sodium dodecyl sulfate was used as a positive 
irritant control. The test materials were: 
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1. Cylindrospermopsis raciborskii non-axenic strain AWT 205 from Australian 
 Water Technologies culture collection; produces cylindrospermopsin. 
 
2. Field sample from North Pine Dam, contains Microcystis aeruginosa, 
 Cylindrospermopsis raciborskii and Aphanizomenon sp, produces 
 microcystins and cylindrospermopsin. 
 
3. Microcystis aeruginosa field sample collected from Lake Coolmunda; non-
 toxic. 
 
4. Microcystis aeruginosa non-axenic strain QH/NR/Ma/03 from Queensland 
 Health Scientific Services culture collection; produces microcystins 
 (predominantly microcystin-LR).  
 
5. Anabaena circinalis field sample collected from Lake Coolmunda; 
 produces saxitoxins. 
 
6. Chlorella vulgaris strain CS-42 from the CSIRO Collection of Living 
 Microalgae (CSIRO, Hobart). 
 
7. Planktothrix sp non-axenic strain QH/NR/Px/01 from Queensland Health 
 Scientific Services culture collection; non-toxic.  
 
8. Sodium dodecyl sulfate (SDS, a.k.a. sodium lauryl sulfate), supplied by 
 Sigma Aldrich P/L. 
 
9. Lipopolysaccharide (LPS) from Microcystis aeruginosa field sample 
 collected from Lake Coolmunda. 
 
10. LPS from Cylindrospermopsis raciborskii non-axenic strain AWT 205 from 
 Australian Water Technologies culture collection. 
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4.2.4.2. Culturing of isolates; preparation of stock extracts 
 
Cyanobacteria and C. vulgaris were used for skin patch testing in three 
aqueous concentrations: 0.25%, 0.05% and 0.005% (w/v lyophilised material 
in Milli-Q® filtered water). 
 
Cyanobacteria isolates were non-axenic laboratory cultures grown by IS in 
sterile inorganic media in an illuminated growth chamber at 280C with a 14:10 
light/dark cycle. Culture vessels were aerated with aquarium pumps and air-
stones connected by PVC tubing; air was delivered through 0.45µm Millipore® 
filters, and all culture vessels and air delivery components distal to the filter 
(tubing, weights and air-stones) were sterilised prior to use by steam 
autoclaving or Sterrad® hydrogen peroxide plasma sterilisation (the latter for 
heat labile plastics – done at Brisbane’s Queen Elizabeth II Jubilee Hospital’s 
Central Sterilising Supply Department).   
 
M. aeruginosa and Planktothrix sp cultures were grown in 20L batch cultures; 
C. raciborskii was produced by a continuous culture method adapted from the 
method of Court et al (1981). M. aeruginosa cells were harvested by placing 
the culture vessel in a darkened cupboard overnight. This caused cells to rise 
to the surface of the vessel where they were aspirated with a syringe and PVC 
tubing. Planktothrix sp is a filamentous cyanobacterium, so was easily 
harvested by plucking it in several continuous sheets from the vessel walls 
and aeration tubing.  C. raciborskii cells were concentrated by centrifugation in 
750mL centrifuge bottles, then decanting and discarding media. Cells were 
double-washed by repeat suspension in de-ionised water followed by 
centrifugation. 250mL of C. vulgaris culture was purchased, which, after 
double washing yielded sufficient cellular material for this work. 
 
Harvested cells were lyophilised, powdered with a domestic coffee grinder and 
stored in the dark at room temperature in air-tight containers. 
  
Stock extracts were prepared by suspending 25mg lyophilised cells in 10mL 
Milli-Q® filtered water to produce 0.25%w/v crude extracts. Cell suspensions 
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were steeped overnight at 40C. Cell integrity was disrupted by subjecting each 
extract to ultrasonic pulsing for 30 seconds, using a Branson Ultrasonics 
Sonifier 450 instrument. 1mL of each 0.25% extract was added to 4mL Milli-
Q® water to produce the 0.05% extract, and 0.5mL of that extract was added 
to 4.5mL water for the 0.005% extract. All extracts were stored at -200C. 
  
Lipopolysaccharide (LPS) solutions were prepared from LPSs isolated and 
purified as described in Chapter 6, Sections 6.2.1.1 to 6.2.1.1.4. LPS 
concentrations were based on the percentage yield from cyanobacterial whole 
cells they were extracted from: 
 
• M. aeruginosa LPS was 0.51% of dry cell weight, so the maximum 
 concentration of LPS for skin patch testing was (5.1x10-3) x 0.25% w/v, i.e. 
 12.8 ppm. Intermediate and low concentrations were prepared by diluting 
 the 12.8ppm concentration as described above for the crude extracts, to 
 give 2.6ppm and 260ppb concentrations. 
• C. raciborskii LPS was 1.25% of dry cell weight, so the three 
 concentrations of this LPS were 31.3ppm, 6.3ppm and 630ppb. 
  
A stock solution of each LPS was prepared by weighing 5.0mg lyophilised 
extract and dissolving in 5mL Milli-Q® water (stock solution = 0.1%w/v). 
Working solutions were prepared: 25.5µL of M. aeruginosa LPS stock solution 
was added to 1,974.5µL Milli-Q® water to give the 12.8ppm solution; 62.5µL of 
C. raciborskii LPS stock solution was added to 1,937.5µL Milli-Q® water to 
give a 31.3ppm solution. All solutions were stored at -200C. 
 
Sodium dodecyl sulfate was prepared at concentrations of 2.0%, 0.4% and 
0.04% (w/v in Milli-Q® 0 water) and stored at -20 C.  
 
 
4.2.4.3. Biomass estimates 
 
Biomass estimates of lyophilised cyanobacteria were calculated from C. 
raciborskii AWT 205 cultures grown as described above (Section 4.2.4.2). 
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Prior to harvesting cells from a 20L culture vessel, a 1L sample of the culture 
was lyophilised, and a culture sample was fixed in Lugol’s iodine for counting 
under phase contrast microscopy. Under the tutelage of Dr Maree Smith of 
Queensland Health Scientific Services, IS determined the cell count of this C. 
raciborskii culture, from which biovolume and surface area estimates were 
determined. A Sedgwick-Rafter volumetric counting chamber was used; 
trichomes were counted in ten fields, and cells per trichome were counted in 
ten trichomes per field.  
 
The cells in the 1L sample of this culture were not washed in order to avoid 
losses during centrifugation; therefore a separate experiment was conducted 
on another batch of C. raciborskii AWT 205 culture, to determine the relative 
weight of salts from the culture medium. Triplicate samples of 500mL fresh 
culture were lyophilised, as were 500mL samples of culture filtrate (0.45µm 
Millipore® filter), and 500mL samples of fresh Jaworski medium. Results of 
these procedures are given in Appendix 5. 
 
 
 
4.2.4.4. Quantification of cyanotoxins 
 
Microcystins, saxitoxins and cylindrospermopsin were quantified at the 
laboratory of Mr Geoff Eaglesham at Queensland Health Scientific Services, 
Brisbane. Methodology and instrumentation were as outlined in Chapter 3, 
Section 3.3.9.2. 
 
 
4.2.4.4.1. Quantification of cyanotoxins to check stability of 
cyanobacterial crude extracts 
 
Cyanobacterial extracts were stored in a dermatology outpatient clinic 
refrigerator at 40C for three to four months, after which time they were 
replaced with fresh material from frozen stock solutions. To check on the 
stability of these extracts, we compared freshly thawed and 4-month-old 
cylindrospermopsin and total microcystin concentrations in three extracts (C. 
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raciborskii AWT 205; North Pine Dam bloom sample, and M. aeruginosa 
QH/NR Ma03). Analytical methods per Chapter 3, Section 3.3.9.2. Results 
and further discussion are in Table 4.6 and Section 4.4.7; there was no 
evidence of cyanotoxin degradation under these storage conditions.  
 
 
4.2.4.5. Working extracts, coding 
  
1mL aliquots of the three concentrations of each of the ten test materials were 
pipetted into 1.5mL centrifuge tubes (i.e. 30 tubes in total). Dermatology clinic 
staff were blinded to the identity of each test material, but were not blinded to 
the test concentration. Test materials were identified by numbers 1 to 10; high 
concentrations were labelled “A”, intermediate concentrations were labelled 
“B” and low concentrations were marked “C”. So the 30 tubes were labelled 
1A, 1B, 1C through to 10A, 10B and 10C. Working extracts and solutions were 
stored at 40C in the RBH dermatology clinic.  
 
 
 
4.2.5. Timeframe 
 
Skin patch testing began in March 2002 and concluded in November 2003; no 
testing was done in the summer months from December 2002 to February 
2003. It is routine procedure at RBH to delay bookings for diagnostic skin 
patch testing until autumn, as the typically humid Brisbane summers can 
make the procedure somewhat less reliable due to excessive perspiration on 
patients’ skin.  
 
 
4.2.6. Ethical approvals 
 
Ethical approvals for this study and amendments were granted by the Royal 
Brisbane Hospital Health Service District’s Human Research Ethics 
Committee, protocol number 2001/151, and the University of Queensland’s 
Medical Research Ethics Committee, clearance number 2002000099. 
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4.3. RESULTS 
 
4.3.1. Recruitment of outpatient subjects 
 
A consecutive series of outpatients presenting for routine diagnostic skin 
patch testing were invited to participate in the study. Two patients declined to 
participate (1 x male; 1 x female). Another female outpatient in the 
consecutive series agreed to participate but was not included because of an 
administrative oversight (cyanobacteria patch strips were not placed on the 
skin).  
 
 
4.3.2. Demographic details, case matching 
 
Figure 4.1 shows the age and sex distribution of the outpatient and reference 
groups. All outpatient subjects were matched to reference subjects by sex 
(females: n=12; males: n=8), although one female reference subject was 
excluded from the analysis because of uninterpretable results. Age matching 
was planned (reference subject age = outpatient subject age ±5 years). Age 
matching was successful except for three male outpatient subjects aged 54, 
56 and 62 years. 
 
Age and sex of individual study subjects are also given in Appendix 6: 
“questionnaire replies” raw data file. 
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Skin patch testing study - case matching: age, sex
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Figure 4.1. Age and sex distribution of study subjects. 
 
4.3.3. History of skin disease, allergy 
 
Responses to the questionnaire enquiry regarding a previous history of 
allergic illness and acute or chronic skin reactions are summarised in Table 
4.2. 
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Table 4.2. Summary of questionnaire responses: history of cutaneous and allergic 
illness. n (%). 
                                   Outpatients                               Reference subjects 
    Yes   No    Not sure  Yes   No              Not sure 
 
Eczema or Dermatitis 
Ever diagnosed  12(60) 4(20) 1(5)  7(37) 12(63)  0 
Last two years  11(55) 3(15) 3(15)  5(26) 13(68)  0 
 
Asthma 
Ever diagnosed  6(30) 13(65) 0  8(42) 10(53)  0 
Last two years  5(25) 14(70) 0  5(26) 13(68)  0 
 
Hay fever 
Ever diagnosed  2(10) 15(75) 1(5)  5(26) 14(74)  0 
Last two years   3(15) 14(70) 1(5)  4(21) 15(79)  0 
 
Urticaria 
Ever diagnosed  1(5) 17(85) 1(5)  2(11) 16(84)  0 
Last two years  0 17(85) 1(5)  1(5) 16(84)  1(5) 
 
Rash of unknown cause 
Last two years   10(50) 4(20) 3(15)  3(16) 15(79)  0 
 
Rash after freshwater 
recreation  1(5) 16(80) 1(5)  0 15(79)  3(16) 
 
n=20 for the outpatient subject group; n=19 for the reference group. Where sum of row 
answers (yes/no/not sure) is below the total, shortfall represents unanswered questions.  
 
 
4.3.4. Skin patch testing – cyanobacterial and algal extracts 
 
Raw data files for the 48 and 96 hour patch test readings are given in 
Appendix 6. The salient features of these results are: 
 
• Only one of the outpatient group (and none of the reference group) 
 showed an unequivocal reaction to cyanobacterial extracts. Patient PT19, 
 a 35 year-old male, responded with strong (++) reactions to all three 
 concentrations of the C. raciborskii extracts at 48 hours. Reactions had 
 receded to “+” grade by 96 hours, but all three concentrations were still 
 eliciting equal cutaneous reactions at this time. This patient also 
 responded to another four extracts: the North Pine Dam (NPD) mixed 
 cyanobacteria bloom sample, with “+” grade reactions at the high and low 
 dose, and a “++” reaction at the intermediate dose at 48 hours; all NPD 
 concentrations provoked “+” reactions at 96 hours. Planktothrix sp isolate 
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 elicited a weak reaction from the intermediate dose at 48 and 96 hours, 
 with a reaction also seen at the high dose patch site at 96 hours. Weak 
 reactions to the Lake Coolmunda M. aeruginosa bloom sample were seen 
 only at 96 hours (“+” at low and intermediate doses; equivocal response to 
 the high dose). Finally, this patient also displayed weak reactions to all 
 three concentrations of the green alga C. vulgaris at 48 hours; these patch 
 sites were all normal at 96 hours.  
 
• A weak irritant response was seen on PT01 to the high dose of the 
 Lake Coolmunda A. circinalis bloom sample at 48 hours.  
 
• Equivocal responses were seen in some subjects from both outpatient 
and reference groups at 48 hours. No clear pattern was seen with respect 
to dose: Four equivocal reactions were seen from various extracts at the 
high dose (subjects PT02, PT06); three reactions were seen only at the 
intermediate dose (CO05, CO08, PT06); four uncertain reactions were 
seen only at the low dose (CO05, CO06, PT01). Finally, one subject 
(PT04) showed equivocal 48-hour reactions to C. vulgaris at all three 
concentrations.  
 
• Subjects CO10 and PT05 were removed from consideration of summary 
 statistics given in Figure 4.1 and Tables 4.2 and 4.3. Subject CO10 
 developed a localised folliculitis over four test series sites – one being the 
 SDS series – so 96-hour readings were uninterpretable. The 
 dermatologist noted a general irritant reaction over the patch area. Subject 
 PT05 developed “angry back”, which is a state of skin hyper-reactivity 
 caused by a strong reaction to one or more patch-test allergens, and is 
 associated with false-positive reactions to other test materials (Rietschel & 
 Fowler, 2001 pp16-17); another outpatient subject was recruited to replace 
 this subject in the study.  
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4.3.5. Skin patch testing – sodium dodecyl sulfate (SDS) 
 
Table 4.3 presents patch test responses to SDS. These data are summarised 
with the exclusion of subjects CO10 and PT05. Original data files can be seen 
in Appendix 6.  
 
Table 4.3. Skin patch testing – sodium dodecyl sulfate patch readings. n (%). 
         Outpatients                 Reference subjects 
       – +/-   +  ++   IR      –  +/-   + ++  IR 
 
48 hours   
 2%w/v  11(55) 1(5) 5(25) 1(5) 2(10)  12(63) 1(5) 4(21) 1(5) 1(5) 
 0.4%w/v 13(65) 2(10) 2(10) 1(5) 2(10)  17(89) 1(5) 0 0 1(5) 
 0.04%w/v 20(100) 0 0 0 0  19(100) 0 0 0 0 
 
96 hours   
 2%w/v  8(40) 0 7(35) 3(15) 2(10)  9(47) 3(16) 5(26) 2(11) 0 
 0.4%w/v 14(70) 1(5) 5(25) 0 0  17(89) 0 2(11) 0 0 
 0.04%w/v 20(100) 0 0 0 0  18(95) 0 1(5) 0 0 
 
 
 
 
4.3.6. Cyanotoxin quantification; calculation of doses applied to skin 
 
Table 4.4 gives results of cyanotoxin analyses performed in the laboratory of 
Mr Geoff Eaglesham, Queensland Health Scientific Services.  
 
Table 4.4. Cyanotoxin quantification (µg/L) of patch testing extracts. 
    CYN  MCs  STXs 
 
C. raciborskii  
 AWT 205  2000   
M. aeruginosa 
C. raciborskii 
Aphanizomenon spp 
 North Pine Dam 6.4  200 
M. aeruginosa 
 Lake Coolmunda   ND 
M. aeruginosa 
 QH/NR/Ma03    1600 
A. circinalis 
 Lake Coolmunda     19 
Planktothrix sp 
 QH/NR/Px01                ND  
 
CYN: cylindrospermopsin 
MCs: total microcystins expressed as MC-LR 
STXs: total saxitoxins expressed as saxitoxin 
ND: not detected 
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Extracts were applied to filter paper discs that fit into each Finn chamber. A 
plastic transfer pipette was used to saturate each disc; one or two drops – 
mostly one drop – are sufficient to saturate the disc. The volume of two 
transfer pipette drops was measured with an air displacement pipette and 
found to be 65μL. Assuming that two drops were required for each Finn 
chamber, and also assuming that the entire volume applied to filter paper 
discs was in contact with subjects’ skin, Table 4.5 represents the estimated 
dose of cyanotoxin applied to the skin of each subject. Doses were calculated 
from the maximum concentration (0.25%w/v), then one fifth and one fiftieth of 
the maximum dose, representing the 0.05%w/v and 0.005%w/v 
concentrations, were added to achieve the estimated dose per subject, 
rounded to two significant figures. An idealised weight of 65 kg was used to 
estimate the per kilogram cutaneous dose.  
 
 
Table 4.5. Estimated doses of cyanotoxins by the cutaneous route. 
  Cyanotoxin     Dose per subject        Dose by weight  
 
Cylindrospermopsin  160ng   2.4ng/kg 
 
Microcystins   170ng   2.6ng/kg 
 
Saxitoxins   3.8ng   58pg/kg 
 
Dose by weight estimated for a 65kg individual 
 
 
Table 4.6 shows analysis of three extracts conducted to monitor the stability of 
cylindrospermopsin and microcystins at 40C over a four-month period. 
 
0Table 4.6. Stability of cylindrospermopsin and microcystins at 4 C.  
0 0C    Dilution factor         Cyanotoxin         4 C: four months     Freshly thawed from -20
 
Cylindrospermopsin 
 AWT 205  214.73µg/L  192.22µg/L   10 
 
 North Pine Dam     3.09µg/L      3.36µg/L    2 
 
Microcystins as MC-LR 
 QH/NR/Ma/03     1600µg/L       600µg/L    1 
 
 North Pine Dam      530µg/L       340µg/L    1 
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4.4. DISCUSSION 
 
4.4.1. Background and pre-planning 
 
A clinical human study was not planned as part of this PhD research. Our 
serendipitous collaboration began when IS wrote to two Brisbane 
dermatologists to put some specific questions about animal dermatotoxicology 
research. Dr Ivan Robertson suggested we pursue the prospect of a clinical 
study at RBH, so we began the process of submitting an ethics proposal. Our 
initial challenge was to determine appropriate doses to apply to human skin. 
At the time, preliminary irritant mouse ear swelling work had been done with 
two cyanobacterial extracts at 5%w/v and 10%w/v (lyophilised cyanobacteria 
in 75% methanol), with negative results (see Chapter 5, section 5.4.1.1). 
Rietschel & Fowler (2001 p15) nominate appropriate steps for testing non-
standard contactants: initial test concentrations of 0.1% to 1.0% performed on 
several volunteers, including the investigator. Therefore we sought to conduct 
pretesting experiments on a group of five colleagues in order to determine 
non-irritating concentrations of cyanobacteria that would be suitable for patch 
testing outpatients and healthy volunteers. Three colleagues plus IS and Dr 
Robertson expressed interest in participating in pretesting experiments, 
however the University of Queensland’s ethics officer cautioned against such 
work without formal consideration by the relevant ethics committee. Therefore 
an autoexperiment was conducted on IS in May 2001. Eight Finn chambers 
containing 5%w/v extracts of M. aeruginosa QH/NR/Ma03 and a non-toxic 
bloom sample (Gordonbrook Dam, Queensland) containing predominantly A. 
circinalis were prepared; each extract was applied with three vehicles: Milli-Q® 
water, 50%v/v methanol in Milli-Q® water, and acetone. Lyophilised, powdered 
M. aeruginosa and A. circinalis cells were each mixed in petrolatum and 
placed into two of the Finn chambers. Mild irritant reactions were seen on the 
aqueous A. circinalis extract site, and on the two petrolatum sites.  
 
Because IS has never suffered from dermatitis, we suspected that the irritant 
reaction, albeit mild, was probably the result of an artificially high 
concentration of cyanobacterial cells. One of the problems of working with 
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lyophilised cyanobacteria is relating the re-wetted concentration back to the 
biomass of cells when they were originally harvested. Cyanobacteria can 
achieve very high concentrations in bloom conditions, with densities of up to 
3x109 cells/mL in what are described as hyperscums (Zohary & Madeira, 
1990). Cell counts of this magnitude equate to cell surface area estimates of 
>200,000mm2/mL, using the methods described in Chapter 3, Section 3.3.9.1. 
The authors measured M. aeruginosa biovolumes of 153 cm3/L at cell counts 
of 2.5x109 cells/mL (Zohary & Madeira, 1990). Cutaneous exposure to bloom-
scale cell densities undoubtedly occurs in recreational and occupational 
settings, but the more common exposures would be to biomass 
concentrations several orders of magnitude lower than those reported by 
Zohary & Madeira (1990). The highest cyanobacterial biomass seen in 
recreational waters in the epidemiology study conducted as part of this thesis 
(Chapter 3) was estimated at 318mm2/mL. From results in Appendix 5, 
biomass estimates for the 0.25%w/v maximum concentration extracts using 
washed cells would therefore be in the cell surface area >1,000mm2/mL 
range. A possibly more meaningful assessment of the doses applied to the 
skin of volunteers is that 0.25%w/v is a 20-fold lower concentration of 
cyanobacteria than that which elicited a mild irritant reaction on the skin of IS 
during pre-testing experiments. 0.25%w/v is also a 20-40 fold lower 
concentration than those which failed to elicit observable or measurable 
reactions on mouse ears during open application experiments for irritancy 
(section 5.4.1.1).  
 
We did not proceed with using powdered, lyophilised cyanobacteria mixed in 
petrolatum because of the anticipated loss of precision in determining doses. 
We decided to use aqueous cyanobacterial extracts for these patch testing 
studies, as water is the solvent of choice in the vast majority of recreational 
settings, from which arise reports of acute cyanobacteria-related dermatoses.  
Concomitant exposure to ethanol can often be observed in Australian 
recreational environments, but not by the cutaneous route.  
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4.4.2. Recruitment concerns 
 
Recruitment of subjects from the outpatient group did not present any 
particular difficulties, presumably because the application of extra Finn 
chamber strips did not represent a significant extra burden. Subjects in this 
group were presumably motivated to attend clinic sessions primarily by 
receiving the diagnostic series of patch test extracts for their presenting 
condition.  
 
Recruiting the “convenience” sample for reference purposes was more 
difficult. Three visits to the dermatology clinic within the one week is a big ask 
of healthy but busy individuals. We paid all reference subjects – not outpatient 
subjects – a sum of A$50.00, to compensate for time and travel, but we were 
unable to recruit three males in the >50 year age group. We anticipated 
difficulties in recruiting control subjects in older age-groups, which is why we 
designed the study to encompass the 18 to 65 year age range. Due to a 
communication problem at the start of the study, we inadvertently recruited a 
73-year old outpatient subject; however, we were able to recruit a 71-year old 
reference subject for age-matching (see Figure 4.1). As the 73-year-old 
patient had agreed to participate in the study, we did not wish to devalue his 
contribution, so, with ethics committee approvals, we retained this subject and 
patch-tested his age-matched non-patient volunteer.  
 
 
4.4.3. History of skin disease, allergy 
 
As anticipated, the outpatient group represented a higher percentage of 
subjects with cutaneous disease than the reference group (see Table 4.2). 
However, the percentage of subjects reporting hay-fever, asthma and 
urticarial diagnoses was higher in the reference group. To the extent that 
future research efforts in this field may need to concentrate on those 
individuals with atopic illness, recruitment from a dermatology outpatient 
population may not confer any particular advantage over recruitment from the 
general population.  
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4.4.4. Patch-testing of cyanobacteria and Chlorella vulgaris 
 
Only one clear responder to this skin-patch testing study was seen, in PT19, a 
male outpatient subject aged 35 years. We did not conduct any statistical 
analysis of these results, as it is not appropriate to make such comparisons on 
the basis of a single subject response. Therefore we can conclude that this 
pilot study has shown a clinically significant but statistically insignificant 
response to cyanobacterial extracts by the cutaneous route. Interestingly, of 
the brief diagnoses noted by dermatologists for outpatient subjects, the sole 
responder is the only one of the 20 outpatients to have a diagnosis of atopic 
dermatitis (see Appendix 6). This subject developed unequivocal responses to 
two cyanobacterial isolates, two bloom samples, and probably to C. vulgaris 
as well. There was no evidence of any dose-response effect in the reactions 
on this subject’s skin. Another point of interest in this subject’s patch-test 
results is that reactions developed to the non-toxic Lake Coolmunda M. 
aeruginosa bloom sample, but no reaction was produced by the toxin-
producing M. aeruginosa isolate. While the Coolmunda bloom sample was 
largely a monoculture of M. aeruginosa, as with many cyanobacteria blooms 
there were other cyanobacterial species and genera present in smaller 
amounts. This leaves open the possibility that this subject has demonstrated 
hypersensitivity reactions to components other than M. aeruginosa in the two 
bloom samples. Subject PT19 also registered positive responses to both 
patch series – at all three concentrations – containing C. raciborskii and 
cylindrospermopsin (C. raciborskii AWT 205 isolate and North Pine Dam 
bloom sample). This is interesting in light of the findings of the following 
chapter (Chapter 5), which demonstrates that C. raciborskii and purified 
cylindrospermopsin are capable of producing irritant and delayed-contact 
hypersensitivity in mice.  
 
The principal conclusions from this study are that cutaneous responses to 
cyanobacteria are uncommon, with only one of 39 subjects demonstrating 
significant cutaneous responses to cyanobacterial extracts. Given this 
patient’s diagnosis of atopic dermatitis, and reports in the literature which are 
suggestive of other features of atopy (see Chapter 1, Table 1.1 and Section 
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1.4.2.2), further research into this matter may benefit from more specific entry 
criteria to allow investigation of atopic individuals. This sole diagnosis of atopy 
must be interpreted cautiously, however, in that diagnoses were only available 
for the twenty outpatients. As the reference group did not have a 
comprehensive medical history taken, we cannot infer presence or absence of 
atopic subjects within the reference group.  
 
Weak reactions to C. vulgaris were seen on the skin of subject PT19, and 
possibly one other subject (PT04). C. vulgaris, a common and widespread 
eukaryotic alga, was chosen as a reference material; Chlorella spp are 
reportedly allergenic (Bernstein & Safferman, 1966; Tiberg et al, 1990), 
although C. vulgaris has been promoted as an allergy preventative and has 
some anti-inflammatory properties (Hasegawa et al, 1999). Acute skin 
symptoms have been reported from exposure to other freshwater and marine 
eukaryotic microalgae (Ellis, 1985; Cronberg et al, 1988; Lowitt & Kauffman, 
1998; Shoemaker & Hudnell, 2001).   
 
Considering the single subject response to cyanobacterial patch testing, these 
data were used to determine sample size estimates that would produce a 
statistically significant study. Using nQuery Advisor 4.0 (Elashoff, 2000), a 
Fisher's exact test with a 0.050 two-sided significance level will have 80% 
power to detect the difference between a Group 1 proportion of 0.050 and a 
Group 2 proportion of 0.001 when the sample size in each group is 167. A 
study involving over 300 volunteers would be prohibitively large and 
expensive; a more targeted approach in future to recruit subjects from more 
at-risk populations awaits further knowledge of the mechanisms of 
cyanobacterial toxicity by the cutaneous route.  
 
 
4.4.5. Reactions to sodium dodecyl sulfate 
 
The overall response to SDS amongst study subjects was not what we 
expected. Kligman & Wooding (1967) published a dose-response curve to 
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SDS, and determined the ID84 in human volunteers to be 1.15%. Extrapolating 
from that curve, we expected that a 2% concentration should initiate irritant 
responses in >95% of volunteers. However, 44% of all subjects (n=17) 
showed no response to SDS at both 48 and 96-hour readings. Dermatologists 
also reported most SDS responses as hypersensitivity reactions, not irritant 
reactions as expected. SDS is widely used as a positive control cutaneous 
irritant in human and animal studies; it is rarely found to be a sensitiser (Prater 
et al, 1978; Cronin, 1980 p817; Lee & Maibach, 1995). Indeed, SDS is 
recommended as a negative control for skin sensitisation studies, despite 
occasional positive patch test findings (Dooms-Goossens & Blockeel, 1996; 
ECETOC, 1999a p77).  
 
Interpreting less severe patch test reactions as being either irritant or allergic 
is a well-recognised challenge; extensive training and experience is required 
to become proficient in the technique of skin patch testing. Several authors 
note that the critical factor to successful skin patch testing is the skill and 
experience of the interpreter (Amin et al, 1996; Kligman, 1996; Hunter et al, 
2002 p36). Considerable research effort has been applied to supplementary 
diagnostic tools such as skin electrical impedance spectrometry or flow 
cytometry analysis of suction blister-derived epidermal cells as a means of 
helping to discriminate between allergic and irritant patch responses 
(Gerberick & Sikorski, 1998; Nyrén et al, 2003). Other techniques such as 
laser Doppler perfusion imaging appear to be less successful (Goon et al, 
2004).  
 
Some questions that we put to ourselves to consider the interpretation of 
patch test responses to SDS were: 
 
• The same dermatologist was not always available to conduct patch test 
 readings, so were we seeing the result of subjective differences in 
 interpretation? 
0• Was the stability of SDS in aqueous solution at 4 C for up to four months 
 beyond question? We satisfied ourselves that cylindrospermopsin at least 
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 was not degraded under these storage conditions, but whether that finding 
 is generalisable across all patch test extracts is debatable. However, other 
 workers have adopted a similar regime to ours, storing aqueous solutions 
 of SDS for three months at 40C (Geier et al, 2003).  
 
Closed patch testing is the most standardised and widely used diagnostic tool 
for allergic contact dermatitis, and the Finn chamber method has been shown 
to be reliable (Amin et al, 1996). It is however a bioassay, and one that does 
not differentiate between mechanisms of reactivity (Rietschel & Fowler, 2001 
p11). Irritant reactions, especially mild ones, can be easily misinterpreted as 
allergic (Amin et al, 1996; Kligman, 1996; Rietschel & Fowler, 2001 pp10-11; 
Welss et al, 2004). The morphology of a patch-test response is an unreliable 
means of differentiating a weak allergic response from a weak irritant 
response (Rietschel & Fowler, 2001 p24). Kligman (1996) disputes the 
standard rationale for discriminating between irritant and allergic patch test 
reactions; he was reportedly able to mimic allergic contact dermatitis in all 
respects with numerous irritants, including SDS.  
 
There are many variables impacting on the irritant response: concentration, 
vehicle, the length and method of exposure, the site at which the test chamber 
is applied, ambient temperature and humidity, age and the presence of skin 
disease, especially atopic dermatitis (ECETOC, 1990b p73; Lee & Maibach, 
1995; Uter et al, 2003). Basketter et al (1997) note significant variability in 
human volunteer responses to SDS in 4 hour patch test experiments, with 
some individuals reacting to low concentrations (0.1%) whereas others only 
responded to much higher concentrations (10% or 20%) or not at all. 
Interestingly, the sole obvious responder to cyanobacterial extracts in this 
patch testing regime (PT19) only had a mild reaction to SDS at the highest 
concentration of 2% at the 48-hour reading, despite his diagnosis of atopic 
dermatitis.  
 
Some workers have added SDS to their standard allergy patch test series in 
order to help differentiate between irritant and allergic reactions (Geier et al, 
2003; Uter et al, 2003). However, these workers did not appear to have 
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blinded themselves to the location of SDS patches; they were apparently 
using reactions to SDS as reference irritant responses from which to compare 
reactions to allergen patches.  
 
Therefore it appears that the inclusion of SDS as a positive irritant control may 
not have been the most appropriate procedure in this diagnostic patch testing 
study. The patch testing technique is highly standardised and validated, but it 
is a test for delayed-contact hypersensitivity, not primary irritancy. The dose-
response curve of Kligman & Wooding (1967) was obtained from a study of 10 
volunteers, using woven patches, i.e. not Finn chambers, with doses applied 
for unspecified periods of up to 24 hours, and readings taken at 24 hours after 
application commenced. Therefore the variability in responses to irritants and 
the non-standardised procedures may have thwarted the reliability of the 
irritant positive controls done for this study.  
 
One final observation is that responses to SDS appeared to display a dose-
response effect (Table 4.3 & Appendix 6), with most reactions to the high 
concentration, and only one responder to the lowest concentration. Irritant 
patch test reactions tend to stop abruptly below a threshold concentration, 
whereas allergic reactions are maintained at lower doses (Wilkinson & Shaw, 
1998). The patch test reactions seen in PT19 to cyanobacterial and Chlorella 
extracts demonstrate a very clear absence of dose-response effects, thus 
supporting the interpretation of hypersensitivity reactions in this case.  
 
 
4.4.6. Cyanotoxin doses by the cutaneous route 
 
As seen in Table 4.5, estimated doses are well below any conceivably 
hazardous concentration in terms of systemic absorption. The mouse 
intraperitoneal LD s for the three main cyanotoxins are: 50
 
• Cylindrospermopsin: 2.1mg/kg (24 hours); 200µg/kg (5-6 days) (Ohtani et 
 al, 1992). 
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• Microcystins: 45-70µg/kg (most toxic forms) (WHO, 2003 p140). 
• Saxitoxins: 10-30µg/kg (WHO, 2003 p140). 
 
So the doses applied to volunteer skin are more than four orders of magnitude 
lower than LD50 doses administered by the much more direct i.p. route. 
Another useful comparison that suggests the cutaneous doses applied to our 
subjects were not acutely hazardous comes from guideline values for the 
acceptable daily intake of cyanotoxins by the oral route. Guideline values for 
microcystins in drinking water have been set at 1.3µg/L (NHMRC & 
ARMCANZ, 1996 & 2001, Fact Sheet No. 17a), and a safety guideline of 
1µg/L for cylindrospermopsin in drinking water has recently been 
recommended (Humpage & Falconer, 2003). A concentration of 80µg 
saxitoxin equivalents per 100g shellfish is used in North America as a trigger 
for the closure of shellfish harvesting (Falconer et al, 1999).  
 
 
4.4.7. Stability of extracts at 40C 
 
This study was conducted over a longer time period than was initially planned. 
This was due to a lower than anticipated number of outpatient presentations 
for diagnostic skin patch testing. We were concerned about the stability of 
aqueous extracts at 40C over prolonged periods, so we conducted before and 
after analyses of extracts containing cylindrospermopsin and microcystins. As 
seen in Table 4.6, there was no degradation of cylindrospermopsin over the 
four month period. Microcystins were measured at higher concentrations in 
the four month old extract, which is not easily explained. One possibility is that 
ultrasonication during preparation of these extracts was not sufficient to fully 
lyse M. aeruginosa cells, and cell lysis continued over time at 40C, thus 
releasing more intracellular microcystins into the extract.  
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4.4.8. Biomass estimates 
 
From results given in Appendix 5, it is not clear why the lyophilised weight of 
the 0.45µm filtrate should be higher than the lyophilised salts from fresh 
media, but these biomass estimates from lyophilised material should be 
viewed as fairly crude measures, as there are several sources of error here: 
 
• Weight differential between container and yield: 500mL capacity 
 polypropylene containers weighed 27.5 – 29.0 grams, whereas net yields 
 were in the 60 – 150 mg range 
• Dilution factors for microscopy 
• Hygroscopic properties of freshly lyophilised material – a temporary 
 desiccator was constructed from a polystyrene box, with Si granules and 
 displacement of air with argon, but ambient water vapour was probably 
 being absorbed even during the short period on the electronic balance.  
• Cells used for patch-test extracts were concentrated and washed prior to 
 lyophilisation 
 
 
4.4.9. Comparison of this study with recently published work 
 
The recently published work of Pilotto et al (2004) presents an opportunity to 
compare and contrast the study design and findings of these two human 
dermatological investigations of cyanobacteria. The two studies differ 
fundamentally in that the study of Pilotto et al (2004) was an investigation into 
the irritant potential of cyanobacteria, whereas this work was concerned with 
identifying hypersensitivity reactions. However, as these are the only two 
recent human volunteer clinical dermatology studies to examine the effects of 
cyanobacteria, some consideration of similarities and differences is warranted: 
 
• Study subjects: Pilotto et al (2004) recruited a single group of student 
and staff volunteers, though not all subjects were tested with identical 
cyanobacterial preparations (n=114). This IS-led study involved two 
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groups – dermatology outpatients presenting for diagnostic skin patch 
testing, and a “normal” group of staff, students and word-of-mouth 
volunteers. All subjects had the same cyanobacterial extracts applied to 
the skin (n=39). 
• Cyanobacteria: Pilotto et al (2004) used live and lysed cyanobacteria, 
quantified by cells/mL counts. This work used washed, lyophilised 
cyanobacteria quantified by biomass estimates. 
• Concentration range: Pilotto et al (2004) used six concentrations of 
each cyanobacteria in their Finn chamber series. Concentration ranges 
varied by species, but the average range (low to high concentration) 
was x50 (x4.3 for Aphanocapsa incerta; x84 for Anabaena circinalis). 
The IS-led study used three concentrations, with a x50 spread 
(0.005%, 0.05% and 0.25%w/v aqueous extracts of lyophilised 
cyanobacteria).  
• Doses: It is difficult to compare the two studies because of the different 
methods of quantifying cyanobacteria – cells/mL used by Pilotto et al 
(2004) vs biomass estimates used for this work. However, it is likely 
that the concentrations used in this study were significantly higher – 
greater than one order of magnitude – than those used by Pilotto et al 
(2004). Assuming that the average cell dimensions for 
Cylindrospermopsis raciborskii used to calculate cyanobacterial 
biomass in this study – 1.625µm radius and 5.25µm length – can be 
applied to the C. raciborskii cells used by Pilotto et al (2004), the 
biovolume equivalent of their maximum concentration of 150,792 
cells/mL is 6.57mm3/L. The estimated biovolume for the maximum C. 
raciborskii dose of 0.25%w/v used in this study was 386mm3/L, which 
equates to 8.86x106 cells/mL (see Section 4.2.4.3 and Appendix 5).  
• Blinding: Both studies were conducted with the staffer applying the 
patches and the dermatologist unaware of the identity of preparations 
in the patch series. However, Pilotto et al (2004) reportedly blinded 
their investigators to test concentration by randomly assigning test 
materials and concentrations across the patch series. The IS-led study 
blinded workers to the identity of test materials (patch series columns) 
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but not to test concentrations (patch series rows). We deliberately did 
not blind our dermatologists to test concentrations, because we thought 
that identification of concentration-dependent (i.e. dose-response) 
reactions to any particular test extract would assist in the differentiation 
of irritant and hypersensitivity responses. We reasoned that clear dose-
response patterns would allow us to identify – and hence discount – 
irritant reactions. 
• Grading of skin reactions: Again, an important consideration here is 
that these two studies were examining different endpoints – irritancy 
and hypersensitivity. However, the grading scale used in the IS-led 
study incorporated an equivocal response (+/-), whereas the work of 
Pilotto et al (2004) did not. Equivocal readings to cyanobacteria 
extracts were not considered by the IS-led team when interpreting the 
results of this study. 
• Negative control patches: Pilotto et al report that 23% of their 
volunteer subjects developed positive responses to negative control 
patches. Their report does not state what proportion was from blank 
chambers and which responses were from chambers containing 
cyanobacteria culture medium. It would be interesting to know whether 
precipitated salts in the culture medium were causing a significant 
number of their positive skin reactions. The IS-led study did not use 
negative control patches, as these are not routinely used in skin-patch 
testing, at least at Royal Brisbane Hospital. Aluminium Finn chambers 
are considered to be inert on the skin of most subjects. However, for 
research purposes, it could be argued that our cyanobacteria patch 
series should have included a solvent chamber, which in this case 
would have been de-ionised, filtered water.  
 
The conclusions of Pilotto et al (2004), that a small number of their study 
subjects developed irritant reactions to cyanobacteria but no dose-response 
relationships were seen, are difficult to reconcile with the concepts of irritancy 
and hypersensitivity. If Pilotto’s team were applying irritant doses of 
cyanobacteria to normal, i.e. non-allergic individuals, we might expect to see: 
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a) a larger proportion of individuals affected, and b) a dose-response pattern. 
However, the concept of hypersensitivity, where susceptible individuals 
respond to much lower doses of toxicants than those that will affect normal 
individuals is clearly demonstrated in the IS-led study. The sole unequivocal 
responder in our study, who had a diagnosis of atopic dermatitis, responded to 
several cyanobacterial extracts at two or three concentrations, whereas the 
proportion of subjects responding to identical doses at either 48 hours or 96 
hours was much lower than that reported by Pilotto et al (2004).  
 
Considering the probability that the doses applied to the skin in the IS-led 
study were significantly higher than those used by Pilotto et al (2004), we may 
have expected to see more unequivocal reactions in our study during the 
initial readings after patch removal if the doses were truly in the irritant range. 
Many substances will produce irritant reactions (i.e. in non-allergic individuals) 
if the dose is high enough. The scoping autoexperiment performed on IS (see 
Section 4.4.1) produced a mild irritant reaction, which guided our decision to 
use 20-fold lower concentrations as the maximum concentration on study 
volunteers.  
 
Notwithstanding the different approaches in design with these two studies 
(fresh vs lyophilised cyanobacteria, patch application for 24 vs 48 hours), the 
possibility should still be considered that Pilotto’s team may have been 
working with sub-irritant doses in their study, and the positive but dose-
unrelated skin reactions they saw in a small proportion of subjects actually 
represented early signs of delayed-contact or late-phase type I 
hypersensitivity responses. Pilotto et al (2004) reported no difference in 
positive response rates between atopic and non-atopic individuals; however 
their definition of atopy is difficult to determine from their report. Atopy is 
defined by Pilotto et al (2004) as “self report of ever being diagnosed with 
asthma, eczema, hayfever or atopy”, which includes a circular definition. A 
self-reported diagnosis of asthma, eczema or hayfever cannot exclude non-
atopic allergic conditions, especially in the case of asthma.  
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The conclusions of the IS-led study concentrate on the observation that the 
sole unequivocal responder to cyanobacteria was also the only study subject 
with a diagnosis of atopic dermatitis. While Pilotto’s team could be criticised 
for embracing an overly-broad definition of atopy, the IS study may also be 
guilty of using the concept somewhat loosely, possibly in the other direction. 
We noted that the sole responder had a diagnosis of atopy in his hospital 
records, but we did not examine the medical records of the remaining patients 
to attempt to confirm the absence of atopy, nor can we reasonably consider all 
the non-patient volunteers who self-reported diagnoses or history of allergy to 
be non-atopics.  
 
Supplementary studies would be of value to address the potential for 
cyanobacteria, and particularly toxin-producing cyanobacteria, to elicit 
cutaneous irritant reactions at concentrations that might feasibly be 
encountered in recreational or occupational settings, using dose ranges that 
include the high end of the spectrum, i.e. cyanobacteria concentrations that 
mimic exposure to dense scums. A sample of “normal” volunteers should be 
recruited for this follow-up work, i.e. with rigorous exclusion criteria for 
individuals with any personal or family history of allergic disease.  
 
Studies to examine the response of atopic individuals to commonly-
encountered and widely distributed cyanobacteria would also be useful, and, 
in this author’s opinion, more interesting and relevant than the questions about 
irritant potential. Again, rigorous entry criteria would need to be applied to the 
definition of atopy, perhaps including confirmatory serum IgE levels. 
Investigations into the presence of antigen-specific IgE against cyanobacterial 
components would be of interest. Carefully defined non-atopic volunteers 
would make a useful control group. 
 
 
4.4.10. General discussion and conclusions 
 
The findings of this small human study are that cutaneous reactions to 
cyanobacteria are infrequent, at least in the populations we sampled. The 
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work in the following chapter complements this study, and demonstrates that 
purified cylindrospermopsin is capable of eliciting irritant and delayed-contact 
hypersensitivity reactions in mice. The small number of case and anecdotal 
reports in the literature (Chapter 1, Table 1.1) also shows that cyanobacteria-
associated dermatoses are infrequently reported, although mild, self-limiting 
illnesses, including pruritic rashes, are likely to be under-reported and under-
diagnosed (Ressom et al, 1994 p69).  
 
With the usual cautions applying to anecdotal reports, four more reports (3 x 
human, 1 x canine) of possible cyanobacteria-associated cutaneous eruptions 
can be added to the literature. All were reported to IS during field recruitment 
for the epidemiology study reported in the previous chapter. 
 
• At Lake Coolmunda (Queensland, Australia) in Easter 2001, a frank M. 
 aeruginosa bloom was evident throughout the holiday period. Low levels 
 of MC-LR (12µg/L) were measured in water samples. A camper pointed to 
 his Australian Cattle Dog and described how the animal went swimming in 
 the lake, and “some hours” later, developed an intensely itchy, generalised 
 rash which lasted about 24 hours. The owner stated he had never seen 
 his dog suffer a skin reaction of that severity before. Many dogs were seen 
 in the lake over the two days IS spent there; some owners were asked 
 whether their pets had suffered any illness at the time. None reported any 
 problems. 
• Also at Lake Coolmunda at that time, a pregnant female described an 
 intensely pruritic rash which she attributed to contact with lake water from 
 a camp shower. She showed part of the rash to IS: it was a dark red, 
 bullous eruption across the back of her shoulder and upper arm, with a 
 linear, streaky pattern. She denied any history of allergic illness, and 
 stated that she could not remember having previously suffered a similar 
 eruption. 
• At Little Lake Harris, Lake County, Florida (USA), a pregnant female 
 described a pruritic, erythematous, macular rash which appeared while 
 she was still in the water, and “appeared to spread to other parts of the 
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 body”, and lasted for 5-7 days. She experienced this rash on three 
 occasions over a 1-2 month period; these being the only times she had 
 previously been in the water at that location. On the occasion she saw IS 
 at Little Lake Harris in June 2002, she did not experience the rash. She 
 denied any history of allergic illness. Little Lake Harris is part of a chain of 
 interconnected lakes that are often subject to toxic cyanobacteria blooms.  
• Two siblings, a female aged 11 years and her younger brother, were in a 
 tube towed from a powerboat at Doctors Lake, Clay County, Florida in 
 August 2002. The lake was subject to a surface bloom of M. aeruginosa 
 and A. circinalis at the time. They were in the water for about 5-10 minutes 
 when both children complained that “something is eating us”, and 
 demanded to be pulled out of the water. Their parents described a 
 “diffuse, pale rash” on both children, which lasted about two hours, then 
 progressed to a pruritic, papular eruption mainly on the trunk, both 
 posterior and anterior. The girl’s rash lasted about five days, and was 
 treated with hydrocortisone cream. Both children suffer from asthma, and 
 both had partaken in recreational activity at Doctors Lake on one previous 
 occasion, without incident, about one month prior to this event. The story 
 was complicated by the presence of “many tiny grey creatures, looked like 
 lice – little black dots all over the lining of their bathing costumes” to which 
 the parents attributed their children’s skin reactions. Mr John Burns, an 
 aquatic biologist working with us on the epidemiology study, thought that 
 the observed beasties would most likely have been crustaceans of the 
 order Amphipoda (Fasulo, 2001). These small shrimp-like creatures are 
 attracted to floating substrates, hence may be felt moving on the skin, but 
 are not biting animals. Gammarus spp and Hyalella azteca are common 
 amphipods found in Doctors Lake and the St Johns River. Amphipods are 
 often found attached to floating vegetation and other debris in the 
 waterway. We found a single case report of IgE-mediated asthma caused 
 by occupational exposure to the dried dust of Gammarus sp; these 
 amphipods are processed into fish food (Baur et al, 2000). We have been 
 unable to find any references to amphipod-associated dermatoses. The 
 description of events associated with these children’s skin eruptions does 
 not tally with the phenomena of “sea lice” attack, these also being small 
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 free-swimming crustaceans (order Isopoda, sub-order Cymothoidea). 
 Cymothoids have a powerful biting mechanism causing haemorrhagic 
 puncture wounds on the skin (Rietschel & Fowler, 2001 p705).  
 
Again, these anecdotal reports of acute skin reactions must be viewed with 
caution in the absence of further diagnostic confirmation. The two pregnant 
women who took the trouble to mention their skin rash would presumably be 
investigated for PUPPP (pruritic urticarial papules and plaques of pregnancy), 
which is one of the more common gestational dermatoses, and its aetiology is 
unknown (Yancey et al, 1984; Aronson et al, 1998; Habif, 2004 pp152-3). 
Normal pregnancy is characterised by enhanced innate immune functioning 
and suppression of adaptive immunity (Luppi, 2003). It is a general premise of 
this thesis that innate immune responses to cyanobacteria have not been 
satisfactorily investigated, and may be highly significant. While it would be 
foolish to make any claims on the basis of two anecdotal reports, it is 
nonetheless tantalising to speculate on the possibility of differential cutaneous 
signalling in pregnancy to immunologically active components of 
cyanobacteria.  
 
Clear anecdotal reports of incident-free exposures to high levels of 
cyanobacteria were also received during recruitment for the epidemiology 
study reported in Chapter 3. During recruitment at Lake Coolmunda, southern 
Queensland, two visitors described skiing on the lake during 1997, when a 
toxic cyanobacteria bloom led authorities to close access to the lake. These 
individuals described, with a certain laconic pride familiar to Australians, how 
they and “only about five or six other boats” gained access to the lake via an 
adjacent private property, as the main access gate was padlocked. They 
described their ski wake in terms of a “beautiful, bright green wall of water”. 
Both individuals denied any ill-effects after exposure. That particular bloom 
event is known to workers in our facility; from it we have lyophilised A. 
circinalis with high levels of saxitoxins (approx 20ppm total saxitoxins 
expressed as saxitoxin, per Mr Brad Davis, QHSS laboratories). Similar 
reports were garnered from holidaymakers at Myall Lakes, NSW, who 
described swimming through surface scums of a cyanobacterial bloom in 
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Easter 2000. Some visitors expressed the opinion that they had invested a lot 
of planning time and anticipation in their holiday, and they were not going to 
let a cyanobacteria bloom spoil their fun. This author has tried without success 
to generate a cutaneous response on his own skin through open application of 
concentrated cyanobacterial cells on many occasions, from both field samples 
and laboratory isolates. Images of field workers demonstrating similarly 
enthusiastic disregard for occupational health and safety matters can be seen 
at  
http://www-cyanosite.bio.purdue.edu/images/lgimages/collec.jpg
http://www-cyanosite.bio.purdue.edu/images/lgimages/microcy5.jpg
and 
http://www-cyanosite.bio.purdue.edu/images/lgimages/bloom11.jpg
 
The commercial sector has not been slow to realise that cutaneous responses 
to cyanobacteria are not unequivocally hazardous. A Google search using the 
terms “blue green algae” “soothes” and “skin” will reveal a bewildering array of 
products and services that promise relief from much of what ails you. Clinical 
and research dermatologists will no doubt be pleased to hear about: 
 
Spirulina Wrap 
Wrapping the body in antioxidant-rich "super blue/green" algae envelops 
the body in powerful antioxidants. This treatment hydrates skin from the 
inside out, with powerful vitamins, minerals and proteins. (50 minutes) 
http://www.arizonabiltmore.com/spa/bodytreatments.asp
 
The point of all this is that there is still a great deal to learn about 
cyanobacteria and the skin. To what degree these widespread organisms may 
affect the health of individuals with atopic and non-atopic allergic disease is 
unknown, but deserves the attention of researchers. The subject of 
photoallergy and photoirritancy has not been investigated. Most environmental 
exposures to aquatic cyanobacteria occur in recreational settings, which 
correlate strongly with exposure to sunlight, so photic effects should 
presumably be investigated.  
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The following chapter (Chapter 5) reports findings of primary irritant and 
hypersensitivity reactions to cylindrospermopsin, which, like all the common 
cyanobacterial exotoxins, is highly water-soluble. The animal model described 
in Chapter 5 is an artificial system in several respects: use of inbred mice, i.e. 
genetic isotypes, unusually high concentration of toxicant, use of an 
immunoadjuvant, and disruption of barrier function, although the principal 
reason for using these animal models is to determine – or in this case to 
discover – whether mechanisms of cutaneous toxicity are biologically feasible. 
Environmental exposures in more genetically variable groups of humans 
present much more complex arrangements from which to determine human 
health risks. Two environmental variables that are likely to interact in 
recreational settings may help illustrate the complex nature of cutaneous 
exposures to cyanobacteria: the topic of barrier function and the potentially 
antagonistic effects of water and sunlight.  
 
Water is known to disrupt normal barrier function; the stratum corneum of 
terrestrial animals has an intercellular lamellar bilayer ultrastructure that is 
designed to withstand air, not prolonged water exposure (Tsai & Maibach, 
1999; Warner et al, 1999; Warner et al, 2003). The stratum corneum can 
absorb a significant amount of water from prolonged immersion, reducing the 
efficiency of barrier function against hydrophilic compounds (Cohen & Rice, 
2003). Therefore a presumably relevant question is whether individuals with 
extended exposure to cyanotoxin-affected water during recreational activities 
may be at greater risk due to the combined effect of water and water-soluble 
toxins.  
 
Sunlight, on the other hand, may have very different effects. Langerhan’s cells 
(LCs), the principal antigen-presenting epidermal cells, are inactivated by 
ultraviolet-B; UV-B is known to suppress contact hypersensitivity responses 
(Roitt et al, 2001 p372; Ito et al, 2003). 
 
In vivo and in vitro experiments to examine the interacting effects of barrier 
disruption and UV-B exposure were conducted by Ito et al (2003). Barrier 
disruption by tape stripping augmented the expression of several Langerhan’s 
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cell surface markers, while UV-B treatment tended to downregulate them. A 
combination of barrier disruption and UV-B antagonised the enhancing effects 
of barrier disruption on LCs, but produced significant additive effects on IL-1β 
mRNA expression by LCs. Barrier disruption or UV-B alone did not influence 
LC IL-1β expression. Synergistic effects on IL-1α and TNF-α expression by 
keratinocytes were also observed. If these experimental findings of cellular 
and molecular enhancement, suppression and synergism by various 
interactions of just two variables are applicable to any significant degree in 
environmental exposures, the cutaneous immunological effects of various 
aquatic cyanobacterial products may be very complex.  
 
Apart from considering the impact of water and UV-B on the epidermal and 
barrier function of healthy individuals, we need to understand whether people 
with abnormal barrier function, specifically those with allergic skin disease, 
may be more susceptible to cyanobacteria. Whether sunlight might 
exacerbate or mitigate contact hypersensitivity reactions is worthy of 
consideration.  
 
Whether cyanobacteria-associated cutaneous eruptions in susceptible 
individuals are primarily irritant reactions, immediate hypersensitivity or 
delayed contact hypersensitivity responses is not at all clear. The picture may 
turn out to be complex and varied, with similarities to the broad topic of 
phytodermatitis. Wilkinson and Shaw (1998) list the principal presenting 
features of phytodermatitis thus: 
 
1. irritant contact phytodermatitis - both chemical and physical. 
2. allergic contact phytodermatitis -  both immediate and delayed. 
3. phytophototoxic dermatitis. 
4. pseudophytophotodermatitis… 
5. allergic contact phytodermatitis with secondary photosensitivity… 
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Cyanobacteria-related dermatoses may also operate through different 
molecular mechanisms and may therefore vary in clinical presentation. Some 
sources of variability in the equation may be: 
 
• Individual susceptibility, e.g. atopic phenotype. 
• Cyanobacteria profile in waterbodies – different species, genera, cell 
 biomass. 
• Cyanotoxins – different types, different mechanisms of toxicity, and 
 variable concentration in waterbodies (i.e. exposure and dose concerns). 
• Disruption to barrier function from waterlogged skin. 
• Influence of UV irradiation – phototoxic effects or immunosuppressive? 
 
 
In conclusion, this pilot study of 39 volunteers has revealed a single individual 
with atopic disease responded to several cyanobacterial extracts applied to 
the skin by closed patch testing. Dose-response relationships were not 
observed in this individual, which supports the clinical findings that these were 
hypersensitivity reactions. This subject developed positive responses to all 
patch sites containing cylindrospermopsin, whereas none of the remaining 38 
subjects showed any response to cylindrospermopsin. This work 
complements a mouse model study of delayed-contact hypersensitivity that 
demonstrates cylindrospermopsin is active in mammalian epidermal tissues. 
Future work into cutaneous effects of cyanobacteria in humans may benefit 
from improved awareness of cellular and molecular mechanisms to allow 
more refined targeting of higher-risk populations.  
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CHAPTER 5: CUTANEOUS TOXICITY STUDIES – THE MOUSE EAR 
SWELLING TEST 
 
5.1. INTRODUCTION AND AIMS 
 
Cyanobacteria, also known as blue-green algae, are common inhabitants of 
freshwater lakes and reservoirs throughout the world. Under favourable 
conditions, certain cyanobacteria can dominate the phytoplankton within a 
waterbody and form nuisance blooms. Anecdotal and case reports have 
documented skin rashes associated with contact exposure to cyanobacteria, 
from recreational and occupational settings (see Chapter 1, Table 1.1). Some 
reports and health advisories refer to irritant reactions (NSW Blue-Green 
Algae Task Force, 1992 p32; Carmichael et al, 1985; Health Canada, 2003) 
but there are also convincing reports of hypersensitivity reactions (Heise, 
1949; Cohen & Reif, 1953). By way of contrast, some cyanobacterial products 
appear to possess dermal anti-inflammatory properties (Romay et al, 1998; 
Garbacki et al, 2000). 
 
The mouse ear swelling test (MEST) was chosen as a model to investigate 
crude extracts of freshwater cyanobacteria, with the reported advantages over 
guinea-pig models of cost-effectiveness, reduced test duration and objective 
data generation as opposed to visual scaling (Gad et al, 1986). Mouse ear 
swelling at the challenge phase was developed as a model of dermal 
sensitisation in the 1960s (Asherson & Ptak, 1968), refined and named the 
mouse ear swelling test by Gad et al (1986), and the test was later revised 
(Gad, 1994). Briefly, the procedure involves four applications of test material 
to the abdomen – the induction phase – followed by challenge application to 
the ear. A micrometer gauge is used to measure ear thickness; an increase in 
ear swelling of 20 per cent or greater in one or more test mice is regarded as 
a positive result (Gad, 1994).  
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5.2. MATERIALS AND METHODS 
 
5.2.1. Cyanobacteria crude extracts  
 
Three cyanobacterial extracts were tested by separate MEST procedures: 
  
- Microcystis aeruginosa strain QH/NR/Ma/03/3 from the Queensland 
 Health Scientific Services Culture Collection. This strain produces 
 microcystins, predominantly microcystin-LR (MC-LR). Microcystins are a 
 group of >60 structurally related cyclic peptide toxins; microcystins in this 
 extract were measured at 13.6 mg/L total microcystins expressed as MC-
 LR. 
- Anabaena circinalis strain AWQC Gar 311FR from the Australian Water 
 Quality Centre, Adelaide. This strain produces saxitoxins, which are 
 structurally related alkaloid neurotoxins, measured at 6.0 mg/L total 
 saxitoxins in this extract. 
- Cylindrospermopsis raciborskii strain AWT 205 isolated and cultured from 
 a Sydney ornamental lake (Hawkins et al, 1997), and supplied by Dr Peter 
 Hawkins of Australian Water Technologies, Sydney. This strain produces 
 the alkaloid toxin cylindrospermopsin, measured at 73mg/L in this extract.  
 
Growth, harvesting, lyophilisation and storage of cells were conducted as 
described in Chapter 4, section 4.2.4.2. A. circinalis was grown and harvested 
as per M. aeruginosa cells in 20L batch culture.  
 
Extracts were prepared by suspending 200mg lyophilised cells in 10mL 
70%v/v ethanol in Milli-Q® filtered water to produce 2%w/v crude extracts. Cell 
suspensions were steeped overnight at 4 0C. Cell integrity was disrupted by 
subjecting each extract to ultrasonic pulsing for 30 seconds, using a Branson 
Ultrasonics Sonifier 450 instrument. Extracts were stored at -20 0C prior to 
use. 
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5.2.2. Quantification of cyanotoxins 
 
Microcystin-LR, saxitoxins and cylindrospermopsin were quantified at the 
laboratory of Mr Geoff Eaglesham at Queensland Health Scientific Services, 
Brisbane. Methodology and instrumentation were as outlined in Chapter 3, 
section 3.3.9.2.  
 
 
5.2.3. Cylindrospermopsin (CYN) solution 
 
Dr W Wickramasinghe of NRCET provided purified CYN. It was produced 
from strain AWT 205, grown by IS in continuous culture as described above, 
isolated by solid phase extraction, purified by preparative HPLC and 
quantified by HPLC/MS/MS per section 3.3.9.2 of this thesis.  1.15mL of a 
521µg/mL solution of CYN in methanol was received, the solvent was 
evaporated under N2, and 6mL 70% ethanol was added to produce a 
100µg/mL solution.  
 
 
5.2.4. DNCB solution 
 
A 0.1%w/v dinitrochlorobenzene (1-Chloro-2,4-dinitrobenzene, purchased 
from Sigma-Aldrich P/L) in 70%v/v ethanol/water solution was used for a 
positive control MEST.  
 
All extracts and solutions were stored at -20 0C prior to use.  
 
 
5.2.5. Ethical approval 
 
The Queensland Health Scientific Services Animal Ethics Committee granted 
approvals for the original study protocol and all subsequent amendments 
under clearance number NRC 3/98/20 IS. 
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5.2.6. Mice 
 
Specific-pathogen-free female Balb/c mice were supplied by either Laboratory 
Animal Services, University of Adelaide, or bred in-house at Queensland 
Health Scientific Services Biological Research Facility. Mice were 8-10 weeks 
of age, housed in groups of five with free access to food and water. An 
exercise wheel was placed in each cage for environmental stimulation.  
 
 
5.2.7. Other materials 
 
• Standard rodent chow enriched with vitamin A acetate 250IU/g was 
 purchased from Glen Forest Stock Feeds, Western Australia.  
• Freund’s complete adjuvant was purchased from Sigma-Aldrich P/L.  
• A micrometer gauge, model 2046F was purchased from Mitutoyo Corp., 
 Tokyo.  
• A proprietary depilatory cream (Nair brand; active ingredient calcium 
 thioglycolate <10%w/w) was purchased from a retail pharmacy. 
• A domestic mains-powered hair-dryer was purchased from a retail outlet. 
 
 
5.2.8. MEST procedures 
 
5.2.8.1. Preliminary investigations – MEST for irritancy 
 
The original approach to this work was to conduct modified MESTs for primary 
irritant reactions, as described by Patrick et al (1985) and Patrick et al (1987). 
Six female mice from each of four strains (Balb/c, C57BL/6J, C3H/HeJ, 
C3H/HeJARC) were purchased from Animal Resources Centre, Canning 
Vale, W.A., and Animal Services Division, John Curtin School of Medical 
Research, Canberra, A.C.T. These mice were dosed with extracts of M. 
aeruginosa (QH/NR/Ma/03, 5%w/v lyophilised cells in 75% methanol) and A. 
circinalis (non-toxic bloom sample, Gordonbrook Dam; 10% w/v in 75% 
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methanol). Test ears were dosed over four consecutive days; ear thickness 
measurements were taken at regular periods throughout. 
 
 
5.2.8.2. MEST for delayed contact hypersensitivity (DCH) 
 
5.2.8.2.1. Pre-testing 
 
After deciding to proceed with experiments to investigate the potential for 
cyanobacteria to elicit DCH reactions (see discussion, Section 5.4.1.1 for 
rationale), and with the approval of the QHSS Animal Ethics Committee, nine 
female C57BL/6J mice were used for pre-testing experiments with M. 
aeruginosa QH/NR/Ma/03 2%w/v extract. Experiments were conducted to 
determine optimal methods for fur removal and tape-stripping, intra-dermal 
adjuvant injection and to find the best vehicle. These tests were also used to 
ascertain the lowest non-irritating induction dose, per methods of Gad (1994).  
 
• Fur removal was conducted with a domestic battery-powered hair trimmer, 
 using the smallest blade (6mm width). Several attempts were needed to 
 procure acceptable clearance of fur, as most mice become agitated after 
 being held for > 1-2 minutes. Use of the trimmer itself appeared to be well-
 tolerated by the mice, but the time taken to complete the procedure 
 effectively seemed to be the weak point, with the majority of mice having a 
 limited tolerance for prolonged handling.  
• Elastoplast, Sleek and generic office sticky-tape were trialled for tape-
 stripping; Elastoplast was found to be the most effective, and well-
 tolerated by mice. 
• Water, 50% aqueous methanol, 75% aqueous ethanol and 100% acetone 
 were investigated to determine the best vehicle. Water was quickly 
 eliminated, as the surface tension of water precludes dispersal and 
 evaporation from prepared abdominal skin. Acetone appeared to induce 
 undesirable attributes to the prepared cyanobacteria suspension, with 
 powdered solids poorly suspended in the extract. Ethanol and methanol 
 218
Chapter 5: Cutaneous toxicity studies – the mouse ear swelling test 
 both gave homogeneous suspensions; the ethanol extract appeared to be 
 most effectively evaporated from abdominal skin.  
• Four concentrations of M. aeruginosa extract were applied: 0.25%, 0.5%, 
 1% and 2%w/v. No erythema or oedema was seen at any dose.  
 
 
5.2.8.2.2. Initial positive control MEST 
 
20 female C57BL/6J mice were used for a positive control MEST with 0.05% 
DNCB. MEST procedures were as described below (Section 5.2.8.2.3). 
Parenteral anaesthesia (ketamine 100mg/kg + xylazine 10mg/kg i.p.) was 
used to facilitate abdominal fur removal with electric clippers. 
 
 
5.2.8.2.3. MEST procedures 
 
All procedures were performed as described in the method of Gad (1994), 
with the following modifications: 
 
• Individual mice were identified by tail markings using a permanent marker 
 pen. This is necessary for research purposes if histopathological 
 examination of ears is performed after the MEST is complete. Individual 
 identification also allows test and control ears to be randomly allocated 
 (see below). 
• Abdominal fur was removed with depilatory cream. Tape stripping to 
 remove the stratum corneum was performed on days 1, 3 and 5 (i.e. tape-
 stripping was not conducted on day 0, after depilatory treatment).  
• Mice were anaesthetised for ear thickness measurements with a 50:50 
mixture of CO and O , as described by Blackshaw & Allan (1995 p73). 2 2
• The test ear of each mouse was randomly assigned as either the left or 
 right ear, using a spreadsheet random number generator (even number = 
 R ear, odd number = L ear).  
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At least two, and more frequently three micrometer readings were taken on 
each ear, depending on the time that each mouse remained motionless after 
CO /O2 2 anaesthesia. Measurements were dictated onto audio cassette tape 
and later transcribed into a spreadsheet. The average of the two or three 
readings taken on each ear was used to determine differences in ear 
thickness between test ears and control ears. Percent ear swelling at each 
measurement period was determined by the formula: % ear swelling = 
,100*⎟⎠
⎞⎜⎝
⎛ −
B
BA  where A = mean test ear thickness and B = mean control ear 
thickness. This formula was also used to determine the percentage ear 
swelling for test groups, where A = sum of mean test ear thickness 
measurements, and B = sum of mean control ear measurements. 
 
All challenge and rechallenge concentrations were the same as for the 
induction doses (2%w/v lyophilised cyanobacteria in 70%v/v ethanol), with the 
exception of the cylindrospermopsin MEST. In this test, the challenge dose 
was 20μL to the ventral pinna and 20μL to the dorsal pinna of each test ear 
using a 50μg/mL CYN in 70% ethanol solution, i.e. half the concentration of 
the induction dose. CYN rechallenge doses were performed with the normal 
induction concentration of 100μg/mL CYN in ethanol.  
 
Briefly, the routine MEST procedures described by Gad (1994) and followed in 
these experiments were: 
 
• All mice were supplied the vitamin A-enhanced diet for two weeks prior to 
 any procedures. This diet was maintained throughout the test. Vitamin A 
 induces epidermal hyperplasia in mice; most cell-mediated immune 
 responses are stimulated by vitamin A supplementation (Thorne et al, 
 1991). 
• Abdominal fur was removed on Day 0; bilateral intradermal injections of 
 Freunds complete adjuvant were administered to all mice.  
• Abdominal skin was tape-stripped prior to dosing (except on Day 0 as 
 noted above and on affected animals per Section 5.3.3). 
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• Test material was applied to the abdominal skin of test mice on days 0, 1, 
 3 and 5. Vehicle only was similarly applied to the abdomens of control 
 mice. Abdominal skin was dried with a hair-dryer after each application. 
• Test ears of the test mice and five control mice were challenged with test 
 material on day 10. Vehicle was applied to control ears. Ears were dried 
 with a hair dryer. 
• Ear thickness was measured with a micrometer at 24 and 48 hours after 
 challenge dosings. 
• Ears of the test mice and the remaining five control mice were dosed with 
 test material on day 17 (rechallenge). Control ears were dosed with 
 vehicle. 
• Ear thickness readings were done at 24 and 48 hours after rechallenge 
 dosings. 
 
 
5.2.9. Histopathology 
 
Mice were sacrificed by CO2 inhalation; ears from five test mice and five 
control mice in the CYN MEST were removed and fixed in 10% phosphate-
buffered formalin. Ears from test mice that produced positive MEST 
responses were selected for histopathology examination. Ears from test mice 
in the C. raciborskii MEST were not considered in this examination as these 
mice were subjected to ear thickness measurements beyond day 19, i.e. past 
the 48-hour post-rechallenge period, in order to monitor their return to 
baseline.  However, ears from three C. raciborskii MEST control mice were 
collected after the 48-hour post-challenge measurements and prepared on 
microscopy slides. Ears from two mice in the A. circinalis and M. aeruginosa 
MESTs were also collected. Liver, kidney, spleen and lung tissue were 
harvested from three mice that were peak responders in both the C. 
raciborskii and CYN MESTs (i.e. organs from six mice were prepared). These 
organs were fixed as for ears. Tissues were prepared at the School of 
Veterinary Science, Department of Veterinary Pathology (Histopathology), 
University of Queensland, stained with haematoxylin and eosin and mounted 
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on glass slides for microscopic examination. Slides were identified with a 
double-letter code generated by spreadsheet random number and ranking 
functions, to allow the examiner to be blinded to the treatment status of each 
slide. Histopathological examination was conducted by presenting the 
pathologist (Emeritus Professor Alan Seawright) with identified slides from 
one control ear and two test ears from the positive control MEST (0.1% 
DNCB) to allow for familiarisation with normal mouse ear morphology and 
type-IV hypersensitivity-related changes. All subsequent slides were read with 
the examiner blinded to their identity. Slides were examined using a light 
microscope fitted with dual binocular eyepieces; the examination of slides 
served as a teaching session for IS. After the initial examination, Prof. 
Seawright was presented again with slides that were reported as equivocal or 
incongruous, given their known status (by IS) as either test or control ears. 
Prof. Seawright was again blinded to the identity of all slides during this repeat 
examination.  
 
We subsequently secured the assistance of Professor David Weedon, clinical 
professor of pathology at the University of Queensland. Prof. Weedon has 
specific interest and expertise in pathology of the skin, and he kindly agreed to 
examine our histopathology slides, so we now have two independent expert 
pathologist assessments of these slides. Prof. Weedon, Dr Ivan Robertson 
and three dermatology registrars simultaneously examined all slides at the 
RBH Department of Dermatology’s microscopy teaching lab. All examiners 
were presented with slides of two DNCB-treated ears and one vehicle-treated 
ear per Prof. Seawright’s examination above. The examiners were blinded to 
the treatment status of all remaining slides. Reporting of each slide was by 
consensus between the five examiners. Dr Robertson and IS met after the 
examination to discuss the findings and unblind the examiners. Slides were 
categorised as either normal or positive thus: 
 
• “neg”, “+/-“ or “+” = normal (most slides rated “+” were described as “focal 
 +”, i.e. sparse or minimal inflammatory cells seen, probably representing 
 normal tissues). 
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• “++” or “+++” = positive. 
 
Measures of inter-observer agreement were estimated using Cohen’s kappa 
and McNemar’s statistics. Fisher’s exact test was used to test the categorical 
response distributions between examiner results. Statistical tests were 
performed using SPSS version 11.5 (SPSS Inc, 2002), and a significance 
level of 5% was employed.  
 
 
5.3. RESULTS 
 
5.3.1. Positive control MEST 
 
Figure 5.1 shows the mean ± SEM ear thickness increase of ten Balb/c mice 
at 24 and 48 hours after ear challenge.  
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Figure 5.1. Mouse ear swelling test: positive control. 0.1%w/v DNCB in 70% 
ethanol. Mean ± standard error of ear thickness increase.  
 5.3.2. Cyanobacteria MESTs 
 
Ear thickness increases, expressed as percent ear swelling, for the four cyanobacterial MESTs and the positive control MEST 
(0.1% DNCB) are given in Table 5.1. 
 
TABLE 5.1. Mouse ear swelling tests (MESTs): positive control + three cyanobacteria crude extracts + purified cylindrospermopsin. 
 
 
Number of mice per 
test group with ear 
swelling >20% after 
challenge 
Number of mice per 
test group with ear 
swelling >20% after 
re-challenge 
Ear swelling (%)* of 
highest responder 
test mouse after 
challenge  
Ear swelling (%)* 
of highest 
responder test 
mouse after re-
challenge  
Mean per cent 
ear swelling* of 
test group after 
challenge (S.D.) 
Mean per cent 
ear swelling* of 
test group after 
re-challenge 
 (S.D.) 
Per cent ear 
swelling of 
highest responder 
control mouse 
after challenge 
and re-challenge 
TEST SUBSTANCE        
 
 
0.1% DNCB 
 
10 Not done 130 Not done 83 (21) Not done Not done 
2% w/v 
M. aeruginosa 
microcystins 13.6 µg/mL 
0 0 11 10 3.1 (7.1) 2.0 (4.1) 8.9 
        
2% w/v 
A. circinalis 
saxitoxins 6.0 µg/mL 
0 0 8.2 9.5 0.8 (2.9) 2.1 (4.1) 12 
        
2% w/v 
C. raciborskii 
CYN 73 µg/mL 
6 
n=2 at 24 hrs  
n=4 at 48 hrs 
6 
n=6 at 24 hrs  
n=2 at 48 hrs 
39 47 19 (7.4) 24 (12) 11 
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2 4 4.8 (challenge)  100µg/mL CYN** 26 49 11 (7.4) 17 (14) n=1 at 24 hrs  n=1 at 24 hrs  28 (re-challenge) n=1 at 48 hrs n=3 at 48 hrs 
 
* ear measurements recorded at 24 and 48 hours after challenge/re-challenge. Tabled results are the higher of the two readings. 
 
** challenge concentration applied to test ears was 50µg/mL. Rechallenge concentration was 100µg/mL (= induction concentration).  
 
 Figures 5.2 and 5.3 show results of MESTs conducted with 2%w/v suspensions of A. circinalis and M. aeruginosa. No test mice in 
these MESTS produced ear swelling readings greater than 20% (Table 5.1), therefore these experimental findings were negative. 
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Figure 5.2. Mouse ear swelling test: 2%w/v Anabaena circinalis 311 Gar in 
70% ethanol. Mean ± standard error of ear thickness increase.  
Figure 5.3. Mouse ear swelling test: 2%w/v Microcystis aeruginosa Ma/03/3 in 
70% ethanol. Mean ± standard error of ear thickness increase.  
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Figures 5.4 and 5.5 show results of MESTs using a 2%w/v suspension of C. raciborskii and purified cylindrospermopsin 100µg/mL. 
A clear average increase in ear swelling can be seen in the test animals. Several mice produced ear thickness increases of more 
than 20% in each experiment (Table 5.1), thus positive results are demonstrated with these two experiments. 
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MEST - Cylindrospermopsis raciborskii crude extract
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Figure 5.4. Mouse ear swelling test: 2%w/v 
Cylindrospermopsis raciborskii AWT 205 in 70% 
ethanol. Mean ± standard error of ear thickness 
increase.  
Figure 5.5. Mouse ear swelling test: 100 µg/mL 
cylindrospermopsin in 70% ethanol. Mean ± standard 
error of ear thickness increase.  
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5.3.3. Induction-phase reactions – C. raciborskii extract and CYN 
 
 
As well as the ear thickness changes given in the above table and histograms, 
primary irritant reactions were seen on the abdominal skin of mice tested with 
the C. raciborskii extract, and with purified CYN. No signs of irritancy were 
seen on the abdominal skin of mice treated with extracts of M. aeruginosa or 
A. circinalis, or DNCB solution. The reaction seen on C. raciborskii and CYN-
treated mice occurred on all test mice with varying degrees of severity. Image 
5.1 shows a test mouse with this reaction. Image 5.2 shows a control mouse 
for comparison; vehicle only (70%v/v ethanol/water) was applied to the 
abdominal skin of control mice.  
 
 
 
 
 
 
 
IMAGE 5.1. Reaction seen at induction phase – cylindrospermopsin 100µg/mL in 70% 
ethanol. 
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IMAGE 5.2. Cylindrospermopsin MEST control mouse at induction phase - dosed with 
vehicle (70% ethanol). 
Lesions produced on abdominal skin were noted from the second induction 
day onwards. Abdominal skin was dry, with yellowish/brown crusts and 
desquamation seen especially in inguinal areas and on upper hind limbs. Only 
very gentle tape-stripping was required in order to produce shiny abdominal 
skin, and in some mice with these lesions, tape stripping was not performed 
when evidently painful (manifested by shrill vocalising and struggling). These 
lesions did not appear to be chronically painful when not disturbed, as 
affected mice were observed to be eating, sleeping and using their exercise 
wheel. More severely affected mice walked with an unusual gait, holding their 
abdomens clear from cage bedding. This was presumably in order to avoid 
contact by wood shavings with encrusted lesions, which, when dislodged, 
resulted in blood or serous fluid oozing from exposed skin. Healing was very 
rapid after induction dosing was complete; by the completion of the 
experiments at re-challenge (day 17), abdominal skin appeared essentially 
normal, with minor residual scarring seen on two animals.  
 
There was a noticeable reduction in self-grooming and mutual grooming of 
abdominal skin and ears in mice dosed with C. raciborskii extract compared to 
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mice dosed with M. aeruginosa and A. circinalis. Even though abdomens and 
ears were dried with a hair dryer after extracts were applied, residual cellular 
material was seen adhering to the skin 24 hours after dosing. Indeed, some C. 
raciborskii debris had to be washed off the test ears of some mice with 70% 
ethanol to allow post-challenge and post-rechallenge readings, as the residue 
was causing spurious measurements with the micrometer. This effect was 
never seen with M. aeruginosa and A. circinalis extracts, as vigorous post-
dose grooming was observed in cages after these applications.  
 
 
5.3.4. Histopathology 
 
5.3.4.1. Prof. A. Seawright’s examination 
 
Test ears from two mice dosed with 0.1% DNCB were described as 
presenting with hyperaemia, infiltration of inflammatory cells – mainly 
mononuclear cells with occasional polymorphonuclear leucocytes (PMNs); 
dilated lymphatic vessels and oedema (increased space between connective 
tissue).  Typical findings from the test ears of test mice dosed with 
cylindrospermopsin were: oedema, thickening, and inflammatory cell 
infiltration – mainly mononuclear cells, though varying degrees of PMN 
infiltration were also seen. One test ear slide showed an epidermal lesion, 
with hyperkeratinisation and associated PMN infiltration. The overall 
impression was of mostly mild inflammatory reactions to cylindrospermopsin, 
with occasionally more severe effects. No pathological changes were seen in 
any of the organs (liver, spleen, kidney, lung) from mice cutaneously exposed 
to C. raciborskii extract or cylindrospermopsin.  
 
 
5.3.4.2. Prof. D. Weedon / Dr I. Robertson examination 
 
Test ears from the two mice dosed with DNCB were described as inflamed, 
and rated “+++”. Remaining ear tissue slides were rated as per Section 5.2.9. 
One ear from a cylindrospermopsin-challenged mouse was rated “+++ with 
 229
Chapter 5: Cutaneous toxicity studies – the mouse ear swelling test 
eosinophilia”, and a control ear (i.e. vehicle-only treated) from another 
cylindrospermopsin-challenged mouse was rated “++ with some eosinophils”. 
Again, liver, kidney, lung and spleen tissues from all six mice dosed with C. 
raciborskii extract or purified cylindrospermopsin were reported as normal.  
 
 
5.3.4.3. Measures of inter-rater agreement 
 
Of the 32 ear tissue slides examined, Prof. Seawright called 30 as either 
positive or normal. The remaining two slides were rated “equivocal pathology” 
and therefore not called. The examination by Prof. Weedon, Dr Robertson et 
al called all 32 slides, which were categorised as either positive or negative. 
Of the 30 slides rated by both examiners as positive or normal, the two 
examiners agreed on 28 slides. Two slides rated as normal by Prof. Weedon’s 
group were called positive by Prof. Seawright.  
 
Fisher’s exact test to examine marginal distributions gave a p-value of 0.35, 
which shows that the marginal distributions of both examiners responses were 
not significantly different. 2x2 crosstabulations on the 30 slides rated by both 
examiners gave a Cohen’s kappa score of 0.83 (95% CI: 0.61, 1.0). 
McNemar’s test returned a two-sided probability of 0.50.  
 
Table 5.2 shows the results of the microscopy examinations, with results 
summed into positive, negative and equivocal categories.  
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• All control ears (test and control mice) were dosed with vehicle only. 
• Test ears of test mice were subject to challenge and rechallenge following abdominal skin 
induction dosing of test material. 
• Test ears of control mice were dosed with no prior induction dosing of test material, i.e. should 
produce a negative MEST if sub-irritant doses are applied. 
 Initial examination Re-examination (Seawright) 
 Positive 
reaction 
Normal 
histology 
Equivocal 
histology 
Positive 
reaction 
Normal 
histology 
Equivocal 
histology 
       
CYN  
test mice  
test ears  
n=5 
3 
4 
2 (2) 
1  1 1  
       
CYN  
test mice  
control ears  
n=5 
1 (1) 
1 
4 
4  1   
       
C. raciborskii 
control mice  
test ears  
n=3  
 
 
2  
3 
 
1 (1)  1  
       
C. raciborskii 
control mice 
control ears  
n=3 
 2 3 1 (1)  1  
       
CYN  
control mice 
test ears  
n=5 
2 (2) 
2 
1  
3 2 (2) 3 1  
       
CYN  
control mice 
control ears 
n=5 
 5 5     
       
A. circinalis  
test mice  
test ears  
n=2 
 1 (1) 2 1 (1)  1 1 
       
A. circinalis  
test mouse 
control ear  
n=1 
1 (1) 1   1  
       
M. aeruginosa 
test mice 
test ears  
n=2 
 2 (2) 2   1 1 
       
M. aeruginosa  
test mouse 
control ear  
n=1 
 1 1     
Table 5.2. Histopathology results – mouse ear swelling test. Prof. A. Seawright’s 
examination and re-examination: black font. Prof. D. Weedon et al: red font. 
Numbers in parentheses show which slides were re-examined. 
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Images 5.3 and 5.4 are examples of histopathology findings. Note the test ear inflammatory cell infiltrate, thickening  
of dermal structures and the area of epithelial hyperplasia. Both ears are from the same mouse. 
 
 
            
Image 5.3. Cylindrospermopsin MEST, control ear (vehicle only).             Image 5.4. Cylindrospermopsin MEST, test ear. 
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5.4. DISCUSSION 
 
5.4.1. Preliminary investigations 
 
5.4.1.1. MEST for irritancy 
 
No clear positive result was seen with either M. aeruginosa or A. circinalis, 
which were very concentrated extracts – these 5%w/v and 10%w/v 
concentrations being about the maximum amount of lyophilised cyanobacteria 
we could get into a viscous suspension. We then returned to the literature, 
and with some human case reports giving convincing descriptions of 
hypersensitivity reactions (Heise, 1949; Cohen & Reif, 1953), we decided to 
try the full MEST procedure for delayed-contact hypersensitivity.  
 
When deciding which mouse strain would be the most appropriate for these 
tests, we decided to use C57BL/6J mice, on the basis that from the MEST 
irritancy experiments described above, two of six C57BL/6J mice had ear 
thickness increases ≥20% (two non-consecutive measures from each mouse 
from a total of 16 and 17 ear thickness measures respectively). The only other 
response seen in these experiments was from one Balb/c mouse, which 
yielded one ear thickness increase of 26% from a total of 18 measurements. 
While these data were not at all convincing in terms of deciding on an 
appropriate mouse strain, we surmised that, all other things being equal, 
C57BL/6J mice would not likely be any worse responders than mice from the 
other three strains.  
 
 
5.4.1.2. Initial positive control MEST 
 
No C57BL/6J mice used for the initial 0.05% DNCB MEST responded, with no 
ear measurements at either challenge or rechallenge showing ≥20% increase 
in thickness. We considered abandoning this work, however, on re-reading the 
original paper by Gad et al (1986), we discovered that C57BL/6 mice 
frequently fail to respond to DNCB, and that CF-1 and Balb/c strains were 
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superior to seven other strains in their response to a range of test compounds. 
The obvious lesson here is to be fully conversant with the relevant literature; 
while ostensibly a waste of time and animals in conducting this test with the 
wrong strain, valuable experience was gained by IS in refining the techniques 
of abdominal fur removal and intradermal injection. Intraperitoneal 
anaesthesia, while effective in terms of eliminating restraint-associated stress, 
opened another realm of disadvantage, with the inherent risks of small-animal 
parenteral anaesthesia immediately apparent on the death of one mouse 
about five minutes after injection. Prior to completion of this MEST, depilatory 
cream was applied to the abdomens of two mice; this appeared to be well-
tolerated by the animals, and produced excellent fur removal with minimal 
handling. All subsequent MESTs were performed with depilation.  
 
One final, possibly pyrrhic, result of this test on the wrong mouse strain is that 
we can confirm the findings of Gad et al (1986) that C57BL/6J mice are non-
responders to DNCB in the mouse ear swelling test.  
 
 
5.4.2. MEST for delayed-contact hypersensitivity 
 
A repeat positive control MEST was successfully conducted with Balb/c mice 
(see Figure 5.1) at a concentration of 0.1%w/v DNCB in 70% ethanol, which, 
while higher than the recommended concentration of 0.05% (Gad, 1994) is a 
clearly acceptable sensitising, below-irritant dose (Garrigue et al, 1994; Howell 
et al, 2000). All ten mice gave ear swelling readings >20%, with a maximum 
ear thickness increase of 130% (see Table 5.1). Unilateral ear erythema was 
seen as soon as one hour after challenge dosing; at 24 hours there was 
obvious unilateral erythema and swelling on the ears of all animals.  
 
A MEST using M. aeruginosa extract was then conducted. Because of the 
negative response seen on abdominal and ear skin to the highest dose of M. 
aeruginosa extract during pre-testing experiments, the MEST pre-test irritancy 
screen in the methods of Gad (1994) was dispensed with in order to limit the 
required number of experimental animals (Gad recommends at least eight 
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mice for each MEST pre-test). As seen in Table 5.1, this MEST was negative, 
as no mice produced ear thickness increases greater than 20 percent. No 
abnormalities (erythema, oedema) were seen on the abdominal skin of any 
mice.  
 
The next MEST was conducted with a crude extract of C. raciborskii, at a 
concentration of 2%w/v in 70% ethanol, as per the previous MEST with M. 
aeruginosa. As the previous cutaneous-route experiment with toxic M. 
aeruginosa was negative, we reasoned that the experiment with C. raciborskii 
would probably elicit similar findings; therefore pre-testing experiments were 
again dispensed with. However, it became clear on day three of induction 
dosing, i.e. some 72 hours after the first induction dose, that something very 
different was happening. Dry, encrusted lesions were seen on the abdomens 
of all test animals – and on no control animals – from day three onwards. No 
abnormalities were seen on day one, i.e. 24 hours after the first dose. No 
observations were taken on day two, following the second induction dose, so it 
is not known whether these abdominal lesions would have been apparent any 
earlier than when first observed at 72 hours, following two dosings at 0 and 24 
hours. Aware of the possibility that the reactions seen on abdominal skin 
would also be found on the test ears of control (i.e. naïve to C. raciborskii) 
mice, thus invalidating the MEST, we decided to proceed with the test. 
Fortunately, no such reaction was seen (see Table 5.1 and Figure 5.4) in any 
of the ten mice used in challenge and rechallenge tests, thus confirming the 
findings of Gad (1994), who notes that a concentration of test material that is 
irritating to one site – abdomen or ear – may not be an irritant concentration 
for the other. Irritant concentrations for ears are frequently higher than 
concentrations that will irritate abdominal skin (Gad et al, 1986). Therefore this 
MEST has shown that a 2%w/v concentration of C. raciborskii extract 
produces both a primary irritant reaction on mouse abdominal skin, and 
delayed-contact hypersensitivity. Unilateral erythema and swelling was seen 
on the ears of some test mice, similar to but of lesser intensity than the 
reactions seen on positive control MEST mice dosed with 0.1% DNCB. No 
such reactions were seen on any control mouse ears. No signs of cutaneous 
injury similar to that seen on abdominal skin were observed on any ears. 
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Reactions were more pronounced after rechallenge compared to challenge 
readings, as seen in Table 5.1 and Figure 5.4. 
 
A MEST to investigate a 2% w/v concentration of A. circinalis AWQC 311 
GarFR was then conducted, but no positive findings were produced (Table 5.1 
and Figure 5.2). 
 
Finally, we decided to conduct one more MEST using purified 
cylindrospermopsin, to investigate further the findings from the C. raciborskii 
MEST. The concentration was higher than the measured concentration of 
cylindrospermopsin in the 2% C. raciborskii extract (100µg/mL cf 73µg/mL), 
therefore, again mindful of the risk of inducing an irritant reaction on the test 
ears of control mice, the challenge concentration of cylindrospermopsin 
(50µg/mL) was half that of the induction dose. The result of this phase of the 
MEST experiment, where two of nine test mice produced ear swelling >20% 
and no control mice had increased swelling, leads us to declare that purified 
cylindrospermopsin is also a Type IV sensitiser. Rechallenge was conducted 
with the induction concentration of 100µg/mL, but one of six control mice 
produced an ear swelling of 28%, therefore no clear statement can be made 
about these MEST rechallenge readings, as 100µg/mL cylindrospermopsin is 
most likely an irritant dose for the mouse ear. Two other control mice at 
rechallenge had ear thickness increases of 16% and 12%, which contributed 
to the mean control ear swelling of 13% (see Figure 5.5). 
 
Reactions seen on abdominal skin in the cylindrospermopsin MEST were 
identical to those seen during the C. raciborskii MEST. Again, all test mice had 
visible lesions to varying degrees. Healing was rapid after the final induction 
dose on day 5, so that by day 8, one mouse had a residual dry scab on the 
abdomen, and the remaining eight mice had essentially normal looking 
abdominal skin.  
 
Because of the different challenge dose used in the cylindrospermopsin MEST 
and the probable irritant reactions seen at rechallenge, it is not possible to 
make confident predictions about the relative contribution of 
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cylindrospermopsin to the reactions seen in the C. raciborskii MEST. 
However, the gross similarity of reactions seen on abdominal skin in both 
tests, and the met criteria for delayed-contact hypersensitivity from both 
MESTs suggests that cylindrospermopsin is the major contributor to the 
results of the C. raciborskii MEST.  
 
There are several specific points of departure when attempting to apply the 
results of these findings to assessing the risk for humans in recreational or 
occupational contact with cylindrospermopsin-producing cyanobacteria:  
 
• The concentration of cylindrospermopsin was well above that likely to be 
 encountered in natural waters (see following discussion, Section 5.4.6.4.). 
• Barrier function was disrupted by tape-stripping during the induction 
 phase. Removal of the stratum corneum by tape-stripping stimulates the 
 release of pre-formed IL-1α and other inflammatory cytokines from the 
 epidermis (Nickoloff & Naidu, 1994; Wood et al, 1996). 
• A vehicle (70% ethanol) was used to aid the transport of soluble factors 
 across the epidermis. Matrix effects can be highly significant determinants 
 of the potency of allergens, with reported variability of more than two 
 orders of magnitude due to different vehicles (Boukhman & Maibach, 
 2001).  
• Mice were immunologically primed to respond to sensitisers by use of 
 Freunds adjuvant and the high vitamin-A diet.  
 
However, the main aim of conducting animal models in this kind of exploratory 
work was to determine whether the mechanism of irritancy and 
hypersensitivity was feasible with these cyanobacterial extracts. Further 
investigation to determine dose-response relationships and cellular and 
molecular mechanisms should follow from this work.  
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5.4.3. Histopathology 
 
The kappa score of 0.83 indicates “almost perfect” agreement between the 
two independent, blinded examiners (Landis & Koch, 1977), and the non-
significant McNemar’s test indicates that the discordance between examiners 
is random rather than systematic. 
 
From Table 5.2, there are apparently three false positive readings: test ears 
from two control mice tested with 100μg/mL purified cylindrospermopsin at 
rechallenge, i.e. test material applied to naïve mice (Table 5.2, row 5). 
However, from Table 5.1, Figure 5.5 and discussion in Section 5.4.2, it seems 
clear that the rechallenge CYN concentration of 100μg/mL was an irritant dose 
for at least one mouse, as determined by an ear thickness increase greater 
than 20 per cent. Both pathologists rated the same two test ears as positive 
from this group of five control mice. One of these “false positive” test ears was 
from a mouse that produced a 28% difference in ear thickness after 
rechallenge (Table 5.1). Therefore, because both examiners rated the same 
two ears as having a positive reaction, and the dose applied to the ears of 
these naïve mice was probably in the irritant range, the most likely 
interpretation is that these were not false positive readings, but true positive 
findings. Prof. Seawright described the slide from the mouse producing the 
28% ear swelling reading as having “oedema, mild inflammatory infiltrate, with 
some polymorphs”; Prof. Weedon’s group rated this ear at “+++”.  Prof. 
Seawright rated the test ear of another mouse in the CYN control group 
initially as equivocal, and then as displaying a mild positive reaction when re-
examined. Prof. Weedon’s group rated this ear as “minimal +”, which was 
interpreted as normal by the agreed scoring method.  
 
The other “false positive” reading is from a control ear, i.e. dosed with vehicle 
only (Table 5.2, row 2). Prof. Seawright was twice presented with this slide; he 
reported it positive on both occasions, describing it as oedematous, with 
polymorph infiltration. Prof. Weedon’s group also described this slide as 
positive, rating it “++ with some eosinophils”. Therefore, it would appear that 
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this slide also represented true positive histopathology. The explanation is not 
so obvious on this occasion: several possibilities spring to mind: 
 
1. The control ear was wrongly dosed with test material – in this case 
 cylindrospermopsin 100μg/mL CYN at rechallenge. 
2. The control ear was incorrectly identified post-mortem. 
3. The ear was incorrectly identified during the staining and mounting 
 process. 
4. The ear had encountered some unidentified trauma in the period before 
 the experiment ended, thus establishing an inflammatory reaction. 
 
Points 1 and 4 above seem unlikely to have occurred in this instance, as the 
ear thickness readings for this mouse throughout the MEST procedure were 
always positive, i.e. the test ear consistently produced higher micrometer 
readings than the control ear in question. Care was taken during the MEST 
procedure to prevent incorrect dosing of test and control ears: the test ears of 
all mice in each MEST were dosed and dried, then the container with the test 
extract or solution was sealed, the container tube for the vehicle was opened, 
and each mouse was taken from its cage for dosing of control ears. The 
histopathology of the test ear from this mouse was also clearly positive: Prof. 
Seawright described it as having cellular proliferation, polymorphs and 
mononuclear cells and oedema. Prof. Weedon’s group rated this test ear at 
“+++”.  
 
One CYN MEST test ear (mouse B6) was reported as normal by Prof. 
Seawright (after two inspections) and by Prof. Weedon’s group (Table 5.2, row 
1). This finding correlates with the MEST results insofar as the mean 24 and 
48-hour post-rechallenge ear thickness increases for mouse B6 were 5.5% 
and 6.5% respectively. The 24 and 48-hour post-rechallenge readings for the 
other four mice whose test ears returned positive histopathology findings 
were: 18%, 15%, 18% and 7.4% (24 hour readings) and 22%, 18%, 49% and 
22% (48 hour readings).  
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Ears from test mice (i.e. subject to induction and challenge dosing) from the C. 
raciborskii MEST were not included in the measures of agreement statistics 
and their data are not presented in Table 5.2. This is because these mice 
were monitored for ear swelling after the 48-hour post challenge / rechallenge 
reading period, at which time the other MEST experiments were terminated 
and ears were harvested. Ear swelling data for the C. raciborskii MEST are 
given in Appendix 7. Ears of five mice (B1, B6, B7, B8 and B9) were fixed, 
stained and mounted on slides as described in Section 5.2.9.  The test ear of 
mouse B7 was described as positive by both pathologists, which correlates 
with the ear thickness increase of 25% prior to termination of the experiment. 
The other mouse (B6) with increased ear thickness (24%) at time of death 
was reported as having positive histopathology in the test ear by Prof. 
Seawright only. All control ears and the test ears of the remaining three mice 
(B1, B8, B9) had apparently normal histology. 
 
No positive histopathology was seen in test ears of mice from the A. circinalis 
and M. aeruginosa MESTs; this supports the negative findings of both those 
MESTs.  In conclusion, the histopathology findings correlate well with the 
MEST results, and the two independent pathologist examinations demonstrate 
excellent agreement.  
 
 
5.4.4. General discussion 
 
5.4.4.1. Previously published animal-based studies of skin reactions to 
cyanobacteria 
 
Dermal toxins produced by the marine filamentous cyanobacterium Lyngbya 
majuscula have been investigated and characterised (Moikeha & Chu, 1971; 
Hashimoto et al, 1976; Solomon & Stoughton, 1978; Moore, 1984), but there 
is little published research on the cutaneous effects of planktonic freshwater 
cyanobacteria. 
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Only two reports referring to experimental cutaneous reactions to toxic 
freshwater cyanobacteria were found in the literature. The first, by van Hoof et 
al (1994), was a conference poster presentation in which skin irritation and 
sensitisation tests were used in conjunction with LD50 and in vitro mutagenicity 
tests as a toxicity screen for bloom samples. Supernatants of four toxic M. 
aeruginosa strains were applied to the shaved skin of rabbits; patches were 
used to apply the supernatants. No signs of irritancy were observed at 24, 48 
and 72 hours. Interpretation of the reported test for delayed contact 
hypersensitivity is more problematic. Notwithstanding the size limitations for 
such a presentation, it appears from the description of the methods that 
supernatants from two of the M. aeruginosa strains tested on rabbits were 
applied to the skin of guinea pigs (20 test animals plus 10 controls for each of 
the two tests) over a six-hour period. Animals were then examined at 24 and 
48 hours. If these experiments were conducted entirely within a 54-hour 
period, they were also tests for irritancy, not DCH. Either way, no adverse 
signs (“symptoms”) were found. Treatments applied to control guinea pigs 
were not reported. 
 
The other publication, by Torokne et al (2001) is more detailed, but again 
some aspects of the report are difficult to interpret. Seven bloom samples, two 
non-axenic laboratory cultures and six axenic cultures were tested. Purified 
microcystin-LR (reported at a concentration of 1.5mg/mL once in the abstract 
and 1.5μg/mL three times in the body of the report) was also tested. Crude 
extracts and cyanotoxin doses were apparently significantly lower than those 
used in this MEST work, although it is difficult to make reliable comparisons, 
as Torokne et al (2001) used the intradermal induction route, whereas these 
MEST studies involved topical application. Table 5.3 presents estimated dose 
comparisons for the two sets of experiments.  
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Table 5.3. Comparison of test concentrations and estimated induction and irritant doses between mouse ear 
swelling test studies and work of Torokne et al (2001).  
         Mouse ear swelling test studies            Torokne et al (2001) studies 
   Cyanobacteria Microcystins     CYN   Cyanobacteria Microcystins    CYN 
   crude extracts     crude extracts 
 
Concentration  2% w/v in 70% 13.6µg/mL 100µg/mL** 0.1% w/v in  10.2µg/mL* 800ng/mL** 
   aq ethanol     water + NaCl 
 
Dose per animal 8mg topical 5.44µg topical 40µg topical 100µg i.d. 1.04µg i.d. 80ng i.d. 
   (=4x100µL     (guinea pig) (guinea pig) (guinea pig) 
   induction     200µg i.d. 2.08µg i.d. 160ng i.d. 
   doses)      (rabbit)  (rabbit)  (rabbit) 
 
Estimated dose 381mg/kg 238µg/kg 2.3mg/kg 143µg/kg 1.49µg/kg 114ng/kg 
by weight  (average (average (average (guinea pig®) (guinea pig®) (guinea pig®) 
   mouse   weight  weight 
   weight  = 22.9g) = 17.7g) 80µg/kg 832ng/kg 64ng/kg 
) (rabbit ) (rabbit )    = 21.0g)     (rabbit% % %
 
 
 * = highest concentration from nine microcystin-producing cyanobacteria strains 
** = highest cylindrospermopsin concentration from two studied preparations 
®:Assumed guinea pig weight: 700g 
%: Assumed rabbit weight: 2.5kg 
 
 
Intradermal irritancy tests were conducted on rabbits; results were described 
as slight or negligible. Guinea pig maximisation tests were used for DCH 
determination; the reported proportion of sensitised animals ranged from 30% 
from two Microcystis blooms to 91% from an Aphanizomenon bloom. A non-
axenic C. raciborskii extract reportedly sensitised 50% of guinea pigs. These 
proportions were applied to allergen rating scales of “moderate allergen” for 
the Microcystis and C. raciborskii extracts to “extremely strong allergen” for 
the Aphanizomenon extract (Torokne et al, 2001). 
 
The difficulties in interpreting the work of Torokne et al (2001) come from the 
reported percentages of sensitised guinea pigs, which are not derivable from 
the reported number of animals tested. Also, no details are given about the 
grading of end-points (erythema and oedema) in either test animals or 
controls; no photographic evidence of positive and negative reactions was 
published.  
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The authors noted that no irritant or DCH effects were seen with axenic 
cyanobacterial extracts, and therefore concluded that the lipopolysaccharides 
(LPS) of contaminating bacteria were implicated in their positive findings from 
non-axenic cyanobacteria (Torokne et al, 2001). As discussed in Chapter 2, 
the attribution of LPS involvement – cyanobacterial or otherwise – in skin 
pathology is uncertain at best, and the only references to reports of LPS-
associated acute skin rashes appear to be from the cyanobacteria literature, 
with no specific research findings to support such attribution.  
 
If the findings of Torokne et al (2001) can be repeated in other laboratories, 
supporting evidence such as histopathological examination of challenged skin 
would be helpful.  
 
In addition to the two papers discussed above examining cutaneous effects of 
toxic cyanobacteria, Shirai et al (1986) describe an intraperitoneal induction 
and subcutaneous challenge test for delayed-type hypersensitivity, examining 
responses to non-toxic Microcystis bloom samples and an axenic non-toxic 
culture of M. aeruginosa. Mice were challenged two weeks after i.p. 
inoculation of cells by s.c. injection into a rear footpad, and increases in 
footpad thickness were measured. The authors report induction of delayed-
type hypersensitivity by this mouse footpad swelling test.  
 
Finally, Krishnakumari et al (1981) reported dermal testing of Spirulina 
platensis, a non-toxic cyanobacterium. S. platensis is widely used as a human 
and animal food supplement (Ciferri, 1983). The authors used an occlusive 
application technique to apply doses of up to 2g/kg to the dorsal skin of rats 
for 24 hours; the animals were observed for two weeks, with no signs of 
erythema or oedema reported. Like the study by van Hoof et al (1994) 
discussed above, Krishnakumari et al (1981) suggest that they found no 
evidence of cutaneous allergy to their test cyanobacteria, whereas their study 
was clearly a test for primary irritancy. 
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5.4.4.2. Use of the MEST for regulatory and research purposes 
 
Gad and Chengelis (1998 p115) noted two disadvantages of the MEST: the 
database is not as extensive as that of standard tests such as the guinea pig 
maximization test or the Buehler test, and fewer people have experience with 
the MEST. The European Centre for Ecotoxicology and Toxicology of 
Chemicals (ECETOC, 1990a pp37, 39; ECETOC, 1999b p2) suggested that 
the MEST will require more inter-laboratory validation testing before it will be 
acceptable as a regulatory tool for the assessment of environmental 
sensitisers. However, OECD 1992 guidelines support the use of the mouse 
ear swelling test as a first-stage assessment of sensitising potential. A positive 
result in a MEST allows a test substance to be designated a potential 
sensitiser without the requirement for a guinea-pig test. Negative results in a 
MEST would necessitate a guinea pig test for regulatory assessment 
purposes (OECD, 1992). Another murine test, the local lymph node assay, 
has recently gained acceptance by several regulatory agencies as a 
standalone alternative to established guinea pig tests after extensive inter-
agency validation (ECETOC, 2000 pp19-21; Basketter et al, 2003).  
 
rdFour literature searches conducted on March 23  2004, using the terms 
“mouse ear swelling test” and “MEST AND sensit*” run on PubMed and Web 
of Science yielded 47 references for dermal-related publications since the 
beginning of 1999. The “sensit*” term was used to narrow that search, as 
MEST is not an exclusive acronym for the mouse ear swelling test. The 
abstracts of these 47 publications were perused. 18 papers describe mouse 
ear swelling used for investigating anti-inflammatory properties of various 
materials, i.e. an inflammatory agent was used to produce ear swelling, and 
the test materials examined to determine any reduction of swelling. Three 
abstracts did not refer to any mouse ear work, and one paper reported mouse 
ear swelling used to determine irritancy. Two papers were review articles, and 
one abstract on guinea pig models for contact allergens had MEST as a 
keyword. Of the remaining 22 publications, 10 used the MEST to investigate 
various molecular mechanisms of DCH, 10 used the MEST to determine the 
sensitising potential of a range of materials, and two were comparison studies 
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of the MEST and other DCH methods. MEST publications prior to 1999 were 
not reviewed. This cursory review of MEST publications is intended to do no 
more than point out that the MEST is being used as a research tool. Our 
research group also found the MEST to be a useful “first-look” methodology 
for investigating the sensitising potential of cyanobacteria. The 10 references 
for papers using the MEST for molecular mechanisms of DCH are: (Wille et al, 
1999; Sailstad et al, 2000; Dufour et al, 2002; Ohtsu et al, 2002; Tumpey et al, 
2002; Becker et al, 2003; Curiel-Lewandrowski et al, 2003; Lu et al, 2003; 
Okamura et al, 2003; Shimizu et al, 2003). Ten studies using the MEST to 
investigate the sensitising potential of various compounds are: (Hayes & 
Meade, 1999; Hegde & Niederkorn, 2000; Ptak et al, 2000; Karrow et al, 2001; 
Gregerson & Dou, 2002; Ikarashi et al, 2002; Karrow et al, 2002; Kato et al, 
2002; Xu et al, 2002; Klink & Meade, 2003). Two papers comparing the MEST 
with other DCH methods are Howell et al (2000) and Lee et al (2003).  
 
 
5.4.4.3. Innate immunity of the skin and cyanobacteria 
 
An important question concerning the public health impact of freshwater 
cyanobacteria in untreated and reticulated water relates to whether complaints 
of acute skin reactivity are due to cutaneous irritant reactions, hypersensitivity 
reactions, or both. Epidemiological reports of mass outbreaks of acute 
dermatitis and subsequent laboratory investigations have demonstrated that 
the phorbol ester-like toxins produced by the marine filamentous 
cyanobacterium Lyngbya majuscula are capable of producing true irritant 
reactions by a mechanism involving protein kinase C activation (Grauer, 1959; 
Grauer & Arnold, 1961; Moikeha & Chu, 1971; Hashimoto et al, 1976; 
Solomon & Stoughton, 1978; Moore, 1984). However, the structurally 
unrelated toxins produced by planktonic freshwater cyanobacteria have not 
been systematically studied for their actions on the skin. Reports of large 
numbers of individuals describing acute skin rashes related to recreational 
contact with freshwater cyanobacteria do not appear in the literature. Pilotto et 
al (2004), in their recent human volunteer study, reportedly demonstrated 
infrequent cutaneous irritant reactions to cyanobacteria, but as outlined in 
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Chapter 4, section 4.4.9, it is possible that Pilotto et al (2004) may have 
witnessed early signs of hypersensitivity reactions in their study subjects. 
 
A common theme throughout this thesis is that of innate immune responses to 
cyanobacteria and cyanotoxins. Understanding the nature of the cutaneous 
irritant and hypersensitivity reactions to cylindrospermopsin will also likely fall 
within the scope of the immunologically-conscious toxicology investigator. The 
role of the skin is not only to provide a physical barrier to separate the 
individual from the outside world, but it also serves as a dynamic environment 
for the innate immune system to recognise and respond to pathogens (Rich & 
Kupper, 2001). While skin irritation is defined as a non-immunogenic, locally-
arising inflammatory reaction (Homey et al, 1998; Welss et al, 2004), the term 
“non-immunogenic” refers to the non-requirement of clonal components and 
mechanisms of acquired immunity in initiating primary irritant reactions, in 
contrast to the antigen-specific T cell-mediated (“immunogenic”) mechanism 
of DCH. The innate immune system is fundamentally involved in irritant skin 
reactions (Müller-Decker et al, 1994; Kimber, 1996; Parish & Breathnach, 
1998; Wilkinson & Willis, 1998); perhaps “non-specific” rather than “non-
immunogenic” might be a better description of irritancy. Cytokines such as 
TNF-α, IL-1, IL-3, IL-6, GM-CSF and many more are released by 
keratinocytes, which are activated by both irritants and allergens (Roitt et al, 
2001 p372; Gröne, 2002).  Keratinocytes, which comprise some 95% of the 
epidermal cell mass, are principal signalling mediators that translate 
exogenous stimuli into endogenous signals regulated by various pro-
inflammatory cytokines and eicosanoids (Barker et al, 1991; Müller-Decker et 
al, 1994). Keratinocytes contain pre-formed IL-1α in their cytoplasm; this pro-
inflammatory cytokine is described as the main switch in the induction of 
cytokine cascades (Müller-Decker et al, 1994; Welss et al, 2004).  Other 
innate immune cells such as neutrophils, dermal dendritic cells and epidermal 
Langerhans cells are pivotal components of irritant-induced inflammatory 
reactions (Willis et al, 1993; Gröne, 2002; Castellano et al, 2004).  
 
Acute inflammatory reactions in the skin are another example of the concept 
alluded to in this thesis, that the adverse responses to some cyanotoxins may 
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be understood in terms of endogenous mediators of innate immunity. Like the 
indirect responses to LPS and the endogenous mechanisms of fever, so acute 
skin reactions to cyanobacteria are not direct effects, but are the hallmarks of 
a complex repertoire of endogenous inflammatory mediators. That pro-
inflammatory cytokines are primary mediators in skin reactions is 
demonstrated by the use of transgenic mice. Animals that overexpress IL-1α 
and TNF-α in the epidermis develop inflammation and skin disease, 
demonstrating that these cytokines are capable of inducing inflammation in 
vivo (Kupper & Groves, 1995). 
 
While the distinction between innate and adaptive immunity is a useful 
descriptive concept, it is an arbitrary distinction, and the two arms are 
inextricably linked. This is also clearly the case with skin irritancy and 
hypersensitivity. While the molecular mechanisms of irritancy and type IV 
hypersensitivity are clearly different, the resultant inflammatory reactions show 
some similarities. The clinical presentation of irritant and allergic contact 
dermatitis can be difficult to differentiate, with erythema, oedema, 
desquamation and pruritus being common to both (Welss et al, 2004). 
Kligman (1996) notes that inflammatory events, once begun, and whether 
stimulated by irritants or allergens, proceed along a common, stereotyped 
pathway. Similarities are also seen at the molecular level: antigens or irritants 
stimulate signalling of TNF-α, IFN-γ and GM-CSF in Langerhan’s cells shortly 
after topical application (Boukhman & Maibach, 2001; Roitt et al, 2001 p373). 
Langerhan’s cells are the principal antigen-presenting cell to T lymphocytes, 
which then undergo clonal expansion in sensitised individuals (ECETOC, 
2000 p23; Roitt et al, 2001 p372). The activation of memory T-cells by antigen 
results in the release of cytokines and chemokines that attract and stimulate 
other leucocytes to participate in the inflammatory reaction that is seen 
clinically as delayed-contact hypersensitivity (ECETOC, 2000 p24). As with 
other immunologically-mediated events discussed in this thesis, the processes 
involved in irritant and hypersensitivity reactions are very complex. While 
some of the same pro-inflammatory cytokines are produced in both irritant and 
DCH reactions, it is the complex signalling and interplay between the various 
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pro and anti-inflammatory mediators that characterises the responses. 
Different patterns of cytokine production in the induction phase of DCH are 
seen to those involved in irritant reactions (Enk & Katz, 1992), and structurally 
different irritants induce skin irritation by different mechanisms (Patrick et al, 
1985; Willis et al, 1990; Willis et al, 1993; de Boer & Bruynzeel, 1996).  
 
 
5.4.5. Problems and suggested solutions 
 
5.4.5.1. CO /O  anaesthesia 2 2
 
The method of 50:50 CO /O2 2 anaesthesia described by Blackshaw & Allan 
(1995 p73) is an excellent form of very short-acting chemical restraint, ideally 
suited to the requirements of the mouse ear swelling test. When delivered at a 
flow rate of 10L/min in a 1L beaker (to prevent dilution of gases with ambient 
air), a mouse will lose consciousness in about 20-30 seconds and will remain 
motionless when removed from the beaker for about 15-20 seconds. This is 
sufficient time for an experienced investigator to record four to six ear 
thickness readings with a micrometer gauge on both ears. The mouse will 
rapidly regain awareness after this time, and will respond to attempts to 
manipulate the ears by retracting them towards the body. Recovery from 
anaesthesia is invariably rapid, with the mouse lying motionless or moving 
slowly, hyperventilating and with apparently increased tidal volume for about 
one minute. After about three minutes, no residual effects can be observed, 
with anaesthetised mice behaving normally.  
 
The above description applies to the proceedings observed when the 
technique works well, which was the case in the overwhelming majority of 
CO /O2 2 anaesthetics conducted by IS over the course of these experiments, 
with over 400 performed without incident in the MEST irritancy experiments 
conducted before the delayed-contact hypersensitivity MESTs. However, 
serious intermittent and unexplained problems render this technique 
somewhat unreliable. During the M. aeruginosa MEST, conducted in May 
2002, all 15 mice (10 x test mice, 5 x control mice) anaesthetised for 
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challenge readings were slow to recover from the anaesthesia. One mouse 
died some 3½ hours after anaesthesia, with signs of respiratory distress and 
pulmonary oedema (hyperventilation, use of accessory muscles, some 
peripheral cyanosis and pink, frothy exudate on nares). Lungs at post-mortem 
examination were congested and enlarged. Concerned that we may have 
witnessed an interaction between systemically absorbed microcystin-LR and 
the anaesthetic, IS anaesthetised three control mice held over for rechallenge, 
i.e. they were naïve to test material. All three mice were similarly slow to 
recover. Mice were observed over the following three hours, and most 
appeared to be recovering well. However, the following morning one mouse 
was dead, and another mouse was immobile, with marked piloerection, a 
respiratory rate of 176/minute. This mouse was thought to be moribund, so it 
was euthanised. These deaths explain the reduced number of test mice in this 
MEST (see Figure 5.3). Subsequent anaesthetics on the remaining mice at 
the 48 hour post-challenge period, at which time all twelve mice had 
apparently recovered fully, were equivocal in that recovery times were 
somewhat prolonged compared with the usual response to CO /O2 2, but were 
markedly improved over the recovery times of the initial anaesthetics given the 
previous day. This feature of the severity of anaesthetic-related problems 
being most evident after the initial anaesthetic was thought to be relevant 
when, during rechallenge readings, the two remaining control mice that had 
not been previously anaesthetised were slow to recover, whereas the seven 
test mice and the other three control mice recovered normally.  
 
Extensive investigations failed to identify the cause of this problem. We initially 
suspected a contaminant within the gas lines – gases are piped through the 
facility from a central dual size G cylinder source. We isolated the gas supply 
by using local cylinders of CO  and O2 2, and changed both flowmeters. The 
next MEST, using C. raciborskii extract, was uneventful in regard to CO /O2 2 
anaesthesia. However, the problem again returned with the next experiment, 
the MEST for A. circinalis, with 10 of 15 mice slow to recover from 
anaesthetics given for challenge ear measurements. These ten mice were all 
apparently well the following day, and all mice responded normally to 
anaesthetics for the 48-hour post-challenge readings. The five control mice 
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held over for rechallenge readings were similarly sickened after their first 
anaesthetic, whereas test mice were not adversely affected. 
  
We considered the possibility that these anaesthetic-related illnesses may 
have been batch-related, i.e. affecting specific groups of mice that may have 
been ill or stressed in some way. However, this seemed unlikely after 
conducting the final cylindrospermopsin MEST. During this experiment, all test 
and control mice responded normally to anaesthetics for challenge readings, 
but at rechallenge, the five control mice were ill after their initial anaesthetic, 
though they recovered after about four hours. The nine test mice again all 
responded normally after anaesthesia.  
 
Other workers at NRCET have also reported similar experiences, in that 
CO /O2 2 anaesthesia is a useful short-acting restraint for small rodents, and 
mostly works without incident, but infrequently and inexplicably some mice 
and rats are sickened, occasionally fatally. 
 
The conclusion drawn from this experience is that, in the absence of 
explanations and solutions for these intermittent problems, an alternate short-
acting chemical restraint should be used to facilitate ear measurements. This 
would ideally be an inhalational agent, e.g. diethyl ether or one of the 
halogenated vapours, e.g. halothane, enflurane or isoflurane. A 70:30 nitrous 
oxide and oxygen mixture may be a suitable restraint and, if successful would 
have the added advantage of rapid recovery and would lend itself well to 
repeat administration. Gad (1994) recommends ether anaesthesia, but other 
workers frown on this because of occupational safety matters (ether is 
flammable and an explosion hazard) and the increased respiratory secretions 
may compromise the airways of small animals (Blackshaw & Allan, 1995 p74).  
 
 
5.4.5.2. Pre-dose ear thickness readings 
 
Gad (1994) stipulates that mouse ears should be examined prior to 
commencement of a MEST, and any mice showings signs of erythema on 
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either ear should not be used. This was done with all the MESTs conducted 
for this work, however, it may be worthwhile conducting pre-dose ear 
thickness readings to reveal subtle abnormalities of the ear that are not 
obvious by visual inspection, but will significantly compromise the 
performance of a MEST. This problem occurred in the final 
cylindrospermopsin MEST, where one test mouse was found to have a 
deformity of one ear – the pinna was reduced in length, with a small notch and 
thickening of skin around the notch. This abnormality was not discovered until 
day 10 of the MEST, prior to challenge readings. This mouse was removed 
from the experiment, leaving 9 test mice in this MEST (see Table 5.5). If we 
had conducted ear thickness readings at the commencement of the 
experiment, before induction dosing, we could have allocated a spare animal 
to the test group rather than to the control group.  
 
 
5.4.6. Suggested improvements to the standard MEST 
 
5.4.6.1. Depilation of abdominal fur 
 
The use of depilatory cream was thought to be a significant improvement over 
the use of electric clippers to remove abdominal fur. IS had difficulty in 
achieving adequate fur removal in a single attempt on individual mice, with 
mice clearly expressing their displeasure when restrained for prolonged 
periods. Depilatory cream appeared to be well-tolerated, and with experience 
gave excellent fur removal. Abdomens were depilated in batches of five: 
cream was applied, mice were placed in a holding cage without wood 
shavings, and then after 5-7 minutes, excess cream was gently removed with 
warm water and a cloth. Other workers have used depilation to remove 
abdominal fur in MEST work (Thorne et al, 1991). 
 
Two basic tips for the novice dermal toxicologist or pet beautician working on 
mice are: 
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• Apply the cream against the grain of the fur, i.e. in a posterior to anterior 
 direction. This results in better penetration of the cream. 
• If fur removal is patchy or inadequate, resist the temptation to apply a 
 second dose of cream within a 48-hour period. This will damage the skin. 
 Careful application of cream in a posterior to anterior direction should 
 produce excellent fur clearance with a single application of cream.  
 
Recent work in our laboratory has shown that a domestic electric shaver 
produces rapid and acceptable fur removal, though an assistant is required to 
hold the animal’s feet clear of the shaver. A shaver, i.e. with blades enclosed 
within a metal mesh, appears to be preferable to the use of open-blade 
clippers.  
 
 
5.4.6.2. Random allocation of test ears 
 
Random allocation of test ears allows the investigator to be blinded to the 
status of ears if colourless solutions are applied, which was the case for the 
cylindrospermopsin MEST in this work. It was not possible to be blinded when 
working with cyanobacterial crude extracts, which stained test ears a green 
colour. However, there may be a further benefit in random allocation of test 
ears through elimination of a systematic measurement error. The moving plate 
of the micrometer contacts the ventral pinna when measuring the right ear, but 
to measure the left ear, the moving plate must contact the dorsal pinna in 
order to read the micrometer gauge. While any systematic left vs right 
measurement error is not likely to be large, non-lateral allocation of test ears 
within a MEST experiment negates the possibility of such error. A simple 
spreadsheet algorithm facilitates separation of test and control ears for data 
analysis.   
 
Blinding of investigators is an important means of reducing bias in animal and 
human clinical and epidemiological research (Schulz & Grimes, 2002; Festing, 
2003). Other work in Chapter 6 describes blinding by random allocation of test 
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and control mice within each cage. This was not done in these experiments as 
we did not want to risk control mice having premature contact with test 
material through grooming of cage companions, so test and control mice in all 
MESTs were housed in separate cages.  
 
 
5.4.6.3. Dictation onto audiotape 
 
A portable cassette recorder and microphone headset is invaluable for 
transcribing repeat ear measures when a single investigator conducts a 
MEST. Speech-recognition software may in the near future, if not already, 
allow for reliable transcription of data directly into a spreadsheet or database.  
 
  
5.4.7. Relative sensitising potency of cylindrospermopsin 
 
Understanding the relative potency of a toxin is an important step in defining 
the associated public health risk. This also applies to safety assessments of 
skin sensitisers, which may vary up to 10,000-fold in sensitising potency 
(Kimber et al, 2003). The induction and sensitisation concentrations of CYN in 
the C. raciborskii and CYN MESTs (50, 73 and 100μg/mL) were artificially 
high, with field concentrations in lakes and ponds typically less than 1mg/L 
(Saker & Eaglesham, 1999; Shaw et al, 1999; McGregor & Fabbro, 2000; 
Saker & Griffiths, 2001). However, when considering these concentrations in 
the context of proposed thresholds for sensitising chemicals, 50μg/mL 
(0.005%w/v) and 100μg/mL (0.01%w/v) are in the range of concentrations to 
be classified as “extreme” sensitisers (Kimber et al, 2003). Therefore, DCH 
generated by CYN at any concentration below those used in these MESTs 
will, by this rating, still classify cylindrospermopsin as an extremely potent 
sensitiser.  
 
Threshold concentrations can be determined for chemical sensitisers, and 
dose-response relationships are apparent in both induction and sensitisation 
phases (Boukhman & Maibach, 2001; ECETOC, 2003 pp2, 3, 17; Kimber et 
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al, 2003). If dose-response studies show that cylindrospermopsin is capable of 
eliciting DCH at lower concentrations than the artificially high doses used in 
these experiments, the appropriate question will be whether CYN at naturally 
occurring levels is below the threshold for DCH – and irritant reactions.  
 
 
5.4.8. Cylindrospermopsin – more than a hepatotoxin 
 
Cylindrospermopsin, a cyclic guanidine alkaloid, is well-recognised by 
cyanobacteriologists as a potent water-soluble toxin. Many workers describe 
cylindrospermopsin as a hepatotoxin (e.g. Lawton & Codd, 1991; Runnegar et 
al, 1995; Chiswell et al, 1997; Kaebernick & Neilan, 2001; Norris et al, 2001), 
because significant pathology is found in the livers of experimentally and 
accidentally poisoned animals. However, it is highly likely that CYN exerts 
toxic effects on other mammalian tissues, as CYN-containing cyanobacterial 
crude extracts damage kidney, thymus, heart, spleen, adrenals, lungs and the 
gastrointestinal tract (Hawkins et al, 1985; Hawkins et al, 1997; Falconer et al, 
1999b; Seawright et al, 1999). Purified CYN has been shown to produce 
pathologic effects on various organ systems – thymus, kidney and heart – as 
well as hepatic toxicity (Harada et al, 1994; Terao et al, 1994).  
 
Other authors describe cylindrospermopsin as a generalised or non-selective 
cytotoxin, because multiple organs appear to be affected (Ressom et al, 1994 
p32; Falconer, 1998; Falconer, 1999). This first report of cylindrospermopsin-
associated pathology involving cutaneous tissues lends support to the idea 
that this toxin is better described as a generalised or non-specific cyanotoxin.  
 
 
5.4.9. Future research 
 
Further dermatological investigation into toxigenic cyanobacteria is warranted, 
given the well-known toxicity of these organisms, and the tantalising prospect 
that improved knowledge of the mechanisms of innate immune signalling in 
the skin may advance the understanding of systemic mammalian responses. 
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Standard guinea pig tests using a closed-patch method would be an 
appropriate initial step, in order to either confirm the negative sensitisation 
findings of these MESTs on M. aeruginosa and A. circinalis, or to confirm the 
positive findings of Torokne et al (2001). The Buehler test is an epidermal 
induction, closed-patch test that is accepted by regulatory authorities 
worldwide (Botham et al, 1991). The murine local lymph node assay may also 
be an appropriate confirmatory test (Gerberick & Sikorski, 1998; Basketter et 
al, 2003; ECETOC, 2003 pp6-8). 
 
Investigation of irritant and sensitising reactions at the molecular level would 
be of significant interest; some of this early work could be done using in vitro 
systems. Human keratinocyte cultures could yield initial clues from cytokine 
expression at the protein or mRNA level. This would tell us whether 
cylindrospermopsin behaves like other well-understood skin toxicants, or if 
there are unusual mechanisms at play. It will be important to know if and how 
CYN is conjugated to a protein in order to become immunogenic. Low 
molecular weight compounds (less than about 1kDa) are not of themselves 
antigenic; they must cross the epidermis and conjugate to a protein in order to 
become immunogenic. The resultant macromolecular complex is termed a 
hapten (IPCS, 1999 p131; Roitt, 2001 p371). Cylindrospermopsin has a 
molecular weight of 415 daltons (Ressom et al, 1994 p32). Understanding the 
mechanism of sensitisation of this toxin will require knowledge of how it forms 
a hapten and whether it needs to be metabolised in order to do so. Smith 
Pease (2003) suggests that all low molecular weight compounds, even ionised 
chemicals, will cross the epidermis to some degree, so the pertinent matter 
then becomes the toxicological significance of penetration across the skin.  
 
Several anecdotal and case reports of recreational exposure to cyanobacteria 
refer to a group of symptoms that fit the clinical description of immediate (Type 
I) hypersensitivity reactions: rhinitis, conjunctivitis, asthma-like symptoms and 
urticarial eruptions (see Chapter 1, Table 1.1 and Section 1.4.2.2). Predictive 
dermatological investigations will also need to examine the potential for 
cyanobacteria and cyanotoxins to elicit Type I hypersensitivity reactions. 
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Production of specific cytokines following exposure to cyanotoxins may be 
revealing, e.g. IL-12, which is reportedly elicited by allergens but not irritants 
or tolerogens (Gröne, 2002). This kind of work could be done with in vitro 
human keratinocyte cultures. Allergens, and not irritants, can also modulate 
CD62L and CD44, these being T cell activation markers, as well as 
modulating the proportion of B cells in draining lymph nodes (Gerberick & 
Sikorski, 1998).  
 
The limitations of techniques such as diagnostic patch testing and 
histopathology in discriminating between irritant and allergic reactions is 
troubling. Kligman (1996) suggested that significant advances would come 
from the field of immunology with the use of appropriate cytokine markers, 
stating: “Again, immunology will lead us out of darkness!” Improved 
understanding of immune signalling stimulated by various cyanobacterial 
products should also illuminate some fundamental toxicological processes, not 
only in the skin, but across most, if not all target organ systems.  
 
 
5.4.10. SUMMARY AND CONCLUSIONS 
 
Using a mouse model of delayed-contact hypersensitivity, we have 
demonstrated that both a cylindrospermopsin-containing crude extract of C. 
raciborskii and purified cylindrospermopsin elicit irritant and hypersensitivity 
reactions. Toxin-producing extracts of M. aeruginosa and A. circinalis failed to 
induce any observable or measurable adverse reactions. All three crude 
extracts were applied to mouse skin at identical concentrations (2%w/v 
lyophilised cyanobacteria).  
 
Some modifications to the mouse ear swelling test are suggested: random 
allocation of test ears, and the use of depilatory cream or an enclosed-blade 
electric shaver rather than electric clippers.  
 
Further experimental work should follow in order to confirm positive and 
negative findings of this study and previously published work. Studies of the 
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cellular and molecular processes involved in the cutaneous toxicity of 
cylindrospermopsin would be of great interest. 
 
Cylindrospermopsin-producing cyanobacteria are widely distributed in tropical, 
subtropical and temperate waters. Public health authorities and recreational 
water managers are aware of the potential for harm through accidental or 
deliberate ingestion of water contaminated by cylindrospermopsin; authorities 
may also need to consider the potential for cylindrospermopsin-producing 
cyanobacteria to be associated with complaints of acute skin reactions. 
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CHAPTER 6: CYANOBACTERIA AND THERMOREGULATION 
 
 
6.1. INTRODUCTION, AIMS, HYPOTHESES AND RESEARCH STRATEGY 
 
6.1.1. Introduction 
 
Fever is one of the many signs and symptoms reportedly associated with 
recreational exposure to cyanobacteria (see Chapter 1, Table 1.1), and 
several authors have attributed cyanobacterial lipopolysaccharides (LPS) with 
pyrogenic properties (Chapter 2, Table 2.1). An outbreak of pyrogenic 
reactions in a haemodialysis clinic in Washington, D.C. was retrospectively 
associated with LPS from an unidentified algal bloom – presumably 
cyanobacteria – that affected the Potomac River, from which the clinic 
sourced its dialysate. The report of this outbreak appears to be the first in the 
literature to ascribe biological activity to cyanobacterial LPS (Hindman et al, 
1975).  
 
Experimental work on sheep given a lethal dose of microcystin-producing 
Microcystis aeruginosa showed a variable temperature rise of 1.5 to 2.50C, 
reportedly in conjunction with the onset of clinical signs at 15 hours after 
dosing (Jackson et al, 1984).  
 
Fever is a regulated rise in core body temperature. The regulatory apparatus 
involves neuronal control of the “set-point” temperature, which is normally 
maintained within narrow limits as a principal mechanism of homeostasis 
(Boulant, 1997). Fever is one of the most frequently observed responses to a 
variety of infectious, inflammatory and traumatic insults (Kluger et al, 1998). 
Fever is regarded as a hallmark response to biologically active LPS from 
heterotrophic Gram-negative bacteria; nanogram quantities of LPS elicit fever 
in animals and humans (Dal Nogare & Sharma, 1997).  
 
Small rodents respond to a sufficient dose of a pyrogen such as LPS by 
initially lowering the hypothalamic set-point, i.e. they develop a regulated 
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hypothermia. A secondary fever is subsequently seen, peaking at around 24 
hours (Gordon & Yang, 1997; Kozak et al, 1998; Leon et al, 1998). The larger 
surface area to mass ratio of small animals allows them to rapidly lower their 
core temperature in response to toxins and pathogens; larger mammals such 
as humans do not have this ability, so regulated hypothermia is not seen in 
larger animals to the degree observed in rodents. Regulated hypothermia in 
small rodents is analogous to fever in larger animals insofar as both 
responses appear to confer benefits in terms of recovery from infectious 
pathogens (Chatenoud et al, 1991; Gordon & Yang, 1997). So the ostensibly 
paradoxical responses (hypothermia vs hyperthermia) by mice and humans to 
similar insults have a significant similarity in that both responses are 
regulated, i.e. the hypothalamic set-point is altered.   
 
A broad spectrum of xenobiotic, pathogenic and endogenous substances will 
elicit temporary thermoregulatory changes in mammals: microbes (fungi, 
bacterial cell wall components, protozoans); microbial, insect and reptile 
toxins; antibody-antigen complexes (including viral antigens); activated 
complement components; inflammatory bile acids; many pharmaceuticals; 
polynucleic acids; pesticides; heavy metals; solvents; ethanol and other 
alcohols (Dal Nogare & Sharma, 1997; Dinarello, 1997; Gordon & Yang, 1997; 
Gordon & Rowsey, 1998; Mims et al, 2001 pp330-1).  While many of these 
pyrogens are exogenous substances, the current understanding of fever 
dictates that the concept of exogenous pyrogens is obsolete. Regulated fever 
and hypothermia are entirely mediated by endogenous substances, chiefly 
three cytokines: TNF-α, IL-1 and IL-6. These cytokines in turn mediate 
prostaglandin E2, which is a principal mediator of fever, directly stimulating 
thermoeffector neurons in the brain’s principal thermoregulatory centre, the 
preoptic area and the anterior hypothalamus (Boulant, 1997; Dal Nogare & 
Sharma, 1997; Coceani & Akarsu, 1998; Gordon & Rowsey, 1998). 
Exogenous pyrogens do not elicit fever unless they stimulate the production of 
cytokines (Dal Nogare & Sharma, 1997).  
 
Therefore the biological activities of LPS have a common mechanism with the 
fever-producing capacity of other exogenous pyrogens: probably the full 
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complex repertoire of pathophysiological responses to LPS and the 
thermoregulatory effects of pyrogens all operate indirectly in vivo, i.e. under 
the influence of endogenous mediators, of which cytokines are paramount 
(see Chapter 2, Section 2.5).   
 
 
6.1.2. Aims 
 
This study was conducted to investigate the biological activity of 
cyanobacterial lipopolysaccharides and purified cyanobacterial exotoxins, 
using thermoregulatory change as an indicator of innate immune surveillance. 
Specific aims were to:  
 
1. Extract and purify LPS from cyanobacterial cells using established 
methods for LPS isolation from heterotrophic Gram-negative bacteria 
2. Determine the ability of cyanobacterial LPS and exotoxins to initiate 
 hypothermia and/or pyrexia using a mouse model of rectal temperature 
 measurement. 
 
 
6.1.3. Research strategy 
 
The general approach to these in vivo studies was based on some of the 
methods and findings of Leon et al (1997). Their work used a “septic-like” 
dose of 2.5mg E. coli serotype 0111:B4 LPS as a positive control in 
experiments of 44 hours duration. While the studies of Leon et al (1997) and 
this work differed significantly in the methods used to measure core 
temperature – continuous radiotelemetry vs intermittent rectal temperature 
measurement – the time course of their experimentally induced temperature 
changes served to guide us in determining our monitoring regime.  We 
expected to see rapid development of hypothermia after dosing, followed by a 
gradual onset of fever that would peak at around 24 hours before rectal 
temperatures returned to normal. We aimed to conduct a pre-test experiment 
using positive and negative controls (E. coli LPS and physiological saline) in 
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order to determine the sensitivity and practicality of measuring mouse rectal 
temperatures, and to use those data in sample size estimates for the following 
experiments.  
 
 
6.1.4. Hypotheses 
 
Some cyanobacterial LPSs have been shown to be weakly active, compared 
with LPS from heterotrophic Gram-negative cyanobacteria (reviewed in 
Chapter 2, Section 2.9). Spirulina platensis is somewhat unusual amongst 
cyanobacteria in that it is widely used as a human and animal dietary 
supplement. It has a long history of use, and there is a significant body of 
evidence that suggests consumption of Spirulina spp is either beneficial or at 
least not harmful (reviewed in Chapter 2, Section 2.10).  
 
Microcystin-LR has been shown to induce production of TNF-α and IL-1β in 
vitro (Kaya, 1996; Pahan et al, 1998; Rocha et al, 2000). The in vivo 
toxicological profile of cylindrospermopsin suggests that endogenous 
mediators of the innate immune system may be involved in the pathological 
processes initiated by this cyanotoxin (see Chapter 7).  
 
The hypotheses tested by this study were: 
 
1. Cyanobacterial LPS from toxic and non-toxic strains of toxin-producing 
genera will stimulate hypothermia and subsequent fever in laboratory 
mice  at higher doses than required of Escherichia coli LPS. 
2. LPS from Spirulina spp will not initiate thermoregulatory change and 
will serve as a negative control. 
3. Purified MC-LR and cylindrospermopsin will initiate measurable 
changes in thermoregulation. 
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6.2. MATERIALS AND METHODS 
 
6.2.1. Lipopolysaccharide extraction and purification 
 
Thermoregulation experiments using LPS were conducted in two series of 
experiments. The initial studies were undertaken with LPS that was extracted 
and purified by IS at NRCET. We subsequently formed collaborative links with 
Dr John Papageorgiou of the Australian Water Quality Centre in Adelaide, 
who extracted and purified cyanobacterial LPS by novel methods. 
Investigations into endogenous nitrate and IL-6 production, as well as 
thermoregulation studies, were conducted and coordinated by IS on the LPSs 
supplied by Dr Papageorgiou and his team. Nitrate and IL-6 results are not 
presented in this thesis due to text limitations; we will submit those studies for 
separate publication.  
 
 
6.2.1.1. LPS extraction and purification at NRCET 
 
Two cyanobacterial lipopolysaccharides were extracted at NRCET: 
 
1. Bloom sample collected in April 2001 from Lake Coolmunda, southern 
Queensland. This bloom consisted primarily of M. aeruginosa, with 
minor  contributions of A. circinalis. A sample of lyophilised material 
was examined for the presence of microcystins by methods outlined in 
Chapter 3, Section  3.3.9.2. No microcystins were reported, so this 
bloom material was  considered to be non-toxic. 
2. C. raciborskii AWT 205 was grown in continuous culture, harvested and 
lyophilised as described in Chapter 4, Section 4.2.4.2. AWT 205 is a 
toxic  strain of C. raciborskii; it produces cylindrospermopsin under 
culture conditions.   
 
 
The LPS extraction and purification was performed with a hot phenol method 
and ultracentrifugation, per procedures No. 4: Bacterial lipopolysaccharides – 
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Gram-negative (modified Westphal) and No. 27: Purification of 
lipopolysaccharide (modified Westphal) (Keleti & Lederer, 1974 pp 3, 4, 31, 
32), from the process described by Westphal & Jann (1965).  
 
 
6.2.1.1.1. Crude LPS extract 
 
LPS from the Lake Coolmunda bloom sample was extracted in May 2001. The 
procedure involved extracting 20g of lyophilised cells by adding to 350mL 
Milli-Q® water; 350mL 90% phenol was added and the mixture was heated 
and stirred for 30 minutes, then cooled to approx. 100C as per method No.4 
above. The mixture was centrifuged at 3900 rpm, not 7000 rpm per method 4, 
as our centrifuge rotor at the time was not rated for work above 4000 rpm. The 
aqueous layer was aspirated and retained. 350mL water was added to the 
phenol layer and this mixture was heated, stirred, and then cooled, centrifuged 
and the water layer was aspirated. The two water layers were combined, and 
the product was dialysed against reverse osmosis de-ionised water in 
SnakeSkin pleated dialysis tubing, pore size 7,000 MWCO (Pierce, Rockford 
IL; www.piercenet.com) to remove phenol. After dialysis, the product was 
centrifuged at 4,000rpm for 30 minutes and the supernatant was lyophilised to 
give a crude LPS extract. 
 
LPS was extracted from C. raciborskii AWT 205 cultured cells, using a scaled-
down process due to a lower availability of lyophilised cells than was the case 
with the M. aeruginosa bloom sample. 5.0g cells were added to 88mL Milli-Q® 
water; 88mL 90%w/w phenol was added, and the procedure continued as 
described above. 
 
A second LPS extraction from lyophilised M. aeruginosa cells was conducted 
in January 2002. This was undertaken using the scaled-down method 
described above, as it was thought that better relative yields could be obtained 
by aspirating aqueous layers from 50mL centrifuge tubes as opposed to 
750mL centrifuge bottles used in the full-scale extraction.  
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6.2.1.1.2. Estimation of glucan in LPS crude extract 
 
Keleti et al (1979) suggested that a significant proportion of the yield of a 
crude cyanobacterial LPS extract may be attributable to the presence of 
glucan. The authors reported a reduction in the yield of a crude extract from 
7% to 1.5-2% after removal of glucan, which suggests that >70% of their 
crude extract was due to contamination by glucan. Therefore, in order to 
remove glucan, an enzymatic digestion using cellulase was conducted based 
on the methods of Volk (1968) and Keleti et al (1979). The following solutions 
were prepared: 
 
• A 2.5mg/mL cellulase (Sigma-Aldrich P/L) solution was prepared, 
 ultracentrifuged at 37,000 x g for 15 minutes, and passed through a 
 0.45µm filter.  
• 0.05M citrate buffer was prepared from 59mL 0.05M citric acid added to 
41mL 0.05M trisodium citrate; this was titrated with 0.05M trisodium 
citrate to pH 4.0. 
 
248 mg lyophilised crude LPS was added to the citrate buffer and shaken for 
40 minutes to dissolve the LPS. 25mL of the cellulase solution was added, 
and the mixture was gently agitated at 250C for 14 hours. A further 25mL 
cellulase solution was added, and the mixture was again agitated overnight at 
250C. The product was heated to 65-700C for 30 minutes to denature any 
remaining cellulase, then dialysed using SnakeSkin dialysis tubing (per 
Section 6.2.1.1.1) for 48 hours against RO water to remove free glucose 
liberated by the enzymatic hydrolysis of glucan.  
 
The proportion of glucan in the crude LPS extract was estimated by 
measuring free glucose liberated by the enzymatic digestion. Glucose was 
measured by a colorimetric method, using hexokinase and glucose-6-
phosphate dehydrogenase, purchased in a kit from Sigma Diagnostics 
(Procedure No. 115). 0.1mL aliquots of the LPS solution were taken at each 
stage of the enzymatic digestion – prior to addition of cellulase, after the first 
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digestion, and after the second digestion prior to dialysis. Standards and test 
solutions were prepared in duplicate, according to the kit instructions. 
Rationale and calculations for determining liberated glucose are presented in 
Appendix 8. Absorbances were measured on a Varian Cary 3E UV-Visible 
spectrophotometer.  
 
 
6.2.1.1.3. Purification of LPS extracts 
 
Nucleic acids were separated from crude LPS extracts by a three-stage 
ultracentrifugation process, as described by Keleti & Lederer (1974 pp31-2). 
The product of C. raciborskii AWT 205 LPS after dialysing off free glucose 
was ultracentrifuged for four hours at 35,700 rpm (=105,000 x g). The pellet 
was resuspended in 80mL Milli-Q® water, and the ultracentrifugation and 
resuspension process was repeated another two times. The ultracentrifugation 
pellets were poorly soluble, and solubility appeared to decrease after each 
ultracentrifugation step. Agitation for 2½ hours was required to achieve visible 
solubility after the first stage, yet overnight steeping at 40C, vigorous shaking 
for 5½ hours and heating to 65-720C for 30 minutes was needed to fully 
dissolve the final product. The final product was centrifuged at 3,000 rpm, and 
the supernatant was lyophilised and weighed. Ultracentrifugation was 
performed with a Beckman Optima L-70 refrigerated ultracentrifuge, using a 
type 55.2 Ti rotor. 
 
Crude and purified LPS extracts were stored at room temperature in sterile, 
airtight tubes after air was displaced by argon. 
 
An experiment was conducted to determine the fate of cellulase remaining in 
the LPS product after dialysing off glucose. A 0.25%w/v solution of cellulase 
was prepared as described above (Section 6.2.1.1.2), and it was heated to 65-
720C for 30 minutes to simulate the process of glucan digestion of the LPS 
extract. It was then ultracentrifuged at 35,700 rpm for I hour, and again for 4 
hours. The appearance of the supernatant and pellet formation was used to 
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make conclusions about the likely fate of cellulase during the LPS purification 
procedure.   
 
Purification of the Lake Coolmunda M. aeruginosa LPS crude extract was 
performed without conducting the cellulase digestion to remove glucan, as the 
estimated glucose / glucan proportion was low (2.2% - see Appendix 8). We 
considered the benefits of removing small quantities of glucan by hydrolysis to 
be outweighed by the risk of introducing microbial contaminants during more 
multi-step processing.  
 
Purification of LPS by this triple ultracentrifugation process was conducted a 
further two times, once for each of the M. aeruginosa and C. raciborskii crude 
extracts. The second purification of C. raciborskii crude LPS was performed 
without the cellulase digestion steps.  
 
® All glassware was rinsed with Milli-Q filtered water, dried, then steam 
autoclaved prior to use. Plastic ware (storage containers, centrifuge tubes, 
pipette tips etc.) were purchased as sterile, pyrogen-free items.  
 
 
6.2.1.1.4. Nuclear magnetic resonance (NMR) studies 
 
NMR studies were conducted on the two LPSs extracted by IS at NRCET. 
LPS samples (approx 2%w/v) were dissolved in deuterated methanol (D-4). 
Both C. raciborskii and M. aeruginosa LPS were not completely soluble in D-4 
methanol, so the preparations were centrifuged and supernatants were 
aspirated and transferred into NMR tubes. Air in the NMR tubes was displaced 
by argon. 500 MHz NMR spectroscopy was conducted at the University of 
Queensland’s Centre for Magnetic Resonance by Dr Chris Jones, formerly of 
NRCET. According to Dr John Papageorgiou of AWQC, if LPS was present in 
the samples, we would expect to see numerous peaks at 1-2 ppm (fatty acids) 
and 3.5 to 5 ppm (sugars). 
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6.2.1.2. LPS extracted at AWQC 
 
After commencing these studies, we formed a collaboration with Dr John 
Papageorgiou of the Australian Water Quality Centre (AWQC), Adelaide. Dr 
Papageorgiou and his team have devised and published novel techniques for 
the extraction and purification of LPS, which they applied to cyanobacteria 
(Papageorgiou et al, 2004). IS agreed to conduct in vivo toxicity studies – 
thermoregulation, serum nitrate and IL-6 – on cyanobacterial LPS extracted by 
Dr Papageorgiou. 13 LPS samples were received, but four samples did not 
contain enough material to administer to the required number of mice at 
planned doses. So nine LPS extracts were investigated: six were from 
cyanobacteria blooms, two were laboratory isolates, and Spirulina sp was 
purchased from a retail health food outlet, and then sent to AWQC for LPS 
extraction. Table 6.1 lists the AWQC LPS extracts examined. 
 
Table 6.1. Lyophilised LPS samples received from AWQC. 
Source cyanobacteria                 Supplied weight    
C. raciborskii CYP020A        13.7mg 
Phormidium formosum (Paskeville Reservoir)     13.4mg 
M. aeruginosa (Mt Bold Reservoir)      84.5mg 
Nodularia spumigena (East Gippsland)      97.8mg 
Microcystis flos-aquae (Bolivar Lagoons)     21.4mg 
M. aeruginosa / M. flos-aquae 50:50 (Army Range wetlands, Murray Bridge) 14.6mg 
A. circinalis (Birdwood)        26.0mg 
M. aeruginosa AWQC MIC 338           6.7mg 
Spirulina powder (Healtheries Ltd www.healtheries.co.nz)   61.8mg 
 
 
One sample in sufficient quantity, Microcystis botrys (QLD) was prepared for 
injection, but contained an insoluble residue, so this LPS extract was not 
examined. It was replaced in our schedule by the M. aeruginosa MIC 338 
extract listed above in Table 6.1. MIC 338 was administered at a lower dose 
than the other LPS extracts due to the small quantity received.  
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6.2.2. Calculation and preparation of doses 
 
6.2.2.1. LPS doses and preparation for i.p. injection 
 
Because of the wide variation in toxicity of cyanobacterial LPS in previously 
published reports (see Chapter 2, Table 2.2), the rationale for these 
experiments was to work with three dose levels: low, intermediate and high. 
The aim was to examine two doses of each LPS extract, commencing with the 
intermediate dose, then conducting a follow-up experiment with either a higher 
or lower dose, depending on the group response to the intermediate dose.  
 
The most toxic cyanobacterial LPS reported in the literature is from M. 
aeruginosa NRC-1 isolate, with a mouse i.p. LD50 of 27-40mg/kg for mice 
weighing 20-30g (the authors did not report the weights of dosed mice) 
(Raziuddin et al, 1983). Our dosing regime took ¼ of the most conservative 
LD50 estimate, i.e. 7mg/kg, as the low dose, with the intermediate dose (i.e. 
starting dose) at 70 mg/kg, and the high dose at 350mg/kg.  
 
Concentrations for dosing were calculated on the basis of an injection volume 
of 10mL/kg body weight (a mouse-friendly example gives an i.p. injection of 
0.3mL for a 30g animal). Therefore the stock solution for each test substance 
was prepared from the formula: (mg/kg dose)*0.1 = [mg/mL].  
 
Stock solutions of 7mg/mL for the LPS starting dose of 70mg/kg were 
prepared in sterile 1.5mL cryopreservation tubes using sterile, pyrogen free 
isotonic saline for injection (0.9% w/v NaCl). Solutions were stored at -200C 
before use. 7 mg/kg LPS doses were prepared from a 1:10 dilution of the 
7mg/mL stock solution.  
 
Pre-testing experiments were performed with E. coli serotype 0111:B4 LPS, 
purchased from Sigma-Aldrich. 0111:B4 serotype was chosen to allow 
comparison with the work of Leon et al (1997), some of which was used to 
guide the study design for this work. E. coli 0111:B4 LPS was also extracted 
by the same hot phenol process used for this work. 50mL sterile 0.9% NaCl 
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was added to 12.52mg of E. coli LPS to make a 250μg/mL stock solution for 
2.5mg/kg doses; 1mL of this stock was added to 24mL 0.9% NaCl for 
100μg/kg doses.  
 
  
6.2.2.2. Purified cyanotoxin doses 
 
Purified microcystin-LR (MC-LR), cylindrospermopsin (CYN) and anatoxin-a 
were tested for their ability to affect thermoregulation. The initial approach 
taken for dosing with these cyanotoxins was to use ¼ of the mouse LD50 for 
the maximum dose, as per advice from the Queensland Health Scientific 
Services Animal Ethics Officer, Mr Lee Smythe. As for the regime with 
cyanobacterial LPS, we started with an intermediate dose, aiming to give 
either a higher or lower dose in a follow-up experiment, depending on the 
response to the intermediate dose. Table 6.2 shows the initial dose regime for 
CYN and MC-LR. 
 
 
 
Table 6.2. CYN and MC-LR intraperitoneal doses, μg/kg. 
(Reference)   Low        Intermediate High  Mouse i.p. LD50 
CYN  10  100  500  2100 (Ohtani et al, 1992)* 
 
MC-LR  0.35  3.5  17  60-70 (Ressom et al, 1994 p31) 
* LD at 24 hours 50 
 
 
During the second phase of these experiments (see Section 6.4.3.4), after it 
was clear that ¼ LD50 doses were inadequate for MC-LR, we administered ½ 
LD50 doses, i.e. 35μg/kg for MC-LR and 175μg/kg for anatoxin-a,  based on 
the i.p. mouse LD50 for anatoxin-a of 375µg/kg reported by Fitzgeorge et al 
(1994). CYN in all experiments was administered per doses in Table 6.2.  
 
CYN was provided by Dr Wasa Wickramasinghe as described in Sections 
5.2.3 and 3.3.9.2 of this thesis. 
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MC-LR used in these experiments was obtained from two sources: 
 
1. For initial phase experiments (3.5μg/kg and 17μg/kg) we used our 
 laboratory standard, purchased from Calbiochem (Merck Biosciences 
 www.merckbiosciences.com).  
2. Second phase experiments used MC-LR prepared in our laboratory by 
Dr Wasa Wickramasinghe. A bloom of M. aeruginosa from a southern 
Queensland farm dam was the source; MC-LR was isolated by solid 
phase extraction, purified by preparative HPLC and quantified by UV 
spectrophotometry and HPLC diode array.  
 
Anatoxin-a was the standard used in the laboratory of Mr Geoff Eaglesham 
(QHSS) and obtained originally from Calbiochem.  
 
All cyanotoxins were prepared in sterile 0.9% NaCl according to the formula in 
Section 6.2.2.1.  
 
 
6.2.3. Blinding of investigator to identity of test materials 
 
Preparation of all injectable solutions at a concentration of 0.01mL per gram 
mouse body weight allowed the investigator (IS) to be blinded to the identity of 
test and control solutions. Each group of mice was assigned a code (A, B, 
C…) for the solution to be injected. Test solutions were prepared in identical 
sterile 1.5mL cryopreservation tubes; for each experiment, a colleague not 
involved in this work (Ms Corinne Garnett) removed the label identifying the 
contents of each tube and relabelled each tube with the single-letter code. A 
numbered die was used to randomly assign the code number to each 
cryopreservation tube. Code assignation was retrieved from Ms Garnett 
following data entry after completion of each experiment. Some cyanobacterial 
LPS working solutions were not colourless; initial experiments with 
cyanobacterial LPS (experiments 1 & 2) were conducted by having another 
investigator (Dr Glen Shaw) administer i.p. injections to mice in the absence of 
IS. Thermometry and sickness behaviour observations were then conducted 
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with IS blinded. This procedure could not be carried out with all experiments; 
the final experiments (experiments 3-5) using coloured LPS solutions 
commenced with i.p. injections given at around 2200 hours in order to 
coordinate the collection of blood from experimental animals in daylight hours. 
In this case, IS gave the i.p. injections and was not blinded to the identity of 
coloured solutions, while remaining blinded at all times to the identity of all 
purified cyanotoxins, colourless cyanobacterial LPS and NaCl solution. The 
final experiment (experiment 5) included repeat thermometry of mice dosed 
with cylindrospermopsin at 500μg/kg. These mice were dosed at 24 hours 
prior to termination, whereas the remaining mice were injected with various 
cyanobacterial LPS 12 hours before the termination of the experiment. In the 
case of this final experiment, IS was not blinded to the dosing regime of 
control mice and CYN-dosed mice. This final experiment commenced with 
dosing then thermometry of CYN and NaCl mice at around 1100, followed by 
dosing and thermometry (with IS blinded) of remaining LPS mice at around 
2300, after which all mice were sacrificed between about 1000 and 1200 the 
following day for collection of blood for supplementary experiments on serum 
nitrate and IL-6.  
 
 
6.2.4. Mice; random treatment allocation; acclimation to handling 
 
Specific-pathogen-free female Balb/c mice were supplied by either Laboratory 
Animal Services, University of Adelaide, or bred in-house at Queensland 
Health Scientific Services Biological Research Facility. Mice were 6-10 weeks 
of age, housed in groups of five with free access to food and water. The 
animal housing facility has an automated 12-hour light/dark illumination cycle.  
 
An exception to these methods occurred with the initial pre-testing experiment, 
when three male mice were erroneously supplied in the group of 30 mice bred 
at QHSS BRF. These three males were replaced with female mice by BRF 
when discovered by IS prior to dosing. However, after the experiment 
commenced, three of the female mice in this group were found to be pregnant; 
one delivered before the completion of the experiment and two were seen to 
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be pregnant at post-mortem. Because of the inability of staff at this facility to 
identify and segregate sexes on this occasion, all subsequent experiments 
were conducted without similar incident with mice purchased from the 
University of Adelaide.  
 
For pre-testing and initial experiments (Pre-test + experiments 1 & 2) with 
NRCET-extracted LPS, CYN and MC-LR, mice were randomly assigned to 
treatments so that IS could be blinded to any intra-cage treatment effects. 
Spreadsheet random number and ranking functions were used to assign equal 
numbers of mice to each experimental treatment. The final thermoregulation 
experiments (experiments 3-5) were combined with experiments to collect 
blood for plasma nitrate and IL-6 analysis. Because of the need to sacrifice 
mice within a narrow time window after dosing, mice in these final experiments 
were not randomly assigned to treatments across cages, but were dosed, 
monitored and terminated in cage-specific batches.  
 
Mice can transiently increase their core temperature in response to 
procedures such as weighing and dosing by injection. This stress-related 
response can be observed in thermoregulation studies where continuous 
telemetry is used to generate data (Kozak et al, 1998; Leon et al, 1998). In an 
effort to reduce handling-related artefacts in core temperature measurement, 
attempts were made to habituate mice to rectal thermometry. Mice were 
subjected to once or twice daily handling, stroking and rectal thermometry 
over three days (but not always consecutive days) prior to commencement of 
experiments. Only IS handled mice – except for dosing in some experiments 
per Section 6.2.3 – and gloves were not worn, so that mice could (in theory at 
least) habituate to the scent of their human contact.  
 
A maximum of 33 mice were used for each experiment. This number of mice 
can be sequentially instrumented for thermometry by a sole investigator in 
about 50 minutes, so 30 is a reasonable number of test animals for 
experiments in which hourly or greater temperature measurements are 
required.  
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An extra mouse was purchased in each delivery of mice from the University of 
Adelaide as a contingency in case of pre-experimental sickness. This has 
been observed in previous studies conducted by IS, and one mouse was 
found to be unwell on release from in-house quarantine during this series of 
experiments. When not required to replace a sick animal, the extra mouse 
was randomly assigned to one of the treatment groups.  
 
 
6.2.5. Thermometry 
 
Rectal temperature measurements were conducted with a mouse rectal probe 
(RET-3, manufactured by Physitemp Instruments www.physitemp.com). This 
device is a Type T thermocouple, with a time constant of 0.05 seconds, which 
provides rapid equilibration under experimental conditions. The probe was 
used with a battery-powered digital thermometer (TX10, manufactured by 
Yokogawa M&C Corp www.yokogawa.com). 
 
A proprietary water-based lubricant was used for all measurements: a 
sufficient measure of lubricant was placed in a specimen container lid, and the 
bulb tip of the probe was immersed in lubricant prior to each recording. The 
probe was cleaned with a single-use isopropyl alcohol gauze wipe after each 
measurement.  
 
 
6.2.6. Data recording; reporting sickness behaviour 
 
Thermometry readings were dictated on-the-fly into a portable audio cassette 
recorder with a headset microphone, and later transcribed into a spreadsheet. 
Observations of sickness behaviour – piloerection, immobility, muscle 
weakness, eyelid ptosis, isolation from cage companions – as well as changes 
in gut function manifesting as diarrhoea or expulsion of mucus were recorded 
on each mouse at each measurement point. Observations were not 
systematically graded in terms of severity for each mouse, but comments 
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were made about the relative severity of specific signs on individual mice or 
treatment groups within each experiment. 
 
 
6.2.7. Statistical analysis 
 
Data were analysed using one-way analysis of variance (ANOVA). Tukey’s 
HSD post-hoc tests were used to identify differences between treated and 
control mice. Because these tests assume that samples are normally 
distributed and group variances are equal, these parameters were examined 
for this dataset. Normal distributions were checked by examining normal 
probability plots and Shapiro-Wilk’s and K-S Lilliefors tests for normality 
(p>0.05). Equality of variances were checked with Levene’s test (p>0.05). 
Time points at which statistically significant differences between control mean 
and treatment mean temperatures were revealed but where the data failed 
either or both assumptions were examined further by non-parametric tests. 
Mann-Whitney tests for differences between two independent samples were 
conducted between control and treatment temperature data at those time 
points. Analyses are reported at a significance level of 0.05. All statistical tests 
were conducted with SPSS v11.5 (SPSS Inc, 2002).  
 
 
6.2.8. Pre-testing experiment 
 
A pre-test experiment was conducted with positive and negative control mice, 
to determine the response to LPS injection under our experimental conditions. 
This pre-test experiment was also conducted to determine the appropriate 
sample size for experiments using cyanotoxins and cyanobacterial LPS. Three 
groups of 10 mice were injected with:  
• E. coli 0111:B4 LPS  2.5mg/kg 
• E. coli 0111:B4 LPS 100μg/kg 
• 0.9% NaCl 
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LPS doses are identical to those reported by Kozak et al (1998) and Leon et al 
(1998) that generated fevers at 3-5 hours (100μg/kg) or hypothermia followed 
by fever peaking at approximately 24 hours after injection (2.5mg/kg).  
 
Sample size estimates were conducted with an on-line sample size algorithm 
(Brant, 2004), using a significance level of 0.05 and power of 0.8.  
 
 
6.2.9. Ethical approvals 
 
Ethical approval to conduct this work was granted by the Queensland Health 
Scientific Services Animal Ethics Committee under project numbers NRC 
1/02/30 and NRC 1/03/30.  
 
 
6.3. RESULTS 
 
6.3.1. Lipopolysaccharides 
 
6.3.1.1. Extraction, purification and physical properties of cyanobacterial  
             lipopolysaccharides 
 
The first LPS extraction, from a M. aeruginosa bloom (Lake Coolmunda) gave 
a white, fluffy product at both the crude and purified extract stage. This 
matched the description of LPS from heterotrophic Gram-negative bacteria 
extracted by this method (Westphal & Jann, 1965). Indeed, this LPS extract 
was indistinguishable in appearance from the E. coli LPS purchased for 
positive control experiments in this work. LPS from C. raciborskii AWT 205, 
however, was a straw-coloured material, with the appearance and consistency 
of fibreglass insulating material. Subsequent receipt of 13 cyanobacterial LPS 
samples from AWQC revealed more diversity in appearance: some had a 
greenish tinge, others were a pure white colour, and still others were straw-
coloured. Interestingly, LPS from the C. raciborskii CYP020A strain extracted 
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by Dr Papageorgiou’s team was very similar in appearance to the C. 
raciborskii AWT 205 LPS extracted by IS, i.e. straw-coloured, like fibreglass. 
 
There were some differences in solubility between the two LPSs extracted at 
NRCET, with the C. raciborskii AWT 205 LPS requiring more effort to fully 
dissolve than was the case for M. aeruginosa Coolmunda LPS. The 
preparation of AWQC LPS extracts again revealed more diversity in solubility, 
with some dissolving very rapidly, others were similar to the two NRCET 
extracts, and one sample – Microcystis botrys – contained an insoluble 
residue. Two readily soluble samples – Nodularia spumigena and M. 
aeruginosa Mt Bold Res – were significantly hygroscopic, which presented 
difficulties in accurate weighing. There also seemed to be some diversity in 
the densities of these cyanobacterial LPSs: from light, fluffy material to more 
dense residues that rattled against the walls of their container when shaken. 
Table 6.3 shows the yields of cyanobacterial LPS extracted by the hot phenol 
method at NRCET. 
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Table 6.3. Cyanobacterial lipopolysaccharide yields. 
         Dry cell weight Crude LPS weight (% of dry cell weight)   Purified LPS weight (% of dry cell weight) 
M. aeruginosa Coolmunda    
1st extraction  20.00g   565.0mg (2.85%)    19.0mg from 106mg crude LPS (0.51%)  
            41.5mg from 200mg crude LPS (0.59%) 
 2nd extraction  5.00g   114.8mg (2.30%) 
 
C. raciborskii AWT 205  5.00g   343.0mg (6.86%)    22.8mg from 125mg crude LPS (1.25%)* 
             33.5mg from 201mg crude LPS (1.14%) 
* This extract subjected to cellulase hydrolysis of crude LPS 
Supernatants from a cellulase solution were homogeneous and an identical 
colour to the pre-spun solution. No pellet was formed, but a faint orange ring 
was seen at the base of the ultracentrifuge tubes, resembling the start of a pellet 
formation. Dr Wasa Wickramasinghe thought that the cellulase was most likely 
soluble and would remain in the supernatant. The orange discolouration in the 
tubes appeared to re-solubilise. Our conclusion was that cellulase would not 
remain in the LPS product after ultracentrifugation. However, this conclusion 
was somewhat moot, as we did not proceed with hydrolysis of glucan in 
subsequent LPS extractions because of low glucose yields (see Appendix 8). 
6.3.1.2. Fate of cellulase during ultracentrifugation 
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6.3.1.3. NMR spectroscopy 
 
NMR spectrographs of M. aeruginosa Coolmunda LPS and C. raciborskii AWT 
205 LPS are in Appendix 9. Peaks corresponding to fatty acids and sugars are 
seen at 1-2ppm and 3.5-5ppm in both traces. Dr John Papageorgiou from 
AWQC has examined these NMRs, and he expressed confidence that LPS 
was present in both samples. The peak at 0.1ppm in the C. raciborskii AWT 
205 LPS NMR shows a possible contaminant. 
 
 
 
6.3.2. Thermoregulation studies 
 
6.3.2.1. Pre-testing 
 
Figure 6.1 shows rectal temperatures of mice dosed in a pre-test experiment 
to examine E. coli LPS at two i.p. doses, compared with isotonic saline. Note 
the discontinuous time scale on the horizontal axis. Line plot points are group 
mean rectal temperature ±SEM; (n) = number of mice in each treatment 
group. Statistically significant (p<0.05) differences in mean temperature 
between mice dosed with E. coli and saline are shown at the time points 
highlighted by asterisks.   
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Figure 6.1. Thermoregulation pre-test experiment. Intermittent thermometry readings. 
Data points are group mean rectal temperature ±SEM; n = number of mice per 
treatment group. Asterisks show time points at which statistically significant 
temperature differences (p<0.05) between labelled treatment and 0.9% NaCl-treated 
mice were recorded. 
 
 
 
 
6.3.2.2. Sample size estimates 
 
Data from the pre-test experiment using a sample size generator gave sample 
size estimates of 8-13 mice per group in the 2-4 hour period after dosing. 
Because of concerns about the reliability of the pre-test experiment given that 
some mice in the group were pregnant, and the female mice that were 
provided to replace three male mice were heavier and older than the rest of 
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the group (as discussed in Section 6.2.4), we repeated this test comparing E. 
coli LPS 2.5mg/kg and NaCl-treated mice. This latter test gave sample size 
estimates of 5 mice per group for the 2 and 4 hour after-dosing times. We 
decided to conduct subsequent experiments with particular attention directed 
towards measuring hypothermia in the hours immediately following i.p. 
injection.  
 
 
6.3.2.3. Cyanotoxins and cyanobacterial lipopolysaccharides 
 
Figures 6.2 to 6.6 show line plots for thermoregulation experiments on 
cyanobacterial lipopolysaccharides and the cyanobacterial toxins microcystin-
LR, cylindrospermopsin and anatoxin-a. Asterisks identify measurement times 
where statistically significant temperature differences were found between 
control mice and the stated test material. Note discontinuous thermometry 
times on horizontal axes. Data points are group mean rectal temperature 
±SEM; (n) = number of mice in each treatment group. 
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Figure 6.2. Thermoregulation experiment #1. Intermittent thermometry readings. Data 
points are group mean rectal temperature ±SEM; n = number of mice per treatment 
group. Asterisks show time points at which statistically significant temperature 
differences (p<0.05) between labelled treatments and 0.9% NaCl-treated mice were 
recorded. 
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Thermoregulation studies: 2nd experiment
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Figure 6.3. Thermoregulation experiment #2. Intermittent thermometry readings. Data 
points are group mean rectal temperature ±SEM; n = number of mice per treatment 
group. Asterisks show time points at which statistically significant temperature 
differences (p<0.05) between labelled treatments and 0.9% NaCl-treated mice were 
recorded. 
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Figure 6.4. Thermoregulation experiment #3. Intermittent thermometry readings. Data 
points are group mean rectal temperature ±SEM; n = number of mice per treatment 
group. Asterisks show time points at which statistically significant temperature 
differences (p<0.05) between labelled treatments and 0.9% NaCl-treated mice were 
recorded. 
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Figure 6.5. Thermoregulation experiment #4. Intermittent thermometry readings. Data 
points are group mean rectal temperature ±SEM; n = number of mice per treatment 
group. Asterisks show time points at which statistically significant temperature 
differences (p<0.05) between labelled treatments and 0.9% NaCl-treated mice were 
recorded. 
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Thermoregulation studies: 5th experiment
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Figure 6.6. Thermoregulation experiment #5. Intermittent thermometry readings. Data 
points are group mean rectal temperature ±SEM; n = number of mice per treatment 
group. Asterisks show time points at which statistically significant temperature 
differences (p<0.05) between labelled treatments and 0.9% NaCl-treated mice were 
recorded. 
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6.3.3. Observations of physiological changes, including sickness 
behaviour 
 
While taking thermometry readings after dosing, observations of 
pathophysiological changes were recorded for each animal. These 
observations are condensed and summarised in Table 6.4. 
Table 6.4. Observed pathophysiological changes, including sickness behaviour. 
                    Piloerection  Decreased movement    Isolation         Eyelid ptosis           Weakness           Diarrhoea   Mucus per rectum 
C. raciborskii LPS (AWT 205)  
 70mg/kg    +++   +++  +  +++  +++  +++  ++ 
 7mg/kg    +   +          +/-  
M. aeruginosa LPS (Coolmunda) 
 70mg/kg    ++   ++    +++  ++  +  + 
 7mg/kg    +   +      + 
C. raciborskii LPS (CYP020A) 
 70mg/kg    ++   ++    ++  ++    ++ 
M. aeruginosa LPS (MIC 338) 
 50mg/kg    +++   +++    +++  ++  +  ++ 
M. aeruginosa LPS (Mt Bold Res) 
 70mg/kg    +       +      +/- 
M. aeruginosa / 
M. flos-aquae 50:50 LPS 
 70mg/kg    +++   ++  +  ++  ++  +  ++  
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M. flos-aquae LPS (Bolivar) 
 70mg/kg    ++   ++        +/-  +/- 
P. formosum LPS (Paskeville) 
 70mg/kg    ++     +    +  ++  ++ 
A. circinalis LPS (Birdwood) 
 70mg/kg    ++         +  +  + 
N. spumigena LPS (E Gippsland) 
 70mg/kg               ++  + 
Spirulina sp (Healtheries) 
 70mg/kg             +/-  +  + 
 350mg/kg                ++ 
E. coli LPS (0111:B4) 
 2.5mg/kg   +++   +++  +  +++  +++  +++  +++ 
Cylindrospermopsin  
 500μg/kg   +++   ++  ++    ++ 
 100μg/kg 
Microcystin-LR 
 35μg/kg 
 17μg/kg 
 3.5μg/kg 
Anatoxin-a 
 175μg/kg 
0.9% NaCl
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6.3.4. Group distributions and variances 
 
Rectal temperature measurements were conducted at 82 time periods over 
the course of all five experiments and the pre-test experiment. Normal 
probability plots, Shapiro-Wilk’s and K-S Lilliefors tests for normality, and 
Levene’s test for equality of variances were conducted on temperature data at 
each time point. Both assumptions of equal variance and normally distributed 
data were met on 51 of the 82 time points. Data at 11 time points failed both 
assumptions; 9 failed equal variance measurements, and 10 exceeded the 
parameters for normally distributed data.  
 
 
6.4. DISCUSSION  
 
6.4.1. Cyanobacterial lipopolysaccharide extractions 
 
The inter-laboratory and inter-operator yields of purified LPS were remarkably 
reproducible, at least for the M. aeruginosa Lake Coolmunda sample, which 
was extracted twice by IS using the same method (see Table 6.3). Only one 
crude extraction of C. raciborskii AWT 205 LPS was possible, as 20g of 
lyophilised cells represented most of the available resource of that 
cyanobacterium. However, a repeat purification of AWT 205 crude LPS also 
gave a very similar weight of finished product.  
 
The effort needed to produce 20g of lyophilised cells from 20L continuous 
culture was considerable, requiring many (IS lost count) 20L harvests, and the 
time needed to prepare and sterilise media and vessels, and to concentrate, 
wash and lyophilise the cells was not a trivial matter. Bloom material, on the 
other hand, is much easier to work with, as a significant cell biomass can be 
obtained from collecting scum material. The point here is that further 
investigations of the biological activity of cyanobacterial LPS should be 
directed towards axenic strains; researchers considering such work may need 
to consider scaling up their cell production process in order to get good 
working quantities of LPS.  
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Cyanobacterial LPS extracted from bloom material and non-axenic cultures 
will be contaminated by LPS from commensal or epiphytic Gram-negative 
bacteria. The proportion of heterotrophic bacterial LPS contaminating 
cyanobacterial LPS may well be low: Zohary & Madeira (1990), using a direct 
counting method, estimated that bacteria contributed less than 1% of the 
biomass of a Microcystis aeruginosa scum. Keleti et al (1979) cultured 
Enterobacteriaceae from a non-axenic strain of Schizothrix calcicola and 
estimated the bacterial biomass to be 0.04% of the total. However, as 
discussed in Chapter 2, Section 2.7 the lipid A structures, and hence the 
biological activity, will probably vary within and across cyanobacterial and 
heterotrophic bacterial LPS, so investigation of cyanobacterial lipid A 
structures and their toxic potential will require the growth of axenic isolates.  
 
 
6.4.2. Thermometry results 
 
6.4.2.1. Pre-test experiment (Figure 6.1) 
 
Figure 6.1 shows a clear, statistically significant trend towards hypothermia in 
mice dosed with E. coli LPS at 2.5mg/kg. These mice developed obvious 
sickness behaviour signs, with pronounced piloerection, diarrhoea, eyelid 
ptosis and weakness. This latter sign is readily apparent during the 
thermometry procedure; each mouse is placed on top of the cage grille, which 
they hold onto with their foreclaws while their rear is lifted by the base of the 
tail for passage of the thermometer probe. After removal of the probe, healthy 
mice will retain their foreleg grip and present a typical and predictable degree 
of resistance to being lifted from the bars for return to their cage. Sick animals 
will also hold onto cage bars with foreclaws during thermometry, but display 
markedly less resistance to removal after the procedure.  
 
The large standard errors seen in the E. coli 2.5mg/kg group are explained by 
variable responses and recovery times within that group of mice. For example, 
at 19 hours after dosing, two of ten mice registered sub-300C temperatures, 
one mouse with a temperature of 32.50C at 8 hours was normothermic at 19 
 289
Chapter 6: Cyanobacteria and thermoregulation 
hours, two mice had temperatures of 35.30C, and the remaining mice were 
normothermic, with temperatures ranging from 36.40 0C to 38.3 C. Three mice 
remained normothermic and apparently unaffected throughout the experiment, 
and one mouse died before the experiment was completed. We were 
uncertain whether the variable responses to E. coli LPS at the 2.5mg/kg dose 
were partly due to the presence of pregnant and older mice in this experiment 
(see Sections 6.2.4 and 6.3.2.2). However, further work with E. coli LPS at 
doses of 2.5mg/kg and 4mg/kg (for serum nitrate and IL-6 studies) has shown 
that responses are indeed variable, though in the first instance the variability 
was lower to the extent that we were able to use smaller sample sizes for 
experiments with cyanobacterial LPS than would have been the case with the 
initial pre-test experiment.  
 
No statistically significant temperature differences were seen between control 
mice and mice dosed with E. coli LPS at the 100µg/kg dose. The line plot 
(Figure 6.1) shows a trend towards increased temperatures over control mice 
in the immediate hours after dosing, which may be indicative of the low grade 
fever described in the studies of Kozak et al (1998) and Leon et al (1998) in 
mice injected with E. coli LPS at this dose. As all mice in the three treatment 
groups were randomly assigned to all six cages, presumably any inter-cage 
activity level differences – and hence cage-specific core temperature 
variability – would not have influenced these results (see Section 6.4.3.3 for 
discussion of intra-cage circadian effects). Even though the variability in core 
temperature was much smaller in the E. coli LPS 100µg/kg group than was 
seen in the E. coli LPS 2.5mg/kg group, the mean temperature differences 
between mice dosed with E. coli LPS at 100µg/kg and negative control mice 
dosed with 0.9% NaCl were too small to allow statistically significant 
differences to be detected with reasonable group sizes. Sample size 
estimates using data from this pre-test experiment indicated groups ranging 
from 13 to 23 mice would be required to detect fevers in the four hours after 
dosing. For this reason, we decided to concentrate our efforts on detecting 
after-dose hypothermia in mice injected with cyanobacterial LPS and 
cyanobacterial exotoxins.  
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The work of Kozak et al (1998) and Leon et al (1998) describes a biphasic 
response of mice to E. coli 0111:B4 LPS injected i.p. at 2.5mg/kg, with initial 
hypothermia followed by a fever peaking at around 24 hours. Our pre-test 
experiment failed to show this secondary fever. After discussions with Dr 
Christopher Gordon of the US Environmental Protection Agency, who has 
considerable expertise in rodent thermoregulatory responses to xenobiotic 
toxicants, we requested and were granted permission by our animal ethics 
committee to extend the duration of experiments to 72 hours after dosing.  
 
 
6.4.2.2. Experiment 1 (Figure 6.2) 
 
The first experiment with two cyanobacterial LPSs extracted by IS at NRCET 
showed a clear and rapid hypothermia, detected at one hour after dosing. 
Mice injected with these materials also developed profound and unambiguous 
signs of sickness behaviour, with marked piloerection, eyelid ptosis, 
diarrhoea, muscle weakness and reduced movement. Mice dosed with C. 
raciborskii AWT 205 LPS developed a hypothermia that was more prolonged 
than that of mice dosed with M. aeruginosa Coolmunda LPS. This was 
reflected in the severity of sickness behaviour responses, with C. raciborskii 
LPS-treated mice displaying more pronounced piloerection for longer periods 
than was seen in M. aeruginosa LPS-treated mice. The degree of variability in 
response to these cyanobacterial LPSs were different to that seen with E. coli 
LPS: all five mice injected with C. raciborskii LPS developed a hypothermia 
within two hours after injection, and only one of five mice injected with M. 
aeruginosa LPS appeared to be unaffected throughout the experiment. The 
large standard errors seen in the line plots reflect variable recovery times: at 
the 8 hour measurement time in the C. raciborskii LPS-dosed animals, one 
mouse had a rectal temperature of 30.00C, whereas three of the five mice 
were normothermic. All mice in this group were normothermic at 22 hours. 
Mice dosed with M. aeruginosa LPS were all normothermic by 8 hours 
following injection. Recovery from sickness behaviour signs did not correlate 
with recovery from hypothermia: mice dosed with C. raciborskii LPS were 
seen to have piloerection, decreased movement, pronounced eyelid ptosis 
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and weakness which peaked in intensity on the second day (22-32 hours after 
dosing). These signs were clearly resolving over the third day (46-51 hours), 
and at 72 hours all mice appeared to be behaving normally. Mice dosed with 
M. aeruginosa LPS also had recovery times that differed from return to 
normothermia. One mouse of this group of five had sickness signs observable 
only until four hours after dosing, three of the five appeared to have recovered 
completely by 24 hours, and one mouse had recovered by the start of the third 
day. The other mouse in this group, as mentioned above, seemed to be 
unaffected throughout. Gut signs – diarrhoea, mucus – were early-resolving 
phenomena, with diarrhoea seen from 2-5 hours in C. raciborskii LPS-dosed 
mice, followed by mucus plugs passed per rectum observed up until 11 hours, 
and no further gut signs seen from day 2 onwards. Only one mouse in the M. 
aeruginosa LPS group had any observable gut signs, passing a mucus plug at 
11 hours, although frank diarrhoea was seen in Coolmunda M. aeruginosa 
LPS-treated mice in a subsequent experiment (experiment 5) as a very early 
event, seen only within the first hour after dosing. So the general conclusions 
that can be made from this first experiment are that responses to 70mg/kg i.p. 
injections of C. raciborskii AWT 205 LPS and M. aeruginosa Coolmunda LPS 
both initiated a cascade of responses, with hypothermia and sickness 
behaviour signs occurring, peaking and resolving at different times. Variable 
responses and recovery times were seen in mice within each of these 
treatment groups, and responses to each LPS extract differed, with C. 
raciborskii LPS producing more marked responses. All mice appeared to have 
recovered fully from the effects of these injections by the end of the 
experiment.  
 
No signs of sickness behaviour were seen in mice dosed with microcystin-LR 
3.5µg/kg or cylindrospermopsin 100µg/kg.  
 
 
6.4.2.3. Experiment 2 (Figure 6.3) 
 
C. raciborskii AWT 205 LPS and M. aeruginosa Coolmunda LPS were 
administered at 1/10 of the doses given in experiment 1. Three time points 
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revealed statistically significant differences at the 5% level between C. 
raciborskii LPS-dosed mice and control mice: firstly at 0.5 hours after dosing, 
where a mean starting temperature of 36.40C in the C. raciborskii group (c.f. 
37.90 0C in control mice) climbed to 37.8 C 30 minutes later. One mouse in the 
C. raciborskii LPS group had a mildly hypothermic temperature of 35.30C at 
0.5 hours, with an abnormal reluctance to move noted at that time; this 
reduced spontaneous activity was maintained in this and other mice for 8 
hours after dosing. This mouse’s temperature rose to 38.00C at the I hour 
thermometry mark, which suggests that this was indeed a brief hypothermic 
spike, as this 2.70C temperature increase in 30 minutes was not related to 
physical activity. The statistically significant differences in C. raciborskii LPS 
and control mice temperatures at 6 hours and 22 hours are probably not 
relevant, as C. raciborskii LPS temperatures at that time were all 
normothermic. The upward trend of all temperatures between the 4 and 6 
hour measurement periods and the downward trend from 18 hours are 
examples of circadian, activity-associated effects. The 4-6 hour measurement 
period straddled an on-to-off cycle of illumination in the animal housing facility, 
which is related to a marked increase in spontaneous activity in healthy mice, 
and an associated increase in core temperature; the 18-hour-plus time period 
corresponded to morning, i.e. illuminated times, with concomitant reductions 
in activity and core temperature. Sickness behaviour signs followed a similar 
pattern in C. raciborskii LPS mice at the lower dose compared to mice given 
the higher dose in experiment 1: piloerection and decreased spontaneous 
movement were observable in all six mice, but with markedly reduced 
intensity compared with mice given the higher dose. No signs of eyelid ptosis 
were observed, and recovery occurred within a shorter time, with all mice in 
this group behaving normally by 30 hours. Mice dosed with M. aeruginosa 
LPS showed parallel responses compared with C. raciborskii LPS-treated 
mice, insofar as responses were milder in M. aeruginosa mice compared with 
C. raciborskii mice at the same dose, and responses were markedly less 
severe in M. aeruginosa mice at the lower dose. A statistically significant dip 
(p<0.05) in group temperature is seen with the M. aeruginosa LPS mice at the 
beginning of the experiment, which appears similar to the plot of C. raciborskii 
LPS responses. One mouse with abnormal reluctance to move had a 
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0 0temperature of 35.7 C at 30 minutes after dosing, which rose to 37.1 C at the 
60 minute mark. Three of five mice in the M. aeruginosa LPS 7mg/kg group 
were affected by mild signs of piloerection, movement reduction and muscle 
weakness, with all mice having recovered by 8 hours after dosing.  
 
The pattern of core temperature and sickness behaviour responses to purified 
cylindrospermopsin at 500µg/kg was very different to that seen in response to 
E. coli and cyanobacterial lipopolysaccharides. All CYN-treated mice were 
apparently unaffected during the first post-dosing day, with no observable or 
measurable abnormality seen within the first 8 hours of monitoring. The 
following morning, at 18 hours after dosing, two mice were found to have 
suffered unilateral periorbital and intraocular haemorrhages. Their 
temperatures at this time were 32.80 0C and 35.8 C. One mouse developed 
unilateral periorbital and intraocular haemorrhage during the course of the 
second day, and some stages in the progression of this phenomenon could be 
observed. At 1100 (22 hours after dosing) this mouse was seen to have a 
markedly protruding eye, with an opacity seen within the eye, but no signs of 
haemorrhage. Forty minutes later, blood was seen on the fur surrounding the 
orbit, and clotted blood was seen around the eye. The protrusion of the eye 
settled fairly quickly over the next few hours, and an intraocular haematoma 
was evident. This ocular pathology in mice has been infrequently observed 
before by other workers in our laboratory in association with 
cylindrospermopsin toxicity studies, though three of five mice affected is the 
highest incidence seen to date. Rectal temperature measurements fluctuated 
between hypothermia and normothermia in individual mice after the 18 hour 
post-dose period. The mouse with a temperature of 32.80C at 18 hours 
became normothermic (36.80C) by 30 hours, and then registered a 
temperature of 34.50C at 51 hours. There was a statistically significant 
difference between control and CYN group temperatures over three 
consecutive measurement periods at the end of the experiment. Two mice 
died before the experiment was completed; the final two thermometry time 
points comprise the three remaining mice. Large standard errors after the 18 
hour measurement period are largely due to the normothermic responses of 
one mouse in this group; this mouse appeared to behave normally throughout 
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the experiment, with no pathophysiological signs observed. Sickness 
behaviour signs followed the ocular haemorrhages, which were the initial 
adverse effects seen in this group. The four affected mice in this group 
developed piloerection, reduced movement and muscle weakness, which 
remained until the end of the experiment. These signs were unambiguous but 
of lesser intensity than seen in mice dosed with E. coli and cyanobacterial 
LPS at high doses.  
 
All mice dosed with microcystin-LR at 17µg/kg appeared to be unaffected 
through the entire experiment. The mean temperature recordings seemed to 
largely correspond to those of the control mice during this study, so these 
mice served as a supplementary control group, lending further suspicion that 
the lower mean temperatures recorded in the low dose M. aeruginosa and C. 
raciborskii LPS groups were indeed a real, albeit brief response to those 
materials.  
 
 
6.4.2.4. Experiment 3 (Figure 6.4) 
 
The statistically significant temperature differences between control mice and 
those dosed with A. circinalis are difficult to interpret, but probably not relevant 
in this experiment, as all mice in the A. circinalis group were normothermic 
throughout. These final experiments (experiments 3-5) were conducted with 
treatment groups housed within a cage, i.e. they were not randomly assigned 
to cages across treatments. This was done to facilitate the coordination of 
dosing and termination times to allow blood to be collected for supplementary 
experiments on serum nitrate and IL-6. A downside of this non-random cage 
allocation, which was not appreciated at the time, was that intra-cage 
differences in activity levels may have influenced treatment group temperature 
effects. The significant mean temperature difference between controls and M. 
aeruginosa / M. flos-aquae LPS-treated mice at 30 minutes is also of 
borderline practical significance, with one LPS-dosed mouse registering a 
temperature of 35.40C at the 30 minute mark, and all mice normothermic at 80 
minutes.  
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Sickness behaviour signs were seen in mice dosed with A. circinalis, P. 
formosum and M. aeruginosa / M. flos-aquae LPS. The relative severity of 
sickness signs between these treatment groups was in the order P. formosum 
< A. circinalis < M. aeruginosa / M. flos-aquae. Four of five A. circinalis LPS 
mice developed piloerection and weakness; diarrhoea and rectal mucus was 
seen in four mice, commencing at four hours through to 10 hours, which is a 
later onset than seen in previous cyanobacterial LPS experiments. Two of six 
P. formosum LPS-dosed mice developed mild piloerection, with another two 
having equivocal signs of piloerection. Diarrhoea and rectal mucus were more 
common signs, seen in five of six mice at various times through the 
experiment, commencing unequivocally at 80 minutes after injection. Mice 
dosed with M. aeruginosa / M. flos-aquae LPS were clearly the most unwell in 
this experiment, with piloerection seen in all five mice, two mice developing 
eyelid ptosis, and reduced movement, isolation from cage companions, 
diarrhoea and rectal mucus also seen. An interesting stand-out observation 
seen in this experiment was the response to N. spumigena LPS. Two of five 
mice had diarrhoea at 30 minutes after dosing, and the remaining three had 
possible but equivocal signs of diarrhoea at this time. No further evidence of 
diarrhoea was seen in any of this group for the remainder of the experiment, 
and no sickness behaviour signs were observed in these mice. Equivocation 
in determining diarrhoea comes from the understanding that frank diarrhoea 
may not always be seen during thermometry, but its occurrence in the recent 
pre-measurement period can be deduced from the presence of faecal staining 
of the fur surrounding the anus. The three N. spumigena mice with equivocal 
signs of diarrhoea had some unusually moist fur around the anus, but it was 
not an obviously faecal-stained colour. This suggests that some kind of fluid 
was passed per rectum in all N. spumigena LPS-treated mice, manifesting as 
diarrhoea in two of five mice. This was clearly an early and transient event. 
Spirulina sp LPS at 70mg/kg produced diarrhoea in one mouse at 30 minutes 
after injection, and a rectal mucus plug was seen in another mouse at 8 hours 
after dosing. Equivocal signs of piloerection and weakness were seen in only 
one mouse at one time point. The general conclusion here is that Spirulina 
and N. spumigena LPS do not seem to produce signs of sickness behaviour 
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or thermoregulatory change at i.p. doses of 70mg/kg, but diarrhoea and rectal 
mucus production do occur.  
 
Gaining experience in the sophisticated art of mouse rectal thermometry lends 
itself to the parallel development of a certain finesse in detecting changes in 
the appearance and consistency of faecal pellets. While frank diarrhoea is 
unmissable, the increased production and expulsion of mucus is a subtler 
sign, but with experience can be readily observed, and seemed to be a 
frequent response to dosing with E. coli and cyanobacterial LPS. Excess 
mucus can be seen as a coating on formed pellets, and mucus is sometimes 
passed per rectum as a viscous, opaque plug.  
 
 
6.4.2.5. Experiment 4 (Figure 6.5) 
 
Interpretation of the statistically significant differences in temperature between 
control mice and M. aeruginosa Mt Bold LPS and M. flos-aquae is difficult. All 
mice were normothermic throughout, with the lowest temperature in the Mt 
Bold group being 36.10C at 90 minutes after injection, with three other mice 
having temperatures in the low 370s at that time. Mice in the M. flos-aquae 
LPS group had temperatures in the high 360 0s and low 37 s after dosing. The 
clear difference seen in control mice after dosing is explained by the 
observation that control mice were very active after dosing, as mice in this 
experiment were dosed around 2200-2300, which are peak activity times. The 
pre-dose temperatures taken 4 hours before dosing are instructive here, as 
mice in these experiments began to increase their activity around 1700 hours, 
which is one hour before lights out. So the relative drop in mean temperatures 
in the M. aeruginosa Mt Bold and M. flos-aquae LPS groups came at a time 
when they may have otherwise been expected to be very active, as were 
control mice, with temperatures in the mid 380s. However, whether these 
lower group temperatures were a true pathophysiological response or merely 
associated with reduced movement is not clear. Mice in these two treatment 
groups displayed clear sickness behaviour signs; all five M. flos-aquae LPS 
mice had piloerection and reluctance to move, and three of five M. aeruginosa 
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Mt Bold LPS mice had piloerection, and one mouse had transient eyelid 
ptosis.  
 
Hypothermia was clearly evident in mice dosed with C. raciborskii CYP020A 
LPS and M. aeruginosa MIC 338 LPS. Temperatures in the low 340s were 
recorded in the MIC 338 group, and in the low to mid 350s for the CYP020A 
group. All mice in these treatment groups were affected by piloerection and 
reluctance to move, with eyelid ptosis, diarrhoea and rectal mucus observed 
in most but not all mice.  
 
 
6.4.2.6. Experiment 5 (Figure 6.6) 
 
This experiment included repeat thermometry measurements of three test 
materials conducted in experiments 1 and 2: C. raciborskii AWT 205 LPS and 
M. aeruginosa Coolmunda LPS administered at doses of 70mg/kg, and 
cylindrospermopsin at 500µg/kg. The principal reason for repeat dosing of 
these cyanobacterial toxins was to collect blood for experimental work on 
serum nitrate and IL-6, which was not planned at the time the initial 
thermoregulation studies were conducted. As with all of these experiments, 
the investigator (IS) was blinded to the identity of test materials; rectal 
thermometry was well tolerated by experimental animals, so temperature 
measurements were conducted on mice in all treatment groups before 
terminating the studies 12 hours after dosing for collection of blood. The 
exception in experiment 5 was for cylindrospermopsin 500µg/kg and control 
mice which were sacrificed 24 hours after dosing.  
 
Of the six thermometry measurement points in this experiment that were 
associated with statistically significant differences in group temperature 
between control mice and various treatment groups, only one produced 
unequivocal evidence of pathophysiological responses to treatment materials. 
C. raciborskii AWT 205 LPS and M. aeruginosa Coolmunda LPS clearly 
initiated rapid hypothermia, with low and sub-340C temperatures recorded in 
mice from both treatment groups at 30 minutes after dosing. Pronounced 
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sickness behaviour signs were observed in both groups: piloerection, muscle 
weakness and frank diarrhoea. Eyelid ptosis was seen in two mice dosed with 
C. raciborskii AWT 205 LPS. Two of five mice dosed with M. aeruginosa 
Coolmunda LPS were unaffected and behaved normally throughout the 
experiment.  
 
No signs of sickness behaviour were observed in any Spirulina-treated mice, 
but two mice were unequivocally seen to pass mucus plugs per rectum, and 
the third mouse was given a possible but uncertain rating for expulsion of 
mucus. No signs of sickness behaviour or unusual bowel function were seen 
in any mice dosed with MC-LR or anatoxin-a; these mice behaved normally 
throughout the experiment.  
 
Mice dosed with cylindrospermopsin 500µg/kg registered statistically 
significant decreases in temperature at 10, 14 and 18 hours after dosing. The 
line plot (Figure 6.6) shows a parallel trend with control mice temperatures, so 
we may have been observing cylindrospermopsin-treated mice tracking a 
circadian-related decrease in temperature seen in control mice, as these 
measurements crossed over into simulated daylight hours towards the end of 
this experiment. One possibly significant observation occurred at the 18 hour 
post-dose measurement period, when one mouse with a temperature of 
35.30C had piloerection and a markedly protruding right eye. Your investigator 
assumed that this ocular sign presaged periorbital and intraocular 
haemorrhages, as observed in cylindrospermopsin-treated mice in experiment 
2. However, this anticipated pathology did not occur; at 21 hours the affected 
eye appeared to have retracted to a normal position, but the eyelids seemed 
to resemble those of LPS-treated mice with eyelid ptosis. The exception here, 
being that this cylindrospermopsin-dosed mouse had a unilateral ptosis-like 
appearance, whereas LPS-treated mice with eyelid ptosis always displayed 
this phenomenon bilaterally.  
 
Statistically significant differences in temperature were recorded between 
treatment groups and control mice in the two pre-dose measurement periods. 
Observations at both pre-dosing time points reveal weaknesses in the design 
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of this particular experiment. The 48 hour pre-dose measurements were all 
conducted at the same time, from 1450 to 1600. Mice in this experiment were 
not randomly allocated to cages across treatment groups, as done in 
experiments 1 & 2, and the pre-test experiment. It appears that the low 
temperatures recorded in control mice at the 48 hour pre-dose measures were 
probably due to intra-cage activity level differences, where mice in this cage at 
this time were sleeping, whereas enough mice in the anatoxin-a treatment 
group were active enough to produce higher rectal temperatures. Control mice 
in this experiment were dosed with 0.9% NaCl along with mice dosed with 
cylindrospermopsin 500µg/kg from 1010 to 1025, i.e. in daylight hours, 
because cylindrospermopsin-treated mice were to be sacrificed at 24 hours 
after dosing. Mice in the remaining treatment groups were dosed 
approximately 12 hours later, between 2300 and 0050, i.e. at peak physical 
activity times. So the temperature measurements taken at 4 hours before 
dosing reveal circadian-related differences between MC-LR, anatoxin-a and 
LPS-dosed mice and control mice. This experiment would have been better 
designed with two control groups: one group to be injected with 0.9% NaCl 
along with cylindrospermopsin-treated mice, as done in this case, and another 
control group to be injected alongside LPS-treated mice.  
 
  
6.4.3. General discussion and conclusions 
 
6.4.3.1.1. Sickness behaviour 
 
The introductory remarks to this chapter describe the understanding that 
changes in the thermoregulatory set-point which lead to hypothermia and 
fever in response to microbial and xenobiotic insults are controlled by 
centrally-acting endogenous mediators. What may not be widely understood 
by cyanobacteriologists doing in vivo toxicology studies is that sickness 
behaviour is also mediated by endogenous cytokines. Interferons and major 
pro-inflammatory cytokines such as IL-1α, IL-1β, TNF-α and IL-6 are 
responsible for the behavioural signs of sickness such as lethargy, anorexia, 
adipsia and reduced social interaction seen in humans and experimental 
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animals (Dantzer et al, 1998; Bluthé et al, 2000a; Dantzer, 2001; Kelley et al, 
2003). Piloerection and ptosis are also sickness behaviour signs seen in 
laboratory animals after injection with LPS or the pro-inflammatory cytokines 
that LPS induces (Ferran et al, 1991; Linthorst et al, 1994; Lacosta et al, 
1999; Hayley et al, 2002). These cytokines act on the brain to produce these 
non-specific but profound psychological and behavioural signs and symptoms 
associated with infection. These responses are a coordinated homeostatic 
response to the presence of infection and inflammation that benefits the 
individual and contributes to recovery, and are not the result of weakness and 
debilitation that accompany infection (Dantzer et al, 1998; Kelley et al, 2003). 
This suite of responses, including thermoregulatory changes, is collectively 
termed sickness behaviour, and has been documented in all animal species 
studied in response to infection (Kelley et al, 2003). Because of the ubiquity of 
non-specific signs and symptoms of sickness, medical practitioners frequently 
dismiss them, as they are considered to be an unpleasant but banal 
accompaniment to pathogen-associated debility (Dantzer, 2001). For the 
same reasons, cyanobacterial toxicologists may not have appreciated the 
importance of these observations in laboratory animals. Several authors have 
reported sickness behaviour in response to cyanobacterial extracts and 
purified cyanotoxins (Heaney, 1971; Soltero & Nichols, 1981; Slatkin et al, 
1983; Kotak et al, 1993; Seawright et al, 1999), yet many authors conducting 
in vivo toxicology studies on cyanobacteria have not reported either the 
presence or absence of sickness behaviour in their experimental animals, 
presumably because they did not attach any particular significance to these 
signs. But the associated production of sickness behaviour responses by 
cyanobacterial toxins may be clues to more fundamental processes in the 
toxicology of cyanobacteria. The presence of sickness behaviour signs 
indicates the activity of potent pro-inflammatory cytokines such as TNF-α and 
IL-1β, which themselves are known to be capable of causing significant 
morbidity and mortality through various organ systems, with hepatic and 
pulmonary compartments being primarily affected (Tracey et al, 1986; 
Eichacker et al, 1991; Hewett & Roth, 1993; Gantner et al, 1995; Takei et al, 
1995; Bahrami et al, 1997; Schümann et al, 1998).  
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The understanding of sickness behaviour is a recent development; the 
realisation that pro-inflammatory cytokines acting on the brain induce these 
responses was essentially unknown 10 years ago (Kelley et al, 2003). Much 
of this work has been accomplished with knockout animal models, including 
mice lacking IL-1β or its type I receptor which are resistant to turpentine-
induced anorexia and weight loss, and have impaired production of acute-
phase proteins. Similar results are also seen in IL-6 knockouts (Inui, 2001). IL-
1 receptor type I-knockout mice are resistant to i.p. or intracerebral injection of 
IL-1β, which normally induces sickness behaviour measurable in terms of 
reduced social exploration, body weight, food intake and mobility (Bluthé et al, 
2000b). IL-6-deficient mice demonstrate reduced depressant effects on social 
interaction and weight loss compared to wild-type mice after injection with 
LPS or IL-1β (Bluthé et al, 2000a). Immune-function knockout models have 
been important tools in understanding the mechanisms of fever (Kozak et al, 
1998; Leon et al, 1998), and they may well turn out to be valuable tools to 
help improve the knowledge of broader pathological processes caused by 
cyanotoxins, especially those affecting hepatic function, i.e. microcystins and 
cylindrospermopsin.  
 
 
6.4.3.1.2. Sickness behaviour observations in these experiments 
 
Table 6.4 should be interpreted cautiously, especially with regard to the rating 
scales (+ to +++). The table is of most value when viewed qualitatively, to 
indicate the presence or absence of specific signs within treatment groups. 
There are several variables which were not analysed here: signs were not 
graded for severity on individual mice; the time course, onset and recovery 
from specific signs differed within and across treatments, and the number of 
mice not affected within treatments varied. Nonetheless, some treatments 
clearly resulted in more pronounced and prolonged signs of sickness 
behaviour than others. The rating scales in Table 6.4 should be interpreted as 
denoting relatively increased or decreased severity of effect, with a “+++” 
rating representing a loose incorporation of relatively more severe signs in 
individual mice and relatively more mice affected compared to lower ratings.  
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6.4.3.2. Intermittent thermometry vs continuous telemetry 
 
These intermittent thermometry experiments have successfully demonstrated 
thermoregulatory changes in mice exposed to a variety of cyanobacterial 
lipopolysaccharides, and the purified cyanobacterial exotoxin 
cylindrospermopsin. Continuous radiotelemetry is widely used for rodent 
thermoregulatory studies (Gordon & Yang, 1997; Gordon & Rowsey, 1998; 
Kozak et al, 1998; Leon et al, 1998); such systems are clearly superior with 
respect to data collection, and are not interrupted by the requirements for 
graduate students to go home and sleep occasionally. Transient downward 
trends in core temperatures may have been missed in some instances by the 
intermittent techniques used here, phenomena which would be readily 
identified by continuous telemetry. Circadian effects and activity-related 
changes in temperature would be better monitored and analysed by 
continuous data collection, especially in conjunction with actimetry. Our 
laboratory submitted a funding proposal to purchase a telemetric thermometry 
system, but this proposal was not successful. However, despite these 
limitations, we have shown that intermittent rectal thermometry can be 
successfully used to investigate thermoregulatory changes caused by 
exposure to cyanobacterial products.  
 
The work of Kozak et al (1998) and Leon et al (1998) shows that mice will 
register a stress-related temperature spike when handled. Intermittent 
thermometry will not reveal the presence or absence of such a transient 
change in core temperature, but we suspect that the pre-dose acclimation and 
handling of mice may have been successful, as far as can be ascertained. 
The variability in pre-dose and control mice temperatures throughout these 
experiments was clearly associated with activity levels, and activity levels 
were largely related to circadian effects, with mice becoming highly active in 
darkness. Pre-dose temperatures taken on all mice, plus experimental 
temperatures on 0.9% NaCl-treated mice were analysed: From 1500 rectal 
thermometry readings, the lowest recorded temperature was 35.50C, and the 
highest was 39.20C. Low temperatures in undosed mice (including controls) 
were always associated with sleep, and high temperatures were always 
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recorded in active animals. Temperatures in mice plucked from sleep were 
frequently recorded in the high 350 0’s and low 36 ’s, which suggests that 
transient stress-related temperature spikes were not being measured, at least 
in relatively inactive mice. The choice of mouse strain may have helped in this 
regard. Balb/c mice, at least in the experience of IS, appear to operate at 
lower stress levels than, say, C57BL6 mice. Balb/c mice seem to be generally 
more inquisitive and tolerant towards handling, weighing and housekeeping 
tasks. The procedure of rectal thermometry was surprisingly (to IS) well-
tolerated by mice, with struggling or vocalisation never accompanying the 
procedure. Indeed, some experienced mice could be observed adopting 
postures that can only be described as “assuming the brace position”. On 
being removed from the cage and lifted by the base of the tail in preparation 
for passage of the thermometer probe, some mice could be seen forcibly 
retracting their hind limbs towards the abdomen, possibly indicating that the 
procedure was not entirely unpleasant.  
 
 
6.4.3.3. Intra-cage temperature effects 
 
In all experiments, mice that did not display sickness behaviours were active 
in darkness hours, and were markedly less active in the light. However, some 
mice could be seen throughout the day in varying degrees of activity – eating, 
drinking, social interaction, or exploring cage boundaries. By and large, such 
activities seemed to be cage-specific: of six cages housing five mice per cage, 
the inhabitants of five cages might be asleep at any given time during the day, 
but mice in the sixth cage would be active. Activity levels were always 
transiently increased after thermometry readings were performed, but the 
matter of concern was that of relative increases in activity in one or more 
cages, compared to other cages in which mice were inactive. Relative 
increases in activity during lights-on periods tended not to be distributed 
across cages; more often it was a case of one or two active mice in a cage 
presumably stimulating their cage companions to become more active. Study 
design features to account for relative differences in activity, and therefore 
core temperature, would be to randomly distribute mice in the different 
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treatment groups across all cages. This was done in the pre-test experiment 
and experiments 1 and 2, although not for this reason. Random cage 
allocation was conducted to allow IS to be fully blinded to the treatment status 
of each mouse, and not be influenced by the presence or absence of sickness 
behaviour signs within groups of mice in the one cage. Randomisation across 
cages was not conducted in experiments 3-5, in order to facilitate staggered 
dosing and termination times for supplementary experiments on serum nitrate 
and IL-6. With hindsight, this failure to randomise cage allocation may have 
contributed to some intra-cage temperature differences. Another way to 
control for relative differences in activity within cages would be to record 
simultaneous actimetry and thermometry with a radiotelemetry system, so 
temperature data could be weighted against movement data.  
 
 
6.4.3.4. Cyanotoxins and dose-response curves 
 
Many cyanobacterial exotoxins have very steep dose-response curves (Lovell 
et al, 1989; Ressom et al, 1994 p30; WHO, 2003 p141), which means that 
toxic effects in many cases will not be observed until concentrations are 
administered that approach the lethal dose. Experimental work with sheep 
showed that up to 90% of the lethal dose of microcystin-producing M. 
aeruginosa could be administered without producing clinical signs (Jackson et 
al, 1984). Purified microcystin-LR is capable of producing signs of sickness 
behaviour in experimental animals, with lassitude, hunched posture, 
immobility and piloerection reportedly occurring between 20-40 minutes to 
several hours after parenteral administration (Slatkin et al, 1983; Hooser et al, 
1989; Lovell et al, 1989). The failure of doses up to 35µg/kg to elicit any 
observable or measurable effects in these experiments is an indication that 
the doses of MC-LR administered were too low. There is good reason to 
suspect that pro-inflammatory cytokines are active participants in the 
pathological processes of microcystins in vivo (see Chapter 7), so the 
negative results of these studies should not be interpreted as confirmation that 
MC-LR does not initiate acute phase responses, including thermoregulatory 
alteration.  
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Anatoxin-a also failed to initiate sickness behaviour signs in any of five mice 
injected at a dose of 175µg/kg. Mouse i.p. LD50s for anatoxin-a are variously 
reported at 200µg/kg (Ressom et al, 1994 p28) and 375µg/kg (Fitzgeorge et 
al, 1994). We investigated anatoxin-a in this work because news of the first 
human fatality reportedly associated with anatoxin-a intoxication was released 
while these experiments were in progress (Behm, 2003; Campbell & Sargent, 
2004). Because the circumstances surrounding this teenager’s death were 
unusual and not in concordance with what is known from experimental work 
on anatoxin-a, we requested ethics permission to dose mice with this toxin. 
Anatoxin-a is a potent neuromuscular blocking agent, and death from 
asphyxiation can be very rapid (Ressom et al, 1994 p27). The human fatality 
reportedly involved an unusual set of signs and symptoms, with severe 
gastro-intestinal disturbance and acute cardiac failure. We wished to see 
whether any of the acute-phase responses we were investigating in these 
studies could be initiated by anatoxin-a, which would help to shed some light 
on this boy’s death. Piloerection has been reported in mice after injection with 
bloom samples of Anabaena flos-aquae that, from the reported sequence of 
events, presumably contained anatoxin-a (Soltero & Nichols, 1981), although 
the effects of cyanobacterial LPS in those injections must be considered in 
light of these experiments. The study of sub-lethal properties of cyanotoxins 
with steep dose-response curves presents a dilemma for animal ethics 
committees, as death is not an appropriate or desirable end-point in these 
kind of toxicology studies, yet the administration of sub-toxic doses, in this 
case 50% of the i.p. LD50, has been a waste of animals and other resources. 
The phenomenon of steep dose-response curves from cyanotoxins is a matter 
that will need to be carefully considered by ethics committees in future.  
 
 
6.4.3.5. Interpretation of results, statistical analyses 
 
Because of small sample sizes used in these experiments, the required 
assumptions for ANOVA and Tukey’s post-hoc tests of normally distributed 
data and equality of variances were not always met. The failure to meet these 
requirements was most obvious in the pre-test experiment, where 
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measurements on 11 of 17 time points failed either or both variance and 
distribution assumptions. However, statistically significant differences at the 
5% level between control and treatment mice temperatures at 17 time points 
across the pre-test and five experiments when variance and/or distribution 
assumptions were not met were confirmed by non-parametric tests. Only one 
statistically significant temperature difference identified by ANOVA was 
rejected by the Mann-Whitney test, so it appears that the temperature 
differences were of sufficient magnitude to withstand failure of variance and 
normality assumptions for parametric testing.  
 
In view of the potential for spurious results because of the interaction of 
circadian and activity effects, the statistically significant differences in 
temperature at particular time points were interpreted along with other 
parameters, specifically the trends in temperature change seen in treatment 
groups in each experiment, the crossing of a threshold for normal 
temperature, and the presence or absence of sickness behaviour signs within 
treatment groups. The conclusions drawn from this study therefore err on the 
side of caution. The lessons learned from this study are probably broadly 
applicable to most research topics: that statistical tests are very useful tools, 
but should not be the sole basis for decision-making and conclusions. 
Statistically significant results must be interpreted in conjunction with 
alternative explanations and biological plausibility. So the conclusions of 
positive thermoregulatory changes caused by particular cyanobacterial 
products in these studies are based on the following premises: 
 
1. Statistically significant differences in temperature at the 0.05 level, AND 
 
2. a trend involving consecutive, statistically significant measurement 
 differences, AND 
 
3. one or more mice registering temperatures below 35.50C, AND 
 
4. the presence of sickness behaviour signs in treated mice. 
 
 307
Chapter 6: Cyanobacteria and thermoregulation 
6.4.3.6. CONCLUSIONS 
 
The treatments that meet all four criteria outlined in Section 6.4.3.5 above for 
positive findings of thermoregulatory change are: 
 
• C. raciborskii AWT 205 LPS 70mg/kg 
• C. raciborskii CYP020A LPS 70mg/kg 
• M. aeruginosa MIC 338 LPS 50mg/kg 
• M. aeruginosa Lake Coolmunda LPS 70mg/kg 
• Cylindrospermopsin 500µg/kg 
 
All cyanobacterial lipopolysaccharides except Spirulina sp and Nodularia 
spumigena initiated signs of sickness behaviour in varying degrees. However, 
these two LPSs could not be interpreted as being biologically inactive in mice, 
as both induced effects on the gut, observed as diarrhoea or excess mucus 
production.  
 
In view of the much larger doses of cyanobacterial LPS administered in these 
experiments compared with E. coli LPS, and the dose-response differences 
seen with C. raciborskii AWT 205 LPS and M. aeruginosa Coolmunda LPS, all 
of these cyanobacterial LPSs should be viewed as initiators of weakly toxic 
responses when able to access the circulation, compared with E. coli LPS.  
 
Different cyanobacterial lipopolysaccharides can initiate responses that differ 
both qualitatively and in severity, which suggests that there may be 
differences in lipid A structures and concomitant mammalian signalling 
pathways. However the pattern of response is broadly similar to that of E. coli 
LPS insofar as responses occur rapidly after exposure, there appears to be a 
cascade of effects with different activity peaks – hypothermia, diarrhoea & 
mucus production, piloerection, weakness, immobility – followed by resolution 
to apparent good health. Alterations in gut function appear to be common 
features of cyanobacterial LPS administration by the intraperitoneal route.  
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Cylindrospermopsin was shown to induce hypothermia and sickness 
behaviour at 500µg/kg i.p., but microcystin-LR given at 35µg/kg i.p. is thought 
to be a sub-toxic dose, which would explain the lack of measurable and 
observable effects. No adverse effects were seen with anatoxin-a 
administration at 175µg/kg i.p. 
 
The ability of cyanobacterial lipopolysaccharides and cylindrospermopsin to 
initiate thermoregulatory change and sickness behaviour indicates that potent 
pro-inflammatory cytokines are mediating the responses to these toxins. In 
view of the ability of cytokines such as TNF-α and IL-1β to produce – by and 
of themselves – significant morbidity and mortality through hepatic and 
respiratory systems, investigation of innate immune responses by 
cyanobacterial toxicologists may lead to exciting and fundamental new 
discoveries. Experiments using cytokine knockout models would be a good 
starting point for this work, with a cautious prediction from this author that IL-1 
knockouts or the use of anti-TNF antibodies will demonstrate increased 
resistance to microcystins, nodularin and possibly cylindrospermopsin, 
depending on the measured end-points. 
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CHAPTER 7: ARE THE LIFE-THREATENING SHOCK-LIKE SYNDROMES 
ASSOCIATED WITH HEPATOTOXIC CYANOTOXINS EXPLAINED BY THE 
ACTIONS OF ENDOGENOUS MEDIATORS? 
 
 
7.1. Introduction 
 
This chapter will present a speculative hypothesis: that the rapid development 
of tissue injury and death in experimental animals dosed with cyanobacterial 
hepatotoxins is explained by innate immune dysregulation, mediated by the 
activity of potent pro-inflammatory cytokines. Profound shock-like syndromes 
involving disruption and damage to different organ systems are seen in 
experimental and accidental cyanotoxin poisoning. This chapter will examine 
some of the features common to different manifestations of shock, and 
highlight similarities to clinical and biochemical findings associated with 
cyanobacterial intoxication.  
 
The premise for writing this chapter comes from the review article of Kaya 
(1996), who noted in the conclusion of his paper on microcystin (MC) 
toxicology that the shock-like syndrome produced by MC poisoning has 
similarities to the fulminant multi-system organ failure seen in endotoxin 
shock. That review approached MC pathology from the perspective of some 
processes that are fundamental to the activity of the innate immune system. 
This chapter will incorporate a brief discussion of the paper of Kaya (1996) 
and some more recent findings in related cyanobacteria research. A brief 
overview of the pathophysiological effects of cytokine hyperresponsiveness 
will follow. In addition, some research activities into management and 
intervention in the processes of septic shock will be discussed. The chapter 
will conclude with some suggestions for research into hepatotoxic cyanotoxins 
to further explore the relationship between innate immunity and the 
pathophysiology of cyanotoxins.  
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7.2. Innate immune responses and microcystin 
 
Kaya (1996) discusses some aspects of MC toxicity that are relatively under-
reported in most reviews of the topic. Much research interest is directed to the 
active transport of MC into hepatocytes, and the subsequent intracellular and 
molecular events within parenchymal cells, especially protein phosphatase 
inhibition. While discussing these topics, Kaya (1996) also reviews the 
production of endogenous mediators from macrophages, as well as 
hepatocytes. Principal pro-inflammatory cytokines, notably TNF-α and IL-1, 
are produced in response to MCs; these cytokines then initiate the release of 
a range of secondary inflammatory mediators, such as thromboxane B2, 
prostaglandins and other arachidonic acid metabolites. Anti-inflammatory and 
immunosuppressive agents reduce the activities of MCs. For example, 
glucocorticoids suppressed the release of arachidonic acid, and Cyclosporin A 
protects against MC-LR hepatotoxicity and lethality. Kaya (1996) also reviews 
what this author considers to be a fundamental study by Nakano et al (1991), 
who show that pre-treatment with TNF-α antiserum significantly reduced the 
hepatic injury and mortality from a microcystin-containing crude extract of M. 
aeruginosa.  
 
Other relevant work in this area not reviewed in or published since the paper 
of Kaya (1996) is: 
 
• Hydrocortisone protected against mortality of MC-LR (Adams et al, 
1985). 
• MC stimulated the activation of NF-κB and production of TNF-α in rat 
astrocytes and peritoneal macrophages, but inhibited the LPS and 
cytokine-mediated production of nitric oxide in macrophages (Pahan et 
al, 1998). 
• MC-LR stimulates the release of TNF-α and IL-1β from rat peritoneal 
 macrophages. An isolated rabbit ileum model of intestinal secretion 
 showed increased activity when treated with supernatants from MC-LR-
 treated macrophages. The authors suggest that IL-1β is likely to be the 
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 mediator of this intestinal dysfunction, which could be reduced by pre-
 treatment of macrophages with dexamethasone (Rocha et al, 2000). 
• Renal pathology produced by MC-LR appears to be mediated by 
arachidonic acid metabolites; toxicity was blocked by dexamethasone 
and indomethacin (Nobre et al, 2001). 
 
 
7.3. Cytokines, shock, hepatotoxicity and lethality 
 
Endotoxin is thought to be the principal bacterial product responsible for the 
initiation of septic shock that is often associated with severe infection by 
Gram-negative bacteria. It is well understood that injection of purified 
endotoxin, especially that of Salmonella or E. coli, results in a syndrome 
comparable to Gram-negative septicaemia, involving profound hypotension, 
thrombocytopenia and coagulopathy, and multiple organ dysfunction which 
can progress to multi-system failure (Horn et al, 2000; Cohen, 2002). Other 
bacterial components are also capable of initiating sepsis and shock: 
peptidoglycan from Gram-positive bacteria and prokaryotic DNA are also 
ligands that signal the activation of acute inflammatory responses. Bacterial 
exotoxins are another important group of bacterial products that can bypass 
host defences and initiate shock-like syndromes (Horn et al, 2000). The 
principal aspect of this discussion with respect to the mortality and serious 
morbidity from cyanotoxin poisoning is the realisation that shock is caused by 
overproduction of cytokines (Cohen, 2002; Beutler et al, 2003). Beutler (2004) 
observes the overall functioning of innate immune defence systems as:  
 
 “…remarkably effective insofar as severe or sustained infections are 
 quite  rare. They are imperfect in that…immune responses may 
 sometimes injure the host.” 
 
A fundamental aspect of sepsis is that the beneficial microbicidal mechanisms 
that conquer a limited infection can, if generalised, threaten the survival of the 
host (Beutler, 2004). Cytokines, which are integral intercellular messengers of 
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the immune system, can cause tissue destruction and death when their 
production is amplified and dysregulated (Cohen, 2002). 
   
Shock syndromes may occur by different cellular and molecular mechanisms, 
depending on the microbial pathogen. Other, non-microbial phenomena can 
also cause shock, e.g. hypovolemia, acute pancreatitis, trauma and major 
surgery (Khabar et al, 1997; Riedemann et al, 2003a; Granell et al, 2004). 
Ischaemia/reperfusion is a widely utilised in vivo model of shock (e.g. Bahrami 
et al, 1997). The common underlying mechanism behind shock syndromes is 
the induction of a cytokine cascade, which, if unregulated, will result in tissue 
damage and death. The main pathology is seen in the hepatic and pulmonary 
systems, though other organs, e.g. ileum and adrenals are affected (Hewett & 
Roth, 1993; Bahrami et al, 1997).  
 
Pro-inflammatory cytokines can mediate tissue destruction and lethality. The 
principal cytokine known to injure the liver and lung is TNF-α (Tracey et al, 
1986; Eichacker et al, 1991; Hewett & Roth, 1993; Gantner et al, 1995; Takei 
et al, 1995; Bahrami et al, 1997; Schümann et al, 1998). TNF-α is initiated 
rapidly in response to shock-producing insults, commencing within minutes 
and peaking in the circulation between 30 minutes to 2 hours (Beutler et al, 
1985; Miethke et al, 1992; Hewett & Roth, 1993; Bahrami et al, 1997). TNF-α 
mediates a variety of potent, acute effects in the liver that will be familiar to 
cyanobacteriologists working on the hepatotoxic cyanotoxins: protein 
synthesis inhibition, increased fatty acid synthesis, procoagulant activity and 
apoptotic injury (Hewett & Roth, 1993; Takei et al, 1995; Schümann et al, 
1998).  
 
Some other effects noted by the small number of researchers who have 
investigated the immunopathology of cyanobacterial hepatotoxins are 
mirrored by the actions of endogenous mediators: 
 
• Pre-treatment of mice with sub-lethal doses of either MC-LR or other 
hepatotoxicants such as CCl4 produces a transient refractory state in 
which  lethal doses of MC-LR are ineffective (Adams et al, 1985; 
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Hermansky et al, 1991). This phenomenon resembles the 
hyporesponsiveness to sequential exposure to LPS known as LPS 
tolerance, which is not the same as immunological tolerance. This is an 
active cellular process initiated by the first exposure, mediated by a 
short-term memory of monocytes/macrophages, and resulting in the 
complete abrogation of TNF-α release (Freudenberg & Galanos, 1988; 
Flohé et al, 1991; Holst et al, 1996).  
 
• Age-related effects of exposure to MC-LR (Hermansky et al, 1991) are 
 also reflected in experimental endotoxin-induced liver injury, where 
 young animals demonstrate decreased responsiveness (Durham et 
 al, 1990).  
 
Cyclosporin-A has a clear protective effect on MC-LR toxicity. Cyclosporin-A 
is a T-cell suppressor, and it also blocks the hepatic uptake of bile acids 
(Bunjes et al, 1981; Hermansky et al, 1990; Hermansky et al, 1991). So while 
the protective effect of cyclosporin-A may be related to decreased uptake of 
MC-LR into hepatocytes, the in vivo T-cell activating capacity of microcystins 
is worthy of investigation. T-cells are potent activators of TNF-α (Chatenoud et 
al, 1991; Gantner et al, 1995; Schümann et al, 1998). One possibility that this 
author has pondered is whether cyanotoxins like the microcystins and 
nodularin function as superantigens, like many other bacterial exotoxins. 
Superantigens bind to major histocompatibility class II molecules, activating T-
cells expressing specific Vβ domains. The end result is a massive activation of 
unprimed T-cells and release of pro-inflammatory cytokines (Herrmann & 
MacDonald, 1991; Cohen, 2002). An important model to investigate the effect 
of T-cell-mediated cytokine activation is that of the galactosamine-sensitised 
mouse. Galactosamine pre-treatment results in hypersensitisation to TNF-
mediated lethality, so the damaging dose of a T-cell stimulating hepatotoxin 
can be morphologically and biochemically characterised within hours without 
the primary lesion being obscured by secondary haemorrhagic processes 
(Decker & Keppler, 1974; Miethke et al, 1992; Gantner et al, 1995; Schümann 
et al, 1998).  
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Henderson et al (1998 pp249-50) note that an increasing number of bacterial 
exotoxins have the capacity to stimulate cytokine networks at extremely low 
levels (femtomolar to attomolar range), i.e. at sub-toxic concentrations. This 
suggests that the activity of many bacterial exotoxins depends on their 
capacity to initiate cytokine synthesis (Henderson et al, 1998 pp334-5).  
 
Some aspects of cylindrospermopsin toxicity deserve investigation from the 
perspective of immunotoxicology. The multiple organ pathology associated 
with cylindrospermopsin poisoning has similarities to that of LPS-related (i.e. 
cytokine-regulated) pathology, although the mechanisms are clearly different 
in that the adverse sequence of events can be seen at a very early stage in 
LPS-initiated toxicity, whereas deleterious exposure to cylindrospermopsin 
manifests after many hours and peak effects are seen in days (Falconer et al, 
1999b; Seawright et al, 1999). However, some specific features of 
cylindrospermopsin toxicity that warrant targeted investigation are: 
 
• Protein synthesis inhibition. Decreased protein synthesis is a 
 commonly reported facet of cylindrospermopsin-related pathology, 
 although this is not a complete explanation for the harmful effects 
 (Froscio et al, 2003; Hoeger et al, 2004). Protein synthesis inhibition is 
 a general cytokine-induced response to tissue injury or infection; 
 protein synthesis may be increased or decreased, depending on the 
 proteins being measured. Albumin synthesis decreases, whereas 
 acute phase proteins are increased (Hewett & Roth, 1993). The 
 presentation of acute hepatotoxicity caused by Pseudomonas 
 aeruginosa exotoxin A (PEA) provides an interesting comparison to 
 the picture seen in cylindrospermopsin intoxication. Schümann et al 
 (1998) report that intravenous injection of PEA into mice induces 
 dose-dependent hepatocyte damage within 12 hours; fatty 
 accumulation is seen, which the authors attribute to a PEA-
 dependent inhibition of apolipoprotein synthesis. The authors propose 
 a mechanism for liver failure and lethality from PEA exposure: T-cell 
 activation results in TNF production by Kupffer cells, and protein 
 synthesis inhibition sensitises the liver to the cytotoxic action of 
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 TNF. Fatty degeneration of the liver and renal proximal tubular 
 epithelial necrosis are seen in intoxication with the superantigen 
 pyrogenic exotoxin B, produced by the Gram-positive bacterium 
 Streptococcus pyogenes, with TNF-α again implicated in the 
 mechanism of tissue injury (Kuo et al, 2004). Fatty accumulation in the 
 liver and renal tubular injury are also important features of
 cylindrospermopsin toxicity (Harada et al, 1994; Terao et al, 1994; 
 Falconer et al, 1999). 
 
• Thymic atrophy. Cylindrospermopsin toxicity can involve the thymus, 
 with atrophy reported (Terao et al, 1994; Seawright et al, 1999). 
 Complement pathways are activated by various exogenous and 
 endogenous stimuli during systemic inflammatory reactions. C5a 
 protein exerts proinflammatory and procoagulant effects, including 
 thymocyte apoptosis (Riedemann et al, 2003a). Bacterial 
 superantigens, as well as activating large populations of T-cells, can 
 also cause the deletion of developing T-cells in the thymus 
 (Henderson et al, 1998 p246).  
 
 
7.4. Intervention in the process of shock 
 
Sepsis affects 700,000 people and is responsible for 210,000 deaths annually 
in the US (Riedemann et al, 2003a). It is therefore not surprising, and 
absolutely appropriate, that a considerable research effort is underway to 
develop therapeutic interventions in various stages of the progression of 
sepsis and shock. It is beyond the scope of this thesis to review these 
developments in detail, but a variety of theoretical and practical approaches 
are being investigated, including anti-cytokine therapies, anticoagulants, nitric 
oxide inhibitors, synthetic TLR-family immunostimulants, insulin therapy, 
apoptosis inhibitors and C5a antibodies (Cohen, 2002; Hackett, 2003; 
Riedemann et al, 2003a; Riedemann et al, 2003b). The relevance of this for 
the field of cyanotoxin research may be that discoveries in the field of septic 
shock intervention may be applied to cases of cyanotoxin poisoning, if the 
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hypothesis posed in this chapter is correct and innate immune responses to 
hepatotoxic cyanotoxins are significant mediators of morbidity and mortality. 
Some applications may turn out to be especially useful in the treatment of 
cyanotoxin poisoning, e.g. anti-cytokine therapies are considered very 
cautiously in the intervention of sepsis related to invasive microbial 
pathogens, as suppression of pro-inflammatory cytokines may place people at 
risk of overwhelming infection by the microbes that were responsible for the 
initiation of sepsis in the first place (Horn et al, 2000). Presumably this 
situation would be somewhat different in the case of intoxication by non-
proliferative cyanobacteria, so anti-cytokine therapies may be more 
applicable. However, this is highly speculative, and the clinical features 
impacting on possible interventions will likely be very complex, especially if 
secondary infection from gut-derived bacteria is involved in cyanotoxin 
poisoning.  
 
The pioneering work of Hermansky et al (1990) and Hermansky et al (1991) in 
investigating chemoprotectants against microcystin toxicity should continue, 
with a view to further understanding innate immune responses to 
cyanobacteria, and including the investigation of cylindrospermopsin toxicity. 
The creation and standardisation of animal models that closely mimic human 
clinical sepsis has been recommended (Horn et al, 2000); more studies that 
reflect real human exposures to cyanobacteria may be warranted, especially 
oral dosing studies. The intestinal epithelium is damaged by hepatotoxic 
cyanotoxins (Hawkins et al, 1985; Falconer, 1994b; Falconer, 1996; 
Carmichael, 2001b). Disruption of gut barrier function by cyanotoxins is 
therefore likely to be a pivotal process for increased translocation of bacterial 
ligands from commensal flora into the portal circulation (Hewett & Roth, 1993; 
Bahrami et al, 1996; see also discussion in Chapter 2, Section 2.8.3). Gut 
pathology is considered one of the most potent triggers for TNF-α release in 
shock-like syndromes (Bahrami et al, 1997).  
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7.5. Concluding remarks  
 
This discussion of dysregulated innate immune responses and associated 
morbidity and mortality is of necessity only a very superficial overview. Most of 
the discussion has concentrated on TNF-α, which is a very potent pro-
inflammatory cytokine and mediator of rapid hepatic injury and death. 
However, the innate immune system is extraordinarily complex, with myriad 
feedback loops, and augmentative and suppressive processes. TNF-α, like 
other cytokines, does not act alone; TNF-α and IL-1β often synergise, and 
neutrophils are closely associated with TNF-α in various protective and 
pathological processes (Curran et al, 1990; Hewett & Roth, 1993; Jaeschke et 
al, 1996). This review has also not discussed the production of reactive 
oxygen intermediates, especially nitric oxide, by pro-inflammatory cytokines, 
which are fundamentally involved in tissue injury. Cells, cytokines, and other 
soluble mediators act in a coordinated fashion that differs according to the 
microbial ligands that signal each particular insult. While the innate immune 
responses to commonly studied microbial pathogens are far from completely 
understood, there is much that is known, and this knowledge can be applied 
to the study of cyanobacterial toxicity. 
 
Toxicologists studying cyanobacterial hepatotoxins have understandably 
directed their attention towards the mechanisms of transport and uptake into 
hepatic parenchymal cells, and the metabolic and molecular processes 
therein. This preoccupation, however, may have led to the relative lack of 
enquiry into associated processes in non-parenchymal cells, especially 
Kupffer cells, the liver’s resident macrophages. An example of the importance 
of considering both parenchymal and non-parenchymal reactions is seen in 
the work of Younis et al (2003). In their study of 1,2-dichlorobenzene-induced 
hepatotoxicity, the authors suggest that signalling initiated by damaged 
hepatocytes activates adjacent Kupffer cells, which have a much greater 
capacity to produce and secrete cytokines. Isolated hepatocytes from rat 
strains with significantly different in vivo sensitivities to 1,2-dichlorobenzene 
and other hepatotoxicants show similar responses in vitro. The issue here is 
that Kupffer cells are absent in the in vitro model.  
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Cyanobacterial toxicology that concentrates exclusively on hepatocytes, 
especially in vitro models, may likewise be missing the bigger picture. This is 
not to belittle the importance of in vitro studies, which are very important for 
many reasons, and should certainly continue. As Younis et al (2003) note, the 
lack of correlation between in vitro and in vivo studies does not devalue the 
importance of working with primary hepatocyte cultures, because molecular 
and cellular changes that occur in vivo also operate in vitro. Refining the 
measurement of endpoints such as oxidative stress and cytokine production 
will better allow the extrapolation of in vitro findings to in vivo studies.  
 
Kupffer cells may be important in other processes that are relevant to the 
study of cyanobacterial hepatotoxins. Curran et al (1990) showed that 
proinflammatory cytokines produced by Kupffer cells signal the production of 
nitric oxide within hepatocytes, which in turn results in the inhibition of 
hepatocyte total-protein synthesis.  
 
Kupffer cell activity is reported in cyanobacterial hepatotoxin-related 
exposures: Heaney (1971) reported “considerable Kupffer cell reaction” in the 
livers of mice fed (presumably) microcystin-containing M. aeruginosa.  
 
The suggestion outlined in this chapter that shock is an important aspect of 
cyanotoxin poisoning is not new. Many authors accept that hypovolemia and 
circulatory collapse are probably the cause of early death from microcystin 
poisoning (Ashworth & Mason, 1946; Ressom et al, 1994 p52; Carmichael, 
1996; Falconer, 1999). However, the hypothesis posited in this thesis is that 
the circulatory changes and coagulopathy associated with microcystin and 
nodularin poisoning are not incidental to the metabolic events occurring within 
hepatocytes, but are integral to a cytokine-directed cascade of events in which 
death represents the final stage of an overwhelming dysregulation of a 
normally highly coordinated process. That inflammatory products may be 
involved in lethality from microcystin poisoning was raised by Nakano et al 
(1989), who suggested that IL-1 and secondary mediators produced by 
Kupffer cells may accelerate liver damage and death. 
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The majority of cytokine-related responses are self-limiting (Dinarello, 1996). 
The fact that serious illness and death due to cyanotoxin exposures are 
infrequently reported in humans may be indicative of immune defence 
systems doing their job. This review has discussed dysregulated cytokine 
responses causing disease and death in situations where the microbial or 
non-infectious insult overwhelms the body’s capacity to defend itself, and such 
situations are deservedly the main topic of research attention. However, the 
mechanisms of innate immunity may be seen operating in other cyanobacteria 
exposures. The transient flu-like illnesses reported by individuals exposed to 
cyanobacteria in recreational waters are indicative of non-specific, cytokine-
regulated responses. Many researchers have observed a 15-30 minute latent 
period between dosing experimental animals with microcystin-containing 
cyanobacteria and the onset of clinical signs (Ashworth & Mason, 1946; 
Gorham & Carmichael, 1980; Slatkin et al, 1983; Shirai et al, 1986; Kotak et 
al, 1993). This may be explained by the development of a cytokine cascade, 
presumably with TNF-α directing the initial signs. And the normal appearance 
of livers in animals given sickness-producing but sub-lethal doses of toxic 
cyanobacteria may be understood in terms of the resolution of inflammation, 
with apoptosis fundamental to the process (Ashworth & Mason, 1946; Raff, 
1992).  
 
The actions of cyanobacterial neurotoxins have not been discussed in the 
context of this review, mainly because the mechanistic studies of purified 
toxins demonstrate rapid fatality due to neuromuscular blockade. But could 
exposure to a large but sub-lethal dose of anatoxin-a-containing 
cyanobacteria, by the oral route, signal the initiation of an acute inflammatory 
process? Saxitoxin has been shown to stimulate the release of arachidonic 
acid and thromboxane B2 from rat alveolar macrophages, albeit at lower levels 
than produced by MC-LR (Naseem et al, 1989). The death of a teenager 
attributed to anatoxin-a poisoning leaves many questions unanswered, 
specifically the signalling processes involved in the severe gastro-intestinal 
illness that preceded his death, and the references to shock and acute cardiac 
damage (Behm, 2003; Campbell & Sargent, 2004). Studies into the immune 
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signalling capacity of cyanobacterial neurotoxins may shed some light on this 
tragedy.  
 
Following are some recommendations to further investigate innate immune 
responses to cyanobacteria, concentrating on the modern view of ligands and 
receptors. 
 
• Studies into the Toll-like family of receptors. Which receptor or 
 receptors signal various cyanobacterial toxins? Are cyanobacterial 
 lipopolysaccharides signalling through TLR2 or TLR4? 
 
• Cytokine knockout mice. Are IL-1 or IL-1 receptor-deficient animals less 
 responsive to cyanotoxins? Also IL-6? CD28 receptor knockouts? 
 
• In vitro cytokine production studies. 
 
• Galactosamine-sensitised mice. This will allow investigation of T-cell-
 mediated TNF-α production. 
 
• Confirmatory studies of anti-TNF antibodies in microcystin exposure, 
 also anti-TNF antibodies in cylindrospermopsin toxicity. 
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CHAPTER 8: SUMMARY DISCUSSION OF THE THESIS 
 
 
8.1. Review of anecdotal reports, case studies and epidemiology 
 
The topic of recreational exposure to freshwater cyanobacteria was 
investigated for this thesis using the tools of epidemiology and laboratory-
based toxicology.  A review of anecdotal reports, case studies, and the small 
number of formal epidemiologic investigations was presented in Chapter 1. 
Anecdotal and case reports were tabulated in order to demonstrate the 
variable nature of relevant information in these reports. This collation of 
reports represents the most comprehensive review of anecdotal and case 
reports on this topic to date. Viewed from a public health perspective, the 
collected reports are highly variable in terms of the severity of illnesses, 
ranging from descriptions of mild, presumably self-limiting disease through to 
worryingly serious reports of gastro-intestinal and neurological effects. The 
finding of a US coroner that a 17 year-old died as a result of anatoxin-a 
intoxication after recreational exposure to a golf course pond has raised the 
stakes somewhat, probably being viewed as a sadly predictable event by 
cyanobacteriologists who are well aware of the potency of many 
cyanobacterial toxins. There were some unusual features to this fatality, 
principally associated with the time to death following exposure. The only 
publicly available reports of this case to date are from newspaper articles; the 
cyanobacteria research community awaits with interest the publication of a 
case report in the medical literature.  
 
 
8.2. Cyanobacterial lipopolysaccharides review 
 
As cyanobacterial lipopolysaccharides are often presented in the literature as 
putative toxins responsible for a variety of symptoms in humans, a review of 
cyanobacterial LPS was presented in Chapter 2. Because very little work has 
been done on the mechanisms of toxicity of cyanobacterial LPS, this author 
approached the literature on heterotrophic Gram-negative bacterial LPS, 
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which is by contrast enormous in scope. This review reveals that there is 
considerable diversity in lipid A structure across Gram-negative bacteria, lipid 
A being the moiety that determines toxicity – or lack of toxicity – of specific 
lipopolysaccharides. Subtle differences in lipid A structure can result in 
dramatically different expressions of LPS toxicity in mammalian cells and 
systems, ranging from potent pathological effects from the most toxic forms, to 
weak toxicity and LPS antagonism. No cyanobacterial lipid A structures have 
been described and published to date, so the recommendation is made that 
cyanobacteriologists should not continue to attribute such a diverse range of 
clinical symptoms to cyanobacterial LPS without research confirmation. 
Indeed, many of the symptoms ascribed to cyanobacterial LPS only seem to 
appear in the cyanobacteria literature, and were not found in the literature 
describing toxic effects of the much more widely studied heterotrophic 
bacterial LPS. 
 
The realisation that the potent pathophysiological effects of some 
heterotrophic bacterial lipopolysaccharides are the result of indirect toxicity 
(“endotoxicity”) was, in this author’s opinion, a significant insight gained from 
the broader LPS literature. Endotoxic effects are directed by a complex 
cascade of endogenous mediators, principally cytokines. LPS-resistant rodent 
strains and cell lines confirm the concept that LPS is not directly toxic, and the 
pathophysiological changes following exposure to LPS are the result of host-
mediated responses. Knowledge of the mechanisms of LPS toxicity lies within 
the domain of immunotoxicology, and particularly in the area of innate 
immunity. These readings constituted the idea seed for a theme that has been 
woven throughout this thesis: that the field of immunotoxicology may yield 
important insights into the mechanisms of toxicology of some cyanobacterial 
exotoxins, particularly the microcystins, nodularin and cylindrospermopsin. 
From the description of flu-like illnesses in the anecdotal reports of 
recreational exposure to cyanobacteria, which suggest that a cytokine 
cascade similar to that which operates in many acute viral and bacterial 
illnesses may be at work, through to the understanding of skin irritancy and 
delayed-contact hypersensitivity, which are immunologically-mediated 
reactions, there are many opportunities to view cyanobacteria-related disease 
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from the perspective of immunotoxicology. The experiments on 
thermoregulation presented in Chapter 6 were designed to develop this 
theme, as regulated hypothermia and pyrexia are indirect, i.e. host-mediated 
responses to various toxins and pathogens.  
 
 
8.3. A prospective cohort study of recreational exposure to 
cyanobacteria  
 
Chapter 3 presents a prospective cohort epidemiology study of recreational 
exposure to freshwater cyanobacteria which was conducted in south-east 
Queensland, the central coast area of New South Wales, and central Florida. 
The study was planned with the aim of extending the limited data available 
and also to tighten some design weaknesses of previously conducted 
epidemiological studies into this topic. This questionnaire and telephone 
follow-up interview-based study suffered from a low  questionnaire return rate, 
although there does not appear to be any obvious reason to suspect that 
study subjects who returned questionnaires and those who failed to do so 
would have differed significantly in their overall propensity to report acute 
illness following exposure to study waters. The sample size (n=1331) was 
large enough to detect an increase in respiratory symptoms and overall 
symptom reporting in subjects exposed to high levels of cyanobacteria (cell 
surface area >12mm2/mL) compared to subjects exposed to low levels 
(<2.4mm2/mL). Mild symptoms appeared to predominate. There was a similar 
trend for increased reporting of ear symptoms, skin symptoms and fever, but 
95% confidence intervals were too wide, i.e. the sample size was not large 
enough to satisfactorily determine whether these latter symptom groups were 
over-reported amongst subjects exposed to high levels of cyanobacteria.  
 
Exposure assessment is probably the most difficult aspect of this work. This 
project compared the traditional reporting method of cyanobacterial cells per 
mL with biomass assessments: biovolume and cell surface area. 
Recommendations are presented for recreational water managers to 
determine cyanobacterial standing crop in their waterbodies by use of a 
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biomass measure in the interim. However, public health priorities would 
appear to militate against attending solely to the levels of cyanobacterial cells 
or biomass in recreational waters, as resident cyanobacteria and even blooms 
may be non-toxic or produce low levels of toxin. The potential for severe, life-
threatening cyanobacteria-related illness is clearly greater in recreational 
waters that have significant levels of cyanobacterial exotoxins, so future 
epidemiological investigations should be directed towards recreational 
exposure to cyanotoxins. 
 
 
8.4. Human dermatology studies 
 
A human volunteer study was presented in Chapter 4: a clinical dermatology 
study to investigate the potential for aqueous cyanobacterial extracts to initiate 
cutaneous reactions. A Finn chamber technique was employed, this being a 
routine diagnostic tool in dermatology clinics worldwide. A consecutive series 
of patients presenting for diagnostic skin patch testing at a Brisbane hospital 
clinic was invited to participate in the study; a convenience sample of non-
patients was recruited for a reference group. Only one volunteer – a patient – 
developed unequivocal skin reactions to a number of cyanobacterial extracts. 
This patient was also the only one with a diagnosis of atopic dermatitis. The 
lack of a dose-response pattern supports the suspicion that this subject 
developed hypersensitivity reactions to cyanobacteria. A recently published 
human volunteer patch testing study examining the irritant potential of 
cyanobacteria found a low rate of reactions to cyanobacteria, which appears 
to support the anecdotal and epidemiological reports of infrequent cutaneous 
reactivity to cyanobacteria. However, the results of the study presented in this 
chapter suggest that allergic responses to cyanobacteria may warrant further 
investigation.  
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8.5. The mouse ear swelling test 
 
Chapter 5 continued with the topic of cutaneous toxicity, presenting an in vivo 
study of delayed-contact hypersensitivity, the mouse ear swelling test (MEST). 
2%w/v extracts of three toxic cyanobacteria – A. circinalis, M. aeruginosa and 
C. raciborskii – were investigated in separate experiments. Only C. raciborskii 
produced positive reactions in test mice, and a further experiment with the 
isolated toxin from this cyanobacterium – cylindrospermopsin – showed that 
the toxin itself is capable of producing both irritant and hypersensitivity 
reactions. These studies have shown the MEST to be a useful research tool 
for investigating the cutaneous toxicity of cyanobacteria, and some 
modifications (principally the random allocation of test and control ears) are 
suggested to refine the method.  
 
The immunotoxicology of cutaneous reactions to cyanobacteria will be an 
important future research endeavour. While bioassays such as the mouse ear 
swelling test are useful practical tools for differentiating irritant and allergic 
skin reactions, studies into these reactions at the molecular level should 
complement the understanding of this topic. Delayed-contact (type IV) 
hypersensitivity is a T-cell mediated pathology of acquired immunity, but 
primary irritant reactions are inflammatory responses regulated by 
endogenous mediators of the innate immune system; this latter point may not 
be well understood throughout the cyanobacteria research community at 
present.  
 
 
8.6. Cyanobacteria and thermoregulation 
 
The final animal experiments conducted for this thesis are presented in 
Chapter 6: studies of the capacity of cyanobacterial lipopolysaccharides and 
exotoxins to affect thermoregulation. These experiments were designed to 
explore the immunotoxicology of cyanobacteria, as endogenous mediators, 
principally the pro-inflammatory cytokines TNF-α, IL-1β and IL-6, are 
responsible for regulating changes to the hypothalamic set-point in response 
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to various toxic insults. A mouse model of electronic rectal thermometry was 
used. In addition to monitoring rectal temperatures, observations of sickness 
behaviour were conducted on experimental mice, with this investigator blinded 
to varying degrees as to the identity of test and control mice. Sickness 
behaviour, e.g. piloerection, eyelid ptosis, lethargy and reduced social 
interaction, is a coordinated response to toxin exposures, directed by pro-
inflammatory cytokines and interferons. This vivid suite of sickness signs is 
familiar to cyanobacteriologists, but is probably not widely recognised within 
the discipline as a facet of innate immune activity.  
 
Several isolated and purified cyanobacterial lipopolysaccharides initiated 
profound hypothermia and sickness behaviour in experimental mice, within 
minutes following exposure. Initial experiments revealed a sequence of 
pathophysiological events which resolved to apparent good health in test 
animals. However, the doses of cyanobacterial LPS needed to initiate 
pathological signs were much larger than those required of heterotrophic 
bacterial LPS, leading to the conclusion that the LPSs examined have weak 
toxic potentials, which supports the findings of previously published work 
(reviewed here in Chapter 2).  
 
Purified cylindrospermopsin was also shown to initiate hypothermia and 
sickness behaviour, though a much longer latent period was apparent. 
Purified microcystin-LR and anatoxin-a failed to initiate any thermoregulatory 
changes or sickness behaviours, but the strong suspicion here is that, 
because dose-response curves for these toxins are very steep, doses 
administered in these experiments were sub-threshold. 
 
 
8.7. Immunotoxicology of cyanobacteria – hypothesis generation 
 
This thesis concludes with Chapter 7, which selectively reviews the literature 
on cyanobacterial hepatotoxins from the perspective of innate immune 
endpoints. Several authors have published studies that demonstrate the 
association of important pro-inflammatory cytokines, the transcription factor 
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NF-κB, and arachidonic acid metabolites with exposure to microcystins.  
However, there does not appear to be a unified hypothesis circulating within 
the cyanobacteria research community that suggests the activities of 
endogenous mediators may be important determinants of the toxicity of 
hepatotoxic cyanotoxins. This chapter, while unashamedly speculative, aims 
to draw together features common to both innate immune mechanisms and 
cyanobacteria toxicity. Probably the most important parallel is the observation 
that potent pro-inflammatory cytokines, particularly TNF-α, are themselves 
capable of mediating tissue destruction, particularly in hepatic and pulmonary 
systems. Resident hepatic macrophages have a much greater ability to 
activate cytokines than parenchymal liver cells, so inquiries into the signalling 
mechanisms associated with cyanotoxin ligands might yield discoveries that 
are equally or more important than investigations into the transport and uptake 
of cyanotoxins into hepatocytes. A better understanding of the 
immunotoxicology of cyanobacterial hepatotoxins may eventually help to 
develop strategies for intervening in and managing disease processes for 
individuals poisoned by these potent toxins.  
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 PUBLIC HEALTH AND RECREATIONAL WATER ACTIVITIES 
 
You are invited to take part in a survey of recreational users of some lakes and rivers 
in Florida. We want to find out how many people have changes in their health after 
water contact, how many people are not affected by water contact, and whether 
some health effects might be caused by water contact at particular sites. 
 
If you are planning to swim, water-ski or windsurf at this site today, and you agree to 
take part in this survey, we would like you to do two things: 
 
Fill in the questionnaire today, while you are at the site1. . We need to know 
 what time you enter and leave the water, how long you spend in the water, and 
 what kind of activity you do today in the water. We would also like you to answer 
 some questions about yourself, your health, and previous visits to this site and 
 other places. 
 
Let us speak with you in three to five days time by telephone2. .  We will call at 
 a time that suits you to ask you some more questions. This usually takes between 
 five and ten minutes. 
 
If you are the parent or guardian of a child under 13 years of age that is going in the 
water today, you may wish to complete the questionnaire on his/her behalf. We will 
speak to you, and not your child, when we call you in 3-5 days. 
 
If you are the parent or guardian of a teenager aged between 13 and 17 who is going 
in the water today, either you or your daughter/son can complete the questionnaire. 
Please write (Question 4 of the Questionnaire) the name of the person we should ask 
to speak to when we phone to ask about your teenager (i.e. if you agree, we will 
speak to your daughter/son directly, or you may want us to speak to a parent). 
 
Please answer all of the questions; the strength of the survey and the quality of the 
results will depend on us receiving completed questionnaires. 
 
We hope that the results of this study will help authorities provide a better 
recreational environment for visitors and local residents who use these waters. 
 
 
CONFIDENTIALITY: We need to know your name and telephone number so that we 
can call you in 3-5 days. However, no names or telephone numbers will be entered 
into a computer or in any subsequent publications or reports from this study; only 
reference numbers will be used. You can see from the questionnaire that names and 
phone numbers are on a separate page of the form. We will separate that page from 
the rest of the questionnaire after we have spoken to you by phone, so no details that 
you give us can be related back to you. 
 
We appreciate the time you have taken from your leisure activities to complete the 
questionnaire. As a token of our thanks, we will enter your name into a draw for 
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prizes, which are listed on the orange slip. No names or phone numbers will be sold 
or given to any third party for promotional or marketing purposes.  
 
If you have any questions about the survey, please contact either Dr Lora Fleming 
(305) 243-5912 or Mr Ian Stewart, (386) 328-0882. 
 
If you would like to speak to an officer of the University not involved in the study, you 
may contact Maria Arnold, University of Miami School of Medicine Human Subjects 
Committee Administrator, at (305) 243-3327. 
 
Your participation in this survey is voluntary, and you are free to withdraw at any 
time. 
 
If you wish to know the results of this survey, please contact Dr Fleming, (305) 243-
5912.  
 
 
 
 
THANK YOU FOR YOUR HELP! 
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PAGE 1 
 
QUESTIONNAIRE – PUBLIC HEALTH AND RECREATIONAL WATER ACTIVITIES 
 
 
Your assistance is valuable and will help us to provide appropriate environmental and public 
health policies, so these waters can continue to be quality recreation sites. 
  
Answer by filling out the items on the questionnaire as they relate to you. If you are the parent 
of a child under 13 years of age that is taking part in the study, please complete the form for 
your child. If you are less than 18 years of age, your parent or legal guardian must complete 
the Consent Section below. 
 
Please answer as many questions as possible. Indicate the best or closest answer by writing 
in the space or box, or by checking the appropriate box.    
 
Please complete this form before you leave the site today, seal it in the envelope, and place it 
in the box at the exit gate. 
 
 
PART 1: ABOUT YOURSELF 
THIS PART ASKS FOR SOME DETAILS ABOUT YOU. WE WILL REMOVE THIS PAGE 
(QUESTIONS 1-4) FROM THE REST OF THE FORM AFTER WE CALL YOU, SO THAT ALL 
THE DETAILS ARE CONFIDENTIAL. NAMES AND PHONE NUMBERS WILL NOT BE 
ENTERED INTO A COMPUTER. 
 
  
1. What is your name?  ________________     __________________    
                                           First Name                     Last Name                                                    
 
 
 
2. Please tell us the time and day that suits you for us to phone you  __.__ am  or  __.__ pm 
         
 NEXT                  Monday        Tuesday       Wednesday       Thursday          
                           Friday           Saturday      Sunday 
 
3. What phone number should we call?                                              
                                                                Area Code 
  
4. If the person named in question 1 is a child or teenager, please tell us the name of the    
    person we should speak to when we call   
                                                                        ______________  _________________ 
 
 
 
 
 
 
 
 
 
 
 
 
CONSENT FOR VOLUNTEER UNDER 18 YEARS OF AGE 
 
I agree      I do not agree     to participate in this survey, which I have read or has been 
explained to me by __________ 
                                                                          __________________________________ 
                                                                 (Please sign if you are between 7 and 17 years of age) 
 
As the parent/legal guardian, I consent to my child being a volunteer in this health survey   
 
_________________ 
     (Please Sign) 
 
Date: ____/____/2002
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UNIVERSITY USE ONLY 
  PAGE 2   Form #    
  Date:  
  Site: 
  Subject # 
PART 2. PEOPLE WHO USE THIS SITE: 
WE WANT TO FIND OUT WHAT KIND OF PEOPLE USE THIS WATER FOR 
RECREATION. PLEASE NOTE THAT THE FOLLOWING ANSWERS ARE THE ONLY 
ONES WE WILL ENTER INTO A COMPUTER. YOUR NAME AND PHONE NUMBER ARE 
ON THE PREVIOUS PAGE AND WE WILL NOT USE THOSE DETAILS FOR THIS 
SURVEY. 
 
5. Are you                        (Please check) 
                       Male?   Female? 
 
6. What is the Zip Code at your home?       
7. What was your age at your last birthday?      years. 
 
PART 3: SPECIFIC ILLNESSES:  
THIS SECTION ASKS ABOUT SOME SPECIFIC CONDITIONS.  
 
8. IN THE LAST TWO YEARS, HAVE YOU HAD ANY OF THE FOLLOWING ILLNESSES: 
 
• Eczema? YES        NO   • Stomach ulcer? YES        NO   
• Dermatitis? YES        NO   • Irritable Bowel Syndrome? YES        NO          
• Asthma?         YES        NO   • Chronic headaches?   YES        NO    
• Hay fever? YES        NO            • Urticaria (Hives)?        YES        NO   
 
 
9. IN THE LAST TWO WEEKS HAVE YOU HAD ANY OF THE FOLLOWING CONDITIONS: 
 
• Runny nose?  YES        NO   • Sore throat?           YES        NO      
• Repeated sneezing? YES        NO   • Discharge from ear? YES        NO      
• Productive cough YES        NO   • Pain in ear?           YES        NO       
  (coughing up phlegm)? 
• Dry cough (no phlegm)?  YES        NO   • Redness of eyes?    YES        NO    
• Difficulty breathing? YES        NO   • Eye discharge?        YES        NO    
• Wheezy breathing? YES        NO   • Eye irritation?          YES        NO    
• Nausea?  YES        NO   • Muscle aches?         YES        NO    
• Vomiting?  YES        NO   • Fever?           YES        NO    
• Pain in abdomen? YES        NO   • Skin rash?           YES        NO    
• Diarrhea?  YES        NO   • Unusual itchiness?   YES        NO   
 
 
10. IN THE LAST SEVEN DAYS, HOW MANY TIMES HAVE YOU HAD A HEADACHE? 
  no headaches in the last seven days 
  one headache in the last seven days 
  two or more headaches in the last seven days 
PLEASE TURN OVER 
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PART 4: YOUR DAY AT THE WATER: 
PLEASE TELL US ABOUT THE ACTIVITIES YOU DO TODAY IN THE WATER.  
 
11. What time did you first go in the water today? ___.___ 
   
12. What time did you get out of the water for the last time today? ___.___ 
 
13. Please estimate how much time you spent in the water today:           
                                                                               less than 30 minutes  
                                                               between half an hour and one hour 
                                                                             between one and two hours 
                                                                             between two and four hours 
                                                                             more than four hours 
 
14. What did you do in the water?  Swim   Ski     Jet ski     Sailboard  Other  __________
                                                                     (please specify) 
 
15. Did you put your head under the water? (or was your hair wet when you got out of the water?)     
      YES        NO         NOT SURE    
16. Did you wear a wetsuit for water recreation today? YES       NO  
   
17. Did you have a shower at this site before leaving today?    
             YES   → what time did you shower? __.__      
               NO   
18. Did you swallow any lake or river water today? YES       NO     NOT SURE     
 
19. How many times have you visited this site before today for recreation in the water? 
 
        Never, this is my first time here 
        Once 
        Two to ten times 
        More than ten times 
 
20. In the five days before today, have you been to any of the following locations for water 
recreation activities: 
 
• This lake or river?               YES   NO   
• Public swimming pool?   YES   NO   
• Backyard swimming pool?         YES   NO   
• Beach?     YES   NO   
• Lake? (different lake to this site)  YES   NO   
• River? (different river to this site) YES   NO   
• Spa pool?                         YES   NO   
 
NO MORE QUESTIONS! THANK YOU FOR YOUR HELP, PLEASE REMEMBER TO RETURN THIS FORM TO 
US BY PLACING IT IN THE BOX AS YOU LEAVE THE SITE TODAY. IF YOU LEAVE LATER IN THE 
AFTERNOON AND THE BOX HAS GONE, PLEASE RETURN THE ENVELOPE BY MAIL. NO STAMP IS 
NEEDED.  
 
CHILDREN AND TEENAGERS WHO ARE NOT WITH THEIR PARENTS TODAY, PLEASE TAKE THIS FORM 
HOME FOR YOUR PARENT OR GUARDIAN TO SIGN, AND RETURN IT TO US BY MAIL AS SOON AS 
POSSIBLE. THANK YOU! 
 
YOUR CONTRIBUTION TO THIS SURVEY IS GREATLY APPRECIATED! 
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TELEPHONE FOLLOW-UP: 
 
1. Date of follow-up:   __ __ ____                        Time: _______ 
 
“Between (?Sunday?) and (?Wednesday?) did you notice any of the following conditions for any 
reason?”    [***Cut-off day is 3rd day post exposure****] 
 
2.  Itchy eye or eyes   F NO        F YES →  If YES:  F One eye  F Both eyes 
 
3.  Sore eye or eyes   F NO        F YES →  If YES:  F One eye  F Both eyes 
  
4. Redness of eye or eyes:   F NO        F YES →  If YES:  F One eye  F Both eyes 
 
5. Discharge from eye or eyes:   F NO        F YES →  If YES:  F One eye  F Both eyes 
 
6. Skin rash       F NO        F YES →  If YES, ask where on body ________ 
 
7. Redness of skin (not related to sunburn) F NO        F YES →  If YES, ask where on body ________
   If YES, ask for description (was redness blotchy?       F NO    F YES 
      associated with blisters?  F NO     F YES  
      raised?                F NO    F YES 
      itchy?                   F NO    F YES 
  Or did it have a broad, even distribution on skin?)       F NO    F YES 
 
8. Blisters on skin    F NO        F YES →  If YES, ask where on body ________ 
 
9. Itchiness anywhere on body  F NO        F YES →  If YES, ask where on body ________ 
 
10. “Did you remember having a prickling sensation (maybe like something moving under   
      your skin) about an hour after getting out of the water last (Sunday)?”  F NO F YES 
 
11. “Any small, raised, red, itchy bites?”       F NO        F YES  →  If YES: Ask for description             
                                                                                              (distribution, size of bites, number) 
 
12. Sore ear or ears    F NO        F YES →  If YES:  F One ear  F Both ears 
 
13. Discharge from ear or ears   F NO        F YES →  If YES:  F One ear  F Both ears 
 
14. Blisters on lips   F NO        F YES 
 
15. Swollen lips    F NO        F YES 
 
16. Blisters in mouth                   F NO        F YES 
 
17. Any difficulty breathing   F NO        F YES 
 
18. Productive cough   F NO        F YES 
 
19. Dry cough              F NO        F YES 
 
20. Runny nose     F NO        F YES 
 
21. Repeated sneezing                F NO        F YES 
 
22. sore throat                               F NO        F YES 
 
23. wheezy breathing                      F NO        F YES 
 
24. Muscle aches & pains    F NO        F YES 
 
25. Headache                               F NO        F YES 
 
26. Vomiting     F NO        F YES 
 
27. Diarrhea (defined as two or more loose stools in a 24 hour period) F NO        F YES 
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28. Abdominal pain   F NO        F YES 
 
29. Nausea     F NO        F YES 
 
30. Fever      F NO        F YES  → If yes: “Did you measure your  
                                                                                                     temperature?  
    
                                                                                                     F NO → “Please tell us how    
                                                                                                                     you knew you had a    
                                                                                                                     fever?”  _________ 
       
                                                                                                      F YES→ What was the   
oF                                                                                                                          temp?” ____
                                                                     
Check Q’s 3-30. If any YES’s, ask: 
 
• “what day was the symptom first noticed? _______ (if >1 symptom, ask what day each symptom  
 started, note response next to relevant question) 
 
• “what day did the symptom/s end”?  _________ 
 
• “are any symptoms still present”? __________ 
 
• “ the (name symptom) that you reported…..How would you describe it, either MILD,   
        MODERATE or SEVERE?”      (NOTE RESPONSE NEXT TO RELEVANT QUESTION). 
 
If any YES’s for Q’s 3-30, ask Q31. If 3-30 responses were all NO, go to Q34 
 
31. “For the (name symptom/s), did you: 
 
• take any medicine or ointment?   F NO        F YES →  If YES, ask what _________ 
 
• visit a pharmacist for advice?      F NO        F YES 
 
• visit your GP?   F NO        F YES  
 
32.  “Did the (name symptom/s):  
 
• keep you awake at night?     F NO        F YES 
 
• Cause you to miss time from work or school? F NO        F YES→  If YES:  F SCHOOL   
                                                                                                                                 F WORK 
 
                     →   If YES: “How much time was lost from (work or school)?”   ________ days 
 
33. If YES answered for any Q’s 3-30, ask “Did anyone else in your home have (name symptom/s) at 
around the same time?”  F NO        F YES  
 
           →  If YES: ask if this/these person/s were also at the lake? F NO         F YES 
           →  If YES: ask if this/these person/s went in the water?             F NO         F YES 
 
 34. “Would you visit (Lake _______) again in future?”   F NO         F YES      FNOT SURE 
 
 
35.  “Are you a smoker or a non-smoker?”   F SMOKER   F NON-SMOKER  ** SKIP THIS QUESTION 
IF THE VOLUNTEER IS A CHILD UNDER 12 YEARS OF AGE 
 
36. Ask this question only if the answer to Q35 is “Non-smoker” OR if the respondent is aged less than 
12 years:  “Does any member of your household smoke in the house?” F NO  F YES 
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“Are you currently using any of the following kinds of medicines?” 
 
37. Inhalers for asthma           F NO        F YES →  If YES: which one/s?______________ 
 
38. Prescription skin creams or ointments?”  F NO F YES →  If YES: which one/s?______________ 
 
39. Oral asthma medication F NO        F YES →  If YES: which one/s? _____________ 
 
40. Oral steroids    F NO        F YES →  If YES: which one/s? ____________ 
 
41. Antihistamines                    F NO        F YES →  If YES: which one/s? ____________ 
 
42. Nasal decongestants   F NO        F YES →  If YES: which one/s? ____________ 
 
43. Eye drops             F NO        F YES →  If YES: which one/s? ____________ 
  
“Between going in the water at the lake on (?Sunday) and (?Wednesday?), have you been to any of the 
following for water recreation”:  ***[cut-off day is 3rd day post exposure]*** 
 
44. Same location   F NO        F YES 
45. Public swimming pool    F NO        F YES 
46. Backyard pool    F NO        F YES 
47. Beach     F NO        F YES 
48. Other lake     F NO        F YES 
49. River     F NO        F YES 
50. Spa pool    F NO        F YES 
 
51. “At the lake site on (?Sunday) did you see a sign warning about the presence of blue-green algae in 
the lake?         F NO        F YES      FNOT SURE   F DIDN’T SEE SIGN BUT AWARE OF IT 
 
“Between  (?Sunday?) and (?Wednesday?) have you eaten any of the following foods?”    [***Cut-off 
day is 3rd day post exposure****] 
 
52. Chicken?  F NO        F YES      F NOT SURE  
 
53. Eggs?            F NO        F YES      F NOT SURE 
 
54. Takeaway salads?   F NO        F YES      F NOT SURE 
 
55. Takeaway sandwiches?            F NO        F YES      F NOT SURE 
 
56. Shellfish? (oysters or mussels)  F NO        F YES      F NOT SURE 
 
57. If any positives for G-I symptoms (Q’s 26-29) ask: “Do you have any reason to suspect that your 
(diarrhoea, nausea etc) was related to food poisoning or alcohol consumption? (If YES, note details) 
 
58.  Have you taken part in this health survey before (i.e. have you previously completed one of these 
questionnaires and telephone interview)?   F NO        F YES      F NOT SURE 
  
59. Please estimate how much time you spent in the water at Lake……. on (Sunday): 
                                             less than 30 minutes  
                                                                                                  between half an hour and one hour 
                                                                                                                between one and two hours 
                                                                                                                between two and four hours 
                                                                                                                more than four hours 
 
60. Did any other member of the household complete one of these surveys on (Sunday)? 
                         
                                                                                          F NO        F YES      F NOT SURE 
 
                                                                           If YES, note FG code:   
 
“THAT’S ALL THE QUESTIONS – THANKS VERY MUCH FOR YOUR 
HELP” 
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APPENDIX 2 
 
FROM CHAPTER 3; EPIDEMIOLOGY STUDY 
 
FINAL REPORT TO FUNDING BODY (NIEHS) FOR STUDY  
RECRUITMENT IN FLORIDA 
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Original Abstract 
 
Blue green algae (cyanobacteria) represent a diverse group of organisms that are 
common inhabitants of freshwater lakes and reservoirs, and produce potent natural 
toxins. Potential routes of exposure for these toxins are dermal, oral, and possibly 
inhalation; humans can be exposed through drinking water, as well as recreationally 
and occupationally. There have been case reports of severe morbidity and mortality 
in domestic animals through drinking contaminated water, but little epidemiologic 
research on the human health effects of cyanobacteria and their toxins. 
 
Recently in Florida, cyanobacteria and their toxins have been identified in freshwater 
lakes and reservoirs, with growing media and community concern.  This proposed 
research will be a prospective cohort study of recreational users in Florida freshwater 
lakes with and without toxic cyanobacteria.  Participants will be evaluated by initial 
and follow up interview as to symptoms and exposures.  Water samples taken on the 
day of exposure will identify organisms and toxins. Reported human symptoms will 
be used to identify cyanobacteria species of potential environmental health impact for 
future study by researchers involved in the isolation and cultivation of cyanobacteria.  
At the end of the study, study participants and recreational lake managers will 
receive outreach and education materials concerning the cyanobacteria, their toxins, 
and possible human health effects. In response to Florida media and public 
concerns, this proposed research will be a prospective cohort study of recreational 
users in Florida freshwater lakes with and without toxic cyanobacteria.  Water 
samples will be collected for toxin and organism identification (including isolation and 
cultivation of potentially toxic species), as well as outreach and educational materials 
distributed. 
 
 
SPECIFIC AIMS 
 
1.  To measure cyanobacteria levels in designated water recreation sites by three 
methods: cell counts (cells/mL), biovolume (mm3/L) and chlorophyll A;  
2.  To identify toxins in designated water recreation sites by toxicologic methods; 
3.  To estimate exposure to cyanobacteria by self-administered questionnaire and 
validation at follow-up phone interview in cyanobacterial exposed and 
unexposed recreational water users; 
4. To measure the incidence of reported symptoms by telephone follow-up 
interview in exposed and unexposed recreational water users; 
H1: There will be a significantly greater incidence of reported symptoms 
among exposed compared to unexposed recreational water users; 
H2: Among exposed recreational water users, there will be significantly 
greater incidence of reported symptoms among those who report 
greater recreational water exposure; 
5. To use reported symptoms to identify cyanobacteria species of potential 
environmental health impact for future study; 
6. To follow up with participants and recreational water managers with outreach 
and education materials concerning the cyanobacteria, their toxins, and 
possible human health effects. 
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BACKGROUND TO THIS STUDY  
 
1. Commencement of the study in Australia 
 
Inland public recreational waterbodies are managed at state and local government 
levels in Australia. Most authorities have adopted – and adapted – guidelines for 
recreational exposure to cyanobacteria. Management authority responses may range 
from occasional, semi-permanent or permanent advisories to the public by way of 
hazard warning signs posted at affected lakes and rivers, press releases to local or 
regional media outlets, and short or long-term closure of severely affected waters. 
With the understanding that risk-assessment methods to determine appropriate 
guidelines are based on a limited knowledge base, especially with respect to the 
epidemiology of recreational exposure to cyanobacteria, funding for work in Australia 
was originally provided by South East Queensland Water to continue research into 
the issue.  
 
SEQ Water Corporation operates three large artificial water storages that supply 
potable water to the city of Brisbane and surrounds. Two of the reservoirs are 
popular recreational waters. The funding grant from SEQWater was provided to the 
National Research Centre for Environmental Toxicology, with the aim of further 
investigating the epidemiology of recreational exposure to freshwater cyanobacteria, 
and conducting laboratory-based toxicology studies. The grant funded a PhD 
scholarship; the primary author of this report is the recipient of this scholarship.  
 
Work commenced on the project in July 1999; study design, survey instrument 
preparation and attainment of ethical clearances were the initial tasks. Recruitment 
into the study began at SEQ reservoirs in November 1999.   
 
A prospective cohort design was employed using a self-administered questionnaire 
and telephone follow-up interview after three days. Study subjects were recruited at 
recreational waters, usually on weekends and public holidays when such facilities are 
more highly frequented. Entry criteria into the study were: 1. Partake or planning to 
partake in water-contact activities in the study lake on the day of recruitment; 2. Able 
to be contacted by phone for follow-up. Prospective subjects were approached either 
by stopping vehicles as they entered recreation sites, or by walking around beach or 
camping sites at recreational waters.  
 
The study design sought to confer some advantages over previous epidemiological 
work on recreational exposure to cyanobacteria (see below). Some disadvantages 
and challenges were also anticipated, and others became apparent during the course 
of the project.  
 
2. Perceived advantages of this study 
 
• Prospective cohort design: this type of study confers significant advantages 
over some other designs, particularly retrospective studies, although there 
are also inherent disadvantages. Discussion of intrinsic study design 
strengths and weaknesses were not part of this report, but will feature in a 
forthcoming review article on the epidemiology relating to exposure to 
cyanobacteria.  
• Direct measurement of cyanobacterial toxin concentration in water samples 
from study sites on recruitment days.  Water samples were analysed by High 
Performance Liquid Chromatography (HPLC), HPLC-tandem mass 
spectrometry and Enzyme-Linked Immunosorbent Assay to determine and 
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quantify microcystins, anatoxin-a and cylindrospermopsin. These assays 
compare favourably with previously published work, which employed mouse 
bioassay on concentrated cell samples collected by plankton net. 
Recruitment of unexposed subjects from control sites• : Recreational waters 
where cyanobacteria were largely or completely absent were visited in order 
to recruit unexposed subjects. This is thought to represent a significant 
improvement over previous work, where unexposed subjects comprised non-
bathers recruited from cyanobacteria-affected sites. There is a tendency, 
reported in the literature on community-based epidemiology study design, for 
individuals to give the kind of answers they think health workers are seeking. 
We were concerned, therefore, that non-bathers answering questions about 
water contact-related illnesses might under-report symptoms. Also non-
bathers may differ systematically from bathers, so our study would be likely to 
reduce the bias due to a healthy user effect. 
• Assessment of symptom severity: Study subjects were asked to rate any 
reported symptoms as mild, moderate or severe, whereas previously 
published studies only differentiated between symptom presence and 
absence. 
 
 
3. Anticipated and unanticipated weaknesses of this study 
 
• Self-reporting of symptoms: Health information gathered by self-reported 
symptoms and history is less reliable than that acquired through interview and 
examination by trained health professionals. However, research costs for a 
study using trained workers and diagnostic equipment would be significantly 
higher, and may still suffer from recruitment difficulties and possible selection 
bias. 
• Participation rate: We were concerned from the outset about the willingness 
of healthy individuals to complete questionnaires during their leisure time. We 
attempted to improve the participation rate by offering an incentive of entry 
into a draw for prizes of consumer electronics goods.  
• Possible reporting bias from specific aquatic sport participants: Some 
individuals expressed concern about the motives for conducting this research, 
with some offering the opinion that the study was a prelude to restricting 
access to certain sites by powered watercraft.  
• Hazard Alert Signs – a potential confounding variable: Cyanobacteria hazard 
warning signs are posted at many Australian recreational waters that are 
affected by cyanobacteria. We were concerned that there may be differences 
in health status between those who heeded the warnings (and thus did not 
bathe in affected waters) and those who, for a variety of reasons, chose to 
ignore the warnings.  
• Ability to determine exposure: This was probably the greatest source of 
uncertainty in this study; in the absence of biomarkers of both exposure and 
effect, we relied principally on estimates of cyanobacterial cell density 
measured from modified grab samples of lake water collected at recruitment 
sites on recruitment days. Phase-contrast microscopy using calibrated 
counting chambers was employed to identify and quantify cyanobacterial 
profiles, and estimates of biovolume and cell surface area were derived from 
these counts. However, significant sources of unreliability could not be 
addressed by a prospective cohort design: heterogeneous spatial and 
temporal distribution of cyanobacteria within study waterbodies, possible 
effects of other phytoplankton types, and diverse cyanobacterial species 
profile in some waters. 
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• Reliance on environmental conditions: While the SEQ Water recreational 
water reservoirs – which were the initial focus of this work – had been 
affected by frank cyanobacterial blooms in the past, the timescales for bloom 
episodes are larger than annual events. One problem with a prospective 
study is that cyanobacterial exposures are beholden to environmental 
conditions in study lakes within the allocated time frame. Unless blooms can 
be predicted to be essentially annual events, a short-term prospective study 
runs the risk of recruiting too many subjects with relatively low exposure 
estimates if blooms do not occur within the study period. However, this 
challenge is not easily overcome, as most funding for science and public 
health projects comes in the form of specific grants, with little scope for 
essentially open-ended time frames that could take advantage of infrequent 
bloom events.  
• Diminishing returns due to regular site use: many recreational waters attract 
regular visitors, as well as individuals who may be first-time or infrequent 
visitors. After the commencement of this project at SEQ Water sites, it 
became apparent that a possibly significant (but unquantified) number of 
potential subjects were regular visitors who did not wish to be enrolled into 
the study more than once. Because of the likelihood of diminishing yield in 
terms of recruitment from any given site, and because of the possibility of 
generating ill-will due to repeated, though minor, disruption to traffic flow into 
the sites, we sought to expand the project to encompass new study lakes.  
• Lack of site similarity: – affected vs. control sites. While we were confident 
that recruiting unexposed subjects from cyanobacteria-free waters would 
improve the robustness of the study with respect to reporting bias and the 
healthy user effect, in practice it was very difficult to identify suitable sites in 
Australian freshwater recreational waterbodies. The ideal control site would 
be a cyanobacteria-free waterbody in close geographical proximity to a 
cyanobacteria-affected site, subject to similar recreational activities. While we 
were successful in the main in identifying sites that were largely or completely 
unaffected by cyanobacteria, such sites differed from cyanobacteria-affected 
sites in several ways. In practice, we recruited unexposed subjects from fast-
moving streams, an acidic lake, and a saline lake. Measured parameters 
apart from cyanobacteria counts that differed at particular control sites from 
those at study sites were: water temperature, pH, salinity and faecal 
coliforms. At the design stage of this work we had considered recruiting 
unexposed subjects from nearby marine beaches, but we decided against 
that option, mainly because of the likelihood of introducing significant 
dermatological confounding variables, particularly from stinging marine 
coelenterates and annelids.  
 
 
4. Expansion of the study to other sites and regions within Australia  
 
With the aim of addressing some of the problems outlined above – diminishing yield 
due to regular visitors and low cyanobacteria counts at study lakes, we sought to 
expand the work beyond SEQ Water recreational reservoirs. Gatekeeper approval 
was secured from a range of state and local government authorities in Queensland 
and northern New South Wales in order to recruit study subjects. Site managers of 
potential study lakes were contacted regularly by phone or email to determine the 
suitability for recruitment at specific times in spring, summer or autumn. The two 
main parameters that determined suitability for recruitment were high cyanobacteria 
counts and a high likelihood of there being a sufficient number of visitors to make 
recruitment efforts viable. This process was successful in recruiting 50 individuals 
 389
Cyanobacteria, their toxins and recreational exposure – UM MFBS Center and FIU ARCH Program 
Pilot Project – Final Report 
from a recreational dam in Southern Queensland over an Easter weekend, when a 
frank bloom of Microcystis aeruginosa affected the water. However, we did not recruit 
at several sites that had historically suffered cyanobacteria blooms, because we 
could not be satisfied that both high cyanobacteria counts and sufficient visitor 
numbers would coincide during the recruitment period, i.e. some sites with high 
visitor numbers were not visited because cyanobacteria counts were not sufficiently 
high, and other sites with high cyanobacteria densities were not subject to 
recruitment visits because of poor patronage.  
 
A ten-day field recruitment drive was conducted in the Myall Lakes area in January 
2000. Mr Michael Burch from the Australian Water Quality Centre in Adelaide and Dr 
Lee Bowling from the NSW Department of Land and Water Conservation arranged 
the funding, which was provided by DLWC.  
Some discussion of the overall problem of cyanobacteria, public recreation and the 
challenges for epidemiology is pertinent here, as the issues were in some ways seen 
in sharp relief. Similarities and differences that were pertinent to the situation in 
Florida will be discussed. 
 
The Myall Lakes are a chain of four large (approx. 10,000 hectares) recreational 
lakes on the NSW central coast, managed by the NSW National Parks and Wildlife 
Service. The lakes are situated some 280km and 150km north of the major 
population centres of Sydney and Newcastle respectively. The lakes are a popular 
holiday destination, with the Myall Lakes National Park receiving some 200,000 to 
300,000 visitors annually. A range of water recreation activities occurs on the lakes, 
from powered and sailing watercraft to swimming and fishing. Several large camping 
facilities are located around lake shores. A significant houseboat hire industry is 
present. Easter 1999 saw a bloom of M. aeruginosa and Anabaena circinalis 
affecting the Bombah Broadwater, the southernmost lake in the chain. Low levels of 
Microcystin-LR were recorded. No adverse human health impacts were reported. 
However, significant adverse public relations impacts occurred. The bloom was 
followed by intense media coverage and community concern. Recreational hazard 
signs were posted, and the houseboat and commercial fishing industries lost income.  
 
During recruitment into the study in January 2001, 300 individuals were recruited 
over seven days from two of the Myall Lakes previously affected by the bloom, 
including 56 from Smith’s Lake, a nearby control site that was known to be 
unaffected by cyanobacteria. Hazard warning signs stating, “DANGER…DUE TO 
THE PRESENCE OF BLUE-GREEN ALGAE THIS WATER MAY CAUSE SERIOUS 
HARM TO HUMANS” were posted at Myall Lake campsites, Myall Lake being the 
northernmost waterbody in the chain.  
 
Cyanobacteria profiles at Bombah Broadwater, the site of a scum-forming bloom 
some 18 months previously with cell densities of a couple of million cells per mL, 
were low, dominated by Chroococcus spp. Cyanobacteria at Myall Lake were higher, 
dominated by Chroococcus and Merismopedia. Neither of these genera are scum-
forming or toxin-producing cyanobacteria; both can be considered picoplankton, i.e. 
they are small spherical cells. The issue of picoplankton dominance, which had been 
encountered at study lakes in Queensland, presented problems in determining 
exposure to cyanobacteria. With heterogeneous cell sizes within and across study 
lakes, the standard method of using cell numbers might not be a reliable estimate of 
exposure. Cell counts of 300,000 cells per mL at Myall Lake resulted in hazard alert 
procedures being initiated, yet the biovolume estimates derived from those counts 
were in the region of 4mm3/L, which was a fairly low exposure category.  
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Some solicited and unsolicited anecdotal comments from holidaymakers at the site 
were instructive: several people indicated that they swam in the Easter 1999 bloom 
without ill effect, suggesting that they had invested considerable planning and 
anticipation energies into their vacation, and were not going to be put off by an algal 
bloom. A National Parks ranger described transient tingling sensation on the skin of 
an arm that was exposed to the bloom when collecting water samples. Reactions to 
the blue-green algae hazard alert signs at Myall Lake were also interesting: a small 
number (approx.10 adult individuals) who were seen reading the signs were asked 
their thoughts; all reported that they were concerned and would not enter the water. 
One family at a nearby marine beach informed the investigators that they had 
planned a camping vacation at Myall Lake, but had changed their itinerary after 
viewing the hazard alert. Conversely, most study recruits could be viewed in large 
part as a group who chose to ignore hazard alert signs, as the awareness of these 
signs amongst the Myall Lake cohort was very high (as determined during follow-up 
interview). Unsolicited opinions of the hazard signs amongst potential recruits varied 
from bemused indifference to outright derision. One subject, when asked at the 
follow-up interview if he had seen the hazard signs, reported: “Yes, and I hope they 
are there again next year”. When questioned further about this he replied: “Because 
it keeps a lot of people away and we have more camping space to ourselves”. Such 
widely disparate viewpoints and responses gave us cause for further concern about 
the potential for selection bias.  
 
 
THE FLORIDA CONNECTION 
 
The author of this report first became aware of the freshwater cyanobacteria situation 
in Florida in the latter part of 1999 when John Burns gave a presentation at the 
National Research Centre for Environmental Toxicology in Brisbane. Mr Burns’ study 
tour of Australian cyanobacteria research activities was funded by the Florida 
Harmful Algal Bloom (HAB) Taskforce, University of Miami NIEHS Marine and 
Freshwater Biomedical Sciences Center, and John Burns, and was organised with 
the assistance of Drs Karen Steidinger and Lora Fleming. Mr Burns’ presentation 
showed that inland waters in various Florida locations could be significantly and 
frequently impacted by toxigenic cyanobacteria. Together with the knowledge that 
central Florida and south-east Queensland share similar latitudes and climatic 
conditions, and the observation that regulatory guidelines for recreational exposure 
were not in use in Florida (i.e. no hazard alerts were routinely posted), we formed the 
opinion that Florida might present particular advantages for studying the 
epidemiology of recreational exposure to cyanobacteria.  
 
After the study had run in Australia for 18 months, by which time many of the study’s 
logistical issues had been ironed out, survey instruments were refined, the database 
was working and field recruitment issues were better understood, we felt it 
appropriate to seek interest from potential collaborators further afield. As we had 
already been apprised of the situation in Florida through John Burns, we resumed 
correspondence with him in March 2001. Discussions continued on the feasibility of 
expanding this work to Florida waters, and contacts for the imperative local academic 
support were made with Dr Fleming (University of Miami) and Dr Lorrie Backer 
(Centers for Disease Control).  
 
Discussions proceeded to a recommendation from Dr Fleming that this author visit 
Florida for a sounding-out and planning visit as an important first step. A ten-day visit 
was arranged, funded by Florida Harmful Algal Bloom (HAB) Taskforce that 
commenced on September 18th, 2001. Ian Stewart and John Burns gave 
presentations at the NIEHS Marine and Freshwater Biomedical Sciences Center at 
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the University of Miami; discussions involving Drs Fleming and Backer led to an 
agreement that we would approach the academic support through the NIEHS Center 
at the University of Miami. The remainder of the visit was based at Palatka, and 
involved field visits to cyanobacteria-affected sites, sourcing potential cyanobacteria-
free sites, meeting with officers of the Bureau of Environmental Epidemiology, 
Department of Health in Tallahassee, and identifying a list of authorities from which 
gatekeeper approvals would be required in order to conduct field recruitment at 
specific water recreation sites.  
 
Work on this project over the subsequent seven-month period consisted of seeking 
Uni of Miami IRB approval, preparation of an itemised budget and applying for funds. 
Funding was secured in April 2002 with a grant from the NIEHS for collaborative 
research through the University of Miami for the epidemiological field recruitment, 
and Florida International University (Dr Miro Gantar’s team) for cyanobacterial 
isolation and culture work. Additional funding was secured by John Burns from Lake 
County Water Authority, South East Florida Water Management District and 
CyanoLab for water sample analyses, and a University of Queensland Graduate 
School Research Travel Award for the author’s airfares and freight costs.  
 
We planned to conduct field recruitment in Florida in the northern summer of 2002. 
Some factors that inspired confidence that the project would be successful were: 
predictability of cyanobacterial blooms in several recreational waters, based on 
occurrence over previous years; presence of cyanobacteria-free “control” sites in the 
study region; significant recreational activity levels in proposed study lakes. As soon 
as NIEHS funding was secured in April 2002, letters were sent to various city, county, 
state and federal government agencies requesting gatekeeper approval to recruit 
members of the public at recreational waters within each agency’s management. A 
total of 19 such requests were sent to different agencies.  
 
 
RECRUITMENT IN FLORIDA 
 
thField recruitment commenced in Florida on July 4 , 2001 and was completed on 
August 18th. The following Table (Table 1) documents the site-specific acceptance of 
questionnaires and recruitment into the study. Manatee Springs and Fanning Springs 
were chosen as cyanobacteria-free sites to recruit unexposed subjects (99 subjects 
enrolled from both sites); all other sites were affected by cyanobacteria (n=117).  
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TABLE 1. Recruitment site details – Florida. 
 
WEATHER 
CONDITIONS 
DATE SITE QUESTIONNAIRES 
ACCEPTED 
NUMBER 
COMPLETED 
TO FOLLOW-
UP 
7/4/02 Hickory Point 
(Little Lake 
Harris) 
40 6 Fine 
7/6/02 Hickory Point 
(Little Lake 
Harris) 
6 6 Fine 
7/13/02 Crescent Lake 0 0 Steady rain 
from 1pm 
 
7/14/02 Manatee 
Springs 
106 56 Fine, brief 
showers x2 
7/15/02 Fanning 
Springs 
117 43 Fine, brief 
shower 
7/20/02 Hickory Point 
(Little Lake 
Harris) 
21 2 Fine, severe 
storm 5pm 
7/21/02 Mt Dora (Lake 
Dora) 
0 0 Fine 
7/21/02 Hickory Point 
(Little Lake 
Harris) 
11 0 Fine, severe 
storms from 
3.30pm 
7/26/02 Lake Seminole 24 5 Fine 
 
 
7/27/02 Lake Seminole 30 8 Thunderstorms 
from 12.30pm 
to 1.45pm 
 
7/28/02 Lake Seminole 31 10 Thunderstorms 
x2 
8/3/02 Lake Seminole 17 7 Intermittent 
showers and 
rain throughout 
day 
8/4/02 Lake Seminole 60 18 Fine 
8/7/02 Doctors Lake 11 1 Fine, brief 
shower x1 
8/10/02 Doctors Lake 61 5 Fine, brief 
shower x1 
8/11/02 Doctors Lake 67 13 Fine, brief 
showers x2 
8/17/02 Lake Cannon 24 22 Fine, severe 
storm 5.30pm 
8/18/02 Lake Shipp 39 14 Fine 
 TOTALS 665 216  
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The following figure (Figure 1) shows some further data related to recruitment and 
inclusion into the study. The most significant loss of potential recruits occurred 
among those who accepted a questionnaire but failed to return it; losses after 
questionnaires were returned (unable to be contacted by phone etc) were minimal. 
This pattern was similar to the recruitment experience in Australia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MET STUDY 
ENTRY 
CRITERIA 
(n=772) 
ACCEPTED 
QUESTIONNAIRE 
(665) 
REFUSED TO 
PARTICIPATE 
(107) 
REFUSED 
FOLLOW-UP 
INTERVIEW (1) 
DID NOT 
PROVIDE 
PHONE 
NUMBER (6) 
DID NOT RETURN 
QUESTIONNAIRE 
(436)
RETURNED 
QUESTIONNAIRE 
(229) 
UNABLE TO 
CONTACT FOR 
FOLLOW-UP 
INTERVIEW (6) 
FOLLOW-UP 
INTERVIEW 
CONDUCTED 
AND 
RECRUITED 
INTO STUDY 
(216)
FOLLOW-UP 
INTERVIEW 
NOT 
CONDUCTED 
(13) 
Figure 1. Flowchart showing recruitment and entry into study – Florida only. 
 
 
We had discussed the topic of expected recruits prior to commencing this work in 
Florida; 500 to 600 enrolments were anticipated and regarded as both achievable 
and manageable. Some possible and probable reasons why we failed to achieve this 
target are outlined under the following headings: Weather; site-specific features 
(competition for boat ramp space, short-stay behaviour); local politics (denial of 
gatekeeper approvals); other Florida issues. Some recommendations for planning 
future work of this kind, based on lessons and insights gained from this work will 
conclude this report.  
 
WEATHER: Recreational water activities are generally abandoned during rainy 
weather, and televised forecasts of storms probably impact on some people’s leisure 
activity planning over subsequent days. Inclement weather was not so much of a 
problem for the recruitment phase in south-east Queensland, where this author and 
study recruiter resides (planned recruitment on a day which turned out to be 
unfavourable simply led to postponement without waste of resources). However, 
recruitment in a distant location during a fixed time period poses risks in terms of lost 
opportunity. To some degree the weather in central Florida may have worked against 
us, insofar as prolonged drought conditions broke in May, June and July 2002. As 
can be seen from Table 1, several recruiting days coincided with severe tropical 
storms that developed rapidly. The obvious concern of recreational boaters during 
the approach and onset of such storms was to get their craft out of the water and exit 
the site as quickly as possible. Completing a (possibly) damp questionnaire was 
probably not a priority. Another repercussion for this study of significant and 
prolonged rainfall over the weeks and months immediately prior to commencing this 
 394
Cyanobacteria, their toxins and recreational exposure – UM MFBS Center and FIU ARCH Program 
Pilot Project – Final Report 
project in Florida appeared to have been that some cyanobacteria-affected 
recreational waters were significantly flushed out by rainwater inputs.  
 
SITE-SPECIFIC FEATURES: The most successful recruitment and response rates 
appeared to be from sites that:  
• Received a majority of visitors who drive distances such that they were 
prepared to “make a day of it”, i.e. they drove to a site in the morning, then 
participated in several periodic cycles of water recreation activities followed 
by a rest on land, taking food and drink. These cycles were repeated, and 
many visitors then left the site after a day’s outing. People could be seen 
completing questionnaires throughout the day at such sites. A corollary to this 
behaviour was that such “whole day out” activities tended to occur at sites 
with features such as adjacent parkland or beaches, often with picnic or 
barbecue facilities.  
• Received significant numbers of families with children. Parents – usually 
mothers – could be observed completing questionnaires while their children 
were active in the water. 
• Received significant numbers of vehicles that were not towing powered 
watercraft, i.e. people who were willing to spend time in the water just 
swimming.   
 
The flip side was that activities at sites that differ markedly from those outlined above 
were likely to result in poorer uptake and response to questionnaires. While all of the 
sites visited in Australia met the above criteria of adjacent beaches and parkland, 
some warning of the difficulties faced in recruiting people engaging in different 
activities was seen in Australia, but these difficulties were bought into stark focus in 
Florida.  
 
Lake Somerset, a study site in south-east Queensland, was visited for recruitment on 
thirteen separate occasions. This site is popular with families and powered watercraft 
users, but the two worst days in terms of the gap between the number of 
questionnaires accepted and the number of completed questionnaires returned both 
coincided with jet-ski race club meetings. This led the author to suspect that jet-skiers 
as a general group might have been, for whatever set of reasons, poor responders 
towards this work. Dates of subsequent jet ski races at Lake Somerset were sourced 
from the site ranger, so that study recruitment could be avoided on those days 
because of the fear of indifferent or hostile responses to this project by jet-skiers in 
general.  
 
Three of the seven recruitment sites in Florida met most of the above criteria (mixed 
use, adjacent parkland, visited by “out-of-towners”), and response rates from these 
sites were within expectations based on the Australian experience. Two of these 
three sites, Manatee Springs and Fanning Springs, were State Forest Reserves with 
no powered watercraft activities permitted that were chosen as control sites. The only 
cyanobacteria-affected site with beaches and adjacent parkland was Lake Cannon, 
which, while only receiving a small number of visitors during the recruitment day, at 
least yielded a high percentage of returned questionnaires.  
 
The main problems with the other four cyanobacteria-affected sites were not 
anticipated from the Australian experience, and appear to be related to the 
predominant activities at these sites, which, broadly speaking, pertain to powered 
watercraft-related exposures and the general exclusion of non-watercraft activities 
such as swimming.  
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The experience at Doctors Lake was salutary, and probably serves as a good 
example of the kind of site to avoid when planning future work of this kind. With 
competition for access to the sole boat ramp, and no on-site rest facilities, most of 
the recreational behaviour occurring via the ramp appeared to involve single 
stretches of powered watercraft-related activity, after which people would exit the 
site. This was thought to be the main reason why the questionnaire 
acceptance/return differential was so large from Doctors Lake, although other factors 
must be considered, as potential recruits were reminded that they could return 
questionnaires by mail if they did not have time to complete them before vacating the 
site.  
 
Similarly, Lake Shipp had no beaches or parkland adjacent to the boat ramps, 
although with multiple ramps and limited rest facilities (shaded wooden tables and 
benches) there did not appear to be as much time pressure on boaters to complete 
their launching and egress tasks.   
 
Hickory Point at Little Lake Harris did have extensive parkland and BBQ/picnicking 
facilities, and a small beach area; some family groups were seen using the beach for 
recreation. However, the predominant water-related activities appeared to involve 
powered watercraft.  
 
Lake Seminole, like Hickory Point, was accessed through extensive parklands that 
were popular with people engaging in water and land-based recreational activities. 
However, there were no beaches adjacent to the dual boat ramps or near to 
picnicking facilities, so water-related activities on this site were restricted to powered 
watercraft, plus a small proportion of wind-powered craft appeared to use the lake.  
 
Florida is very well served by the quantity of inland recreational water sites. There 
are a large number of lakes and springs throughout central and southern regions of 
the state, many in close proximity to other lakes and to towns and cities. Water 
quality across Florida lakes and springs is variable; sinkhole lakes and many springs 
are sources of clean, cyanobacteria-free recreational water, from which a journey 
measured in minutes – not hours – can often deliver a vehicle to waters that are 
severely impacted by cyanobacteria. Such geographically confined variability in water 
quality was very helpful in terms of recruiting unexposed subjects from the same 
region and time period as the study cohort, however this “surfeit of riches” may have 
had repercussions on the number of subjects recruited into the study for two reasons: 
 
• Floridians and visitors have more choice and opportunities to avoid visually 
discoloured water than may be the case in many other regions, e.g. 
Queensland, where demand for recreational access to any given water body 
appears to be higher than in Florida lakes. Many unsolicited comments to the 
effect of “I never go swimming in water I can walk on” were received by 
individuals when being asked if they met study entry criteria (engaging in 
water-contact recreational activity on that day). Such comments were noted in 
the study log at some sites during recruitment for this project.  
• With many freshwater recreation sites to choose from, the pool of individuals 
engaging in water recreation within any given region in central and southern 
Florida could be dispersed over many sites. The study design and budget for 
this project dictated that individuals were recruited – and water samples 
collected for analysis - from one site only on each recruitment day. A 
reconnaissance trip to Polk and Highlands Counties in July revealed that too 
few people to make study recruitment visits worthwhile were visiting many 
small lakes, and some larger ones.  
 
 396
Cyanobacteria, their toxins and recreational exposure – UM MFBS Center and FIU ARCH Program 
Pilot Project – Final Report 
LOCAL POLITICS 
 
As outlined previously in this report, a total of 19 gatekeeper request letters were 
sent to various management authorities seeking permission to recruit study subjects 
from their recreational waters. Of these 19 authorities, eight gave permission, four 
requests were not followed up following discussions with management officials or site 
visits which revealed that those sites would have been unsuitable study locations, 
one agency threw up a formidable series of bureaucratic hurdles, and the remaining 
six authorities refused to allow the study to be conducted at their recreational waters.  
 
Five of the six sites where permission to recruit was denied were known to be 
affected by cyanobacteria (the sixth site was a potential control site). One of the sites 
would likely have yielded better questionnaire return rates, being a lake within a large 
town, with a designated swimming-only sandy beach adjacent to a boat ramp, and 
plenty of adjacent parkland and picnicking facilities.  
 
The recreational water management agencies that supported this work were: Lake 
County Water Authority, Florida Department of Environmental Protection, Clay 
County, Pinellas County, Polk County, City of Mt Dora, Putnam County and Crescent 
City.  
 
 
OTHER FLORIDA ISSUES  
 
One feature of several lakes visited in Florida that was not encountered in Australia 
was that of access routes to the water. Several recreational waters were seen to 
have a considerable number of private jetties, where powered watercraft were 
moored. Such features presented problems for this kind of work, in that diffuse points 
of entry into a particular waterbody served to diminish the number of individuals 
engaging in water recreation that can be recruited on any given day. Disparate entry 
points were encountered at one Australian study lake in the Myall Lakes chain, but 
the problem was overcome by walking around all the beaches on the lake, recruiting 
people where they were resting, with instructions to have questionnaires ready for 
collection at a repeat walk-around in the late afternoon. This was not so much of a 
recruitment challenge insofar as the one authority, which granted approval for the 
work, managed all beaches and campsites on the lake. Accessing private dwellings 
and jetties presents much more formidable problems. The salient point here is that in 
planning future work of this kind, it may not be sufficient to estimate potential 
numbers of recruits based only on the number of individuals that can be seen using 
the water; the means of accessing those individuals must be taken into consideration 
as well.  
 
Furthermore, estimates of the number of people engaging in water-contact 
recreational activities should not be made from counting the number of powered 
boats or boat trailers at any particular site. There appeared to be a high proportion of 
individuals and groups at Hickory Point who were engaging in non water-contact 
boating, and a high proportion of boat fishing activities was seen at Doctors Lake; 
these people did not meet entry criteria for this study. Another group of boaters were 
seen at Lake Seminole who were not available for recruitment: they had been skiing 
and boating at nearby ocean sites and entered the study site at Lake Seminole only 
to flush salt from their motors with fresh water. Data were collected at some sites on 
the number of vehicles and people who approached study sites and did not meet 
study entry criteria; these data will be presented at a later date. Pertinent to planning 
for future studies is the observation that boating activity may not necessarily correlate 
well with water-contact activity.  
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As mentioned earlier in this report, there was some suspicion that jet-skiers in 
general may be somewhat unreliable respondents with respect to this work, as 
suggested by poor response rates coincident with race club meetings on two 
occasions at Lake Somerset in Queensland. The (at present) subjective impression 
of this author is that jet-skiers were over-represented in the group who met study 
entry requirements but refused to participate. Again, some data were collected but 
are not yet analysed. As this project was not a study of the sociology and psychology 
of jet-skiers, any comments on this topic will remain largely speculative. However, 
some consideration of the issue may be helpful in order to shed light on the variability 
of response rates across all study sites, and may be worth discussing when similar 
studies are planned in future.  
 
Taken together, this picture is of jet-skiers and powerboat riders as a group who are 
encouraged and affirmed by individualistic behaviour, who are somewhat 
beleaguered by immediate and future restrictions and poor public perceptions from 
outside their group, and who may be suspicious or at least indifferent towards the 
rationale for this kind of research. Such group behaviour, insofar as it exists, 
mitigates support for research into public health and recreational water quality issues.  
 
 
RESULTS 
 
While we clearly would have liked to recruit a larger cohort, the intention of the 
detailed discussion of the encountered difficulties was to shape discussion and 
recommendations for future work of this kind. Some of the very valuable benefits of 
this work in Florida are summarised thus: 
 
3• 113 subjects with high cyanobacteria exposures (>10mm /L) added to the 
exposure group that was very difficult to find in Australia (n=50 from Australia) 
• A cohort of 216 individuals (includes control subjects) with no exposure to – 
and hence no opportunity to ignore – posted warning signs 
• Stimulating and highly rewarding collaboration on a personal level with 
committed and enthusiastic researchers 
• Enhanced opportunities for collaboration between public health and 
cyanobacteria centres of excellence in Florida and Australia 
 
Preliminary statistical analyses for the overall study cohort have been submitted for 
publication in the Proceedings of the Xth Harmful Algal Blooms Conference held at St 
Petersburg, Florida in October 2002. Presented below are 3x2 contingency table 
histograms and Fisher-Freeman-Halton exact tests for the Florida cohort. 
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No statistically significant differences in symptom reporting at the 5% level could be 
determined between those exposed to no cyanobacteria and those exposed to high 
cyanobacteria biovolumes. The exception is for eye symptoms, with a p-value of 
0.046, however, it is difficult to interpret this result, as there were higher rates of eye 
symptoms reported from the low exposure group (therefore no dose response 
relationship). There appeared to be a slightly higher relative frequency of eye 
symptoms in the Florida cohort than for the overall cohort, and only one report of 
febrile illness from Florida, although the overall reporting of febrile illness was low. 
 
There were three anecdotal reports that were interesting with respect to the concept 
– gleaned also from anecdotal reports in the literature – that recreational exposure to 
cyanobacteria is associated with various illnesses: 
 
1. Two child siblings, one of whom was a study subject, developed diffuse 
erythematous, pruritic skin rashes within minutes of entering the water at 
Doctors Lake, which was subject to a surface bloom of Microcystis 
aeruginosa and Anabaena circinalis. Both children had a previous history of 
asthma, and both had entered the water on one previous occasion, some 
months prior to this event. 
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2. One pregnant adult subject recruited at Little Lake Harris reported that the 
first three times she went in the water there over the previous 1-2 months 
she developed a pruritic, erythematous rash which appeared while she was 
still in the water and lasted for 5-7 days. She did not suffer the same 
complaint on the day she was recruited into this study. 
3. One subject recruited at Lake Seminole reported that he noticed his two 
children were getting sick after spending 4-5 hours tube-riding in the water 
there. Their illness was described as flu-like, with headache, malaise, rhinitis 
and arthralgia. This illness affecting both children, and associated by the 
parents with recreational activity at Lake Seminole, reportedly occurred on 
more than one occasion. 
 
 
SUMMARY AND CONCLUSIONS 
 
A prospective cohort study of recreational exposure to cyanobacteria has been 
running in Australia since November 1999. The study instruments are a self-
administered questionnaire and telephone follow-up interview; water samples were 
collected for total phytoplankton identification and enumeration, cyanotoxin analysis, 
faecal coliform counts and chlorophyll A. Ethical approval from the University of 
Miami’s Institutional Review Board and gatekeeper approvals from various county 
and state agencies with management responsibility for recreational water bodies was 
secured in April and May 2002. Recruitment of study and unexposed subjects was 
conducted in Florida from July 4th th 2002 to August 18  2002. A total of 665 
questionnaires were accepted by individuals who met the study’s entry criteria; from 
these a total of 216 subjects were enrolled in Florida.  
Preliminary analysis of illness reporting rates when the cohort was divided into three 
exposure categories – low, intermediate and high cyanobacterial biovolume – has not 
revealed any statistically significant increase in morbidity that can be related to 
increased exposure to cyanobacteria. Further statistical analysis to examine the 
impact of cyanobacterial exotoxins, salinity, faecal coliforms, history of allergic 
disease and other variables is pending, and we anticipate another peer-reviewed 
publication will follow from this work.  
 
 
LESSONS FOR FUTURE STUDIES OF THIS KIND 
 
Some recommendations for conducting similar prospective studies have been 
alluded to in the discussions above. In summary, improvements in recruitment and 
response rates should be achieved through: 
 
• Longer lead times for planning and securing approvals – the imprimatur of 
state, regional or national health agencies may be helpful in securing more 
cooperative responses from local government authorities 
• Identifying cyanobacteria-affected lakes in regions where demand for 
recreational access is high, and supply of recreational waters is somewhat 
restricted 
• Identifying mixed-use lakes and reservoirs, with significant numbers of visitors 
who are not dependent on powered watercraft for water recreation 
• Identifying lakes and reservoirs with beaches, adjacent parkland and BBQ or 
picnicking facilities 
• Ensuring that recreational users can be approached for possible inclusion into 
studies via public entry roads and/or public beaches and parkland. 
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In countries or regions where the issue of recreational access to cyanobacteria-
affected waterbodies is highly politicised and subject to regulatory actions such as 
short or long-term closure, the recruitment of epidemiology subjects through 
organised user groups, e.g. water ski clubs or sailboat associations, should be 
approached with caution due to the possibility of attempts to influence the outcome of 
such studies by groups with a clearly vested interest in maintaining access to 
recreational waters. 
 
As discussed earlier in this report, cyanobacteria blooms in some regions are not 
predictable as annual events, therefore some opportunistic approaches may be 
required in order to escape the fixed-time constraints of grant-based funding. State, 
regional or national health authorities may be better equipped to conduct these kinds 
of studies, however improved collaboration and reporting between algal toxin 
research centres – which this project hopefully will foster – should help with planning 
and running future studies.  
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APPENDIX 3 
FROM CHAPTER 3; EPIDEMIOLOGY STUDY 
QUEENSLAND DEPARTMENT OF NATURAL RESOURCES AND MINES: 
GUIDELINES FOR RECREATIONAL EXPOSURE TO CYANOBACTERIA 
Available from: 
http://www.nrm.qld.gov.au/water/blue_green/recreation.html
 
 
Appendix 3. Guidelines for recreational exposure to cyanobacteria. Published by the 
Queensland Department of Natural Resources and Mines (2004). 
 
Guidance level or situation Health risks Recommended action 
Cyanobacterial scum 
formation in contact 
recreation areas 
 
OR  
 
> 100,000 cells total 
cyanobacteria mL
Short term adverse health outcomes such as skin 
irritations or gastrointestinal illness following contact 
or accidental ingestion 
 
Severe acute poisoning is possible in worst ingestion 
cases 
Immediate action to prevent contact with scums 
 
Signs to indicate HIGH alert level - warning of 
danger for swimming and other water contact 
activities 
-1  
 
OR  
 
> 50 µg L-1 chlorophyll-a with 
dominance of cyanobacteria 
 
OR  
 
> 12.5 mm3 L-1 cyanobacterial 
biovolume 
20,000 - 100,000 cells 
 
total cyanobacteria mL-1 
 
OR  
 
10 - 50 µg L
Short term adverse health outcomes e.g. skin 
irritations, gastrointestinal illness, probably at low 
frequency 
Signs to indicate MODERATE alert level - 
increased health risk for swimming and other 
water contact activities 
-1 chlorophyll-a 
with dominance of 
cyanobacteria 
 
OR  
 
2.5 - 12.5 mm3 L-1 
cyanobacterial biovolume 
< 20,000 cells total 
cyanobacteria mL-1 
 
OR  
 
< 10 µg L-1 Cyanobacteria either absent or present at low 
levels - continue monitoring 
 chlorophyll-a with 
dominance of cyanobacteria 
 
Short term adverse health outcomes unlikely 
OR  
 
< 2.5 mm3 L-1 cyanobacterial 
biomass 
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APPENDIX 4 
 
FROM CHAPTER 4; SKIN PATCH TESTING 
 
VOLUNTEER INFORMATION SHEET AND CONSENT FORM (PATIENT 
GROUP) + QUESTIONNAIRE 
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Royal Brisbane Hospital and Health Service Districts 
 
 
INFORMATION SHEET 
INVESTIGATION OF CUTANEOUS REACTIONS FROM CYANOBACTERIA (BLUE-
GREEN ALGAE) 
 
We are investigating skin rashes that are related to contact with cyanobacteria (blue-green 
algae). Reports in medical and scientific journals in Australia and overseas describe itchy, red 
rashes which occur shortly after exposure to waters affected by cyanobacteria. The rashes 
are reported to have subsided after a few days without requiring treatment. People who have 
experienced these rashes have had contact with cyanobacteria mainly from engaging in 
recreational activities (swimming, skiing etc) in freshwater lakes and reservoirs. However, 
some reports describe itchy rashes after showering when the local water supply has been 
affected by cyanobacteria. It is also clear that many individuals do not suffer any skin 
symptoms, even after contact with very high levels of cyanobacteria in the water. We are 
trying to find out whether people who have dermatitis are more likely to react to cyanobacteria 
than people who do not have dermatitis, and if so, whether lower levels of cyanobacteria can 
cause such reactions. 
 
You are about to have some patches applied to your skin as part of the investigation of your 
condition at the Royal Brisbane Hospital’s dermatology clinic. If you agree, we would like to 
add some extra patches, which contain extracts of cyanobacteria. These patches will need to 
be treated in the same way as the standard patches applied to your back, i.e. they should stay 
in place until Wednesday, and they should not get wet while they are on your skin. The 
patches will be removed on Wednesday, and they will be inspected on Wednesday and Friday 
by a dermatologist.  
 
The most likely effect you will notice (if any) will be some mild itchiness, and redness of the 
skin that should subside after three days without any treatment. In the unlikely event that a 
prolonged reaction occurs, staff at the RBH dermatology clinic can provide advice and 
treatment if required. The contact phone number for the clinic is 3636-7461. 
 
If a positive result is seen from the cyanobacteria patches, (i.e. a mild reaction on your skin) 
the dermatologist will discuss with you how this relates to the diagnosis of your condition. 
Your participation in this study will help us to understand whether freshwater cyanobacteria, 
which are widespread in the environment, need to be taken into greater consideration by 
dermatologists when investigating people with skin conditions like yours. Your participation 
will also help public health authorities determine appropriate guidelines and advice for people 
engaging in water recreation activities.  
 
Your name and identifying details (address, phone number) will not be entered into a 
computer database for the purpose of this study, and all records will be treated with the 
confidentiality that applies to your medical records.  
 
Your participation in this study is voluntary, and you are free to withdraw at any time. Should 
you choose to withdraw from the study, your decision will not affect any present or future 
relationship you may have with either the Royal Brisbane Hospital or the University of 
Queensland.  
 
If you have any questions about the study, please contact either Mr Ian Stewart, 07 3274-
9147, or Dr Glen Shaw, 07 3274-9120. 
 
This study has been reviewed and approved by the Royal Brisbane Hospital and Health 
Service District Human Research Ethics Committee.  Should you wish to discuss the study 
with someone not directly involved, in particular in relation to matters concerning policies, 
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information about the conduct of the study or your rights as a participant, or should you wish 
to make an independent complaint, you can contact the secretary or chairperson, Human 
Research Ethics Committee, Royal Brisbane Hospital, Herston, QLD, 4029 or telephone (07) 
3636 5490. 
 
This study complies with the requirements of the National Health and Medical Research 
Council’s National Statement on Ethical Conduct in Research Involving Humans, and the 
Recommendations Guiding Physicians in Biomedical Research involving Human Subjects 
from the World Medical Association Declaration of Helsinki.   
 
         
 
 
I agree to participate in this study  
 
 
 
…………………………………………. 
                   (Please sign) 
 
Date:  …./…./2002 
 
 
 
 
 
 
 
 
 
WITNESS TO SIGNATURE 
The study volunteer’s signature was made in my presence. 
 
 
----------------------------------------                      --------------------------- 
           Name of witness                                         Signature 
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ID CODE  
  
CUTANEOUS REACTIONS FROM CYANOBACTERIA (BLUE-GREEN ALGAE) 
 
QUESTIONNAIRE 
 
 
Thank you for taking part in this study. We are asking you these questions so 
we can better understand how cyanobacteria affect people’s skin. The 
information that is on this form will be entered into a computer and used for 
the study. A code number will be used when we include the results of your 
skin tests; no names or other identifying information will be used.  
 
Indicate the best or closest answer by writing in the space or box, or by ticking 
the appropriate box.  
 
1. What was your age at your last birthday?………………                 years 
 
2. Are you                                                     (please tick) 
                    Male?                     Female? 
 
3. Has a doctor ever told you that you have any of the following conditions: 
 
• Eczema?…………….…. YES      NO         NOT SURE   
• Dermatitis?…………….. YES       NO  NOT SURE   
• Asthma?………………… YES        NO  NOT SURE   
• Hay fever?……………… YES       NO  NOT SURE   
• Urticaria (Hives)?……… YES        NO   NOT SURE   
 
 
4. At any time in the last two years, (since January 2000) have you had any of    
    the following illnesses: 
 
• Eczema?…………….…. YES      NO          NOT SURE 
• Dermatitis?…………….. YES       NO          NOT SURE 
• Skin rash of unknown cause?    YES      NO         NOT SURE 
• Asthma?………………… YES        NO          NOT SURE 
• Hay fever?……………… YES       NO            NOT SURE 
• Urticaria (Hives)?……… YES        NO          NOT SURE 
 
 
 
5. If you ticked “YES” to any of the questions above in Question 4, are you   
     presently taking any medicines for any of these conditions?….. YES      NO
  
 
If YES, which medicines?……………………………………………………. 
 
PLEASE TURN OVER PAGE 
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6. Have you ever had a skin rash after water recreation activities in a lake,  
    river or dam (i.e. if you have had a rash after swimming in ocean water, but  
    never after swimming in freshwater, answer “NO”)?  
                                                          YES        Please answer Q7                                                
                                                          NO            Please go to Q8 
          NOT SURE               Please go to Q8 
 
 
7. If you answered “YES” to the last question (Question 6), please describe  
    the rash: Was the rash 
 
• Itchy? …………………………….………      YES       NO      NOT SURE 
• Red?  ……………………………….             YES       NO      NOT SURE 
• Raised up from the surrounding skin? ….   YES      NO       NOT SURE 
• Where on your body was the rash?……………………………….. 
• How long did the rash last?…………………………………… 
• Did you treat the rash with any medicine or ointment? 
 If YES, which medicine or ointment?…………………………. 
 
 
8. How often do you go to a freshwater lake, river or dam for recreation (either  
    swimming, skiing, boating, sailboarding or fishing)? (Tick one box only) 
 
  Frequently – more than ten visits in the last year 
   
  Occasionally – between one and ten visits a year 
   
  Rarely – less than once a year 
 
  Very rarely – once or twice in the last ten years 
 
  Not since I was a child 
 
  I’ve never been to a lake, river or dam for water recreation  
 
 
No more questions…..Thank you for your assistance! 
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APPENDIX 5 
 
FROM CHAPTER 4; SKIN PATCH TESTING 
 
BIOMASS ESTIMATES FROM LYOPHILISED CYANOBACTERIA 
  
Appendix 5. Table 1. Cell counts for biomass estimation: C. raciborskii AWT 205 culture. 
    Number counted  mean  SD 
 
Cells per trichome  100 trichomes    4.21  2.42 
 
Trichomes per field  10 fields   26.3  7.66  
 
Cells per field       110.72 
 
 
X1000 (fields per mL)  = 110,723 
 
X dilution factor (1:20) 
= cells /mL    = 2.214 x106 
 
3Biovolume (from cells/mL)  = 96.45mm /L 
 
Surface Area (from cells/mL) = 155 mm2/mL 
 
Lyophilised yield from 1L culture = 342mg 
 
 
Appendix 5. Table 2. Weight of salts and untreated C. raciborskii AWT 205 culture. 
    Containers weighed (n)   mean weight SD 
  
500mL fresh culture   3   137.0mg 16.2 
 
500mL 0.45µm filtrate   3   85.5mg  21.1 
 
500mL Jaworski medium  3   75.6mg  12.2 
 
 
 
Therefore, 55% of the yield weight is due to salts.  
 
342mg/L = 0.034%w/v 
 
Concentrate x 4: = 0.137%w/v 
 
100x
55
137.0
BUT 55% of this weight is due to salts, ∴ = 0.25% 
 
i.e. in 0.25%w/v lyophilised, unwashed C. raciborskii cells, 45% of which is 
cellular material, cell count is 8.86 x 106 cells/mL, biovolume = 386 mm3/L; 
surface area = 622 mm2/mL. 
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APPENDIX 6 
 
FROM CHAPTER 4; SKIN PATCH TESTING 
 
 
 
 
RAW DATA: QUESTIONNAIRE REPLIES,  
 
48-HOUR AND 96-HOUR PATCH TEST READINGS 
 
 
 
 
 
 
  
 
Questionnaire replies 
 
410 
 
 
  
 
Patch test 48 hour readings 
 
411 
 
 
 
 
 
 
 
Patch test 96 hour readings 
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APPENDIX 7 
 
FROM CHAPTER 5, MOUSE EAR SWELLING TEST 
 
 
 
Appendix 7. C. raciborskii MEST: ear swelling (%) of test mice following    
rechallenge on day 17. 
Day  18 19 21 22 23 24 25 26 
Mouse 
B1  37 19 22 18 25 17 9.5 9.5 
B2  25 19 18 5.5 6.1 14 14 3.1 
B3  27 17 12 13 6.2 12 4.5 7.0 
B4  18 16 20 16 17 15 13 15 
B5  25 24 21 6.7 4.8 19 13 8.9 
B6  48 35 35 24 
B7  16 17 20 25 
B8  5.8 8.5 3.7 4.8 3.5 8.1 8.1 4.5 
B9  30 10 9.0 13 
B10  14 2.2 9.5 10 4.8 1.5 4.5 0 
Mice #s B6, B7 & B9 sacrificed and ears collected after ear thickness  
readings on Day 22 
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APPENDIX 8  
FROM CHAPTER 6; CYANOBACTERIAL LPS  
AND THERMOREGULATION STUDIES 
 
COLORIMETRIC ASSAY FOR FREE GLUCOSE 
 
 
Appendix 8. Table 1. Glucose assay – C. raciborskii LPS extract.  
All readings at 520nm. 
Cuvette sample           Absorbance     Mean absorbance    
1. Blank   0.0107 
 
2. Standard A   0.1298 
3. Standard B   0.1179   0.12385
   
4. Pre-cellulase A  0.0075 
5. Pre-cellulase B             -0.0009   0.0033 
 
6. Ist cellulase A  0.0260 
st7. 1  cellulase B  0.0208   0.0234 
 
8. Standard C   0.1137   
9. Standard D   0.1278   0.12075 
 
nd10. 2  cellulase A  0.0094 
nd11. 2  cellulase B  0.0072      0.0083 
 
 
 
Glucose (mg/dL) calculated by     Atest         x100 (= glucose standard mg/dL) 
                                                  Astandard 
 
 
Samples 4 & 5 – prior to cellulase: below detection, ∴zero free glucose 
 
dL/mg89.18=100x
12385.0
0234.0
Samples 6 & 7:     
 
Volume in flask = 37.5 mL, ∴weight glucose = 18.89 x 0.375 = 7.084mg 
glucose 
 
Initial weight of lyophilised LPS: 125mg 
 
%7.5=100x
125
084.7∴proportion of glucose / glucan =  
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Samples 10 & 11: further dilution – volume = 50mL, absorbances ? below 
detection from dilution effect or ? loss of glucose between 1st and 2nd cellulase 
digestions. 
 
Per above calculations, proportion of glucose after 2nd digestion = 2.75% 
 
 
 
Appendix 8. Table 2. Glucose assay – M. aeruginosa LPS extract.  
All readings at 520nm. 
Cuvette sample                        Absorbance     Mean absorbance    
1. Blank               -0.0094 
 
2. Standard A    0.1573 
3. Standard B    0.1653   0.1613 
   
4. Pre-cellulase A (undiluted)  0.0032 
5. Pre-cellulase B (1:10 dilution)  0.0031    
 
6. Ist cellulase A (undiluted)  0.0116 
st7. 1  cellulase B (1:10 dilution)  0.0027    
 
nd8. 2  cellulase A (undiluted)  0.0040 
nd9. 2  cellulase B (1:10 dilution)  0.0013       
 
 
 
Calculations done on undiluted samples. 
 
Per calcs above, sample 6 = 7.19mg/dL glucose. Volume = 75mL, ∴5.39mg 
glucose 
 
Weight of lyophilised LPS = 248mg, ∴ 2.2% glucose / glucan. 
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APPENDIX 9 
 
 
FROM CHAPTER 6; CYANOBACTERIAL LPS 
 
AND THERMOREGULATION STUDIES 
 
 
 
NUCLEAR MAGNETIC RESONANCE SPECTROGRAMS 
 
Page 417: M. aeruginosa LPS 
                                     Page 418: C. raciborskii LPS 
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